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Presentation 
 
This thesis is presented as compendium of scientific articles accepted in international 
journals with peer review, according to article 41 of the regulations for the PhD studies 
from the University of Santiago de Compostela (“Reglamento de los Estudios de 
Doctorado de la Universidad de Santiago de Compostela”). 
According to this regulation we only include those articles that are published or with 
final acceptance for publication, performed during the academic supervision of the PhD 
and not included as a part of others PhD thesis. 
 
Note: 
Throughout this thesis, when referring to cycloadditions we use the Huisgen notation, 
using parentheses, where the numbers refer to the atoms involved in the forming ring 
(for instance in (4+3), (4+2), (2+2) cycloadditions) to distinguish from the 
Woodward−Hoffmann notation, using brackets, where the numbers refer to the 
electrons involved in bonding changes.1 However due to referee’s requirements in some 
articles we use the brackets notation that is also acceptable. 
 
                                                     
1 Limanto, J.; Khuong, K. S.; Houk, K. N.; Snapper, M. L. J. Am. Chem. Soc. 2003, 125, 16310–16321. 
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Abbreviations and Acronyms 
 
In this manuscript, the abbreviations and acronyms most commonly used in organic and 
organometallic chemistry have been used following the recommendations found in the 
on-line “Guidelines for authors” of the Journal of Organic Chemistry.2 
Additionally, we have also used the following abbreviations and acronyms: 
ADC - acyclic diaminocarbene 
BINAP - (2,2'-bis(diphenylphosphino)-1,1'-binaphthyl) 
COD - cis,cis-1,5-Cyclooctadiene 
Dppb - 1,4-Butanediylbis[diphenylphosphine] 
DMDO – dimethyldioxirane 
dr - diastereomeric ratio 
ee - enantiomeric excess 
EWG - Electron withdrawing group 
IPrAu - [1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene]gold(I) 
JohnPhos - (2-Biphenyl)di-tert-butylphosphine 
L - Ligand 
MOM - methoxymethyl 
MS- molecular sieves 
NAC - nitrogen acyclic carbene 
nbd - norbornadiene 
NHC – Nitrogen‐heterocyclic carbene 
P(O-o-biPh)3- tri-o-biphenyl phosphite 
TBAF - Tetrabutylammonium fluoride 
TBDPS - tert-butyldiphenylsilyl 
TIPS - Triisopropylsilyl  
 
                                                     
2 http://pubs.acs.org/paragonplus/submission/joceah/joceah_authguide.pdf 
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Chemistry has been central to the human civilization since its very beginning. However, 
despite the fact that the light and heat produced by fire comes from chemical 
transformations, it was not until recently that Chemistry, alongside with Physics and 
Biology, emerged as branches of science. The sparkle that could have initiated this 
journey might have been the discussions about the scientific method, or the lack of one, 
which benefit all the areas of science.3 The growth of all scientific areas has allowed 
technological achievements critical to the wellbeinmg of modern society, and of course, 
these technological achievements, in a synergetic way, have also benefited all the areas 
of science. 
Despite the huge amount of methods and new reactions discovered by chemists, 
synthetic chemistry still faces many challenges. Indeed, there is a great need of new 
methodologies, that allow to transform readily available precursors into valuable 
products in a rapid and practical manner. 4 The development of new drugs depends 
largely on the availability of candidates for evaluating their medical and 
pharmacological properties.5 The need for significant amounts of these molecules 
(whether natural or designed by man) quickly and effectively is one of the forces that 
constantly drives the discovery and development of new efficient synthetic 
methodologies.4 Moreover, the high structural diversity and complexity of compounds 
with biologically relevant properties entails extraordinary challenges for synthetic 
chemists in order to discover and develop increasingly efficient, economical and 
versatile synthetic strategies.6  
Not only specific targets, such as natural products, are highly desirable. Often, subtle 
modifications on the core of these natural products, or entirely new designed molecules, 
can have superior properties or interesting new functions. 
It is therefore a major goal in organic chemistry to develop new methodologies that 
allow a rapid and versatile access to complex molecular targets in a reduced number of 
steps, from easy accessible starting materials. In this context, the development of 
catalytic processes is particularly appealing. Catalysts can be heterogeneous if it is not in 
the same phase as the substrate (for instance the catalyst in the solid state and the 
substrate in a solution), or homogeneous if both the catalyst and substrate are in the 
same phase. 
                                                     
3 Laidler, K. J. Acc. Chem. Res. 1995, 28, 187–192. 
4 Wender, P. A; Miller, B. L. Nature 2009, 460, 197–201. 
5 Li, J. W.-H.; Vederas, J. C. Science 2009, 325, 161–165. 
6 a) Wender, P. a.; Bi, F. C.; Gamber, G. G.; Gosselin, F.; Hubbard, R. D.; Scanio, M. J. C.; Sun, R.; Williams, T. J.; Zhang, L. 
Pure Appl. Chem. 2002, 74, 25–31. b) Newhouse, T.; Baran, P. S.; Hoffmann, R. W. Chem. Soc. Rev. 2009, 38, 3010–3021. c) 
Gaich, T.; Baran, P. S. J. Org. Chem. 2010, 75, 4657–4673. 
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Homogeneous catalysis can be further subdivided into biocatalysis, organocatalysis (use 
of non-metal catalysts such as phosphines or heterocyclic carbenes) and transition metal 
catalysis among others. 
In the past decades transition metal complexes have being successfully used not only as 
catalysts that are able to promote known reactions, but also as tools for the discovery of 
novel reactions that are impossible to achieve using conventional synthetic methods. 
Therefore, catalytic transition metal complexes provide excellent opportunities for the 
development of new effective synthetic transformations that can facilitate the access to 
complex molecular patterns.7 
The potential of transition metal catalysis is well patent in a classical example, the Reppe 
cyclization of acetylene to cyclooctatetraene. The first published synthesis of 
cyclooctatetraene (COT) required 13 steps, and the overall yield was very low.8 The 
discovery of a nickel-catalyzed reaction allowed COT to be prepared from acetylene in 
90% yield in only one step.9,10,4 
 
Scheme 1 - The first synthesis of cyclooctatetraene (COT) and its and Ni-catalyzed alternative. 
Several synthetic methodologies involving the use of transition metal catalysts have 
deserved the Nobel Prize recognition. This is the case of Pd-catalyzed cross-couplings, a 
highly practical methodology for C-C bond construction that was discovered in the early 
1970s and revolutionized modern chemistry, both in academia and in industry. This 
breakthrough was recognized in 2010 with the attribution of the Nobel Prize to Richard 
Heck, Ei-ichi Negishi, and Akira Suzuki.11 
The generally accepted mechanisms for these palladium-catalyzed cross-coupling 
reactions are depicted in Scheme 2. Common to these coupling reactions is the oxidative 
addition of the aryl halide (or pseudohalide) to the catalytically active LnPd0 species 
which initiates the catalytic cycle. At this stage, in the Heck-Mizoroki coupling, the 
reaction proceeds by coordination of an alkene to the PdII species, followed by its syn 
migratory insertion. The newly generated organopalladium species then undergoes syn 
β-hydride elimination to afford the alkene product. Subsequently, base-assisted 
elimination of H-X from [LnPd(H)(X)] occurs to regenerate the LnPd0 catalyst (n=2 
typically). Alternatively, in the Negishi and Suzuki–Miyaura reactions (and the related 
Corriu–Kumada, Stille, and Hiyama coupling processes), the oxidative addition is 
followed by transmetalation of an organometallic species to generate a PdII intermediate 
                                                     
7 Transition metals in the synthesis of complex organic molecules; Hegedus, L. S.; Söderberg, B. C. G., Eds.; 3rd ed.; University 
Science Books: Sausalito, California, 2010. 
8 Willstätter, R.; Waser, E. Berichte der Dtsch. Chem. Gesellschaft 1911, 44, 3423–3445. 
9 Reppe, W.; Schlichting, O.; Klager, K.; Toepel, T. Justus Liebigs Ann. Chem. 1948, 560, 1–92. 
10 Wang, C.; Xi, Z. Chem. Commun. 2007, 5119–5133. 
4 Wender, P. A; Miller, B. L. Nature 2009, 460, 197–201. 
11 Johansson Seechurn, C. C. C.; Kitching, M. O.; Colacot, T. J.; Snieckus, V. Angew. Chemie Int. Ed. 2012, 51, 5062–5085. 
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bearing the two coupling partners. Subsequent reductive elimination results in C-C bond 
formation with the regeneration of Pd0 species.11 
LnPd0
R-X
LnPdII
R
X
oxidative
addition
R1-M
M-X
LnPdII
R
R1
R-R1
R1
R
HLnXPdII
R1
syn- -hydride
elimination
H
X
PdIILn
RR1base
RR1H-X
syn-migratory
insertion
reductive
elimination
Negishi
Suzuki-Miyaura Heck-Mizoroki  
Scheme 2 - Palladium-catalyzed cross-coupling reactions. 
These reactions are nowadays one of the most powerful methods for the C-C bond 
formation and are used by some of the most important chemical companies in the drug 
discovery.11 For instance, Pfizer performed the Heck reaction on a 40 kg scale in a key 
step for the preparation of a Hepatitis C Polymerase Inhibitor (Scheme 3).12 
 
Scheme 3 – 40 kg scale Heck reaction. 
Another highly valuated process involving transition metal catalysis that deserved a 
Nobel award for Yves Chauvin, Robert H. Grubbs and Richard R. Schrock in 2005 is the 
metathesis reaction. Nowadays metathesis reactions of alkenes, alkynes and enynes have 
a wide application for the synthesis of natural products in the chemical industry and 
have opened new opportunities for the production of drugs, plastics and other materials. 
The most common catalysts for these reactions are based in Ruthenium, as they are air 
stable while being highly reactive and tolerant to numerous functional groups. Some of 
the most important ruthenium catalysts are shown in Figure 1.13 
                                                     
12 Camp, D.; Matthews, C. F.; Neville, S. T.; Rouns, M.; Scott, R. W.; Truong, Y. Org. Process Res. Dev. 2006, 10, 814–821. 
13 a) Trnka, T. M.; Grubbs, R. H. Acc. Chem. Res. 2001, 34, 18–29. b) Connon, S. J.; Blechert, S. Angew. Chemie Int. Ed. 2003, 
42, 1900–1923. c) Schrock, R. R.; Hoveyda, A. H. Angew. Chemie Int. Ed. 2003, 42, 4592–4633. d) Astruc, D. New J. Chem. 
2005, 29, 42–56. e) Nicolaou, K. C.; Bulger, P. G.; Sarlah, D. Angew. Chemie Int. Ed. 2005, 44, 4490–4527. 
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Figure 1 - Ruthenium catalysts frequently used in the Metathesis reaction. 
Alkene metathesis is the metathesis reaction type most commonly used. Within this 
there are several kinds: ring closing and opening metathesis or alkene cross-metathesis.  
The first step in the catalytic cycle is a (2+2) cycloaddition reaction between olefin 1 and 
a transition-metal carbene to give a metallacyclobutane. The latter undergoes subsequent 
collapse in a productive fashion to afford a new olefin product 3 and a new metal 
carbene (alkylidene), which reenters the catalytic cycle.13b 
 
Scheme 4 - Cross-metathesis of olefins. 
T. J. Donohoe illustrate the potential of this methodology in the synthesis of a precursor 
of (+)-cis-Sylvaticin, a potent antitumoral agent with demonstrated efficacy in lung and 
pancreas.14 
 
 
Scheme 5 - Application of the cross-metathesis reaction to the synthesis of cis-Sylvaticin. 
The use of transition metal catalysis was also central for the attribution of the Nobel 
Prize in 2001 to William S. Knowles and Ryoji Noyori "for their work on chirally 
catalysed hydrogenation reactions" and to K. Barry Sharpless "for his work on chirally 
catalysed oxidation reactions".15 
                                                     
14 Donohoe, T. J.; Harris, R. M.; Williams, O.; Hargaden, G. C.; Burrows, J.; Parker, J. J. Am. Chem. Soc. 2009, 131, 12854–
12861. 
15 a) http://www.nobelprize.org/nobel_prizes/chemistry/laureates/2001/advanced-chemistryprize2001.pdf. b) 
Knowles, W. S. Angew. Chemie Int. Ed. 2002, 41, 1999–2007. c) Noyori, R. Angew. Chemie Int. Ed. 2002, 41, 2008–2022. c) 
Sharpless, K. B. Angew. Chemie Int. Ed. 2002, 41, 2024–2032. 
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An early example of potential of asymmetric catalysis was reported by W. S. Knowles, at 
Monsanto, in particular, a highly enantioselective hydrogenation of enamides with a 
rhodium complex containing a chelating diphosphine with two chiral phosphorus atoms 
(DiPAMP, Scheme 6). The process was used in the syntheses of L-DOPA from enamide 
4, affording the protected amino acid 5 in quantitative yield and 95% ee (Scheme 6).16 
 
Scheme 6 – Synthesis of L-DOPA using Rh catalyzed asymmetric hydrogenation. 
 
                                                     
16 Vineyard, B. D.; Knowles, W. S.; Sabacky, M. J.; Bachman, G. L.; Weinkauff, D. J. J. Am. Chem. Soc. 1977, 99, 5946–5952. b) 
Knowles, W. S. Acc. Chem. Res. 1983, 16, 106–112. 
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Regardless the great development of transition metal catalysis over the 20th century, the 
catalytic properties of gold complexes received only modest attention, probably due to 
the notion that gold is an inert metal. 
In 1986 T. Hayashi reported a gold-catalyzed asymmetric aldol condensation.17 A few 
years later, J. H. Teles reported that a phosphine-based cationic gold(I) was able to 
activate alkynes promoting the nucleophilic addition of alcohols to these C-C 
unsaturated species (Scheme 7). The gold complexes, prepared mostly from a 
combination of LAu(I)Me and methanesulfonic acid or from [LAu(NO3)] and BF3·OEt2 
would set the basis for the development of a great number of new gold (I) catalytic 
systems that were reported afterwards. Significantly a footnote in this paper also reports 
the pioneer use of a gold-NHC-carbene complex as catalyst.18,19 
 
Scheme 7 – Gold catalyzed addition of alcohols to alkynes. 
Since this report, a tremendous growth in the field of homogeneous gold catalysis was 
observed, as researchers realized that the low propensity of carbophilic gold(I) 
complexes to participate in standard redox catalytic cycles, based on oxidative additions 
and reductive eliminations, was indeed an advantage to develop orthogonal reaction 
strategies. Indeed, the unique affinity of gold for -unsaturated systems, such as alkynes, 
alkenes or allenes, allowed the development of novel modes of reaction that do not 
involve redox processes. Part of these characteristics are attributed to the so called 
“relativistic effects”, caused by the electrons in s orbitals moving at speeds approaching 
that of the speed of light. This leads to a contraction of the s orbital and, therefore, 
relatively low-lying LUMO, which is responsible for the good -acidity needed for the 
binding and electrophilic activation of C-C multiple bonds. Accordingly, the electrons 
occupying the external d and f orbitals are better shielded by those at the contracted s 
and p orbitals, causing the expansion of orbitals d and f.20 Consequently the high-lying 
highest occupied molecular orbital (HOMO), limits the participation of gold(I) 
complexes in oxidative additions and related redox process that are very often observed 
with transition metals such as Rh, Pd or Ni. 
                                                     
17 Ito, Y.; Sawamura, M.; Hayashi, T. J. Am. Chem. Soc. 1986, 108, 6405–6406. 
18 Hashmi, A. S. K. Gold Bull. 2004, 37, 51–65. 
19 Teles, J. H.; Brode, S.; Chabanas, M. Angew. Chemie Int. Ed. 1998, 37, 1415–1418. 
18 Hashmi, A. S. K. Gold Bull. 2004, 37, 51–65. 
19 Teles, J. H.; Brode, S.; Chabanas, M. Angew. Chemie Int. Ed. 1998, 37, 1415–1418. 
20 a) Gorin, D. J.; Toste, F. D. Nature 2007, 446, 395–403. b) Fürstner, A.; Davies, P. W. Angew. Chemie Int. Ed. 2007, 46, 3410–
3449. 
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Figure 2 - Contraction of the 6s and expansion of 5d orbitals. 
Au(I) has a pronounced preference to produce two-coordinate linear complexes and to 
induce reactivity it is necessary to abstract one ligand from neutral gold species of the 
type L-Au-X, something which is usually achieved using a silver salt. Furthermore, it is 
inherently difficult to chelate bidentate (phosphane) ligands to a single gold atom. 
Another important consequence of the linear coordination mode of Au(I) complexes is 
that only one site is available for coordination, since the other is permanently occupied 
by a ligand. Therefore Au(I) directly binds and activate a single substrate and disfavors 
processes like cyclometalations.20  
Cl Au PPh3
= 179.6 º
rAu-P = 2.235 Å
rAu-Cl = 2.279 Å
 
Figure 3 – Schematic and crtistal structure representation of Ph3PAuCl.21 
As we have seen above, cationic gold cationic gold complexes can be generated in situ 
from the methyl(triphenylphosphane)gold(I) activated with a strong acid (Scheme 7). 
Nowadays the generation of such a cationic complex is more comun using a gold (I) 
chloride complex of type LAuCl, which is activated by a chloride ‘‘abstractor’’ such as a 
silver(I) salt to generate the mono-ligated cationic catalyst.22 
LAuCl
AgX AgCl + [LAu]+X-
X = TfO-, ClO4-, BF4-, PF6-, SbF6-, NTf2-
active species
 
Scheme 8 - General Formation of Active Gold(I) Species. 
The active cationic complexes can also be prepared from chloride abstraction previous to 
its use and stored if a weakly coordinating counteranion is used, such as NTf2-,22 or a 
nitrile stabilizator is present.23  
                                                     
21 Baenziger, N. C.; Bennett, W. E.; Soborofe, D. M. Acta Crystallogr. Sect. B Struct. Crystallogr. Cryst. Chem. 1976, 32, 962–
963. 
22 Mézailles, N.; Ricard, L.; Gagosz, F. Org. Lett. 2005, 7, 4133–4136. 
23 a) de Frémont, P.; Stevens, E. D.; Fructos, M. R.; Mar Díaz-Requejo, M.; Pérez, P. J.; Nolan, S. P. Chem. Commun. 2006, 
2045–2047. b) Amijs, C. H. M.; López-Carrillo, V.; Raducan, M.; Pérez-Galán, P.; Ferrer, C.; Echavarren, A. M. J. Org. 
Chem. 2008, 73, 7721–7730. 
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Scheme 9 – Formation of Au(I) nitrile stabilized complexes. 
The abovementioned relativistic facilitate C-C multiple bonds of alkynes, allenes, or 
olefins coordinate to gold complexes making possible possible a subsequent attack of a 
nucleophile.24 This electrophilic activation of alkynes was already demonstrated in 1976, 
when C. B. Thomas reported the hydration of several alkynes in aqueous methanol in the 
presence of tetrachloroauric acid (Scheme 10),25 and, moreover it became even more 
evident with the aforementioned nucleophilic addition of alcohols to alkynes reported 
by J. H. Teles with cationic gold complexes.19 
 
Scheme 10 – Gold catalyzed hydration of alkynes. 
A large number of Au-catalyzed reactions of alkynes have since been developed.18,20 
Among then, the cycloisomerizations of enynes flourish as one of the most studied 
reactions. The richness of gold chemistry is well manifested in these reactions in which, 
depending on the conditions, additives and substituents or ligands at gold, a number of 
different products can be divergently obtained. The Au(I) complex usually activates the 
alkyne promoting a nucleophilic addition of the alkene. This addition in general occurs 
by the endo mode (5-exo-dig, IIa) for terminal alkynes, whereas, enynes incorporating 
substituted alkynes or heteroatoms at the connecting tether usually undergo a 6-endo-dig, 
pathway (Ia, Scheme 11). Although this is a general tendency, the real picture is much 
more complex and in many cases is difficult to predict the outcome of the reactions.26 
 
Scheme 11 – Activation of enynes by a gold catalyst. 
These initial intermediates can evolve in different ways, and subtle changes, such as the 
substitution of the connecting tether can be enough to the selective obtaining different 
products. For instance substrate 6 in the presence of Ph3PAuCl/AgSbF6 rearranges to 
give the cyclopropyl gold(I) carbene II. If 6 contain NTs as connecting ether, IIb 
rearranges with ring opening to give cation IV that after metal loss gives 7. Using the 
same conditions, but with a malonate group at the tether, the cyclopropyl gold(I) 
                                                     
24 Hashmi, a S. K. Chem. Rev. 2007, 107, 3180–3211. 
25 Norman, R. O. C.; Parr, W. J. E.; Thomas, C. B. J. Chem. Soc. Perkin Trans. 1 1976, 1983-1987. 
26 a) Jiménez-Núñez, E.; Echavarren, A. M. Chem. Comm. 2007, 333–346. b) Jiménez-Núñez, E.; Echavarren, A. M. Chem. 
Rev. 2008, 108, 3326–3350. 
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carbene IIc rearranges to V, which then undergoes a metal elimination to give 8 (Scheme 
12). 27 
 
Scheme 12 - Gold(I)-catalyzed cyclizations of 1,6-enynes. 
The variety of products obtained from gold catalyzed enyne cycloisomerizations can be 
further extended, simply by the addition of a nucleophile, like an alcohol, an amine or 
even an aromatic compound. This nucleophile can intercept the intermediate IId to give 
products like 9 or 10 (Scheme 13).26,28,27b,29 
 
Scheme 13 - Alkoxycyclization of enynes with gold catalysis. 
Echavarren and coworkers also demonstrated that carbene intermediates of type IIe can 
also be trapped intramolecularly by a ketone or an aldehyde to give intermediates like 
VI, which undergo a Prins-like terminal cyclization with the vinyl gold to afford oxygen-
bridge bicyclic systems 11 (Scheme 14).30 
                                                     
27 a) Nieto-Oberhuber, C.; Muñoz, M. P.; Buñuel, E.; Nevado, C.; Cárdenas, D. J.; Echavarren, A. M. Angew. Chemie Int. Ed. 
2004, 43, 2402–2406. b) Nieto-Oberhuber, C.; Muñoz, M. P.; López, S.; Jiménez-Núñez, E.; Nevado, C.; Herrero-Gómez, 
E.; Raducan, M.; Echavarren, A. M. Chem. Eur. J. 2006, 12, 1677–1693. c) Cabello, N.; Jiménez-Núñez, E.; Buñuel, E.; 
Cárdenas, D. J.; Echavarren, A. M. Eur. J. Org. Chem. 2007, 2007, 4217–4223. 
26 a) Jiménez-Núñez, E.; Echavarren, A. M. Chem. Comm. 2007, 333–346. b) Jiménez-Núñez, E.; Echavarren, A. M. Chem. 
Rev. 2008, 108, 3326–3350. 
28 Muñoz, M. P.; Adrio, J.; Carretero, J. C.; Echavarren, A. M. Organometallics 2005, 24, 1293–1300. 
27b Nieto-Oberhuber, C.; Muñoz, M. P.; López, S.; Jiménez-Núñez, E.; Nevado, C.; Herrero-Gómez, E.; Raducan, M.; 
Echavarren, A. M. Chem. Eur. J. 2006, 12, 1677–1693 
29 Toullec, P. Y., Genin, E., Leseurre, L., Genêt, J.-P., and Michelet, V. Angew. Chem., Int. Ed. 2006, 45, 7427-7430. 
30 Jiménez-Núñez, E.; Claverie, C. K.; Nieto-Oberhuber, C.; Echavarren, A. M. Angew. Chemie 2006, 45, 5578–5581. 
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Scheme 14 - Prins cyclizations in Au-catalyzed reactions of enynes. 
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2.2.1 Synthetic relevance of cycloaddition reactions 
Modern synthetic chemistry requires efficiency, versatility, economy and ecology. 
Therefore there is a great interest on the development of processes that generate 
molecular and stereochemical complexity, in a selective manner, from easily accessible 
materials.6 In this context a particularly interesting type of reactions are cycloadditions, 
as they allow the construction of cycles, usually in selective manner, by the simple 
addition of two or more acyclic fragments.31 
In a simplify way, cycloadditions can be classified as forbidden or allowed by the 
Woodward-Hoffmann rules,32 or the frontier molecular orbital theory of Fukui.33 Those 
permitted can a priori occur spontaneously or by heating, while those forbidden need 
photochemical conditions, radical initiators or other promoting agents. The most 
important type of cycloaddition is the Diels-Alder reaction, as it provides a direct access 
to six-membered rings, and has the capacity to generate up to four contiguous 
stereogenic centers in a single step.34 
 
Scheme 15 – Diels-Alder reaction.  
There are other types of [4+2] annulations, isoelectronic with the Diels-Alder such as 
the dipolar (3+2) cycloadditions between 1,3-dipoles and dipolarophiles,35 or the (4+3) 
cycloaddition between allyl cations and dienes.36 
 
Scheme 16 – Thermally allowed [4+2] cycloadditions. 
                                                     
6 a) Wender, P. a.; Bi, F. C.; Gamber, G. G.; Gosselin, F.; Hubbard, R. D.; Scanio, M. J. C.; Sun, R.; Williams, T. J.; Zhang, L. 
Pure Appl. Chem. 2002, 74, 25–31. b) Newhouse, T.; Baran, P. S.; Hoffmann, R. W. Chem. Soc. Rev. 2009, 38, 3010–3021. c) 
Gaich, T.; Baran, P. S. J. Org. Chem. 2010, 75, 4657–4673. 
31 Kobayashi, S.; Jørgensen, K. A. Cycloaddition Reactions in Organic Synthesis;Wiley-VCH, 2001. 
32 Woodward, R. B.; Hoffmann, R. Angew. Chemie Int. Ed. 1969, 8, 781–853. 
33 Inagaki, S.; Fujimoto, H.; Fukui, K. J. Am. Chem. Soc. 1976, 98, 4693–4701. 
34 a) Vollhardt, K. P. C.; Schore, N. E. Organic Chemistry; 3rd ed.; W.H.Freeman & Co Ltd, 1998. b) Fringuelli, F.; Taticchi, 
A. The Diels-Alder Reaction: Selected Practical Methods; Wiley: Chichester, U.K., 2002. c) Miller, J. P. Advances in Chemistry 
Research. Volume 18 - Recent Advances in Asymmetric Diels-Alder Reactions; Taylor, J. C., Ed.; Nova Science Publishers, Inc., 
2013; 18, 179–220. d) Nicolaou, K. C.; Snyder, S. A.; Montagnon, T.; Vassilikogiannakis, G. Angew. Chem. Int. Ed. 2002, 41, 
1668–1698. e) Takao, K.-I.; Munakata, R.; Tadano, K. Chem. Rev. 2005, 105, 4779–4807. 
35 a) Padwa, A. 1,3-Dipolar Cycloaddition Chemistry; Wiley Interscience, 1984. b) Trost, B. M. Angew. Chemie Int. Ed. 1986, 25, 
1–20. c) Coldham, I.; Hufton, R. Chem. Rev. 2005, 105, 2765–810.  
36 a) Harmata, M. Acc. Chem. Res. 2001, 34, 595–605. b) Harmata, M. Chem. Commun. 2010, 46, 8886–8903. 
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Despite the versatility of these types of cycloaddition is important to note that in most 
cases the presence of functional groups that activate the components are required. 
Additionally, and depending on the case, the cycloaddition process may be induced by 
activating one or more components by a Lewis acid catalyst.37 
More recently, organocatalysis,38,39,40 and, in particular, transition metal catalysis, have 
been shown as highly valuable for the development of new cycloaddition reactions. The 
coordination of transition metals, even to poorly activated substrates, like olefins, dienes, 
or alkynes, significantly modifies their reactivity. Thus, this metal activation allows, for 
instance, to perform room temperature cycloadditions of non-activated substrates, 
processes that otherwise would require extreme temperatures. In addition, transition 
metal complexes have also brought new opportunities for the discovery of new catalytic 
cycloadditions,41 even in enantioselective manner, by using chiral metal complexes. 
Most of the transition metal-catalyzed cycloadditions involved the use of rhodium, 
ruthenium, cobalt, nickel or palladium catalysts. These metals are prone to experience 
redox process, often involving the metallacyclic intermediates and provide the final 
adduct by reductive elimination. For instance, in the following scheme is shown one of 
the first examples of a transition metal catalyzed cycloaddition, namely an 
intramolecular (4+2) cycloaddition reported by P. Wender. Although these reactions 
between non-activated alkynes and dienes may occur at 150 ° C without the catalyst, the 
nickel complex allowed the reaction to be performed at room temperature with excellent 
yields and stereoselectivities. The authors proposed a metalacyclic species like VII as the 
key intermediate (Scheme 17).42 
 
Scheme 17 – Ni catalyzed (4+2) Cycloaddition. 
The potential of transition metal catalysis was further illustrated by P. Wender in a 
remarkable (4+2+2) intermolecular cycloaddition of three different components 
(norbornene, 2,3-dimethyl-1,3-butadiene, and methyl propargyl ether) (Scheme 18).43 
                                                     
37 a) Yates, P.; Eaton, P. J. Am. Chem. Soc. 1960, 82, 4436–4437. For reviews on Lewis Acid Catalyzed Diels Alder reactions 
see: b) Kagan, H. B.; Riant, O. Chem. Rev. 1992, 92, 1007–1019. c) Lewis Acids in Organic Synthesis; Yamamoto, H., Ed.; 
Wiley-VCH Verlag GmbH: Weinheim, Germany, 2000. 
38 a) Lelais, G.; MacMillan, D. W. C. Aldrichimica Acta 2006, 39, 79–87. b) MacMillan, D. W. C. Nature 2008, 455, 304–308. c) 
Pellissier, H. Tetrahedron 2012, 68, 2197–2232. d) Moyano, A.; Rios, R. Chem. Rev. 2011, 111, 4703–832. 
39 Ahrendt, K. A.; Borths, C. J.; MacMillan, D. W. C. J. Am. Chem. Soc. 2000, 122, 4243–4244. 
40 a) Jen, W. S.; Wiener, J. J. M.; MacMillan, D. W. C. J. Am. Chem. Soc. 2000, 122, 9874–9875. b) Chow, S. S.; Nevalainen, M.; 
Evans, C. a.; Johannes, C. W. Tetrahedron Lett. 2007, 48, 277–280. 
41 Lautens, M.; Klute, W.; Tam, W. Chem. Rev. 1996, 96, 49–92. 
42 Wender, P. A.; Jenkins, T. E. J. Am. Chem. Soc. 1989, 111, 6432–6434. 
43 Wender, P. A.; Christy, J. P. J. Am. Chem. Soc. 2006, 128, 5354–5355. 
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Scheme 18 - Rhodium(I)-Catalyzed (4+2+2) cycloaddition. 
The tremendous growth in gold catalysis has also brought opportunities for the 
development of novel types of cycloaddition reactions, usually involving non-activated 
unsaturated systems like alkynes, allenes, alkenes or 1,3- dienes.44 Contrary to those 
more classical transition metal cycloadditions promoted by Rh , Ru or Ni, Au catalyzed 
processes do not involve changes in the oxidation level of the metal, as we will see in the 
following sections. 
 
 
                                                     
44 López, F.; Mascareñas, J. L. Beilstein J. Org. Chem. 2011, 7, 1075–1094. 
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2.2.2 - Gold (I) catalyzed intramolecular cycloadditions 
2.2.2.1 Cycloadditions with alkynes  
One of the very first examples of gold-catalyzed cycloadditions was reported by Hashmi 
in 2000, and consists of a (4+2)-cycloaddition reaction of furyl-tethered alkynes to give 
phenols. Based on extensive mechanistic studies, the authors proposed that the reaction 
proceeds by an initial cyclization that provides the cyclopropyl carbene intermediate 
VIII. Cleavage of the a cyclopropane bond and opening of the dihydrofuran yields IX, 
that cyclizes to give the oxepin 12 which is in equilibrium with the arene oxide 13. A 
subsequent aromatization would deliver the phenolic product 14 (Scheme 19).45,46 
 
Scheme 19 - Gold-catalyzed synthesis of phenols. 
As we saw before, enynes are susceptible of undergoing a variety of processes under the 
influence of a gold catalyst, including cycloadditions. In particular, A. M. Echavarren 
reported that enynes such as 15 can participate in (2+2) cycloaddition reactions.47,48 A 
possible mechanism involves the formation of a cyclopropyl gold carbene IIf, which 
undergo ring expansion to form the benzylic carbocation X. This intermediate then 
presumably undergoes an elimination, followed by the protonolysis of the C-Au bond to 
yield cyclobutene 16 (Scheme 20). 
                                                     
45 a) Hashmi, a. S. K. Angew. Chemie Int. Ed. 2010, 49, 5232–5241. A similar mechanism was proposed for the Pt catalyzed 
process, see: b) Martín-Matute, B.; Cárdenas, D. J.; Echavarren, A. M. Angew. Chemie Int. Ed. 2001, 40, 4754–4757. c) 
Martín-Matute, B.; Nevado, C.; Cárdenas, D. J.; Echavarren, A. M. J. Am. Chem. Soc. 2003, 125, 5757–5766. 
46 a)Hashmi, A. S. K.; Frost, T. M.; Bats, J. W. J. Am. Chem. Soc. 2000, 122, 11553–11554. b) Hashmi, a. S. K.; Rudolph, M.;   
Weyrauch, J. P.; Wölfle, M.; Frey, W.; Bats, J. W. Angew. Chemie Int. Ed. 2005, 44, 2798–2801. 
47 Nieto-Oberhuber, C.; López, S.; Muñoz, M. P.; Cárdenas, D. J.; Buñuel, E.; Nevado, C.; Echavarren, A. M. Angew. Chemie 
Int. Ed. 2005, 44, 6146–6148. 
48 Nieto-Oberhuber, C.; Pérez-Galan, P.; Herrero-Gómez, E.; Lauterbach, T.; Rodríguez, C.; López, S.; Bour, C.; Rosellón, 
A.; Cardenas, D. J.; Echavarren, A. M. J. Am. Chem. Soc. 2008, 130, 269–279. For related reactions using Pt and Pd catalysts 
see: a) Trost, B. M.; Tanoury, G. J. J. Am. Chem. Soc. 1988, 110, 1636-1638. b) Trost, B. M.; Trost, M. K. Tetrahedron Lett. 
1991, 32, 3647-3650. c) Fürstner, A.; Davies, P. W.; Gress, T. J. Am. Chem. Soc. 2005, 127, 8244–8245. 
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Scheme 20 –Gold(I)-catalyzed intramolecular (2+2) cycloadditions of enynes. 
A. M. Echavarren also reported that in the same reaction conditions, similar 1,6-Enynes 
such as 17 undergo a formal (4+2) cycloaddition (Scheme 21). DFT calculations and 
deuterium labeling at the aromatic ring support a stepwise mechanism for the 
cycloaddition initiated by the formation of a cyclopropyl gold(I)-carbene IIg, that 
evolves to the carbocation XI. Rearomatization and a final proto-demetalation afford the 
cycloadduct 18 (Scheme 21).48,49 
 
Scheme 21 – (4+2) cycloadditions of 1,6-Enynes. 
The group of Rai-Shung Liu developed an intramolecular (3+2) cycloaddition of phenyl 
diynes like 19, catalyzed by PPh3AuSbF6 (2 mol %).50 The proposed mechanism is 
initiated by nucleophilic attack of one of the aromatic substituents of intermediate XII on 
the gold activated alkyne, to produce vinylgold(I) intermediate XIII. Then protonation of 
the alkyne generates the vinylcationic intermediate XIV that evolves to diphenyl 
carbocation XIV and finally to the cycloadduct 20 (Scheme 22).  
                                                     
49 Nieto-Oberhuber, C.; López, S.; Echavarren, A. M. J. Am. Chem. Soc. 2005, 127, 6178–6179. 
50 Lian, J.-J.; Chen, P.-C.; Lin, Y.-P.; Ting, H.-C.; Liu, R.-S. J. Am. Chem. Soc. 2006, 128, 11372–11373. 
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Scheme 22 - Intramolecular (3+2) cycloaddition of unactivated arenynes. 
A. Fürstner reported a different type of intramolecular (4+2) cycloaddition between 
alkynes and non-activated dienes. Once again a cyclopropyl carbene intermediate was 
invoked to explain the mechanism. This intermediate rearranges to give XVI, that finally 
leads to the observed cycloadduct 21 (Scheme 23).51  
 
Scheme 23 – Gold catalyzed (4+2) Cycloaddition of Alkyne-1,3-Dienes. 
Iwasawa also reported a related (4+2) intramolecular cycloaddition between terminal 
alkynes and 3-siloxy-1,3-dienes, however, the mechanistic proposal in this case is 
somewhat different. The authors propose an initial 5-exo nucleophilic attack of the silyl 
enol ether to the gold activated -alkyne to give a zwitterionic intermediate. This alkenyl 
gold species adds to the ,β-unsaturated silyl oxonium moiety generating a bicyclic 
carbene complex. A final 1,2-alkyl migration affords the formal (4+2) cycloadducts 22 
which are isolated in good yields (Scheme 24). 52 
                                                     
51 a) Fürstner, A.; Stimson, C. C. Angew. Chemie Int. Ed. 2007, 46, 8845–8849. See also: b) Kim, S. M.; Park, J. H.; Chung, Y. 
K. Chem. Commun. 2011, 47, 6719–6721. 
52 Kusama, H.; Karibe, Y.; Onizawa, Y.; Iwasawa, N. Angew. Chemie Int. Ed. 2010, 49, 4269–4272. 
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Scheme 24 - Gold-Catalyzed (4+2) intramolecular cycloaddition of alkynes and 3-siloxy-1,3-dienes. 
An interesting platinum- or gold-catalyzed (6+2) cycloaddition of alkynes tethered to 
cycloheptatriene allows the formation of tricyclic bridged systems like 35 (Scheme 25).53 
The proposed mechanism entails a stepwise exo cyclization to yield a pentadienyl cation 
which evolves to the bridged tricyclic product 24. Although PtCl2 is the most efficient 
catalyst for these intramolecular cycloadditions, the reaction of 23 can also be performed 
in good yield with AuCl3 (5%) at room temperature. 
 
Scheme 25 - Metal-catalyzed (6+2) cycloaddition of alkynes tethered to cycloheptatriene. 
In 2008, S. Shin described a novel gold-catalyzed intramolecular cascade process of 
substrates containing an alkyne, a nitrone and an alkene (37), to produce interesting 
tetracyclic structures such as 25.54 The coordination of AuCl3 to the alkyne triggers a 6-
exo-dig attack of the nitrone to generate XVII. Then, a retro-electro-cyclization leads to 
an -carbonyl Au-carbenoid, which cyclizes to form an ylide intermediate. A (3+2) 
dipolar cycloaddition reaction with the alkene delivers the tetracyclic 25 (Scheme 26). 
                                                     
53 Tenaglia, A.; Gaillard, S. Angew. Chemie Int. Ed. 2008, 47, 2454–2457. 
54 Yeom, H.-S.; Lee, J.-E.; Shin, S. Angew. Chemie Int. Ed. 2008, 47, 7040–7043. 
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Scheme 26 - Gold-catalyzed generation and reaction of azomethine ylides. 
A particular case of gold activation of alkynes occurs when these are part of a 
propargylic ester like in 26. This systems can undergo a 6-endo-dig cyclization to 
produce allene A (1,3-migration) or a 5-exo-dig cyclization to form intermediate XVIII, 
which upon ring opening forms carbene B, representing in global a formal 1,2-acyloxy 
migration (Scheme 27). 
Usually, if the propargylic systems has an electronically unbiased internal alkyne (R3 ≠ 
H), the 1,3-acyloxy migration takes place. Alternatively, with terminal alkynes (R3 =H), 
the 1,2-acyloxy migration is preferred. However, other factors, such as the choice of 
catalyst, the substitution pattern at the propargyl moiety, and temperature, can influence 
the regiochemical outcome of these reactions.55, 56 
 
Scheme 27 - Competitive 1,2- or 1,3-migration of propargylic esters.  
The reactivity of the allenic intermediates generated from the 1,3-acyloxy migration was 
exploited by L. Zhang in the development of formal (3+2) and/or (2+2) annulations of 
propargylic indole-3-acetates (27). Thus, in the presence of Ph3PAuCl/AgSbF6, the (2+2) 
cycloaddition is favored furnishing 2,3-indoline-fused cyclobutanes 28 (upper arrow) 
(Scheme 28).57 However, when PtCl2 (under an atmosphere of CO) is used, the major 
products are 2,3-indoline-fused cyclopentenes 29, which arise from a formal (3+2) 
cycloaddition (lower arrow) (Scheme 28).58 
                                                     
55 Kazem Shiroodi, R.; Gevorgyan, V. Chem. Soc. Rev. 2013, 42, 4991–5001. 
56 Modern Gold Catalyzed Synthesis; Hashmi, A. S. K.; Toste, F. D., Eds.; Wiley, 2012. 
57 Zhang, L. J. Am. Chem. Soc. 2005, 127, 16804–16805. 
58 Zhang, G.; Catalano, V. J.; Zhang, L. J. Am. Chem. Soc. 2007, 129, 11358–11359. 
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Scheme 28 – Pt catalyzed (3+2) and Au catalyzed (2+2) cycloadditions of indole-3-acetates. 
In 2006 Gagosz and co-workers reported a stepwise formal gold-catalyzed (3+2) 
intramolecular cycloaddition of 5-yn-1-yl acetates (30) to give bicyclo[3.1.0]hexane 
products like 31. The proposed mechanism starts with a gold initiated 1,3-acyloxy 
migration to afford the allene intermediate. The authors proposed that the gold(I) 
catalyst is able to activate these allenic intermediates in situ triggering a nucleophilic 
attack of the alkene that yields intermediate XIX. A subsequent intramolecular attack of 
the vinyl gold moiety to the carbocation affords a cyclopropyl gold carbene, which 
evolves to the final bicyclic product 31 by means of a 1,2-hydride shift (Scheme 29).59 
 
 
Scheme 29 - Gold(I)-catalyzed isomerization of 5-en-2-yn-1-yl acetate 38. 
2.2.1.2 - Cycloadditions with allenes 
Allenes are highly valuable synthetic precursors in preparative organic chemistry, and 
can participate as two or three carbon components in gold-catalyzed cycloadditions. 
Because of their soft and carbophilic character, gold catalysts are particularly well suited 
                                                     
59 Buzas, A.; Gagosz, F. J. Am. Chem. Soc. 2006, 128, 12614–12615. 
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for the selective activation of allenes in the presence of other reactive functionalities.60 
Different structures have been proposed to represent these gold-activated allene 
complexes, including 2-complexes (A, B and C), planar -allylic cations (D), 
zwitterionic carbenes (E) or 1- bent allenes (F) (Scheme 30).61 In some particular cases, 
experimental and theoretical evidences support the participation of one of those 
structures but, in many other cases, the precise nature of these species remains 
unknown.62 
 
Scheme 30 - Various types of gold-activated allene complexes.  
In 2007, L. Zhang and co-workers reported a formal intramolecular (3+2) cycloaddition 
between allenyl MOM ethers and alkenes, reaction in which the allenes behaves as a 
three carbon partner. The proposed mechanism involves the selective gold activation of 
the allenyl ether to yield an oxocarbenium. An intramolecular (3+2) cycloaddition with 
the internal olefin delivered the bicyclo[3.1.0]hexane gold carbene. Fragmentation of the 
cyclopropane ring with the help of the OH group and protodeauration forms the 
product 46 in good yield and excellent diastereoselectivities. 
 
Scheme 31 - Formal (3+2) cycloaddition of allenyl MOM ethers and alkenes. 
F. D. Toste developed an interesting gold(I)-catalyzed (2+2) cycloaddition of 1,6-
allenenes, to afford alkylidene cyclobutane products of type 34.63 The proposed 
mechanism is based on the generation of a gold(I)-linked allyl cation, which undergoes a 
                                                     
60 Krause, N. In Innovative Catalysis in Organic Synthesis; Andersson, P. G., Ed.; Wiley-VCH Verlag GmbH & Co. KGaA: 
Weinheim, Germany, 2012; pp. 195–209. 
61 Gandon, V.; Lemière, G.; Hours, A.; Fensterbank, L.; Malacria, M. Angew. Chemie Int. Ed. 2008, 47, 7534–7538. 
62 López, F.; Mascareñas, J. L. Beilstein J. Org. Chem. 2013, 9, 2250–2264. 
63 Luzung, M. R.; Mauleón, P.; Toste, F. D. J. Am. Chem. Soc. 2007, 129, 12402–12403. 
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cyclization to give a new carbocationic species of type XX, in which the gold center 
establishes a stabilizing electrostatic interaction with the benzylic carbocation (Scheme 
7).64 A subsequent ring closure provides the observed bicyclo[3.2.0]heptanes 34 featuring 
a four membered carbocycle (Scheme 32). 
 
Scheme 32 - Gold(I)-Catalyzed (2+2)-Cycloaddition of Allenenes. 
On the other hand, our group demonstrated the possibility of using allenes as tree-
carbon components in (4+3) intramolecular cycloadditions with dienes (35) promoted by 
Pt or Au catalysts. The (4+3) process can be achieved with PtCl2,65 or with cationic Au(I) 
catalysts containing a σ-donating N-heterocyclic carbene ligand (Au4) which allows 
these reactions to proceed in milder conditions (Scheme 33).66 Later, F. D. Toste reported 
similar results with the related substrates, using a highly donating biaryl di-tert-
butylphosphine ligand (Au5).67 
 
Scheme 33 – Pt and Au(I) catalyzed (4+3) Cycloadditions of allenedienes. 
Remarkably, when allenes are dialkylated at the distal position, a judicious choice of the 
ligand (in case of gold salts) allows to obtain either the (4+3) or a formal (4+2) 
cycloadduct. Thus when these substrates are treated with a gold(I) catalyst bearing a π-
                                                     
64 González, A. Z.; Benitez, D.; Tkatchouk, E.; Goddard, W. A.; Toste, F. D. J. Am. Chem. Soc. 2011, 133, 5500–5507. 
65 Trillo, B.; López, F.; Gulías, M.; Castedo, L.; Mascareñas, J. L. Angew. Chemie Int. Ed. 2008, 47, 951–954. 
66 Trillo, B.; López, F.; Montserrat, S.; Ujaque, G.; Castedo, L.; Lledós, A.; Mascareñas, J. L. Chem. Eur. J. 2009, 15, 3336–3339. 
67 Mauleón, P.; Zeldin, R. M.; González, A. Z.; Toste, F. D. J. Am. Chem. Soc. 2009, 131, 6348–6349. 
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acceptor ligand, such as a triarylphosphite (Au6), (4+2) products like 37 are obtained 
(Scheme 34).68,67 
 
Scheme 34 - Gold(I)-catalyzed (4+2) cycloadditions of allenedienes. 
Combined experimental and theoretical data suggests that both process share the initial 
formation of a metal allyl cation XXI which undergoes a concerted [4C(4) + 3C(2)] 
cycloaddition with the diene moiety, giving a cycloheptanic carbene intermediate XXIIa. 
It’s now when the process becomes divergent: while σ-donor ligands at the gold promote 
a 1,2-hydrogen shift, and therefore lead to a seven-membered carbocycle (36), a gold(I) 
catalyst bearing a -acceptor ligand promote a ring contraction process (1,2-alkyl shift) 
that affords cyclohexene containing bicycles (37, Scheme 35).66,68 
 
Scheme 35 – Divergent mechanism for the (4+3) and (4+2) gold catalyzed cycloadditions of allenedienes. 
Latter, a related (4+3) cycloaddition was also developed by B. W. Gung, namely, an 
interesting transannular cycloaddition of substrate 38 equipped with a furan (4C) and a 
propargyl acetate, which formally acts as an allene surrogate (Scheme 36).69 
                                                     
68 Alonso, I.; Trillo, B.; López, F.; Montserrat, S.; Ujaque, G.; Castedo, L.; Lledós, A.; Mascareñas, J. L. J. Am. Chem. Soc. 
2009, 131, 13020–13030. 
69 a) Gung, B. W.; Craft, D. T. Tetrahedron Lett. 2009, 50, 2685–2687. b) Gung, B. W.; Craft, D. T.; Bailey, L. N.; Kirschbaum, 
K. Chem. Eur. J. 2010, 16, 639–644. 
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Scheme 36 - Gold-catalyzed transannular (4+3) cycloaddition reactions. 
Based on the mechanistic hypothesis for the (4+3) and (4+2) cycloadditions of 
allenedienes, F. D. Toste revisited the gold(I)-catalyzed reaction of allenenes to 
determine whether the ligand could also determine the result of the cycloaddition (See 
Scheme 32, page 25).63,64 Indeed, when a gold catalyst such as Au5/AgSbF6, a (3+2) 
cycloaddition leading to bicyclo[4.3.0]nonanes 39 was observed (Scheme 37).67  
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Scheme 37 - Gold(I)-Catalyzed (3+2)-Cycloaddition of Allenenes. 
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64 González, A. Z.; Benitez, D.; Tkatchouk, E.; Goddard, W. A.; Toste, F. D. J. Am. Chem. Soc. 2011, 133, 5500–5507. 
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2.2.3 - Gold (I) catalyzed intermolecular cycloadditions 
In 2009, a few months before my incorporation to the group, Fürstner published a review 
emphasizing the need of developing gold-catalyzed intermolecular transformations. He 
stated that “a priori, there is no need to tie the two reaction partners together, thus making 
intermolecular transformations feasible, even though the number of successful cases still remains 
somewhat limited”.70 These limitations concerning gold catalyzed intermolecular 
transformations were even more dramatic for the specific case of intermolecular 
cycloadditions, as only a small number of cases had been reported. 
One of them consisted of a gold-catalyzed intermolecular hetero-dehydro-Diels-Alder 
cycloaddition between dienynes and non-activated nitriles, reported by J. Barluenga in 
2008. Treatment of dienynes 40 with various aliphatic or aromatic nitriles, in the 
presence of catalytic amounts of a gold(I) complex, efficiently afforded the pyridines 41 
with satisfactory yields (Scheme 38). The initial coordination of the alkyne to the gold 
catalyst provides the intermediate XXIII. The regioselective nucleophilic attack of the 
nitrile, followed by a cyclization and aromatization yields the reaction products 41.71 
 
Scheme 38 - Gold-catalyzed intermolecular cycloaddition of dienynes with nitriles. 
Y. Yamamoto reported an earlier example of a intermolecular gold catalyzed 
cycloaddition, although it is not fully intermolecular. In particular these authors 
reported the gold (III) catalyzed (4+2) benzannulation between ortho-
alkynylbenzaldehydes 42 and external alkynes, a process that yields substituted 
naphthalenes 43 and related polyaromatics with good regioselectivity.72 Later, B. F. 
Straub reported a DFT study on these cycloadditions. According to the theoretical data, 
an initial 5-endo nucleophilic attack of the carbonyl moiety on the metal–alkyne complex 
generates a carbonyl ylide intermediate, which undergoes a dipolar (3+2) cycloaddition 
with the alkyne to afford an oxabridged carbene species. A subsequent 1,2-alkyl 
                                                     
70 Fürstner, A. Chem. Soc. Rev. 2009, 38, 3208–3221. 
71 Barluenga, J.; Fernandez-Rodríguez, M. A.; García-García, P.; Aguilar, E. J. Am. Chem. Soc. 2008, 130, 2764–2765. 
72 Asao, N.; Takahashi, K.; Lee, S.; Kasahara, T.; Yamamoto, Y. J. Am. Chem. Soc. 2002, 124, 12650–12651. 
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migration yields XXIV and a final elimination finally affords the naphthyl ketones 43 
(Scheme 39). 73 
 
Scheme 39 - AuCl3-Catalyzed Benzannulation. 
In 2009, J. Zhang reported a gold(I)-catalyzed tandem cyclization/(3+3) cycloaddition of 
2-(1-alkynyl)-2-alken-1-ones 44 with nitrones. This reaction proceeds with high levels of 
regiospecificity and diastereoselectivity to produce highly substituted furo[3,4-
d][1,2]oxazines 45. A plausible mechanism includes the formation of the furyl-Au 1,3-
dipole intermediate XXV followed by a (3+3) cycloaddition reaction with the nitrone to 
afford the oxazine derivative 45.74 
 
Scheme 40 - Gold-catalyzed 1,3-dipolar cycloaddition of 2-(1-alkynyl)-2-alken-1-ones with nitrones 
The same group also reported (4+3) cycloadditions of 2-(1-alkynyl)-2-alken-1-ones with 
,-unsaturated imines,75 and 1,3-diphenylisobenzofurans,76 (Scheme 41). In both cases 
the formation of a furyl-Au 1,3-dipole intermediate XXV, previously proposed for the 
                                                     
73 Straub, B. F. Chem. Commun. 2004, 1726–1728. 
74 Liu, F.; Yu, Y.; Zhang, J. Angew. Chemie Int. Ed. 2009, 48, 5505–5508. 
75 Gao, H.; Zhao, X.; Yu, Y.; Zhang, J. Chem. Eur. J. 2010, 16, 456–459. 
76 Gao, H.; Wu, X.; Zhang, J. Chem. Commun. 2010, 46, 8764–8766. 
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1,3-dipolar cycloaddition with nitrones (Scheme 40), is considered key for the 
cycloadditions. 
 
Scheme 41 - Au-catalyzed (4+3) cycloaddition of 2-(1-alkynyl)-2-alken-1-ones. 
Recently, the group of R.-S. Liu developed an interesting intermolecular gold-catalyzed 
(2+2+3) cycloaddition of 1,6-enynes 46 with nitrones.77 The authors propose a 
mechanism consisting of a concerted cycloaddition between the nitrone and a 
cyclopropylgold carbenoid with a strong alkenylgold carbocation character. The 
resulting cycloadducts are obtained in good or excellent yields. 
 
Scheme 42 - Intermolecular gold-catalyzed (2+2+3) cycloadditions of 1,6-enynes with nitrones. 
In all of the abovementioned intermolecular cycloadditions of alkynes, the gold activated 
alkyne was intramolecularly intercepted by an internal nucleophile, and the resulting 
intermediate reacted with an external component. In 2010 A. M. Echavarren reported a 
fully intermolecular (2+2) cycloaddition between aromatic alkynes and -disubstituted 
alkenes to give cyclobutenes 47 regioselectively (Scheme 43). 78 
                                                     
77 Gawade, S. A.; Bhunia, S.; Liu, R. Angew. Chemie Int. Ed. 2012, 51, 7835–7838. 
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Scheme 43 - Gold(I)-catalyzed intermolecular (2+2) cycloaddition of alkynes with alkenes. 
F. D. Toste took advantage of the possibility of generating gold carbenes from propargyl 
esters to develop an intermolecular cyclopropanation of olefins (Scheme 44).79  
 
Scheme 44 - Gold(I)-catalyzed olefin cyclopropanation with propargyl esters. 
The same authors demonstrated that these carbenes can also be used as a 3C component 
in an interesting cycloaddition reaction with ,-unsaturated imines that affords azepine 
derivatives.80 The mechanistic proposal involves the intermolecular addition of the imine 
to the gold carbene XXVI, delivering the allyl gold intermediate XXVII. A final 
cyclization provides the seven-membered heterocyclic products 48 in moderate to good 
yields. 
 
Scheme 45 - Synthesis of azepines by a gold-catalyzed intermolecular (4+3) cycloaddition. 
Azomethine imines 49 can also be used as intermolecular 3C cycloaddition components 
(Scheme 46).81 These (3+3) annulations take place through a stepwise mechanism related 
to that previously shown (Scheme 45) for the formation of azepines. 
                                                     
79 Johansson, M. J.; Gorin, D. J.; Staben, S. T.; Toste, F. D. J. Am. Chem. Soc. 2005, 127, 18002–18003. 
80 Shapiro, N. D.; Toste, F. D. J. Am. Chem. Soc. 2008, 130, 9244–9245. 
81 Shapiro, N. D.; Shi, Y.; Toste, F. D. J. Am. Chem. Soc. 2009, 131, 11654–11655. 
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Scheme 46 - Gold-catalyzed (3+3)-annulation of azomethine imines with propargyl esters. 
When I started this PhD thesis the use of allenes in intermolecular cycloadditions 
catalyzed by gold or any other carbophilic metal catalyst had not yet been described. 
While our work was ongoing Iwasawa reported a Platinum(II)-catalyzed intermolecular 
(3+2) cycloaddition of propadienyl silyl ethers and alkenyl ethers. In most cases a 
competitive (2+2) cycloaddition was also observed. The authors propose that the allene 
is initially activated by the Pt(II) catalyst to give the corresponding  complex XXVIII. 
Then a nucleophilic addition of the 2-methoxypropene to the nonsubstituted terminus 
give zwitterionic intermediate XXIV. Ring closure with electron flow from the anionic 
platinum to the oxonium carbon at the position  to the metal (path a) gives the 
cyclopentylidene Pt(II) carbene intermediate XXX, which finally undergoes a 1,2-
hydrogen shift to give the cyclopentene derivative 50. The methylenecyclobutane 
derivative is thought to be produced by the attack of the silyl enol ether at the oxonium 
carbon to give the cyclobutylplatinum(II) intermedate XXXI (path b), followed by 
elimination of the Pt (Scheme 47).82 Later the same group found that a Pt(II) catalyst and 
a hollow-shaped triethynylphosphine ligand (L1) generates the (2+2) cycloadducts 51 as 
major products.83 
 
Scheme 47 - Pt(II)-catalyzed (3+2) and (2+2) cycloadditions of propadienyl silyl ethers and alkenyl ethers. 
                                                     
82 Kusama, H.; Ebisawa, M.; Funami, H.; Iwasawa, N. J. Am. Chem. Soc. 2009, 131, 16352–16353. 
83 Ebisawa, M.; Kusama, H.; Iwasawa, N. Chem. Lett. 2012, 41, 786–788. 
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There are several ways of producing compounds as single enantiomers. The resolution 
of a mixture of enantiomers can often be the cheapest or the conversion of a 
enantiomerically pure starting material into another derivative represents another useful 
technique in some cases.84 However, asymmetric synthesis can provide a more general 
approach to the preparation of enantiomerically enriched compounds. Although there 
may still be cases where asymmetric synthesis doesn’t provide the best method for the 
preparation of a particular enantiomerically pure compound, it certainly allows for the 
preparation of a more diverse range of structures.  
Asymmetric catalysis is especially appealing.85 In this regard, the rapid rise in interest for 
gold catalysis has been accompanied by efforts to develop enantioselective variants of 
gold-catalyzed reactions to further increase the synthetic utility of these 
transformations.86,87 The linear nature of gold complexes make difficult the design of 
catalysts that can provide asymmetric transformations. As aforementioned, the first 
enantioselective gold (I) catalyzed reaction, consisting of an asymmetric aldol 
condensation in the presence of a chiral ferrocenylphosphine-gold(I) complex, was 
developed by Hayashi et al. in 1986 (Scheme 48).17  
O
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NMe
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O N
CO2MeR
O N
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dr = 84:16 - 98:2  
Scheme 48 - Reaction of aldehydes with isocyanoacetate catalyzed by a chiral Au(I) complex. 
Despite the relevance of this report it was not until very recently when gold 
enantioselective catalysis was again investigated.87 In 2005, A. M. Echavarren and J. C. 
Carretero reported the gold(I)-catalyzed enantioselective alkoxycyclization of 1,6-enynes 
to yield methylenecyclopentanes 9.28 The authors screened various chiral phosphorous 
ligands, and found that a chiral bis-gold complex derived from tol-binap Au10 (1.6%) / 
AgSbF6 (2%) gave the best result (Scheme 49). Although, in general, the asymmetric 
                                                     
84 Chiral Drugs: Chemistry and Biological Action; Lin, G.-Q.; You, Q.-D.; Cheng, J.-F., Eds.; 1st ed.; John Wiley & Sons, Inc.: 
Hoboken, NJ, USA, 2011. 
85 Catalysis in Asymmetric Synthesis; Caprio, V.; Williams, J., Eds.; 2nd ed.; Wiley-Blackwell: West Sussex, United Kingdom, 
2009. 
86 Wang, Y.; Lackner, A. D.; Toste, F. D. Acc. Chem. Res. 2014, 47, 889–901. 
87 Reviews on enantioselective gold catalysis: a) Sengupta, S.; Shi, X. ChemCatChem 2010, 2, 609–619. b) Widenhoefer, R. A. 
Chem. Eur. J. 2008, 14, 5382–5391. c) Pradal, A.; Toullec, P.; Michelet, V. Synthesis 2011, 2011, 1501–1514. d) López, F.; 
Mascareñas, J. L. Beilstein J. Org. Chem. 2013, 9, 2250–2264. 
17 Ito, Y.; Sawamura, M.; Hayashi, T. J. Am. Chem. Soc. 1986, 108, 6405–6406. 
28 Muñoz, M. P.; Adrio, J.; Carretero, J. C.; Echavarren, A. M. Organometallics 2005, 24, 1293–1300. 
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inductions obtained are poor, an enantioselectivity of 94% was achieved in one case. 
Moreover these transformations represent both the first examples of enantioselective 
gold(I) catalysis involving -activation and the first successful application of chiral 
bis(gold)complexes in enantioselective catalysis.87 
 
Scheme 49 – Gold catalyzed Enantioselective Alkoxycyclization. 
In the same year, F. D. Toste also surveyed some chiral bisphosphine gold complexes, in 
the context of gold(I)-catalyzed olefin cyclopropanationS,88,79 and found that DTBM-
SEGPHOS(AuCl)2 (Au14) afforded very good results (Scheme 50). Several styrenes and 
propargyl esters were evaluated with this complex and enantioselectivities ranging from 
60% to 94%ee were obtained for the corresponding cyclopropanes type 52. Later, the 
same group used this DTBM-SEGPHOS gold complex (Au14) in an enantioselective 
version of the Au(I)-catalyzed (2+2)-cycloaddition of allenenes (Scheme 50).89,63.  
 
Scheme 50 – Enantioselective Au(I)-catalyzed cyclopropanation and intramolecular (2+2) cycloaddition. 
Chiral gold complexes of bisphosphine ligands were also successfully employed in the 
asymmetric intramolecular hydroarylation of allenyl indoles developed by R. 
Widenhoefer and co-workers. In this case, very high ee is obtained using the gold 
                                                     
87 Reviews on enantioselective gold catalysis: a) Sengupta, S.; Shi, X. ChemCatChem 2010, 2, 609–619. b) Widenhoefer, R. A. 
Chem. Eur. J. 2008, 14, 5382–5391. c) Pradal, A.; Toullec, P.; Michelet, V. Synthesis 2011, 2011, 1501–1514. 
88 The racemic version was already mentioned in Scheme 44, page 42. 
79 Johansson, M. J.; Gorin, D. J.; Staben, S. T.; Toste, F. D. J. Am. Chem. Soc. 2005, 127, 18002–18003. 
89 The racemic version was already mentioned in Scheme 32, page 34. 
63 Luzung, M. R.; Mauleón, P.; Toste, F. D. J. Am. Chem. Soc. 2007, 129, 12402–12403. 
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catalyst prepared from (S)-MeO-DTMB-BIPHEP (Scheme 51 top).90 The same ligand was 
also effective in the hydroamination of N-allenyl carbamates (Scheme 51 bottom).91 
 
Scheme 51 - Gold(I)-catalyzed intramolecular enantioselective hydroarylation of allenyl indoles. 
More recently, J. Zhang reported an enantioselective version of the (3+3) cycloadditions 
of 2-(1-alkynyl)-2-alken-1-ones with nitrones, to give optically active heterobicyclic 
furo[3,4-d][1,2]oxazines with excellent diastereoselectivities and moderate to excellent 
enantioselectivities.92,74 The key to achieve high enantioselectivities was the use of 
bidentate chiral ligands such as (R)-MeO-DTMB-BIPHEP (Au15) or (R)-C1-Tunephos 
(Au16) (Scheme 52).93 
 
Scheme 52 - Enantioselective Au(I)-catalyzed cyclization of 2-(1-alkynyl)-2-alken-1-ones with nitrones. 
As can be deduced from the above cases, successful asymmetric inductions involve 
chiral gold complexes of phosphines which carry large aromatic groups on the 
phosphorus atom, probably because of a better trasnmision of the stereogenic 
information from the ligand to the product. Indeed these scaffolds might establish 
secondary interactions such as - and -Au(I) stacking, which would allow rigid chiral 
pockets around the metal center to be formed. Although the intrinsic roles of the two 
gold atoms in bisphosphineds are still a matter of debate, aurophilic contacts, which 
have been observed by X-ray crystallographic studies, have been invoked to stabilize 
                                                     
90 Liu, C.; Widenhoefer, R.A. Org. Lett. 2007, 9, 1935-1938. 
91 Zhang Z.; Bender C.F.; Widenhoefer, R.A. Org. Lett. 2007, 9, 2887-2889. 
92 The racemic version was already mentioned in Scheme 40, page 40. 
74 Liu, F.; Yu, Y.; Zhang, J. Angew. Chemie Int. Ed. 2009, 48, 5505–5508. 
93 Liu, F.; Qian, D.; Li, L.; Zhao, X.; Zhang, J. Angew. Chemie Int. Ed. 2010, 49, 6669–6672. 
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reaction intermediates or determine optimal arrangements in the catalyst-substrate 
adducts.94 
The fact that these spatial cationic dinuclear bisphosphine-based gold complexes, 
featuring axially chiral C2-symmetric scaffolds dominates many reports, is probably a 
consequence of the notion that monodentate chiral ligands could not overcome the 
intrinsic limitation of the linear coordination of gold(I) complexes.87 Indeed, the gold 
complexes of monodentate chiral ligands tested before 2009, like Au12 and Au13 
(Scheme 49),28,95 led to very poor enantioselectivities (<2%).  
Nevertheless, in 2009 our group found that binol-derived phosphoramidites featuring 
large aryl substituents at the 3 and 3′ position of the binaphthol unity (e.g. anthracenyl 
groups) were excellent ligands for the asymmetric gold catalyzed (4+2) cycloaddition of 
allene-dienes (Scheme 53).68 In fact, 9-anthracenyl-derived analog (R,R,R)-Au17 was 
highly effective, providing excellent yields of 37 and enantioselectivities superior to 91% 
at -15 °C. Not less remarkable, the chemoselectivity of the process was also very high in 
favor of the (4+2) adduct 37 over the (4+3) adduct 36, that in all cases was superior to 
16:1 (Scheme 53). The enantiomeric excess of the major (4+2) cycloadduct 37 was 
virtually identical to that of the minor (4+3) products 36 regardless of the chiral gold 
catalyst and temperature employed, which supports the mechanistic proposal shown in 
Scheme 35 (page 26) involving a common cycloheptanic carbene intermediate XXIIa for 
both (4+2) and (4+3) cycloadducts. This report constituted the first example of a highly 
enantioselective reaction promoted by a mononuclear gold catalyst.68 
F. D. Toste later reported similar results using related phosphoramidites, equipped with 
pyrenyl groups at the 3 and 3′ position of the binaphthol unity (Au18). Additionally, 
these authors also reported an Au catalyst based on a C3-symmetric phosphite ligand 
(Au19), that was able to provide the (4+2) cycloadduct with excellent enanteomeric 
excess. 96,97 A. Fürstner and coworkers developed a different type of chiral 
phosphoramidite-gold complex based on the Taddol backbone (Au20), which not only 
proved to be effective in these (4+2) cycloadditions (Scheme 53), but also in other 
asymmetric gold catalyzed processes, such as the (2+2) cycloadditions of allenenes, 
cycloisomerizations of O-tethered enynes or hydrofunctionalization of allenes (Scheme 
53).98 
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87 Reviews on enantioselective gold catalysis: a) Sengupta, S.; Shi, X. ChemCatChem 2010, 2, 609–619. b) Widenhoefer, R. A. 
Chem. Eur. J. 2008, 14, 5382–5391. c) Pradal, A.; Toullec, P.; Michelet, V. Synthesis 2011, 2011, 1501–1514. 
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97 González, A. Z.; Toste, F. D. Org. Lett. 2010, 12, 200–203. 
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Scheme 53 –Au-catalyzed enantioselective (4 + 2) cycloadditions of allenedienes. 
DFT calculations demonstrated that the energy barriers of the ring contraction process 
leading to these six-membered systems ((4+2) cycloadduct), and the 1,2-H shifts that 
preserve that seven-membered ring ((4+3) cycloadduct) were very similar. Therefore we 
reasoned that theses phosphoramidite gold complexes could also be good catalysts for 
the (4+3) cycloaddition, provided that the ring contraction process could be somewhat 
deactivated.68 This could be achieved using terminally monosusbtituted allenes, whose 
carbene intermediates are less prone to undergo a ring contraction. The reaction 
provided optically active 5,7- and 6,7-fused bicyclic systems with good yields, complete 
diastereocontrol and excellent enantioselectivities (Scheme 54). 99  
Interestingly, while disubstitution at the allene terminus favors the formation of (4+2) 
cycloadducts 37,68 introduction of the third substituent at the internal instead of the 
terminal position of the allene, allowed to generate cycloheptenyl products 36. Therefore, 
treatment of the 1,3-di-substituted allenedienes 35 under the standard conditions 
[(R,R,R)-Au17/AgSbF6] yielded the (4+3) adducts 36 with good regioselectivities and 
excellent ee. The substitution at the terminal position of the allene encompasses alkylic 
and aromatic groups (Scheme 54).99 
                                                     
68 Alonso, I.; Trillo, B.; López, F.; Montserrat, S.; Ujaque, G.; Castedo, L.; Lledós, A.; Mascareñas, J. L. J. Am. Chem. Soc. 
2009, 131, 13020–13030. 
99 Alonso, I.; Faustino, H.; López, F.; Mascareñas, J. L. Angew. Chemie Int. Ed. 2011, 50, 11496–11500. I also contribute to this 
work, in examples where internal substituted allenes are used, such as those in Scheme 54, especially in those with a 
longer connecting chain. 
68 Alonso, I.; Trillo, B.; López, F.; Montserrat, S.; Ujaque, G.; Castedo, L.; Lledós, A.; Mascareñas, J. L. J. Am. Chem. Soc. 
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Scheme 54 - Au-catalyzed enantioselective (4+3) cycloadditions of allenedienes. 
Curiously, an allenediene equipped with a phenyl group at the allene terminus, reacted 
to give a 4:6 mixture of the expected (4+3) adduct 36 (98% ee) and an interesting bicyclic 
product, 53, formally resulting from a new type of formal (4+2) annulation (Scheme 55). 
Importantly, both adducts were obtained with almost the same enantioselectivity (± 2% 
ee), suggesting that they could arise from a common intermediate. Indeed, the formation 
of 53 can be rationalized in terms of 1,2 migration of the bridgehead tertiary carbon on a 
5,7- cycloheptyl-gold carbene intermediate like XXIIb (Scheme 55). This migration entails 
a ring expansion of the five-membered ring and a concomitant contraction of the seven-
membered carbocycle. 
 
Scheme 55 – Formation of a new (4+2) cycloadduct (91). 
F. D. Toste and coworkers performed an extensive screening of the modular and easily 
available phosphoramidite type ligands, including BINOL, VANOL, VAPOL and 
spirobiindane derivatives in the (2+2) cycloaddition of allenenes. The gold complex 
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derived from the commercially available SIPHOS-PE ligand (R,R,R) Au26a, proved to be 
ideal for this process (Scheme 56).100 
The trans-cyclization/addition reaction of allenenes in the presence of methanol was 
also tested. Although the previously optimal complex (R,R,R) Au26a produced 
methoxycyclization product 54 with low enantioselectivity, a newly designed complex, 
based on a H8-BINOL scaffold, (S,S,S) Au27, increase significantly the enantioselectivity 
of the process up to 92% ee.64 
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Scheme 56 – Phosphoramidite ligands in Au(I) catalyzed (2+2) cycloadditions and alkoxylation of allenenes. 
As we have seen before, N-heterocyclic carbene ligands played an important role in gold 
chemistry, altering reactivities or affording new ones.101,102 However, until 2010, there 
were no reports on any chiral NHC–Au(I) catalyst. In this year, K. Tomioka and 
coworkers reported the use of the chiral C2-symmetric NHC–Au(I) catalysts, like Au28 
in the cyclization reaction of 1,6-enynes.103 The enantioselectivities obtained in these 
cyclizations were just modest (up o 59%).104 
                                                     
100 As we have seen before, (R)-DTBM-Segphos(AuCl)2 Au14 (Scheme 50, page 47) and is also excellent a catalysts for this 
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102 For a recent review on asymmetric reactions chiral catalyzed by carbene–gold(I) complexes see: Gu, P.; Xu, Q.; Shi, M. 
Tetrahedron Lett. 2013, 55, 577–584. 
103 Douthwaite, R. E. Coord. Chem. Rev. 2007, 251, 702–717. 
104 a) Matsumoto, Y.; Selim, K. B.; Nakanishi, H.; Yamada, K.; Yamamoto, Y.; Tomioka, K. Tetrahedron Lett. 2010, 51, 404–
406. b) For the preparation of this type of ligands, see: Matsumoto, Y.; Yamada, K.; Tomioka, K. J. Org. Chem. 2008, 73, 
4578–4581. 
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Scheme 57 –Chiral NHC–Au(I)-catalyzed cyclization of enyne. 
In the same year, P. Espinet reported a series of gold complexes containing acyclic 
diaminocarbene ligands (ADC), also known as nitrogen acyclic carbenes (NAC). These 
complexes were tested in the cyclopropanation of vinyl arenes with propargyl pivaloate 
and in the intramolecular hydroalkoxylation of allenes (55), providing moderate to good 
yields of the expected products, however, the enantioselectivities were only poor or 
modest, not exceeding the 24% (Scheme 58).105 
 
Scheme 58 - Gold chiral nitrogen acyclic carbenes and gold hydrogen bonded heterocyclic carbenes in 
cyclopropanation of vinyl arenes and in intramolecular allene hydroalkoxylation. 
In 2011, F. D. Toste developed a variant of the chiral ADC gold complex Au30b, 
incorporating a p-CF3Ph substituent at the 3,3’ positions of the BINAM (bi- naphthyl-2,2’-
diamine) moiety, and applied it to the enantioselective cyclization of propargyl pivalates 
like 58. The resulting chromenyl pivalates (59) were obtained in excellent yield and 
enantioselectivities ranging from 83 to 95% (Scheme 59).106 
                                                     
105 Bartolomé, C.; García-Cuadrado, D.; Ramiro, Z.; Espinet, P. Inorg. Chem. 2010, 49, 9758–9764. 
106 Wang, Y. M.; Kuzniewski, C. N.; Rauniyar, V.; Hoong, C.; Toste, F. D. J. Am. Chem. Soc. 2011, 133, 12972–12975. 
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Scheme 59 - Synthesis of 2-substituted chromenyl pivalates. 
One year later, L. M. Slaughter reported the enantioselective cyclization of 2-
alkynylbenzaldehydes, catalyzed by a mononuclear ADC-gold complex (Scheme 60).107 
 
Scheme 60 – alkynylbenzaldehyde cyclizations.  
Although the abovementioned examples are excellent contributions in enantioselective 
gold catalysis, there are still many challenges such as the extension to other fold 
catalyzed processes, the development of more general ligands and the gaining of a better 
understanding of the stereoinduction process.87a,62 
                                                     
107 Handa, S.; Slaughter, L. M. Angew. Chemie Int. Ed. 2012, 51, 2912–2915. 
87a Sengupta, S.; Shi, X. ChemCatChem 2010, 2, 609–619. 
62 López, F.; Mascareñas, J. L. Beilstein J. Org. Chem. 2013, 9, 2250–2264. 
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As previously shown, alenes are excellent partners in gold catalyzed processes, owing to 
the ready complexation to the gold salts and cations. The presence of heteroatoms can 
render allenes even more reactive in their reactivity with electrophilic atoms and metals 
while still being relatively stable. Among these type of allenyl derivatives, allenamines 
might have some advantages owing to the trivalent nature of the nitrogen atom, 
allowing, for instance the tethering of a chiral-inducing auxiliary. Unfortunately, 
allenamines are highly sensitive toward hydrolysis and show a great tendency to 
polymerize even at low temperatures, thereby creating serious difficulties in their 
preparation and experimental handling. In this context, allenamides are an attractive 
alternative, once the delocalization of the nitrogen lone-pair into the carbonyl group 
(giving an extra resonance form) diminish its donating ability toward the allenic moiety, 
enhancing the stability.108 
 
Scheme 61 – Allenamide resonance forms. 
 
3.1 - Preparation of allenamides 
The first known preparation of an allenamide was reported by W.B. Dickinson and P.C. 
Lang in 1967.109 These authors coined the term allenamide to describe 1,2-propadienyl-2-
pyrrolidinone, which they had obtained as the major product by treatment of 2-
pyrrolidinone with NaH and propargyl bromide. The reaction proceeds by addition of 
the amide to the propargyl bromide and the resulting propargyl amide undergoes a base 
promoted prototropic isomerization to give the allenamide 60a (Scheme 62 top). This 
protocol was later improved by R. P. Hsung, by splitting in 2 steps the synthesis and 
using tBuOK at room temperature for the isomerization (Scheme 62 bottom). This 
protocol allowed the preparation of a variety of cyclic allenamides, some of them with 
chiral auxiliaries, even in a large scale.110,111 
                                                     
108 Lu, T.; Lu, Z.; Ma, Z.-X.; Zhang, Y.; Hsung, R. P. Chem. Rev. 2013, 113, 4862–4904. 
109 Dickinson, W. B.; Lang, P. C. Tetrahedron Lett. 1967, 8, 3035-3040 
110 Wei, L.; Mulder, J. A.; Zificsak, C. A.; Douglas, C. J.; Hsung, R. P. Tetrahedron 2001, 57, 459–466. 
111 a) Tracey, M. R.; Grebe, T.; Mulder, J. A.; Hsung, R. P. Org. Synth. 2005, 81, 147–151. b) Xiong, H.; Tracey, M.; Grebe, T. 
Org. Synth. 2014, 91, 12–26. 
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Scheme 62 - W.B. Dickinson and  P.C. Lang preparation of 1,2-propadienyl-2-pyrrolidinone (top) and some 
examples of allenamides obtained from Hsung protocol (bottom). 
In 2005, the B. M. Trost and R. P. Hsung independently published another method to 
make allenamides, consisting of a copper-catalyzed coupling between allenyl halides 
and amides. Importantly if carbamates, ureas or tosylamines are used as reaction 
components the corresponding allenamides are also obtained in good yields.112,113 Hsung 
also observed that when optically enriched allenyl halides were used, the chirality was 
transferred to the allenamides. In general both protocols provide the desired allenamides 
in moderate to good yields and are particularly suitable for the preparation of terminal 
alkyl substituted allenamides (Scheme 63). 
 
Scheme 63 - Copper-catalyzed coupling of allenyl halides with amides. 
 
                                                     
112 Trost, B. M.; Stiles, D. T. Org. Lett. 2005, 7, 2117–2120. 
113 Shen, L.; Hsung, R. P.; Zhang, Y.; Antoline, J. E.; Zhang, X. Org. Lett. 2005, 7, 3081–3084. 
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3.2 - Cycloadditions of allenamides 
The electron rich character of allenamides has allowed their use in several thermally 
induced cycloaddition reactions.108 For instance, Y. Tamaru reported a thermal (2+2) 
cycloaddition of allenamides like 61 with alkenes and alkynes to afford cyclobutanes 62. 
The reaction occurs at the terminal double bond of the allene and provides almost 
exclusively the Z isomer. The reaction is limited to terminal alkenes and alkynes and 
requires a large excess of these components (40-120 equiv), which are employed as 
solvent.114 
 
Scheme 64 - Thermal (2+2) Cycloaddition Reaction of Allenes with Alkenes or Alkynes. 
Allenamides like 61 can work as a 2 carbon atom component in a inverse electron-
demand hetero-(4+2) cycloaddition reaction with ,-unsaturated carbonyls under 
thermal conditions. The cycloadditions took place selectively at the internal double bond 
of the allene and provides spiro compounds of type 62 as a major product.114b,115 Later 
Hsung reported that allenamides of type 60 were also good partners for the same 
reaction, and the heterodiene scope could be expanded, tolerating aromatic rings at the 
ketone or even a bromine at the alkene (Scheme 65, right).116,117 
 
Scheme 65 - Inverse electron-demand hetero-(4+2) cycloaddition reaction of allenamides. 
V. Vranken reported the first example of a normal electron demand (4+2) cycloaddition 
of allenamides. In particular they demonstrated that the terminal allenyl double bond of 
a N-allenylsulfenimide works as a dienophile and react thermally with 
cyclopentadiene.118 Later Mapp employed the same reaction, also using cyclopentadiene, 
to demonstrate the utility of N-phosporamidate-substituted allenamides.119 
Unfortunately, despite the significance of the method, no other results on thermal 
                                                     
108 Lu, T.; Lu, Z.; Ma, Z.-X.; Zhang, Y.; Hsung, R. P. Chem. Rev. 2013, 113, 4862–4904 
114 a) Kimura, M.; Horino, Y.; Wakamiya, Y.; Okajima, T.; Tamaru, Y. J. Am. Chem. Soc. 1997, 119, 10869–10870. b) Horino, 
Y.; Kimura, M.; Tanaka, S.; Okajima, T.; Tamaru, Y. Chem. Eur. J. 2003, 9, 2419–2438. 
115 Kimura, M.; Wakamiya, Y.; Horino, Y.; Tamaru, Y. Tetrahedron Lett. 1997, 38, 3963–3966. 
116 Berry, C. R.; Hsung, R. P. Tetrahedron 2004, 60, 7629–7636. 
117 a) Wei, L.; Xiong, H.; Douglas, C. J.; Hsung, R. P. Tetrahedron Lett. 1999, 40, 6903–6907. b) Wei, L.-L.; Hsung, R. P.; Xiong, 
H.; Mulder, J. A.; Nkansah, N. T. Org. Lett. 1999, 1, 2145–2148. 
118 Bacci, J. P.; Greenman, K. L.; Van Vranken, D. L. J. Org. Chem. 2003, 68, 4955–4958. 
119 Danowitz, A. M.; Taylor, C. E.; Shrikian, T. M.; Mapp, A. K. Org. Lett. 2010, 12, 2574-2577. 
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intermolecular Diels-Alder reaction using a diene other than cyclopentadienehave been 
reported. 
 
Scheme 66 - Normal electron demand (4+2) cycloaddition of allenamides with cyclopentadiene. 
R. P. Hsung also reported a thermally-induced intramolecular (4+2) cycloaddition of 
allenamides tethered to furans or 1,3-butadiene (63). The reaction is highly 
stereoselective and tolerates different lengths of the connecting tether, allowing to obtain 
interesting bi or tricyles (64) (Scheme 67). Importantly, R. P. Hsung has also observed 
that AuCl was a good catalyst for this reaction providing up to 66% yield of 64a after 
only 10 min in 1,2-dichloroethane, however the thermal process gave better results.120 
 
Scheme 67 - Thermal intramolecular (4+2) cycloadditions of allenamides. 
In 2001, Hsung and coworkers demonstrated that treatment of oxazolidinone-substituted 
allenamides such as 60b with dimethyldioxirane (DMDO) provides an allene oxide 
which subsequently opens to give a nitrogen-stabilized oxyallyl cation. This oxyallyl 
cationic species could be trapped by cyclic dienes such as furan or cyclopentadiene in a 
standard (4+3) annulation (Scheme 68).121 This cycloaddition chemistry has been 
extensively studied and optimized by Hsung during the last decade, and can be 
considered among the most versatile, selective and efficient (4+3) cycloaddition 
methodologies relying on allyl cation intermediates.122 
                                                     
120 Lohse, A. G.; Hsung, R. P. Org. Lett. 2009, 11, 3430–3433. 
121 a) Xiong, H.; Hsung, R. P.; Berry, C. R.; Rameshkumar, C. J. Am. Chem. Soc. 2001, 123, 7174–7175. b) Antoline, J.; Hsung, 
R. P. Synlett 2008, 2008, 739–744. c) Antoline, J. E.; Krenske, E. H.; Lohse, A. G.; Houk, K. N.; Hsung, R. P. J. Am. Chem. 
Soc. 2011, 133, 14443–14451. d) Du, Y.; Krenske, E. H.; Antoline, J. E.; Lohse, A. G.; Houk, K. N.; Hsung, R. P. J. Org. Chem. 
2013, 78, 1753–1759. 
122 For a review see: Lohse, A. G.; Hsung, R. P. Chem. Eur. J. 2011, 17, 3812–3822 
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Scheme 68 – (4+3) cycloadditions of nitrogen-stabilized oxyallyl cations with furan or cyclopentadiene. 
In their original report,121a the authors demonstrated that by incorporating chiral 
oxazolidinones in the allene moiety, the (4+3) cycloaddition with dienes can take place 
with good to high levels of diastereoselectivity, depending on the chiral oxazolidinone 
used (Scheme 69). The reactions were completely endo selective and the best results (dr 
up to 96:4) were obtained with allenamides that incorporate a phenyl group at the 
nitrogen -position, and using ZnCl2 (2.0 equiv) as additive. Notably, these 
intermolecular cycloadditions can also be carried out in good yields and selectivities 
using N-protected pyrroles as diene counterparts, which provides access to tropinone 
alkaloids.123  
 
Scheme 69 - (4+3) Cycloadditions of allenamides with dienes. 
R. P. Hsung also unveiled an enantioselective version of this process by using catalytic 
CuOTf2 and a C2-symmetric bisoxazoline ligand that afforded the cycloadducts in good 
yields and up to 99% ee (Scheme 70). 124 
                                                     
123 Antoline, J. E.; Hsung, R. P.; Huang, J.; Song, Z.; Li, G. Org. Lett. 2007, 9, 1275–1278. 
124 Huang, J.; Hsung, R. P. J. Am. Chem. Soc. 2005, 127, 50-51. 
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Scheme 70 - Enanteoselective (4+3) cycloadditions of nitrogen-stabilized oxyallyl cations with furans. 
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3.3 - Gold catalyzed reactions of Allenamides 
Given the affinity of Au(I) towards allenes, it was expected that allenamides could be 
even more susceptible to the nucleophilic addition to gold-cationic complexes. As shown 
by G. Broggini, allenamides like 67 readily undergo a gold(III)-catalyzed intramolecular 
hydroamination.125 The reaction produces cis-2-vinylimidazolidinones 68 as the major 
product, however in most cases the trans isomer was also detected. A possible 
mechanism proposed by the authors starts with the activation of the allene moiety by the 
gold complex, which triggers an intramolecular nucleophilic attack by the amino group 
that yield a cyclic vinyl-gold intermediate. A final protonolysis gives the 
imidazolidinone and regenerates the gold catalyst (Scheme 71). 
 
Scheme 71 - Gold(III)-catalyzed intramolecular hydroamination of -amino allenamides. 
In 2010 M. C. Kimber disclosed an intermolecular Au-catalyzed hydroamination of 
allenamides using arylamines. The method is highly efficient, and tolerates either 
electron-donating or electron-withdrawing groups at the arylamine moiety, and the 
corresponding allylamino E-enamides 69 are obtained stereoselectively and generally in 
high yield. The authors propose a mechanism involving the initial activation of the 
allenamide by the Au(I) catalyst to give a stabilized allyl cation intermediate XXXII. The 
aniline derivatives then undergo 1,2-addition giving XXXIII, followed by 
protodemetalation to yield the observed E-enamide 69. 
 
Scheme 72 – Gold(I)-catalyzed intermolecular hydroamination of allenamides with arylamines. 
 
It is also possible to use carbon instead heteroatom nucleophiles, such as electron-rich 
aromatics or heteroaromatics.126 Therefore N. Fujii, and H. Ohno reported a Au-
catalyzed intramolecular hydroarylation of allenamides 70 for the formation of 
dihydroquinolines 71.127 The mechanism involves the allene activation by the gold 
                                                     
125 Manzo, A. M.; Perboni, A. D.; Broggini, G.; Rigamonti, M. Tetrahedron Lett. 2009, 50, 4696–4699. 
126 For a review covering these type of reaction see: Krause, N.; Winter, C. Chem. Rev. 2011, 111, 1994–2009. 
127 Watanabe, T.; Oishi, S.; Fujii, N.; Ohno, H. Org. Lett. 2007, 9, 4821–4824. 
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catalyst, a subsequent electrophilic aromatic substitution with the electron-rich arene to 
give a vinyl-gold complex intermediate that leads to the product 71 by rearomatization 
and protodeauration (Scheme 73). The use of allenamides allows the C−C bond to be 
formed exclusively at the terminal allenic carbon atom, in a 6-endo-trig manner. 
 
Scheme 73 - Gold-catalyzed intramolecular hydroarylation of allenamides. 
In 2012, M. C. Kimber reported a related intramolecular hydroarylation using 
allenamides of type 72, that do not incorporate the aromatic ring directly linked to the N 
atom. In contrast to the process described by N. Fujii (Scheme 73), these substrates 
undergo a 6-exo-trig cyclization, affording -vinyl-substituted tetrahydro isoquinolines 
(73) (Scheme 74).128 
 
Scheme 74 - Gold-catalyzed intramolecular hydroarylation of allenamides. 
M. C. Kimber also developed an intermolecular gold-catalyzed hydroarylation of 
allenenamides. In particular, the group demonstrated that Ph3PAuNTf2 is an excellent 
catalyst for the addition of electron-rich aromatics and heteroaromatics to allenamides in 
a regioselective manner and under mild conditions. The proposed mechanism involves 
the formation of the key acyliminium intermediate XXXIV that undergoes a 1,4-addition 
of the nucleophile to give intermediate XXXV. A subsequent protodemetalation yields 
the E-enamide 74.129 
                                                     
128 Singh, S.; Elsegood, M.; Kimber, M. Synlett 2012, 23, 565–568. 
129 Kimber, M. C. Org. Lett. 2010, 12, 1128–1131. 
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Scheme 75 - Gold-catalyzed intermolecular hydroarylation of allenamides. 
Curiously when the aromatic ring is at the  position of the allenamide an imino-
Nazarov cyclization cascade can take place. The methodology was developed recently by 
R. P. Hsung and proved to be a regioselective method for the construction of aromatic 
ring-fused cyclopentenamides.130 The authors propose that an electrophilic activation of 
the -Aryl-allenamide 75 could give an amido-pentadienyl cation, that can also be 
represented by its resonance structure. An electrocyclization followed by 
protodeauration leads to the cyclopentenamide 76 (Scheme 76).  
 
Scheme 76 - Gold(I)-Catalyzed imino-Nazarov cyclization. 
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General objectives 
As could be deduce from the introduction, at the outset of my PhD, in October 2009, the 
chemistry of gold catalysis had already achieved a considerable development with most 
of the processes consisting of intramolecular reactions. Our group and the group of F. D. 
Toste had reported (4+3) and (4+2) intramolecular cycloadditions of allenedienes 
providing a straightforward access to interesting bicycles incorporating a 7 or a 6 
membered ring respectively.66,67,68 However as commented in section 2.2.3, Au(I) 
catalyzed intermolecular cycloadditions were clearly underdeveloped, and in particular, 
intermolecular Au-catalyzed cycloadditions of allenes were inexistent. The most related 
example was the Pt(II)-catalyzed intermolecular (3+2) cycloaddition of propadienyl silyl 
ethers and alkenyl ethers reported by Iwasawa (Scheme 47, page 32).82 Given these 
circunstances and the relevance of the potential cycloadducts that one could expect from 
the cycloaddition reactions between allenes and second C-C unsaturated cycloaddition 
components (Scheme 77) we decide to investigate the development of novel Au-
catalyzed intermolecular cycloadditions of allenes and derivatives equipped with 
heteroatoms such as allenyl ethers or allenamides. 
 
Scheme 77 - Possible cycloadducts resulting from gold catalyzed cycloaddition of allenes. 
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We were first curious in exploring the viability of develoving intermolecular versions of 
the gold-catalyzed cycloaddition between allenes and 1,3-dienes, which might 
potentially occur via mechanisms similar to those proposed in the intramolecular cases. 
Based on the intramolecular results, one might expect two main types of cycloadducts, 
namely cyclohexene products coming from a formal (4+2) reaction, or cycloheptadienes 
arising from a (4+3) annulation (Scheme 78). 
•
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Scheme 78 – Possible cycloadducts between allenes and dienes. 
Both systems are equally interesting, since the number of catalytic methods that allow 
their construction using an intermolecular cycloaddition of ready accessible, unactivated 
starting materials is extremely low. Moreover, these cycles are present in many 
biologically active products, so the development of new, efficient methods for their 
preparation is highly relevant. 
 
There are several metal catalyzed methods that allow the preparation of 7 and 6 
membered carbocycles by means of cycloaddition reactions albeit the intermolecular 
versions are very scarce. 131,132  
 
Seven membered rings 
A relevant example of an intermolecular (4+3) cycloaddition involving dienes was 
reported by B. M. Trost. He showed that 2-(Trimethylsilylmethyl)allyl acetate (77) in the 
presence of a palladium catalyst generates stabilized trimethylenemethane intermediates 
(Pd-TMM) capable of undergoing a (4+3)-cycloaddition with electron-deficient dienes to 
give cycloheptenes of type 78. However, in some examples a vinyl-substituted 
methylenecyclopentene like 79 was also formed (Scheme 79).133 
                                                     
131 For reviews on the preparation of seven-membered rings see: a) Battiste, M. A.; Pelphrey, P. M.; Wright, D. L. Chem. 
Eur. J. 2006, 12, 3438–3447. b) Harmata, M. Chem. Commun. 2010, 46, 8886–8903. c) Harmata, M. Chem. Commun. 2010, 46, 
8904–8922. d) Lohse, A. G.; Hsung, R. P. Chem. Eur. J. 2011, 17, 3812–3822. e) Fernández, I.; Mascareñas, J. L. Org. Biomol. 
Chem. 2012, 10, 699–704. In the preparation of natural products: f) Hartung, I. V; Hoffmann, H. M. R. Angew. Chemie Int. 
Ed. 2004, 43, 1934–1949. g) Nguyen, Thanh Vinh; Hartmann, Jan Marc; Enders, Dieter, Synthesis, 2013, 45, 845-873. 
132 For Diels-Alder process selected examples with 1,3-dienes see: a) ref 42, page 24: Wender, P. A.; Jenkins, T. E. J. Am. 
Chem. Soc. 1989, 111, 6432–6434. b) Jolly, R. S.; Luedtke, G.; Sheehan, D.; Livinghouse, T. J. Am. Chem. Soc. 1990, 112, 4965-
4966. c) Motoda, D.; Kinoshita, H.; Shinokubo, H.; Oshima, K. Angew. Chem. Int. Ed. 2004, 43, 1860-1862.  
133 a) Trost, B. M.; Nanninga, T. N.; Chan, D. M. T. Organometallics 1982, 1, 1543–1545. b) Trost, B. M.; MacPherson, D. T. J. 
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Scheme 79 – (4+3) Cycloaddition of a trimethylenemethane precursor. 
S. Saito described an interesting Ni-catalysed (4+3) cycloaddition reactions of ethyl 
cyclopropylideneacetate with 1,3-dienes, which provided the corresponding 
cycloheptene derivatives 80 with both moderate yields and regioselectivities (Scheme 
80). 134 
 
Scheme 80 – Ni catalyzed intermolecular (4+3) cycloaddition. 
An interesting alternative way of rapidly assembling seven membered rings consists of 
the (5+2) cycloaddition of vinylcyclopropanes and alkynes or alkenes, first reported by 
P. A. Wender in 1998.135,136 This group showed that the treatment of the 
siloxycyclopropane with an alkyne in the presence of [Rh(CO)2Cl]2 produces 
cycloadducts of type 81, that are hydrolyzed during workup to the ketone. The proposed 
catalytic cycle begins with the coordination of the Rh-complex to the vinylcyclopropane, 
followed by opening of the cyclopropane ring to give a rhodium coordinated -allyl 
system (XXXVI). Subsequent alkyne coordination followed by insertion delivered 
intermediate XXXVII, which gives the observed cycloadduct through a reductive 
elimination (Scheme 81).137 
 
Scheme 81 – Rh-catalyzed Intermolecular (5+2) Cycloaddition. 
                                                     
134 Saito, S.; Takeuchi, K. Tetrahedron Lett. 2007, 48, 595–598. 
135 For reviews on 5+2 cycloadditions see: a) Pellissier, H. Adv. Synth. Catal. 2011, 353, 189–218. b) Ylijoki, K. E. O.; Stryker, 
J. M. Chem. Rev. 2013, 113, 2244–2266. 
136 Wender, P. A.; Rieck, H.; Fuji, M. J. Am. Chem. Soc. 1998, 120, 10976–10977. 
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P. A. Wender also studied the feasibility of the intermolecular process with allenes. The 
introduction of an additional conjugated coordinating group, such as an alkynyl, or 
cyano substituent, allowed a smooth cycloaddition at the distal double bond of the 
allene, providing substituted alkylidenecycloheptanones 82 as mixtures of E- and Z-
isomers (Scheme 82).138  
 
Scheme 82 – Rh-catalyzed intermolecular (5+2) cycloadditions of allenes and vinylcyclopropanes. 
The group of Barluenga developed a formal (3+2+2) cyclization of chromium alkenyl- 
(methoxy)carbene complexes (83) with two unities of allenes in the presence of Ni(0) or 
Rh(I) catalysts. The Ni(0)-mediated (3+2+2) reaction affords 84, that after 
chromatographic purification led to the 3,4-diisopropylidenecycloheptanone 85 (Scheme 
83, left). While using [Rh(COD)Cl]2 as catalyst, the reaction yielded 3,5- 
bis(alkylidene)cycloheptenes 86, which upon protonolysis afforded 2,4-
bis(alkylidene)cycloheptanones 87 (Scheme 83 right). Thus 1,2- and 1,3-dialkylidenecy- 
cloheptane derivatives can be chemo-, regio-, and diastereoselectively obtained 
depending upon the choice of the catalyst.139 
 
Scheme 83 – (3+2+2) cycloaddition of alkenyl Fischer carbene complexes and allenes. 
Six-membered rings 
With regard to the construction of cyclohexanyl adducts using metal catalyzed 
intermolecular cycloadditions, the examples are mainly reduced to Lewis acid promoted 
Diels Alder reactions.31 Some of these reactions involve the use of allenes,140 such as in 
                                                     
138 Wegner, H. A.; de Meijere, A.; Wender, P. A. J. Am. Chem. Soc. 2005, 127, 6530–6531. 
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31 a) Vollhardt, K. P. C.; Schore, N. E. Organic Chemistry; 3rd ed.; W.H.Freeman & Co Ltd, 1998. b) Fringuelli, F.; Taticchi, 
A. The Diels-Alder Reaction: Selected Practical Methods; Wiley: Chichester, U.K., 2002. c) Miller, J. P. Advances in Chemistry 
Research. Volume 18 - Recent Advances in Asymmetric Diels-Alder Reactions; Taylor, J. C., Ed.; Nova Science Publishers, Inc., 
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the reaction of 88 with cyclopentadiene to give the two (4+2) cycloadducts endo and exo-
89. The use of a Lewis acid lowers the reaction temperature and improves the yield and 
endo selectivity (Scheme 84).141  
 
Scheme 84 – (4+2) cycloaddition of allenic ester with cyclopentadiene. 
M. Murakami developed a highly regioselective (4+2) cycloaddition of vinylallene 
derivatives like 90 and alkynes for the synthesis of substituted benzenes, catalyzed by a 
Rh(I) complex.142 The resulting benzene derivatives (91) are obtained with excellent 
regioselectivities and very good yields. A plausible mechanism proposed by the authors 
involves the initial formation of a five-membered rhodacycle intermediate. Coordination 
of the alkyne, followed by a carbometallation step would provide a seven-membered 
rhodacycle. A final reductive elimination followed by isomerization to gain aromaticity 
delivers the benzene product 91. 
 
Scheme 85 - Rh-catalyzed (4+2) cycloaddition of vinyl allene and a terminal alkyne. 
The same authors also demonstrated that related (4+2) cycloadditions between 
vinylallenes 90 and unactivated 1,3-dienes could also be efficiently promoted by a Pd 
catalyst (Scheme 86), affording a cyclohexene derivative (92) in a highly regio- and 
stereoselective manner.143 The proposed mechanism involves the participation of the -
allyl complex XXXVIII, which explains the observed regio- and stereochemical outcome 
of the process. 
                                                                                                                                                              
2013; 18, 179–220. d) Nicolaou, K. C.; Snyder, S. A.; Montagnon, T.; Vassilikogiannakis, G. Angew. Chem. Int. Ed. 2002, 41, 
1668–1698. e) Takao, K.-I.; Munakata, R.; Tadano, K. Chem. Rev. 2005, 105, 4779–4807. 
140 Murakami, M.; Matsuda, T. Cycloadditions of Allenes, in Modern Allene Chemistry; Krause, N.; Hashmi, A. S. K., Eds.; 
Wiley-VCH Verlag GmbH: Weinheim, Germany, 2004.141 Ismail, Z. M.; Hoffmann, H. M. R. J. Org. Chem. 1981, 46, 3549–
3550. 
141 Ismail, Z. M.; Hoffmann, H. M. R. J. Org. Chem. 1981, 46, 3549–3550. 
142 Murakami, M.; Ubukata, M.; Itami, K.; Ito, Y. Angew. Chemie Int. Ed. 1998, 37, 2248–2250. 
143 Murakami, M.; Itami, K.; Ito, Y. J. Am. Chem. Soc. 1997, 119, 7163–7164. 
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Scheme 86 - Intermolecular directed (4+2) cycloaddition of vinylallenes with 1,3-dienes. 
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3.1 Preliminary studies 
Initially we tested the feasibility of the reaction of allenes with pyrroles, because in case 
of a (4+3) cycloaddition the methodology would afford a straighforward way of 
assembling tropane systems. 
 
This type of structure is common to a wide variety of natural products and 
pharmaceutical agents. Therefore, finding methods for their synthesis is highly 
appealing.144 
 
To test the feasibility of the process we mixed phenyl(1H-pyrrol-1-yl)methanone with 
different type of allenes in presence of catalytic amounts of PtCl2 or of the cationic gold 
complex resulting from mixing the phosphite derivative Au6 with AgSbF6. The results of 
the reactions tested are summarized in the Table 1. 
As can be deduced, the reactions led either to low conversions or to the formation of 
complex mixtures of products. The only products that could be identified, albeit in low 
yields, are enamides 93, that arise from an intermolecular hydroarylation reaction 
between the allene and the pyrrole. The best result, shown in entry 5, is obtained with an 
allene having an oxazolidinone group as substituent, and Au6/AgSbF6 as catalyst, whih 
in any case gave only a 12% yield of 93. In none of the cases we could identify the (4+3) 
or a (4+2) cycloaddition products. 
                                                     
144 a) Vaccinine B: Zanolari, B.; Guilet, D.; Marston, A.; Queiroz, E. F.; Paulo, M. D. Q.; Hostettmann, K. J. Nat. Prod. 2005, 
68, 1153–1158. b) 2,7-dihydroxynortropane: Asano, N.; Yokoyama, K.; Sakurai, M.; Ikeda, K.; Kizu, H.; Kato, A.; 
Arisawa, M.; Höke, D.; Dräger, B.; Watson, A. A.; Nash, R. J. Phytochemistry 2001, 57, 721–726. b) Reddy, R. P.; Davies, H. 
M. L. J. Am. Chem. Soc. 2007, 129, 10312–10313. 
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Table 1 - Reaction of pyrrole and allenes in the presence of a Pt or a Au catalyst. 
 
Entry R1 R2 [M] (5 mol%) Time Yield (%) 
1 OMe H Au6 / AgSbF6 10 min -a 
2 OMe H PtCl2 7h - a 
3 Me Me Au6 / AgSbF6 5h 93a, 5% 
4 Me Me PtCl2 7h No reaction 
5 O
N
O
 
H 
Au6 / AgSbF6 2h 93b, 12% 
6 PtCl2 21h No reaction 
7b Si-t-BuPh2 H A 3h No reaction 
a) Allene degradation. b) Using Ethyl acetate as solvent at 76ºC, A = [PtCl2C2H4]2/p-o-tolyl  
 
 
Given the poor results obtained with pyrroles as dienes, we turned our attention to other 
types of dienes. In this case we obtained interesting results when using allenamides as 
allene cycloaddition partners, as described in the next article published in the journal 
Chemical Science.145 
The mechanistic aspects of this chemistry, result of collaboration with theoretical 
colleagues, are described in the second article included in the sections (Chem. Eur. J.).146 
An appendix to this chapter includes notes on the development of an enantioselective 
version. 
 
 
                                                     
145 Faustino, H.; López, F.; Castedo, L.; Mascareñas, J. L. Chem. Sci. 2011, 2, 633-637. 
146 Montserrat, S.; Faustino, H.; Lledós, A.; Mascareñas, J. L.; López, F.; Ujaque, G. Chem. Eur. J. 2013, 19, 15248–15260. 
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Article 1 - Gold(I)-catalyzed intermolecular (4+2) cycloaddition of
allenamides and acyclic dienes 
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View OnlineGold(I)-catalyzed intermolecular (4 + 2) cycloaddition of allenamides and
acyclic dienes†
Helio Faustino,a Fernando Lopez,*b Luis Castedoa and Jose L. Mascare~nas*a
Received 15th December 2010, Accepted 13th January 2011
DOI: 10.1039/c0sc00630kA new type of intermolecular (4 + 2) cycloaddition, based on a gold-catalyzed reaction between
allenamides and acyclic conjugated dienes, is reported. The annulation, which fails under standard
Diels–Alder conditions, provides a straight entry to a variety of differently substituted cyclohexenes,
and takes place with excellent regio- and diastereoselectivity.Intermolecular (4 + 2) Diels–Alder cycloadditions are among the
most powerful synthetic transformations so far described;1
however, their effectiveness is usually restricted to the use of
properly biased dienes and dienophiles. The development of
methods that allow us to perform (4 + 2) cycloaddition of Diels–
Alder-inactive substrates would significantly expand the scope
and potential of this ring assembly strategy.
We and others have recently described gold-catalyzed intra-
molecular (4 + 2) cycloadditions of allene-tethered-dienes,2
reactions that efficiently afford trans-fused bicyclic systems
under very mild conditions. Conversely, more challenging,
intermolecular versions of these cycloadditions have remained
elusive. Herein, we report the discovery and implementation of
such intermolecular process, namely a highly selective gold-
catalyzed (4 + 2) cycloaddition between non-activated 1,3-dienes
and allenamides, a particularly accessible and versatile type of
allenic scaffold.3 To the best of our knowledge, this methodology
constitutes the first transition metal-catalyzed intermolecular
(4 + 2) cycloaddition between allenes (2C) and 1,3-dienes (4C),4
as well as one of the very few types of intermolecular cycload-
ditions of allenes promoted by gold or platinum catalysts.5,6
A preliminary reactivity screening using isoprene (2a) revealed
that its treatment with electronically neutral allenes, such as 3-
methylbuta-1,2-diene (1a, Fig. 1), in the presence of different
sources of Pt or Au catalysts, leads to intractable mixtures of
products. These results confirmed that the development of
intermolecular variants of this type of annulations betweenaDepartamento de Quımica Organica, Centro Singular de Investigacion en
Quımica Biologica y Materiales Moleculares, y Unidad Asociada al CSIC.
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915644853; Tel: +34 915622900
† Electronic supplementary information (ESI) available: Experimental
procedures, characterization data, crystallographic data. CCDC
reference numbers 804843–804850. For ESI and crystallographic data
in CIF or other electronic format see DOI: 10.1039/c0sc00630k
This journal is ª The Royal Society of Chemistry 2011allenes and dienes is not straightforward.7 Electronically rich
allenes such as 1b or 1c also led to complex reaction mixtures.8
Gratifyingly, treatment of isoprene with the allenamide 1d in
the presence of PPh3AuCl/AgSbF6, at 15 C, produced the (4 +
2) cycloadduct 3da in 33% yield together with the (2 + 2) cyclo-
adduct 4da, which was isolated in 19% yield. (Table 1, entry 1).9
As shown in entries 1–4, this reaction could also be promoted by
several other cationic Au-catalysts (B-D). In all the cases, in
addition to the (4 + 2) adduct, we also isolated variable amounts
of the (2 + 2) cyclobutane derivative 4da (14–20% yield).10
Remarkably, neutral gold chloride catalysts turned out to be less
active but more selective in favor of the (4 + 2) process (Table 1,
entries 5–7), with AuCl being the most effective as we observed
only traces of the side (2 + 2) adduct (Table 1, entry 7). Thus,
treatment of 1d with 5 mol% of AuCl in presence of isoprene
(6 equiv) at rt afforded, in a completely regio- and highly
stereoselective manner, the (4 + 2) cycloadduct 3da in a 65%
isolated yield.
Importantly, reducing the amount of isoprene from six to three
equivalents did not influence the efficiency of the process
(Table 1, entry 8), whereas the use of just 2 equivalents provided
a slightly lower reaction yield (Table 1, entry 9). Remarkably, Pt
catalysts that had been previously found useful for inducing
intermolecular (3 + 2) cycloadditions5 gave very poor results in
this process (Table 1, entries 10–11). On the other hand, control
experiments with Brønsted acids or silver salts revealed that
neither of them are able to promote the annulation (Table 1,
entries 13–15), which, as expected, is also unfeasible under
thermal conditions (Table 1, entries 16–17). This result confirms
the Au-catalyzed nature of the process, as opposed to the recent
thermal intramolecular cycloadditions of furan-tethered allena-
mides.9gFig. 1
Chem. Sci., 2011, 2, 633–637 | 633
Table 1 Preliminary Screening of Catalytic Activity with isoprene (2a)
.a
Entry Catalyst Solvent Time (h) T (C) Conv (%)b 3da (%)c 4da (%)c
1 Ph3PAuCl/AgSbF6 (A) CH2Cl2 0.5 15 100 33 19
2 B CH2Cl2 0.1 15 100 41 16
3 C CH2Cl2 0.1 15 100 47 20
4 D CH2Cl2 6 15 100 64 14
5 E CH2Cl2 24 rt 100 46 6
6 AuCl3 CH2Cl2 48 rt 87 28 4
7 AuCl CH2Cl2 6 rt 100 65
d <2
8e AuCl CH2Cl2 6 rt 100 66
d <2
9f AuCl CH2Cl2 12 rt 100 55
d <2
105 [PtCl2(C2H4)]2/P(otol)3
g EtOAc 6 rt 10 2 0
11 [PtCl2(C2H4)]2/P(otol)3
g CH2Cl2 5 rt 57 15 0
12 PtCl2 CH2Cl2 24 rt 0 — —
13 CSA CH2Cl2 5 rt —
h — —
14 PPTS CH2Cl2 5 rt —
h — —
15 AgSbF6 CH2Cl2 18 40 0 — —
16 — THF 4 65 0 — —
17 — toluene 18 150 0 — —
a Allene 1d (1 equiv) was added to a mixture of 2a (6 equiv) and catalyst (5 mol%), in the specified solvent (0.1 M). b Conversion by 1H-NMR. c Isolated
yields. Adducts 3da and 4da are predominantly obtained as Z isomers (Z : E ratio > 9 : 1); determined by 2D-NMR. d Z:E ratio ¼ 93 : 7. e 3 equiv of
diene were used. f 2 equiv of diene were used. g Pt : L ratio ¼ 1 : 2. h Degradation of 1d was seen.
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View OnlineOnce established an optimum catalytic system, we evaluated
the versatility and scope of the process. As shown in Table 2,
allenamide 1d undergoes the cycloaddition reaction with
a variety of differently substituted acyclic dienes (2b-2k). Thus,
reaction of 1d with 2,3-dimethylbuta-1,3-diene (2b) proceeded in
just 10 min to provide a 76% of the expected cycloadduct 3db,
which was isolated as a 93 : 7 mixture of Z : E isomers (Table 2,
entry 1). Reducing the amount of diene from three to two
equivalents slowed the reaction, but 3db could still be isolated in
a satisfactory 63% yield (entry 2). Conjugated dienes 2c and 2d,
equipped with a methyl group at their external positions, also
reacted efficiently, providing the corresponding cycloadducts 3dc
and 3dd in a completely regio- and highly diastereoselective
manner (Table 2, entries 3 and 4). 2,4-Hexadiene 2e, with methyl
groups at the distal positions, afforded a single (4 + 2) isomer 3de
in 44% yield (67% conversion, Table 2, entry 5). Curiously,
a better yield (67%) was obtained in this case when the reaction
was carried out at 15 C with the more reactive cationic catalyst
B, which features a N-heterocyclic carbene ligand (Table 2, entry
6).11 Complex B was certainly the catalyst of choice for the
reaction of allenamide 1d with 1,4-disubstituted diene 2f, reac-
tion that gave cycloadduct 3df as the only identifiable adduct in
52% yield (Table 2, entries 7 and 8). Diene 2g, with two exo-
methylene groups, also participated in the cycloaddition process
affording, upon treatment with AuCl (5 mol%) for 2 min, the
expected adducts 3dg and 3dg0 in a good 80% global yield
(Table 2, entry 9).
Donor substituents at the diene were well tolerated. Indeed,
the reaction of allenamide 1d with diene 2h gave the634 | Chem. Sci., 2011, 2, 633–637corresponding adduct as a single regio- and diastereoisomer, in
76% yield (Table 2, entry 10). Similarly, the presence of aryl
substituents at the diene provided very clean and selective reac-
tions, so the desired (4 + 2) adducts were obtained with complete
selectivities and good yields (Table 2, entries 11–14), even when
only two equivalents of diene were employed (Table 2, entries 12,
14).
Also importantly, the reaction is not limited to allenamide 1d;
other allenamides, such as 1e, or the chiral disubstituted allena-
mide 1f, equipped with a methyl group at the distal position, also
participated in the process, affording the corresponding adducts
3ei and 3fi in good or excellent yields, and as single regio and
diastereoisomers (Table 2, entries 15 – 17).
Confirmation of the structure and stereochemical assignment
of all the products was unambiguously achieved by NMR
analysis and in many cases, such as for cycloadducts 3db, 3dd,
3de, 3df, 3dj, 3di and 3fi, we could also resolve their structure by
X-ray diffraction analysis (Fig. 2).8
The presence of an oxazolidinone moiety in the allenamide
unit brings excellent opportunities for the development of
asymmetric variants of these cycloadditions. As a first approach
toward this end, we prepare chiral allenamides 1g and 1h, easily
accessible in two simple steps from commercially available oxa-
zolidinone precursors.8,9a,c The AuCl-catalyzed cycloaddition of
1g with 2i led to a 5: 1 mixture of diastereoisomers 3gi and 3gi0,
which were isolated in an excellent 95% combined yield (Table 3,
entry 1).13 The diastereoselectivity of the process could not be
improved by lowering the reaction temperature to 0 C (Table 3,
entry 2); however, by using the more reactive catalyst B, we couldThis journal is ª The Royal Society of Chemistry 2011
Table 2 (4 + 2) Cycloaddition of Allenamides (1) and dienes (2)
.a
Entry 1 Diene (2) (4 + 2) adduct (3) [Au] Time 3 (%)b
1 1d AuCl 10 min 76
2c 1d AuCl 6 h 63
3d,e 1d AuCl 1 h 60
4d,f 1d AuCl 6 h 62
5d 1d AuCl 20 h 44g
6h 1d B 25 min 67i
7 1d AuCl 7 h 15
8h 1d B 5 min 52
9 1d AuCl 2 min 80j
10 1d AuCl 2 min 76k
11 1d AuCl 10 min 96
12
c 1d AuCl 4 h 88
13 1d AuCl 26 h 81e
14c 1d AuCl 15 h 70
15 1e AuCl 72h 63
l
16
h 1e B 1h 94
17 1f AuCl 20 min 79
a Allene 1 (1 equiv) was added to a mixture of 2 (3 equiv) and catalyst (5 mol%), in CH2Cl2 (0.1 M) at rt, unless otherwise noted; >99% conversions (
1H-
NMR). b Isolated yields of 3 (Z : E ratio > 93%). c 2 equiv of diene were used. d 6 equiv of diene (unoptimized) were used. e 10 mol% of catalyst. f Diene
2d consists of a 7 : 3 mixture of Z : E isomers. g 67% conversion. h Reaction carried out at 15 C. i The corresponding (2 + 2) adduct 4de was also
isolated in 17% yield;8 Global combined yield: 84%. j Ratio of regioisomers 3dg:3dg0 ¼ 1.8 : 1. k A side adduct (5dh) was also isolated (13%).12
Global combined yield: 89%. l Conversion (by 1H-NMR).
This journal is ª The Royal Society of Chemistry 2011 Chem. Sci., 2011, 2, 633–637 | 635
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View Online
Fig. 2 X-Ray structures of adducts 3de, 3fi.8
Fig. 3 X-Ray structures of adducts 3gi and 3hi.
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View Onlineperform the reaction at 15 C, obtaining an excellent 17 : 1
diastereoisomeric ratio and an overall 95% yield (Table 3,
entry 3).14
On the other hand, cycloadditions of chiral allenamide 1h with
diene 2i were completely selective and very efficient with both
catalysts. Indeed, under AuCl catalysis (10 mol%), a single
diastereoisomer 3hi was obtained in 99% yield (Table 3, entry 4),
whereas employing catalyst B, 3hi could be obtained in identical
yield after just 10 min at 15 C (Table 3, entry 5). The stereo-
chemical assignment of 3hi as well as that of 3gi could be
successfully established by X-ray analysis (Fig. 3).8
The exo-enamide group present in the (4 + 2) cycloadducts of
type 3 should provide for divergent synthetic elaborations.15 As
a preliminary test we found that treatment of adduct 3hi under
acidic conditions followed by reduction with NaBH4 yielded the
expected alcohol in 71% yield (dr: 9 : 1, Scheme 1).
From a mechanistic point of view, the regioselectivity of the
process and the formation of secondary minor (2 + 2) cyclo-
adducts suggest that, at least in some cases, the reaction might
proceed through an stepwise cationic pathway such as that
shown in Scheme 2. Thus, activation of the allene by the Au
catalyst would afford a Au-allyl cation species of type I.2a,b,e
Nucleophilic intermolecular interception of I by the diene would
provide a second cationic intermediate II. This would be the
regioselectivity-determining step, with the formation of the more
substituted allyl cation II being favored. Finally, a ring closing
process through attack of the enamide group to the moreTable 3 Asymmetric Au-catalyzed (4 + 2) cycloaddition
.a
Entry 1 [Au] T (C)
1 1g AuCl rt
2 1g AuCl 0
3 1g B 15
4d 1h AuCl rt
5 1h B 15
a Allene 1 (1 equiv) was added to a mixture of 2i (3 equiv) and catalyst (5 mo
conversions. b dr determined by 1H-NMR on the crude mixtures. c Isolated
catalyst was used.
636 | Chem. Sci., 2011, 2, 633–637accessible a-carbon of the allyl cation, and elimination of the Au
complex would yield the final (4 + 2) adduct 3. Alternatively,
cyclobutane derivatives of type 4 would be produced by the
attack of the enamide group at the internal g-carbon of the allyl
cationic species II.
In consonance with this mechanism, the Au-catalyzed reaction
of 1d and 2b in the presence of exogenous MeOH (3 equiv)
provided, besides 3db (40% yield), the allyl methyl ethers 7db and
8db in a global 14% yield (Scheme 3). These compounds must
result from the nucleophilic trapping of intermediate II at its
a and g positions. Unfortunately, the yield of these compounds
could not be further improved and performing the same reaction
with other dienes such as 2a or 2i, instead of 2b, did not allow to
isolate analogue compounds of type 7 or 8. Therefore, other
mechanisms, in particular those involving either a direct
concerted (4 + 2) cycloaddition of I with the diene, or a (4 + 3)
cycloaddition followed by ring contraction,2 could also be
operative. The predominance of either pathway might depend on
both, the structure of the diene and the nature of the catalyst.
In conclusion, we have developed a new type of (4 + 2)
cycloaddition reaction, namely a gold-catalyzed annulation of
allenamides and acyclic conjugated dienes. The method provides
synthetically appealing cyclohexene derivatives in a highly or
completely selective manner and shows a wide scope and
generality. Work to develop catalytic, enantioselective variants
and to gain a deeper mechanistic understanding is underway.Time Ratio (3: 30)b Yield (%)c
2 h 5: 1 (3gi: 3gi0) 95
3.5 h 5: 1 (3gi: 3gi0) 62
10 min 17: 1 (3gi: 3gi0) 95
10 min 1: 0 (3hi: 3hi0) 99
10 min 1: 0 (3hi: 3hi0) 99
l%), in CH2Cl2 (0.1 M) either at rt (AuCl), or 15 C (catalyst B); > 99%
yields of the mixture of both isomers (Z : E ratio ¼ 1 : 0). d 10 mol% of
This journal is ª The Royal Society of Chemistry 2011
Scheme 1
Scheme 2 One potential mechanistic pathway for the Au-catalyzed
cycloaddition of allenamides 1 and conjugated dienes
Scheme 3 (4 + 2) cycloaddition in the presence of MeOH (3 equiv).
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Introduction
Along the last decade, research in homogeneous gold cataly-
sis has experienced an extraordinary growth.[1] The singular
characteristics of gold catalysts, such as their high carbophi-
licity, has allowed the development of a variety of powerful
and unique transformations. Particularly relevant in terms of
versatility and synthetic potential are the cycloadditions be-
tween allenes and p-unsaturated systems, such as dienes or
alkenes.[2–8] Several intramolecular versions of this type of
reaction have already been described[3–6] and, more recently,
challenging intermolecular variants have also been success-
fully addressed.[7,8] In this context, we recently disclosed
a gold-catalyzed intermolecular [4+2] cycloaddition of 1,3-
dienes (4C) and allenamides (2C),[7a,b,9] which takes place
with good yield and high regio- and diastereoselectivity, by
using AuCl or the cationic gold(I) complex [IPrAuCl]/
AgSbF6 (IPr=1,3-bis(2,6-diisopropylphenyl)imidazole-2-yli-
dene) as catalysts.[7a] In a number of cases, and depending
on the catalyst and diene employed, in addition to the [4+2]
adducts of type 3, we also observed cyclobutane side prod-
ucts arising from a competitive [2+2] cycloaddition between
the allene and one of the C=C double bonds of the diene
(Scheme 1).[8]
Scheme 1. Gold-catalyzed [4+2] cycloadditions of the allenamide 1 and
the dienes 2.[7a]
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From a mechanistic point of view, we preliminary pro-
posed that the activation of the allene by the gold catalyst
could generate a gold–allyl cation species of type I
(Scheme 2), which could be intercepted by a nucleophilic
diene. This attack would trigger a stepwise cationic process
such as that depicted in Scheme 2, to give either [4+2] or
[2+2] adducts, depending on the site selectivity at the ring
closure in intermediate II. Interestingly, when the AuCl-cat-
alyzed reaction of the allenamide 1 and 2,3-dimethyl buta-
diene (2b) was performed in the presence of exogenous
MeOH (3 equiv), small amounts of the allyl ether 5b (12%
yield) could be isolated together with the [4+2] cycloaddi-
tion product 3b, which was also obtained in 40% yield.[7a]
The formation of small amounts of 5b supports a stepwise
pathway like that shown in Scheme 2, but does not rule out
the existence of parallel alternative pathways leading to the
[4+2] cycloaddition products of type 3. In particular, the for-
mation of the products 3 could also be explained by invok-
ing either a [4+3] cycloaddition of I and the diene, followed
by a ring contraction in the resulting gold–carbene species
III (Scheme 3, upper pathway), or a concerted [4+2] cyclo-
addition between intermediate I and the diene (Scheme 3,
lower pathway). Indeed, the former pathway has been dem-
onstrated for the intramolecular [4+2] cycloadditions of al-
lenedienes,[4] whereas the second one has been proposed to
operate in the [Ph3PAu]
+-catalyzed [4+2] cycloaddition be-
tween allenyl ethers and dienes.[7c]
Owing to these open mechanistic questions, we were chal-
lenged to perform additional studies that could shed further
light on these gold-catalyzed cycloadditions as well as on the
reasons behind their high stereo- and regioselectivity.[7a] Re-
lying on a combined experimental and computational study,
we report herein the results of such a study, which not only
confirm that there are several mechanistic pathways that ac-
count for the experimentally observed products, but also
that their respective prevalence is quite dependent on the
particular characteristics of the diene and the catalyst em-
ployed.
Results and Discussion
Our first mechanistic incursions addressed the possibility of
experimentally trapping reaction intermediates of the type
II and III in the AuCl-catalyzed cycloadditions of allena-
mide 1 with neutral dienes, like isoprene (2a) or 2,3-dimeth-
yl butadiene (2b). As mentioned above, the reaction with
2,3-dimethyl butadiene (2b), in the presence of exogenous
MeOH allowed the isolation of the allyl methyl ether 5b
with 12% yield, which must arise from the interception of
a cationic intermediate such as IIb (Scheme 2, R2,3=Me,
R1,4=H; Table 1, entry 2). Carrying out the same reaction
with isoprene (2a) provided a complex mixture of products
containing only traces of the [4+2] cycloaddition product 3a
(Table 1, entry 4). These ambiguous results led us to explore
other nucleophilic reagents as trapping agents. In particular,
we tested several pyridine oxides and aryl sulfoxides, previ-
ously shown effective in the interception of carbocationic
species, or in the oxidation of gold carbenes into their corre-
sponding carbonyl derivatives.[10]
As can be seen in Table 1 (entries 5–13), all reactions pro-
moted by AuCl (5 mol%) between allenamide 1 and the
dienes 2a or 2b in the presence of these external additives
provided, in addition to adducts of the type 3, the seven-
membered [4+3] cycloaddition products 6a or 6b, respec-
tively, which presumably arise from the oxidative intercep-
tion of the gold carbenoid intermediates of the type
III.[10a,11] In the case of isoprene (2a, Table 1, entries 5–8),
product 6a was obtained in a maximum yield of 18% when
the reaction was performed in the presence of 3,5-dichloro-
pyridine oxide (3 equiv) as external oxidant (Table 1,
entry 5). In this reaction, the [4+2] adduct 3a was also iso-
lated in 28% yield. For 2,3-dimethyl butadiene (2b),
a higher yield of 6b (20%) was observed when using 4-ni-
tropyridine oxide (3 equiv) and the reaction also provided
the [4+2] adduct 3b in 52% yield (Table 1, entry 11). Over-
all, and although the yields of 6a or 6b were modest, the
formation of these cycloheptenones points out to the partici-
pation of intermediates of the type III, which should evolve
to the six-membered carbocycles 3a or 3b by means of
a 1,2-ring contraction process.[4] In the presence of the exter-
nal oxidant, this ring contraction competes with the carbene
Scheme 3. Alternative mechanistic pathways that could render the [4+2]
cycloaddition product 3.
Scheme 2. Preliminary mechanistic proposal based on a stepwise cationic
pathway.
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oxidation process and therefore we observe mixtures of the
seven-membered ketone 6a or 6b and the six-membered cy-
cloaddition product 3a or 3b. Importantly, by using these
oxide additives we never detected putative products result-
ing from interception of intermediates of type II
(Scheme 2).[12]
Because the [4+2] cycloadditions can also be performed
with cationic gold complexes (Scheme 1),[7a,b] we also tried
to trap intermediates in the cycloadditions between allena-
mide 1 and the dienes 2a or 2b, carried out in the presence
of 5 mol% of [IPrAuCl]/AgSbF6. In this case, we did not ob-
serve products other than the [4+2] and the [2+2] cycload-
dition products 3 and 4 (Table 1, entries 14–17). These data
suggest that for this cationic catalyst, a concerted [4+2] cy-
cloaddition,[7c] and/or a cationic stepwise pathway could be
operative.
The [4+2] cycloaddition of allenamides can also be per-
formed with electron-rich dienes, such as 1-methoxy-1,3-bu-
tadiene (2c) (Table 2, entry 1).[7a] To assess which of the
pathways could be operative in this case, we performed the
cycloaddition of allenamide 1 and diene 2c in the presence
of trapping agents (Table 2). The reaction between 1 and 2c,
in the presence of MeOH (3 equiv) led to a complex mix-
ture of products, from which the aldehyde 7c was the only
one that could be isolated, in a modest 20% yield (Table 2,
entry 2). The employment of non-protic additives, such as
pyridine oxides or diaryl sulfoxides, allowed to increase the
efficiency of the reaction, providing aldehyde 7c and the
hemiketal 7c’ in good combined yields. Thus, by using
simple pyridine oxide
(3 equiv), 48% yield of the al-
dehyde 7c was isolated togeth-
er with 25% yield of its hemi-
ketal precursor 7c’ (Table 2,
entry 3). Similarly, the bis(p-
chlorophenyl) sulfoxide led to
43% yield of 7c and traces
(2% yield) of the [4+2] cy-
cloaddition product 3c
(Table 2, entry 4). The forma-
tion of the acyclic products 7c
and 7c’ suggests a stepwise
mechanism involving the spe-
cies IIc (Table 2), which is
trapped by the external nucleo-
phile. The [2+2] cycloaddition
product 4c, as well as other
products such as the seven-
membered derivative 6c, po-
tentially arising from the oxi-
dative interception of the cy-
cloheptyl–carbene intermedi-
ates III c, were never detected.
Although the above-de-
scribed experimental data do
not allow to extract definitive
mechanistic conclusions, they
suggest that different mechanistic pathways might be operat-
ing depending on the type of the diene (electron neutral vs.
electron rich), and also on the type of the gold catalyst
(AuCl vs. [IPrAu]+). The use of electron-rich dienes, such as
2c, favors a stepwise cationic pathway, whereas more neu-
tral dienes, such as 2a or 2b, prefer pathways involving con-
certed cycloadditions, albeit competitive stepwise processes
could be simultaneously operative.
Table 1. Assays for capturing reaction intermediates in the cycloadditions of allenamide 1 and the dienes 2a
and 2b.
Entry Diene Additive[a] [Au] 3 ([%])[b] 4 ([%])[b] 5 ([%])[b] 6 ([%])[b]
1 2b – AuCl 3b (76) – – –
2 2b MeOH AuCl 3b (40) – 5b (12) –
3 2a – AuCl 3a (66) 2 – –
4 2a MeOH AuCl 3a (2) – – –
5 2a ACHTUNGTRENNUNG(3,5-Cl2)-Py-O
[c] AuCl 3a (28) – – 6a (18)
6 2a ACHTUNGTRENNUNG(4-NO2)-Py-O AuCl 3a (38) – – 6a (16)
7 2a Ph2S=O AuCl 3a (13) – – 6a (16)
8 2a Ar2S=O
[d] AuCl 3a (24) – – 6a (14)
9 2b Py-O AuCl 3b (32) – – 6b (9)
10 2b ACHTUNGTRENNUNG(3,5-Cl2)-Py-O AuCl 3b (51) – – 6b (18)
11 2b ACHTUNGTRENNUNG(4-NO2)-Py-O AuCl 3b (52) – – 6b (20)
12 2b Ph2S=O AuCl 3b (44) – – 6b (15)
13 2b Ar2S=O
[d] AuCl 3b (35) – – 6b (15)
14 2a –[e] ACHTUNGTRENNUNG[IPrAuCl]/AgSbF6 3a (41) 4a (16) – –
15 2a ACHTUNGTRENNUNG(3,5-Cl2)-Py-O
[e]
ACHTUNGTRENNUNG[IPrAuCl]/AgSbF6 3a (27) 4a (7) – –
16 2a MeOH[e] ACHTUNGTRENNUNG[IPrAuCl]/AgSbF6 3a (4) – – –
17 2b ACHTUNGTRENNUNG(3,5-Cl2)-Py-O
[e]
ACHTUNGTRENNUNG[IPrAuCl]/AgSbF6 3b (44) – – –
[a] Reactions carried out in the presence of three equivalents of the additive in CH2Cl2 at RT for 1–6 h, unless
otherwise noted. Results from entries 1–3 and 14 were taken from reference [7a]. [b] Yield of isolated product.
[c] Py=pyridine. [d] Ar=p-Cl-C6H4. [e] Reaction carried out at 15 8C.
Table 2. Interception of reaction intermediates in the cycloaddition of al-
lenamide 1 and diene 2c.
Entry Additive[a] T [8C] 3c [%][b] 7c [%][b] 7c’ [%][b]
1 – RT 76 – –
2 MeOH 15 – 20 –
3 Py-O 15 – 48 25
4 Ar2S=O 15 2 43 –
[a] Reactions carried out in the presence of three equivalents of the addi-
tive in CH2Cl2 for 1–6 h. [b] Yield of isolated products.
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To further clarify the mechanistic scenario, we performed
DFT calculations by using the allenamide 1, the dienes 2a
and 2c as model substrates, and AuCl and [NHCAu]+ as
gold catalysts.[13] We first evaluated the conformations of al-
lenamide 1 and its behavior with the gold complexes
(Scheme 4). Of the two preferred conformers considering
the dihedral angle C3-N-C-O, conformation 1 is the most
stable one (Scheme 4).[14] The calculations indicate that this
initial h2-coordination by using AuCl takes place through
the internal C2=C3 double bond of 1, with a preference
over the alternative C1=C2 counterpart of 1.6 kcalmol1.
The resulting intermediate (Int-1) evolves to the s-coordi-
nated metal allyl cation intermediate Int-2 (Scheme 4). This
process is accessible with an energy barrier of 4.2 kcalmol1,
and the resultant zwitterionic species Int-2 is just 0.8 kcal
mol1 less stable than its precursor Int-1. An analogue step
was found by using [NHCAu]+ as catalyst, with quite similar
energy values and an energy barrier of 4.6 kcalmol1. The
calculated data indicate that the C2=C3 bond is longer than
the C1=C2 bond and that the C3N bond is shorter than
those of their immediate precursor Int-1, which confirms
that the amide group contributes to the stability of this key
intermediate. Alternative conformations of this type of zwit-
terions, such as Int-2I could not be located, probably due to
a higher allylic strain.
Metal allyl cation intermediates of the type Int-2 are reac-
tive species susceptible of being attacked by the diene
through an exo or an endo mode (Scheme 5).
s-cis Dienes
Exo approach : The energy profile for the exo approach of
isoprene (2a) to Int-2 by using AuCl as catalyst is shown in
Figure 1. As energy reference we chose the allenamide h2-
coordinated to the metal complex (Int-1) in the presence of
the diene 2a arranged in an s-cis conformation (Int-1+2a).
The first step, as previously commented, involves the forma-
tion of the metal allyl cation (Int-2) through an energy bar-
rier of 3.5 kcalmol1 (TS1).[15] The reaction between the
diene 2a and the metal allyl cation moiety was explored
trying to identify the three previously proposed alternatives,
namely a stepwise process involving an allyl cation of the
type II (Scheme 2), a concerted [4+2] cycloaddition
(Scheme 3, lower pathway), or a concerted [4+3] annulation
(Scheme 3, upper pathway). Despite an intensive search,
only the latter pathway could be computationally located.
As shown in Figure 2, the transition state for the [4+3] cy-
cloaddition TS2, is significantly asynchronous, with a CC
bond lengths of 2.186 (C1C4) and 2.986  (C3C7).[16] A
visual inspection of the imaginary frequency motion suggests
Scheme 4. Initial gold activation of allenamide 1 (distances are given in
[], DG values are given in [kcalmol1]).
Scheme 5. Exo and endo approaches exemplified for isoprene (2a) (L=
Cl or NHC).
Figure 1. Energy profile for the exo approach of isoprene (2a) to Int-2 (DG values are given in [kcalmol1]).
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that the driving force for the transformation is the nucleo-
philic attack of the diene (C4) to the former terminal allene
carbon atom (C1), thereby generating the corresponding
C1C4 bond. The cycloaddition process has a relative
energy barrier of 5.2 kcalmol1, and the heptacyclic inter-
mediate Int-3 has an energy of 7.6 kcalmol1. Int-3 is char-
acterized by a chair-like con-
formation with a pseudoequa-
torial disposition of the oxazo-
lidinone moiety. The participa-
tion of the species Int-3 in the
cycloaddition is consistent with
the experimental isolation of
the seven-membered ketone
6a when the AuCl-catalyzed
reaction of allenamide 1 and
diene 2a was carried out in the
presence of gold–carbene oxi-
dants (Table 1, entries 5–8).
The carbene species Int-3
might evolve through different
1,2-hydrogen-atom migrations
or 1,2-alkyl shifts, as previously
demonstrated in the context of
[4+3] intramolecular cycload-
ditions between allenes and
dienes.[3,4] The calculations in-
dicate that the ring contraction
to give the cyclohexene ad-
ducts is clearly favored over
the 1,2-hydrogen-atom migra-
tions, which would generate
cycloheptadienes of the type 8
(never observed experimental-
ly). The energy profile of these
pathways and the structure of
the key stationary points can
be found in Figures 1 and 2.
The stereospecific formation of the Z-enamide moiety is
a consequence of the pseudoequatorial disposition of the ox-
azolidinone group, which determines the stereochemistry of
the alkene resulting from the ring contraction. Indeed, ex-
ploration of the same ring contraction on conformer Int-3I,
which displays the oxazolidinone group in a pseudoaxial dis-
position, led to the isomeric E-enamide cycloadduct, (E)-3a,
through an energy barrier of 6.1 kcalmol1 (TS3I,
Figure 3).[17] The energy barrier for the conversion of Int-3
into Int-3I turned out to be of 8.1 kcalmol1, with Int-3I
being 4.8 kcalmol1 less stable than Int-3. Thus, the global
energy barrier for the formation of E-3a from Int-3 is
10.9 kcalmol1.[18,19] These results explain the high selectivity
towards the Z-enamide cycloadduct Z-3a, which is the
major product in the cycloaddition between allenamide
1 and neutral dienes like 2a (Scheme 1, Z/E ratios93:7, by
using AuCl as catalyst).[7a]
We also explored the pathway leading to the regioisomer-
ic product 9a (Figure 4). We located the transition state for
the corresponding regiocomplementary exo [4+3] cycloaddi-
tion between Int-2 and 2a (regio-TS2) and found that it ex-
hibits a higher relative energy than the alternative TS2 [D-
ACHTUNGTRENNUNG(DG)=1.6 kcalmol1] .[19] Although the difference is not
high, the result is qualitatively in agreement with the experi-
mental observation of 3a instead of 9a.
Figure 2. Structures of the key stationary points leading to Z-3a-(AuCl)
(distances are given in []).
Figure 3. Formation of (E)-3a by conversion of Int-3 into Int-3I (DG values are given in [kcalmol1]).
Figure 4. Regiocomplementary approach between Int-2 and 2a.
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In conclusion, the formation of the [4+2] product 3a (and
other related adducts like 3b) in the AuCl-catalyzed cyclo-
additions of allenamide 1 with diene 2a (or related neutral
dienes like 2b),[7a] as well as the observed regioselectivity
(with diene 2a) and the Z selectivity (typically Z/E93:7)
is consistent with the mechanistic profile outlined in
Figure 1.[20]
Endo approach : In contrast to the exo approach, when the
diene approaches the allyl cation in an endo mode, a transi-
tion state analogous to TS2, leading to a seven-membered
carbene intermediate of the type Int-3 was not found. In-
stead, we located a related transition state, TS2-endo, corre-
sponding to a direct [4+2] cycloaddition between Int-2 and
2a (Figures 5 and 6) that leads to the same product (Z)-3a.
The new transition state is highly asynchronous (TS2-endo :
dACHTUNGTRENNUNG(C1C4)=2.141 and dACHTUNGTRENNUNG(C2C7)=3.395 ), and the driving
force for the reaction is also the nucleophilic attack of 2a to
the metal allyl cation intermediate Int-2 to make the C1C4
bond (Figure 6). The reason for the preferred closure of the
cycle by the C2 atom, leading to the cyclohexene product,
instead of the C3 atom, which would generate the cyclohep-
tene ring, is not evident. However, it is important to note
that in TS2 the C7 atom is nearest to the C3 atom than to
the C2 atom (dACHTUNGTRENNUNG(C2C7)=3.144 and dACHTUNGTRENNUNG(C3C7)=2.986 ),
whereas in TS2-endo C2C7 is the shortest distance (dACHTUNGTRENNUNG(C2
C7)=3.395 and dACHTUNGTRENNUNG(C3C7)=3.419 ) (Figure 6). Important-
ly, TS2-endo is of higher energy than TS2, with a difference
of 1.7 kcalmol1 (8.3 vs. 6.6 kcalmol1). Analysis of both
transition states shows that this difference is mainly pro-
duced by the higher distortion energy of the allenyl–gold
moiety in TS2-endo (Edistortion-allenyl moiety=7.5 kcalmol
1) than
in TS2 (Edistortion-allenyl moiety=6.0 kcalmol
1). Analysis of the
natural orbitals of the reactants showed that the HOMO2
and the LUMO are the orbitals that interact in this step,
with the energy difference between the HOMO2 and the
LUMO being slightly higher for the TS2-endo species.
In summary, we have found different mechanistic paths
for the cycloaddition of isoprene (2a), depending on consid-
ering an exo or an endo approach; although both give rise
to the same six-membered ring product (Z)-3a. The exo
pathway, proceeding through the seven-membered carbene
species Int-3, is favored by 1.7 kcalmol1, though both path-
ways might similarly contribute to the product formation.
s-trans Dienes : In the above-described cases, in which we
considered an s-cis conformation of the diene, stepwise cat-
ionic processes like that drawn in the Scheme 2 could not be
located. However, such a stepwise mechanism was computa-
tionally captured when considering an s-trans conformation
of the diene (Figures 7 and 8). When the s-trans-configured
diene 2a, which is more stable than the s-cis conformer,[21]
Figure 5. Energy profile for the endo approach with isoprene (2a) (DG
values are given in [kcalmol1]).
Figure 6. Comparison of the exo (TS2) and the endo (TS2-endo) ap-
proach.
Figure 7. Energy profile for the exo approach with the s-trans-configured diene 2a (DG values are given in [kcalmol1]).
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attacks the electrophilic species Int-2, a new intermediate,
Int-4, which features an allyl cation moiety (dACHTUNGTRENNUNG(C5C6)=
1.430 and dACHTUNGTRENNUNG(C6C7)=1.356 ) is detected. This process ex-
hibits a relative energy barrier of 9.8 kcalmol1 and Int-4 is
7.4 kcalmol1 less stable than its precursor. At this point,
Int-4 may evolve by attacking the C2 atom of the vinyl gold
species to the allyl cation moiety at the C5 atom to give the
[2+2] product (Z)-4a. This step, which proceeds through
TS5 (dACHTUNGTRENNUNG(C2C5)=2.102 ), has a relative energy barrier of
4.9 kcalmol1, with an overall energy barrier for the forma-
tion of (Z)-4a of 13.5 kcalmol1. The formation of the cis-
enamide adduct, (Z)-4a, can
be understood by analyzing the
structures of Int-4 and the cor-
responding transition state
leading to the cyclobutane
(TS5). It can be observed that
the preferred conformation of
Int-2, displaying the Au atom
and the oxazolidinone in a cis
arrangement is conserved in
TS2-(s-trans), Int-4, and
through TS5.
Int-4 can also evolve to the
formal [4+2] cyclohexene
adduct (Z)-3a. In this case the
preferred path involves the for-
mation of Int-5 (dACHTUNGTRENNUNG(C5Au)=
2.238 ), in which the electron
density of the metal partially
neutralizes the positive charge
of the allyl cation.[22] This sta-
bilizing interaction is also re-
flected in the energy values,
because Int-5 is 5.9 kcalmol1
more stable than Int-4. Ac-
cordingly, the dACHTUNGTRENNUNG(C5C6) value
has now been increased up to
1.475  and the length of the
C6C7 bond is closer to that
of a double bond (dACHTUNGTRENNUNG(C6C7)=
1.343 ) (Figure 8). Interest-
ingly, Int-5 can be readily con-
verted through an energy bar-
rier of 7.2 kcalmol1 to the
rotamer Int-6 (rotation around
the C5C6 s bond). This new
intermediate has the appropri-
ate orientation to evolve to the
[4+2] product (Z)-3a through
transition state TS8 (5.6 kcal
mol1, Figure 7).[23] The whole
stepwise process leading to the
[4+2] adduct (Z)-3a exhibits
an overall energy barrier of
11.4 kcalmol1 thereby being
more favor ACHTUNGTRENNUNGable than that lead-
ing the [2+2] product (Z)-4a (overall energy barrier of
13.5 kcalmol1).[24]
The overall energy barriers leading to the cyclohexene,
(Z)-3a, and the cyclobutane, (Z)-4a, through either mecha-
nistic pathway are indicated in the Table 3. Taking as refer-
ence the energy of Int-1+2a-(s-trans) (Figure 7), which cor-
responds to the less energetic initial intermediate, it can be
observed that in all cases the formation of the [4+2] product
(Z)-3a is preferred. Moreover, and despite the requirement
of an initial s-trans-to-s-cis conformational rearrangement,
the pathway involving a [4+3] cycloaddition followed by
Figure 8. Structures of the key stationary points for the exo approach with the s-trans-configured diene 2a (dis-
tances are given in []).
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a ring contraction process is the most favored (9.9 kcal
mol1). The experimental observation of minor amounts of
the [2+2] product (Z)-4a can be explained according to the
pathway indicated in Figure 7, which begins from species
Int-1+2a-(s-trans), and presents an overall energy barrier of
13.5 kcalmol1. Overall, the energy barriers are in qualita-
tive agreement with the experimental results, because only
a 2% yield of the [2+2] product (Z)-4a was isolated in the
reaction between the allenamide 1 and isoprene (2a) by
using AuCl as catalyst.
Reactions with 1-methoxy-1,3-butadiene (2c): We have also
computationally explored the behavior of the methoxydiene
2c assuming an exo approach and an s-cis conformation
(Figures 9 and 10).[25] After the formation of the gold allyl
cation intermediate, the reaction proceeds by the nucleo-
philic attack of the diene to its terminal unsubstituted C1
atom (TS2OMe; energy barrier of 2.3 kcalmol1), which leads
to the quite stable oxonium intermediate Int-4OMe (7.2 kcal
mol1). In contrast to the case of isoprene, transition states
for concerted [4+3] or [4+2] cycloaddition processes could
not be located. Compared to diene 2a, the higher ability of
the methoxy group of 2c to stabilize the positive charge gen-
erated in this nucleophilic attack seems to disfavor a concert-
ed processes. Int-4OMe easily evolves to the formal [4+2]
product (Z)-3c through TS3OMe, with an energy barrier of
8.2 kcalmol1. Int-4OMe can also be converted to the [2+2]
cycloaddition product (Z)-4c through TS4OMe, although this
step presents a significantly higher energy barrier (12.4 kcal
mol1). Similarly to the formation of the cyclobutane (Z)-4a
from Int-4 (Figure 7), the stereospecific formation of the cy-
clohexene (Z)-3c (and (Z)-4c) is determined by the confor-
mation of the enamide moiety in Int-4OMe. Intermediate Int-
4OMe might also give the seven-membered carbene species
Int-3OMe through transition state TS5OMe but the energy bar-
rier is also higher than that leading to product 3c.
Overall, the calculated stepwise pathway through Int-4OMe
nicely fits with the experimental results given in Table 2,
and with the interception of this species by nucleophilic ex-
ternal agents to afford the aldehyde and hemiketal products
7c and 7c’.
Reactions catalyzed by [NHCAu]+ : As exemplified in
Scheme 1, [IPrAuCl]/AgSbF6 performs differently than
AuCl in the reaction of allenamide 1 with neutral dienes
like 2a or 2b, as in addition to the [4+2] adducts we ob-
served significant amounts of the cyclobutane products (5–
16% yield, Scheme 1).[7a] Therefore, we also decided to com-
putationally explore the different scenarios with this cata-
lyst, considering both an exo and an endo approach of the
Table 3. Overall DG values for the AuCl-catalyzed cycloadditions of al-
lenamide 1 and the diene 2a.[a]
Entry Approach[b] (Z)-3a (Z)-4a
1 Int-1+2a[d] 9.9 –[c]
2 Int-1+2a- ACHTUNGTRENNUNG(endo)[e] 11.6 –[c]
3 Int-1+2a- ACHTUNGTRENNUNG(s-trans)[f] 11.4 13.5
[a] DG values are given in [kcalmol1]. [b] Represented by the initial in-
termediate of the process. [c] A pathway leading to (Z)-4a could not be
located. [d] See Figure 1. [e] See Figure 4. [f] See Figure 7.
Figure 9. Energy profile for the exo approach with diene 2c (DG values are given in [kcalmol1]).
Figure 10. Structures of the key stationary points for the exo approach with the s-cis-configured diene 2c.
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diene, and an s-cis and an s-trans conformation of the diene
2a. Although, the potential energy surfaces revealed similar
mechanistic pathways to those previously found for AuCl,
there are some interesting differences.
Analysis of the exo and the endo approach of the diene
2a in an s-cis conformation revealed that in both cases the
formation of the cyclohexene product involves a direct cy-
cloaddition between this diene and the gold allyl cation Int-
2NHC. In contrast to that observed with AuCl, the [4+3] cy-
cloaddition pathway could not be located.
Figure 11 compares the structure of TS2NHC and that of its
analogue with AuCl (TS2). Both are very close in geometry,
and exhibit a shorter C7C3 distance than C7C2, suggest-
ing that a [4+3] cycloaddition could be feasible (TS2: dACHTUNGTRENNUNG(C2
C7)=3.144 and dACHTUNGTRENNUNG(C3C7)=2.986 ; TS2NHC: dACHTUNGTRENNUNG(C2C7)=
3.276 and dACHTUNGTRENNUNG(C3C7)=3.048 ). The preference of the six-
membered rather than the seven-membered closure could
be related to the subtle differences in the electron density of
the C2 and C3 atoms in these transition states, which is di-
rectly influenced by the electronic properties of the ligand
at the gold atom. However, a definitive conclusion cannot
yet be extracted from the computational data.[26]
In any case, both transition states eventually give rise to
the same final and experimentally observed product, and
both catalysts presents very similar overall energy profiles
(Figure 12). With [NHCAu]+ , the energy barrier for the
allyl cation formation is of 3.4 kcalmol1 (TS1NHC) and that
of the subsequent [4+2] cycloaddition is of 7.6 kcalmol1
(TS2NHC). On the other hand, as above described with AuCl
(Figure 1), the first step through TS1 involves an energy bar-
rier of 3.5 kcalmol1, whereas the [4+3] cycloaddition (TS2)
and the ring contraction process (TS3) present energy barri-
ers of 6.6 and 5.9 kcalmol1, respectively.
The endo approach with [NHCAu]+ also leads to a direct
[4+2] cycloaddition mechanism, with a global energy barrier
of 9.7 kcalmol1 (TS2NHC-(endo)).[19] Thus, like with AuCl,
the endo approach is less accessible than the exo approach
(7.6 kcalmol1, TS2NHC).
The second major difference between the reaction profiles
with AuCl and [NHCAu]+ is relevant to understand the for-
mation of a higher amount of the cyclobutane (Z)-4a when
[IPrAuCl]/AgSbF6 is used as catalyst. The energy profile for
the reaction of diene 2a considering an s-trans disposition is
shown in Figure 13. In contrast to the results with AuCl, the
pathway giving rise to the cyclobutane product (Figure 13,
solid line) is now the less costly, with a global energy barrier
of 14.5 kcalmol1 (through TS10NHC), meanwhile, the route
to the [4+2] product (Figure 13, dashed line) features a max-
imum energy barrier of 19.9 kcalmol1 (through TS8NHC).
Other than the energetic difference, the pathways are quite
similar to those obtained with AuCl (Figure 6). The first
step is the formation of the metal allyl cation, followed by
a nucleophilic attack to form the allyl cation intermediate
Int-4NHC (energy barrier of 12.2 kcalmol1 through TS2NHC-
(s-trans)). Alternative conformations of similar energy to
Int-4NHC, such as Int-5NHC and Int-6NHC, but exhibiting the
allyl cation moiety closer to the metal center could also be
localized (Figures 13 and 14). However, in comparison with
the same intermediate with AuCl (Int-5), the distance be-
tween the metal and the allyl cation in these conformations
is higher (d ACHTUNGTRENNUNG(C5Au)=2.238 (Int-5), 3.935 (Int-5NHC), and
3.755  (Int-6NHC)). Thus, the stabilizing interaction between
the allyl cation and the metal center seems stronger with
AuCl than with [NHCAu]+ . This fact is also reflected by the
higher relative energy of these intermediates (Int-5NHC and
Int-6NHC) compared to Int-5 (Figure 7). As in the AuCl
system, the formation of the formal [4+2] product from Int-
6NHC requires a conformational change through rotation
around the C5C6 bond; the energy barrier for this rotation
turned out to be significantly higher than with AuCl (9.8
(TS8NHC) vs. 5.6 kcalmol1 (TS8)), which is in consonance
with the lower interaction between the metal center and the
allyl cation moiety. Indeed, the structure of TS8NHC shows
Figure 11. Comparison between TS2 and TS2NHC (distances are given in
[]).
Figure 12. Comparison between exo approaches with AuCl and
[NHCAu]+ (DG values are given in [kcalmol1]).
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a C5Au distance of 2.302 , which is higher than that of its
AuCl analog TS8 (dACHTUNGTRENNUNG(C5Au)=2.189 ).
By using Int-1NHC+2a-(s-trans) as energy reference, a com-
parison between the global energy barriers for the different
approaches of the [NHCAu]+-catalyzed cycloaddition of al-
lenamide 1 and the diene 2a, leading to (Z)-3a and (Z)-4a
are presented in Table 4. Additionally, these values are also
compared with those previously obtained for the AuCl-cata-
lyzed reaction (Table 3). It can be deduced that for both
gold complexes the exo approaches between Int-1 or Int-
1NHC and the diene 2a in an s-cis conformation are the less
energetic (Table 4, entry 1), and give rise exclusively to the
cyclohexene product (Z)-3a. On the other hand, the reac-
tion involving diene 2a in an s-trans conformation provides
different results depending on the catalyst: AuCl again
favors the formation of the cyclohexene product, whereas
[NHCAu]+ provides a significantly higher energy barrier for
the formation of this adduct (19.9 kcalmol1), than for the
cyclobutane counterpart (14.5 kcalmol1). This results are
qualitatively consistent with the experimental data indicat-
ing that with [NHCAu]+ the proportion of the cyclobutane
product is higher.
Conclusion
Relying on a combined theoretical and experimental study
we have obtained invaluable mechanistic information on the
reactivity between allenamides and dienes in the presence
of gold catalysts. A common feature is the easy activation of
the allenamide by the gold catalyst to give a gold allylic cat-
ionic species of the type Int-2. Then, the subsequent steps of
the mechanism are highly dependent on the type of catalyst
and diene used in the reaction. With [IPrAu]+ and isoprene
(2a), the experimental observation of the cyclohexene cyclo-
adduct (Z)-3a can be explained in terms of a concerted
[4+2] cycloaddition between the s-cis diene and the allyl
cation intermediate Int-2NHC, whereas the formation of the
cyclobutane (Z)-4a must involve a stepwise cationic process.
The global energy barriers for the formation of the cyclo-
hexene (Z)-3a and the cyclobutane (Z)-4a are 11.2 and
14.5 kcalmol1, respectively (by using species Int-1NHC+2a-
(s-trans) as reference energy), which is in qualitatively
agreement with the yields of these two isolated adducts with
[IPrAu]+ .
With AuCl, the mechanistic picture is somewhat more
complex. The experimental trapping of intermediates of the
types II and III to give the acyclic products 5b or 7c and 7c’
or the cycloheptenones 6a and 6b, gave important clues on
the operative pathways, which were further corroborated by
the computational analysis.
The reaction starts by formation of the metal allyl cation
(Int-2), which undergoes a nucleophilic attack of the more
electron-rich double bond of the diene. In the case of iso-
prene (2a), this attack can result into three main pathways:
1) a concerted [4+3] cycloaddition (Figure 1), 2) a concerted
[4+2] cycloaddition (Figure 5), or 3) a stepwise reaction
(Figure 7). The first one is the most favorable pathway and
leads to the [4+2] adduct (Z)-3a, after a ring contraction
event. The second situation, a concerted [4+2] process, is
Figure 13. Energy profile for the cycloaddition of allenamide 1 and the s-trans-configured diene 2a catalyzed by [NHCAu]+ (DG values are given in [kcal
mol1]).
Table 4. Global DG values for the [4+2] or [2+2] cycloadditions be-
tween allenamide 1 and diene 2a catalyzed by [NHCAu]+ or AuCl.[a]
Approach ACHTUNGTRENNUNG[NHCAu]+ AuCl
(Z)-3a (Z)-4a (Z)-3a (Z)-4a
exo/s-cis[b] 11.2 –[c] 9.9 –[c]
endo/s-cis[d] 13.3 –[c] 11.6 –[c]
exo/s-trans[e] 19.9 14.5 11.4 13.5
[a] DG values are given in [kcalmol1]. [b] See Figure 12. [c] A pathway
leading to (Z)-4a could not be located. [d] See Figure 4 (AuCl) and the
Supporting Information ([NHCAu+]). [e] See Figures 7 (AuCl) and 13
([NHCAu+]).
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slightly more energetic (D(DG)=1.7 kcalmol1) but directly
affords the same [4+2] adduct (Z)-3a. Finally, the latter
stepwise pathway accounts for the formation of both (Z)-3a
as well as for the minor [2+2] adduct (Z)-4a ; although in
the latter case through an energetically less favored route.
The theoretical results are in agreement with the isolation
for products 6a, 6b, and 5b, as well as with the high selectiv-
ity towards the [4+2] adduct, the complete regioselectivity,
and the almost complete selectivity towards the Z isomer.
Finally, in the case of AuCl-catalyzed cycloadditions of an
electron-rich diene such as 1-metoxydiene (2c), the theoreti-
cal calculations are in agree-
ment with the experiments,
predicting a stepwise cationic
pathway through the key inter-
mediate Int-4OMe.
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Our group has also explored the viability of a gold(I)-catalyzed asymmetric version of 
the previous intermolecular (4+2) cycloaddition of allenamides and dienes. Toward this 
end we first tested the phosphoramidite Au17 as precatalyst in the reaction of 
allenamide 60b and 1-phenyl-1,3-butadiene. Unfortunately, we only got a modest 60% ee. 
Curiously the Segphos complex Au14 improved the value up to 77% ee (Scheme 87).148 
Although AuCl was the catalyst of choice in the racemic version, IPrAuCl/AgSbF6 was 
also shown to give a good reactivity. Therefore, we explored the viability of achieving 
this type of allene−diene cycloadditions in an enantioselective manner, by using chiral 
NHC−gold catalysts. 
In this context we prepared and tested many chiral gold catalysts incorporating chiral 
NHC`s already known in the literature (Au33-Au38). In all cases the yields of the (4+2) 
cycloadducts were good but the ee’s was really poor.  
Considering the good catalytic activity of Au38, we decided to explore other triazole-
based NHC ligands that could generate a more effective chiral environment at the 
proximity of the gold center. In collaboration with the group of J. M. Lassaletta, 
experienced of in NHC architectures,149 we envisioned that gold complexes of type A 
(Figure 4) could be particularly well poised for this task. The rigid bicyclic structure of 
these NHC units should fix the relative orientation of the C(carbene)-Au bond while 
forcing the C(5)-aryl substituent in close proximity to this reacting center, and therefore 
might favor an efficient transfer of axial chirality. Additionally, the asymmetric 
induction might be further tuned by modulating the steric demands of substituents R, 
and particularly R’.  
 
Figure 4 – Design of new chiral NHC ligands. 
The group of J. M. Lassaletta provided us this new type of axially chiral N-heterocyclic 
carbene ligands that they had just developed, from which we could readily make the 
corresponding gold complexes (Au39 and Au40). The cycloaddition of allenamide 60 
with 1-phenyl-butadiene catalyzed by the gold cationic complex derived from Au39, 
provided cyclohexene 94 with 82% yield and 63% ee. Gratifyingly, when the reaction was 
                                                     
147 In this work I performed the screening of chiral phosphoramidites and phosphine Au(I) complexes, like those that 
appear in Scheme 87, page 85 and confirmed the reproducibility of experimental procedures in Scheme 88, page 86. 
148 Francos, J.; Grande-Carmona, F.; Faustino, H.; Iglesias-Sigüenza, J.; Díez, E.; Alonso, I.; Fernández, R.; Lassaletta, J. M.; 
López, F.; Mascareñas, J. L. J. Am. Chem. Soc. 2012, 134, 14322–14325. 
149 For instance see: a) Alcarazo, M.; Roseblade, S. J.; Cowley, A. R.; Fernández, R.; Brown, J. M.; Lassaletta, J. M. J. Am. 
Chem. Soc. 2005, 127, 3290–3291. b) Iglesias-Sigüenza, J.; Ros, A.; Díez, E.; Alcarazo, M.; Alvarez, E.; Fernández, R.; 
Lassaletta, J. M. Dalton Trans. 2009, 7113–7120. 
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performed with Au40, which incorporates a cyclohexyl group instead of a Me in the 
ortho position, an ee value of 90% was obtained.  
 
Scheme 87 - Preliminary screening of chiral Au(I) catalysts. 
This ee could be improved by using AgNTf2 as a silver salt (up to 94%). As shown in the 
Scheme 88, a great variety of dienes participate in this process, leading to the desired 
cycloadducts in moderate to good yields, excellent ee’s and good diastereoselectivities. A 
remarkable example of the robustness of this method is illustrated in the cycloaddition 
of 60c with 1-phenyl-4-methyl-1,3-butadiene, which provided the cyclohexenyl adduct, 
including three new stereogenic centers with complete regio- and diastereoselectivity as 
well as with an excellent 91% ee (Scheme 88).148 
                                                     
148 Francos, J.; Grande-Carmona, F.; Faustino, H.; Iglesias-Sigüenza, J.; Díez, E.; Alonso, I.; Fernández, R.; Lassaletta, J. M.; 
López, F.; Mascareñas, J. L. J. Am. Chem. Soc. 2012, 134, 14322–14325. 
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Scheme 88 – Scope of the Au(I)-catalyzed asymmetric intermolecular (4+2) cycloadditions of allenamides 
and dienes. 
The X-ray structures of of the major enateomer of 94a (Figure 5, left) show the S 
configuration for the stereogenic center. Furtermore the X-ray structures of complex (R)-
Au40 (Figure 5, right) was used for the assignment of the absolute configuration of the 
chiral axis. The analysis of these structures confirmed that there might be substantial 
differences in the accessibility of either prochiral face of the allyl-cation gold 
intermediate that is presumably formed by activation of the allenamide.146 
                       
Figure 5 – Right, X-ray structure of (R)-Au40. H-atoms are omitted for clarity. Left, X-Ray structure of 94a. 
 
                                                     
. 146 Montserrat, S.; Faustino, H.; Lledós, A.; Mascareñas, J. L.; López, F.; Ujaque, G. Chem. Eur. J. 2013, 19, 15248–15260. 
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Shortly after our publication on the Au(I)-catalyzed intermolecular (4+2) cycloadditions 
of allenamides,150 a related article by A. Goeke appeared in the literature. This work 
describes a cationic gold(I)-catalyzed intermolecular (4+2) cycloaddition between dienes 
and allenyl ethers 95.151 The scope of the reaction with respect to the allenyl ethers is 
quite narrow, and for instance the reactivity of substituted allenes is not described. The 
reported scope for dienes is also limited, with only three cyclopentadienes and two 
acyclic dienes tested. The reaction has an excellent Z selectivity for all dienes (99:1 or 
higher), except for the unsubstituted cyclopentadiene (from 77:23 to 99:1).  
Therefore it seems that the allenamides, probably owing to presenting a more 
equilibrated reactivity, provide much better results. 
 
Scheme 89 - Au(I)-catalyzed intermolecular (4+2) cycloaddition between dienes and allenyl ethers. 
Based on DFT calculations the authors proposed that the cycloaddition occurs through 
an initial coordination of the gold catalyst to the allenyl ether to generate a zwitterionic 
metal intermediate of type XXXIX. This species undergo a (4+2) concerted cycloaddition 
with the diene, directly leading to the observed carbocycles (96). Depending on the 
conformation of species XXXIX, two different transition states (TS1 and TS2), 
respectively leading to the Z and E isomers, were identified. Transition state TS1, 
leading to the Z isomer turned out to be more favorable, by 2.0 Kcal.mol-1, in qualitative 
agreement with Z-selectivity observed with acyclic dienes (Scheme 90). 
                                                     
150 Faustino, H.; López, F.; Castedo, L.; Mascareñas, J. L. Chem. Sci. 2011, 2, 633-637. 
151 Wang, G.; Zou, Y.; Li, Z.; Wang, Q.; Goeke, A. Adv. Synth. Catal. 2011, 353, 550–556. 
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Scheme 90 – Proposed mechanism for the Au(I)-catalyzed intermolecular (4+2)  
 
5. Conclusion 
In conclusion, we have developed a new Au(I)-catalyzed (4+2) cycloaddition reaction 
between a variety of conjugated dienes and allenamides. For the racemic version, AuCl 
turned out to be a more selective catalyst, however in the cases where AuCl was less 
active, the catalytic system [IPrAuCl]/AgSbF6 was a good alternative. The method 
provides synthetically appealing cyclohexene derivatives in a highly or completely 
selective manner and shows a wide scope and generality. 
Experimental data and computational calculations showed that the mechanism of the 
reaction can diverge depending on the nature of the diene and the type of the gold 
catalyst. In reactions catalyzed by AuCl, electron-neutral dienes favored a concerted 
(4+3) cycloaddition followed by a ring contraction event, whereas electron-rich dienes 
preferred a stepwise cationic pathway to give the same type of formal (4+2) products. 
On the other hand, the theoretical data suggests that by using a cationic gold catalyst, 
such as [IPrAuCl]/AgSbF6, the mechanism involves a direct (4+2) cycloaddition between 
the diene and the gold-activated allenamide. 
Finally, in a separated record, the first examples of a highly enantioselective version of 
this process were described, which also represents the first asymmetric intermolecular 
(4+2) cycloaddition promoted by a chiral carbophilic metal complex. The success in the 
asymmetric induction relies on the development of a novel class of designed N-
heterocyclic carbene ligands (developed by Lassaleta and Fernandez’s group), featuring 
a triazole unit embedded in a rigid axially chiral cyclic frame. 
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In the previous chapter we described the first gold-catalyzed intermolecular 
cycloaddition of non-activated 1,3-dienes (4C) and allenamides (2C). In some cases a 
cyclobutane side product, resulting from a (2+2) cycloaddition of the allenamide with 
one of the double bonds of the diene was also observed. Given the synthetic and 
structural relevance of cyclobutane rings we decided to explore the feasibility of 
achieving the intermolecular (2+2) process in a selective manner. In case of success this 
methodology might represent a rapid and simple manner to construct highly 
functionalized cyclobutanes. 
 
Scheme 91 - (2+2) cycloaddition. 
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Cyclobutanes are widely spread among natural and biologically active products, such as 
antibiotics, terpenes, steroids, fatty acids, or cyctotoxic to cancer cells.152 In many cases 
they constitute the sole ring of the product, while in other they are fused to other cycles. 
Owing to their intrinsic strain, the stereoselective assembly of cyclobutane rings, 
particularly those which present several substitutents, is challenging.153  
 
The main strategies for the formation of the four-carbon ring system involve (2+2) 
cycloadditions, 1,4-cyclizations of acyclic precursors or ring expansion of 
cyclopropanes.153,154 
The ring expansion methodology needs a previous assembly of the required 
cyclopropane precursors, which necessarily involves the introduction of additional steps 
in the synthetic process. In the context of gold catalysis, it is interesting to comment the 
work by Toste and co-workers on the ring expansion of 1-allenylcyclopropanols like 97 
to cyclobutanones in the presence of chiral gold-phosphine complexes.155 The method 
provides synthetically valuable cyclobutanones of type 98, with a vinyl-substituted 
quaternary stereogenic center in high enantioselectivities and yields. The authors 
proposed a mechanism involving a initial external coordination of the Au(I) complex to 
the allene, followed by a ring expansion that results in the formation of cationic 
vinylgold(I) species XL. A subsequent protodemetalation liberates the catalyst and 
releases the product (Scheme 92).  
                                                     
152 a) Sergeiko, A.; Poroikov, V. V; Hanus, L. O.; Dembitsky, V. M. Open Med. Chem. J. 2008, 2, 26–37. b) Dembitsky, V. M. J. 
Nat. Med. 2008, 62, 1–33. c) Hansen, T.; Strenstrøm, Y. In Organic Synthesis: Theory and Applications; Hudlicky, T., Ed.; 
Elsevier Science Ltd, 2001; pp. 1–38. d) Terpenes; Breitmaier, E., Ed.; Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim, 
Germany, 2006. 
153 a) The Chemistry of Cyclobutanes; Rappoport, Z.; Liebman, J. F., Eds.; Patai Series: The Chemistry of Functional Groups; John 
Wiley & Sons, Ltd: Chichester, UK, 2005. b) Namyslo, J. C.; Kaufmann, D. E. Chem. Rev. 2003, 103, 1485–1537. c) Mack, D. 
J.; Njardarson, J. T. ACS Catal. 2013, 3, 272–286. d) Seiser, T.; Saget, T.; Tran, D. N.; Cramer, N. Angew. Chemie Int. Ed. 
2011, 50, 7740–7752.  
154 a) Secci, F.; Frongia, A.; Piras, P. P. Molecules 2013, 18, 15541–15572. b) Lee-Ruff, E.; Mladenova, G. Chem. Rev. 2003, 103, 
1449–1483.  
155 Kleinbeck, F.; Toste, F. D. J. Am. Chem. Soc. 2009, 131, 9178–9179. Previously the same group had reported a related 
rearrangement of 1-alkynylcyclopropanols: Markham, J. P.; Staben, S. T.; Toste, F. D. J. Am. Chem. Soc. 2005, 127, 9708–
9709. 
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Scheme 92 - Gold(I)-catalyzed ring expansion of a allenylcyclopropanol. 
Probably the most attractive method to make a cyclobutane ring relies on the use of a 
(2+2) cycloaddition, since two C−C bonds and up to four stereogenic centers can be 
formed in a single step, and the precursors can be simple alkenes or derivatives. These 
reactions can be thermal, photochemical or promoted by metal catalysts. While thermal 
processes are relatively scarce, (2+2) photochemical cycloaddions have been widely 
used, but they are limited to specific type of activated alkenyl precursors, and only work 
efficiently for homodimerization processes.  
Therefore there is a great interest on the use of transition metals to induce new type of 
catalytic (2+2) cycloadditions that can have a much larger scope than the thermal or the 
photochemical processes.  
Some succesful metal catalyzed (2+2) cycloadditions require that both reacting partners 
are tethered, and therefore the reaction generates fused cyclobutanes, such as the (2+2) 
annulations of propargylic indole-3-acetates catalyzed by Ph3PAuCl/AgSbF6 (Scheme 28, 
page 23),57 or the intramolecular (2+2) cycloadditions of enynes catalyzed by a gold (I) 
phosphine catalyst (Scheme 20, page 19).47,48 
Allenes have also been used as reaction partners in metal catalyzed intramolecular 
reactions.156156,41 
For instance, our group, in collabration with M. A. Esteruelas, has developed a fully 
diastereoselective (2+2) cycloaddition of allenenes or allenedienes (99).157 The proposed 
mechanism, supported with DFT calculations involves the participation of a complex 
like XLI, which evolves into the ruthenabicycle XLII by oxidative cyclometalation. A  to 
-allyl isomerization affords XLIII, which eventually afford the bicyclo[3.2.0]heptane 
products like 100. 
                                                     
57 Zhang, L. J. Am. Chem. Soc. 2005, 127, 16804–16805. 
47 Nieto-Oberhuber, C.; López, S.; Muñoz, M. P.; Cárdenas, D. J.; Buñuel, E.; Nevado, C.; Echavarren, A. M. Angew. Chemie 
Int. Ed. 2005, 44, 6146–6148 
48 Nieto-Oberhuber, C.; Pérez-Galan, P.; Herrero-Gómez, E.; Lauterbach, T.; Rodríguez, C.; López, S.; Bour, C.; Rosellón, 
A.; Cardenas, D. J.; Echavarren, A. M. J. Am. Chem. Soc. 2008, 130, 269–279. 
156 Alcaide, B.; Almendros, P.; Aragoncillo, C. Chem. Soc. Rev. 2010, 39, 783–816. 
41 Lautens, M.; Klute, W.; Tam, W. Chem. Rev. 1996, 96, 49–92. 
157 Gulías, M.; Collado, A.; Trillo, B.; López, F.; Oñate, E.; Esteruelas, M. A; Mascareñas, J. L. J. Am. Chem. Soc. 2011, 133, 
7660–7663. 
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Scheme 93 - Ruthenium-catalyzed (2+2) intramolecular cycloaddition of allenedienes. 
Propargylic esters can also act as masked allenes in the presence of a gold catalyst 
(Scheme 27, page 22).55,56 Using this strategy, Chang Ho Oh reported a gold-catalyzed 
intramolecular (2+2) cycloaddition of 1,8-alkadiynylic pivaloates (101) that afford the 
fused bicyclic compounds incorporating a cyclobutane ring (102) in good yields.158 The 
authors proposed a mechanism involving the activated allene by the gold catalyst, that 
undergoes a (2+2) cycloaddition to give XLIV, which eventually leads to the isolated 
product (102) upon hydrolysis. 
 
Scheme 94 - Au-catalyzed (2+2) cycloaddition of alkyne-propargylic pivaloates. 
An interesting Au(I)-catalyzed (2+2) cycloaddition of 1,5-bisallenes was recently 
reported by Y. K. Chung.159 In particular, the reaction of -unsubstituted-bisallenes 103 in 
the presence of N-heterocyclic carbene gold(I) catalyst, provides interesting 6,7- 
dimethyleneazabicyclo[3.1.1]heptanes (104). Importantly, the method tolerates either 
alkylic or aromatic substituents at the inner double bond of the allenes, affording the 
corresponding bicyclic products in good or excellent yields. Based on DFT calculations, 
the authors proposed a reaction mechanism consisting of an initial activation of the 
                                                     
55 Kazem Shiroodi, R.; Gevorgyan, V. Chem. Soc. Rev. 2013, 42, 4991–5001 
56 Modern Gold Catalyzed Synthesis; Hashmi, A. S. K.; Toste, F. D., Eds.; Wiley, 2012. 
158 Oh, C.; Kim, A. Synlett 2008, 2008, 777–781. 
159 Kim, S. M.; Park, J. H.; Kang, Y. K.; Chung, Y. K. Angew. Chemie Int. Ed. 2009, 48, 4532–4535. 
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allene (that triggers a 6-exo attack of the uncomplexed allene internal double bond to 
give the gold stabilized carbocation XLV. The proximity between the vinylgold and the 
carbocation in intermediate XLVallows the final ring closure to occur, affording the 
desired bicycles.  
 
Scheme 95 - Au(I)-catalyzed (2+2) cycloaddition of 1,5-bisallenes. 
Intermolecular (2+2) cycloadditions are even more challenging. As mentioned in the 
general introduction Tamaru demonstrated that allenamides can work as two carbon 
partners in the thermal intermolecular (2+2) cycloaddition with some alkenes (Scheme 
64, page 44).114 
Intermolecular (2+2) cycloadditions promoted by transition metal catalysts have been 
scarcely studied. A relevant example of Au(I) catalyzed intermolecular (2+2) 
cycloaddition of alkynes with alkenes (Scheme 43, page 31) in the general intruduction.78 
Previous to the initiation of our work, the use of allenes as cycloaddition partners had 
been limited to homodimerization processes. In this context, S. Saito and Y. Yamamoto 
reported an earlier example of a regioselective Ni-catalyzed (2+2) annulation of electron-
deficient allenes under mild conditions to give the head-to-head cyclodimerization 
products.160 The proposed mechanism initiates via initial regioselective coordination of 
the Ni to two molecules of the allene. The reaction of this species would evolve to 
nickelacyclopentane that upon reductive elimination, yields the cyclobutane as the final 
product. 
                                                     
114 a) Kimura, M.; Horino, Y.; Wakamiya, Y.; Okajima, T.; Tamaru, Y. J. Am. Chem. Soc. 1997, 119, 10869–10870. b) Horino, 
Y.; Kimura, M.; Tanaka, S.; Okajima, T.; Tamaru, Y. Chem. Eur. J. 2003, 9, 2419–2438. 
78 López-Carrillo, V.; Echavarren, A. M. J. Am. Chem. Soc. 2010, 132, 9292–9294. 
160 Saito, S.; Hirayama, K.; Kabuto, C.; Yamamoto, Y. J. Am. Chem. Soc. 2000, 122, 10776–10780. 
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Scheme 96 - Nickel(0)-Catalyzed (2+2) cycloaddition of electron-deficient allenes. 
In 2005, P. H. Dixneuf reported a Ru-catalyzed (2+2) cycloaddition of allenyl boronates 
like 105.161 In contrast to the above-mentioned Ni-catalyzed process, this Ru-catalyzed 
(2+2) cycloaddition occurs via an head-to-head (2+2) cyclodimerization of allenyl 
boronates and provided a straight entry to rigid 1,3-dimethyl enecyclobutane derivatives 
106. The (2+2) cyclodimerization products (106) were sequential transformed via Pd-
catalyzed Suzuki coupling in one pot to avoid product decomposition during work up 
(Scheme 97).  
 
 
Scheme 97 - Ru-catalyzed (2+2) cycloaddition of allenyl boronate. 
The only example of an intermolecular (2+2) cycloaddition of allenes involving different 
partners is the Pt(II)-catalyzed intermolecular (2+2) cycloaddition of propadienyl silyl 
ethers and alkenyl ethers described in Scheme 47, page 32), and was published while our 
work was ongoing.82,83  
Therefore, considering this context, the discovery and development of a gold catalyzed 
intermolecular (2+2) cycloaddition was challenging and opportune in terms of interest 
and novelty. Our work in this area was quite successful, as shown in the article included 
in the next section. 
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Abstract: 3-(Propa-1,2-dien-1-yl)oxazolidin-2-one
works as an efficient two-carbon partner in a variety
of intermolecular gold-catalyzed [2+2]cycloaddi-
tions to alkenes. The transformation represents
a simple and practical entry to highly substituted
cyclobutane derivatives and takes place with com-
plete regio- and stereocontrol.
Keywords: allenamides; cycloaddition; cyclobu-
tanes; enamides; gold
During the last decade, homogeneous gold ACHTUNGTRENNUNG(I or III)
catalysis has experienced an extraordinary develop-
ment.[1] The singular characteristics of gold complexes,
such as their high carbophilicity and low propensity to
participate in typical metal redox processes, has al-
lowed the development of a variety of powerful and
unique transformations. Particularly relevant in terms
of versatility and synthetic potential are the cycload-
ditions between p-unsaturated systems and allenes.[2]
Indeed, a variety of new gold-catalyzed intramolecu-
lar [4+3] and [4+2]cycloadditions of allenes and
dienes,[3,4] as well as [3+2] and [2+2]annulations to
alkenes,[5,6] have been recently developed.
In contrast to these intramolecular cases, the more
challenging intermolecular cycloadditions are ex-
tremely scarce.[7,8] In this context, we recently dis-
closed the first gold-catalyzed intermolecular cycload-
dition of non-activated 1,3-dienes (4C) and allen-
ACHTUNGTRENNUNGamides (2C),[7a] a type of allenic scaffold which is par-
ticularly versatile.[9] This [4+2]cycloaddition takes
place with good yield and high selectivity using AuCl
or the cationic gold(I) complex Au1/AgSbF6 as cata-
lysts. However, in a number of cases, in addition to
the [4+2]adducts (3a, b), we also observed cyclobu-
tane side products arising from a competitive
ACHTUNGTRENNUNG[2+2] cycloaddition between the allene and one of the
carbon-carbon double bonds of the diene (4a, b,
Scheme 1).[10]
Scheme 1. Previously reported [4+2] cycloadditions of allenamides and dienes. Isolation of [2+2] side adducts.
1658  2012 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim Adv. Synth. Catal. 2012, 354, 1658 – 1664
COMMUNICATIONS
On this basis, and considering the synthetic and me-
dicinal relevance of the cyclobutane framework,[11] we
decided to specifically pursue the development of
a gold-catalyzed intermolecular [2+2] cycloaddi-
tion.[12] Herein, we demonstrate that the allenamide
1 participates in a variety of [2+2] cycloadditions
with different type of alkenes, in particular with en-
amides and styrene derivatives, to provide excellent
yields of [2+2]adducts of type 6, with complete
regio-, chemo- and stereoselectivity. Our technology
represents a significant addition to the armoury of
catalytic cycloaddition methods and provides a partic-
ularly practical, powerful and versatile manner to con-
struct highly functionalized cyclobutanes.
In order to assess the viability of a robust and selec-
tive [2+2]process, we decided to check the reaction
conditions using as cycloaddition partners the allen-
ACHTUNGTRENNUNGamide 1 and a challenging 1,2-disubstituted alkene,
namely trans-methylstyrene 5a (Table 1). Unfortu-
nately, using the optimal conditions developed for the
[4+2]cycloaddition, we observed the formation of
a relatively complex mixture of products (Table 1, en-
tries 1 and 2). Nonetheless, in this mixture we could
identify traces of the desired [2+2]adduct 6a, togeth-
er with the homodimer 7 and the acyclic hydroalkeny-
lation product 8a.[13] The picolinic acid gold ACHTUNGTRENNUNG(III) deriv-
ative Au3 or the biaryl phosphine-based catalyst Au4/
AgSbF6, also failed to give the desired adduct, but se-
lectively produced the allene homodimer 7 in 64%
and 34% yields, respectively (Table 1, entries 3 and
4).[14] Conversely, the p-acidic cationic phosphite
gold(I) catalyst Au2/AgSbF6 selectively provided the
desired [2+2]cycloadduct 6a in a moderate 51%
yield (Table 1, entry 5). Gratifyingly, running the reac-
tion in the presence of 4  molecular sieves, and
adding the allenamide to the reaction mixture over
a period of one hour, led to a significant increase in
the efficiency of the process, which now provided 6a
in a good 80% yield (Table 1, entry 6). Moreover, the
catalyst loading could be reduced without affecting
the rate and efficiency of the reaction (Table 1,
entry 7). It is important to note that the cycloaddition
process took place with complete selectivity, since no
other regio- or stereoisomers could be detected by
1H NMR analysis of the crude reaction mixtures.
Once having established an optimum catalytic
system, the versatility and scope of the process was
evaluated. As shown in Scheme 2, allenamide 1 also
undergoes the cycloaddition reaction with styrene to
provide, after just 5 min, the corresponding
ACHTUNGTRENNUNG[2+2]adduct 6b in 81% yield. Methyl substituents at
the para, meta, and ortho positions of the phenyl ring
of 5 were perfectly tolerated, so the corresponding
ACHTUNGTRENNUNG[2+2]adducts (6c–6e) could be isolated in good to ex-
cellent yields (80–96%). The presence of a bromine
atom at the aromatic ring is also compatible with the
Table 1. Preliminary screening of catalytic activity between 1 and 5a.[a]
Entry [Au] Temperature [8C] 6a ([%] yield) 7 ([%] yield) 8a ([%] yield)
1 AuCl r.t. – – –
2 Au1/AgSbF6 15 – – –
3 Au3 r.t. 4 64 8
4 Au4/AgSbF6 5 34 0
5 Au2/AgSbF6 15 51 0 0
6[b] Au2/AgSbF6 15 80 0 0
7[b,c] Au2/AgSbF6 15 79 0 0
[a] Allene 1 (1 equiv.) was added dropwise to a mixture of 5a (3 equiv.) and the gold(I) catalyst (5 mol%) in CH2Cl2 (0.1M)
at 15 8C, unless otherwise noted; >99% conversions (1H NMR). Yields indicated correspond to isolated products.
[b] Allenamide 1 was added dropwise over 1 h.
[c] Reaction carried out with 2 mol% catalyst.
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reaction conditions, although the adduct 6f was isolat-
ed in a modest 42% yield.
Importantly, the cycloaddition also proceeded with
1,1-disubstituted alkenes such as 1-phenyl-1-cyclohex-
ene and a-methyl styrene to selectively afford, in 74
and 77% yields, the [2+2] cycloadducts 6g and 6h,
which incorporate one quaternary stereocenter. Inter-
estingly, the cycloaddition with the cis-styrene (Z)-5a
led to a 15% yield of a 1:1.2 mixture of 6a and its syn
isomer 6a’.[15] However, the cycloaddition with 1H-
indene provided the [2+2]adduct 6i in an excellent
82% yield. The stereochemical identity of all these
adducts (6a–6i) was determined by NMR analysis.
Additionally, the structure of 6a and 6i could be fur-
ther confirmed by X-ray diffraction analysis
(Figure 1).[16]
The requirement of an aromatic substituent at the
alkene was next investigated. Initially, we tested the
feasibility of the cycloaddition of 1 with methylenecy-
clohexene (Table 2, entry 1). Unfortunately, although
the desired cycloadduct 6j was detected, the major
product of the reaction was the acyclic compound 8j,
formally resulting from the hydrofunctionalization of
the allenamide unit with the alkene.[13] Both 6j and 8j
were isolated as an inseparable 1:6 mixture in
a global 78% yield.
The observation of allenamide cyclodimerization
side reactions (to 7) suggested the possibility of using
enamides as alkene components. Gratifyingly, enam-
ides 5k–5n are excellent cycloaddition partners, pro-
viding the corresponding cyclobutanic adducts with
complete selectivity and excellent yields (entries 2–
7).[17] Remarkably, as can be deduced from entries 3–
6, both (E) and (Z) isomers of enamides 5l and 5m
provided, with comparable efficiencies, a single ste-
reoisomer of the cycloadducts 6l and 6m, both featur-
ing a trans disposition of the methyl and carbamoyl
groups. These results clearly point out to a reaction
mechanism involving carbocationic intermediates, as
this could explain the observed loss of stereochemical
information of the starting Z-enamides. Finally, the
phenylenamide derivative 5n also participated in the
reaction, leading to cycloadduct 6n, which was ob-
tained with complete regio- and stereoselectivity and
good yield (entry 7).
Scheme 2. ACHTUNGTRENNUNG[2+2]Cycloaddition of allenamide 1 and styrene
derivatives.
Figure 1. X-ray structures of adducts 6a and 6i.[16]
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It was recently reported that indoles react with al-
ACHTUNGTRENNUNGlenamides such as 1 in the presence of [Ph3PAu]
+
complexes to provide hydrofunctionalization products
of type 8o and p.[13b] In consonance, under our catalyt-
ic conditions, indole 5o reacted to provide the hydro-
functionalization product 8o in 75% yield. However,
the reaction of its N-Boc analogue 5p afforded a low
but promising 33% yield of the desired [2+2] cycload-
duct 6p. On the other hand, the reaction with a cyclic
enamide such as 5q proceeded with excellent yield
Table 2. Scope of the cycloaddition with other alkenes.[a]
Entry Alkene 5 Products Yield [%][b]
1 5j 6j+8j : 78
2 5k 6k : 76
3 (E)-5l 6l : 91
4 (Z)-5l 6l : 96
5 (E)-5m 6m : 73
6 (Z)-5m 6m : 71
7 5n 6n : 78
8 5o, R=H 6o : 0; 8o : 75
9 5p, R=Boc 6p : 33; 8p : 21
10 5q 6q : 94
[a] Allene 1 (1 equiv.) was added dropwise over 1 h to a mixture of 5 (3 equiv.) and the gold(I) catalyst (2 mol%) in CH2Cl2
(0.1M) at 15 8C, unless otherwise noted; >99% conversions (1H NMR).
[b] Isolated yields.
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and complete selectivity to provide the 4,6-fused bicy-
clic system 6q in 94% yield. The stereochemical as-
signment of 6k as well as that of 6q could be success-
fully confirmed by X-ray analysis (Figure 2).[18]
From a mechanistic perspective the reaction might
proceed through a stepwise cationic pathway such as
that shown in Scheme 3, at least in the case of the en-
amide partners. Thus, activation of the allene by the
Au catalyst would afford an Au-allyl cation species of
type I.[3,4,7] Nucleophilic intermolecular interception of
I by the alkene would provide a second cationic inter-
mediate II. This would be the regioselectivity-deter-
mining step, with the formation of the more stabilized
bencylic or imonium cation being favoured. At this
point, rotation around the sigma CC bond results in
the loss of the stereochemical information coming
from the alkene. Finally, a ring closing process
through attack of the vinyl gold species to the stabi-
lized cation, and elimination of the Au complex,
would yield the final [2+2] adduct of type 6. Alterna-
tively, when the metal allyl cation intermediate I is at-
tacked by another unit of allenamide 1, a second cat-
ionic intermediate of type III could be formed. After
a ring closing process, this intermediate could give
rise the homodimer adduct 7, observed in certain
cases.
We are currently further investigating the mecha-
nistic aspects of the cycloaddition by theoretical and
experimental means, and seeking an explanation for
the different behaviour of (Z) and (E)-5a.
In conclusion, we have developed an efficient cata-
lytic [2+2] cycloaddition methodology that provides
synthetically appealing cyclobutane derivatives in
a highly or completely selective manner. Work to de-
Figure 2. X-ray structures of adducts 6k and 6q.[18]
Scheme 3.Mechanistic rationale for the [2+2]cycloadditions of allenamide 1 and alkenes.
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velop enantioselective variants and to gain a deeper
mechanistic understanding is underway.
Experimental Section
Representative Procedure for the [2+2]Cyclo-
addition of 1 with 5a
To a cooled solution (15 8C) of trans-b-methylstyrene (5a,
162 mL, 1.25 mmol), AgSbF6 (2.86 mg, 8.31 mmol) and Au2
(7.31 mg, 8.31 mmol) in a dried Schlenk tube, was slowly
added a solution of allenamide 1 (52 mg, 0.426 mmol) in
CH2Cl2 (1 mL), over 1 hour. The mixture was additionally
stirred at 15 8C for 5 min and filtered through a short pad
of florisil, eluting with Et2O. The solvent was evaporated
and the crude mixture was chromatographed to give 6a ;
yield: 80 mg (0.30 mmol, 79%).
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Considering the importance of highly substituted cyclobutanes we also attempted the 
cycloaddition of an allenamide equipped with a methyl group at the distal position (60c) 
with trans--methylstyrene. Unfortunately this reaction does not give the desired 
product (107). However the dimerization (2+2) cycloadduct 108, which itself is a 
cyclobutane substituted in all carbons of the cycle was obtained in a 52% yield and a dr = 
1.25:1 (Scheme 98). 
 
Scheme 98 
Despite the significance of the previous result, a (2+2) cycloaddition between 2 different 
components to obtain a tetrasubtituted cyclobutane could be more interesting. 
Encouraged by the previous result, we use the -subtituted enamide 109 and the -
methyl-allenamide 60d in this process in the presence the benzonitrile stabilized cationic 
Au-Complex Au43. Fortunately these components afford the desired tetrasubstitued 
cyclobutane 107b in a 46% yield (dr = 2.4:1), alongside with the allenamide dimer 108 in 
a 16% yield (Scheme 99). 
 
Scheme 99 
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While the previous manuscript was in preparation,162 a related work by Z. Chen 
appeared in the literature.163 This work describes the gold catalyzed intermolecular (2+2) 
cycloaddition of allenamides with electron-rich olefins, such as vinyl ethers/amides and 
electron-rich styrenes to afford cyclobutanes of type 110. Products coming from 
homodimerization processes (111) were also included in the discussion. As in our case, 
the cycloaddition was completely regio- and stereoselective for most cases, although - 
or -substituted allenamides did not give the desired products. 
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Scheme 100 – Chen’s gold catalyzed (2+2) cycloaddition of allenamides with electron-rich olefins, and 
allenamide dimerization. 
Before submitting our publication we became aware that the group of J. M. González 
was also working in a (2+2) intermolecular cycloaddition of enol ethers with N-
allenylsulfonamides. Despite the similitude of the reaction, the scope of allenes and 
alkenes in this report is complementary to ours, and for this reason both papers were 
published as “back to back” articles.164 Although many of the examples described by the 
group of González overlap with those of Zili Chen, the use of a different catalyst, in this 
case a gold(I)-phosphite Au43 allowed to decrease the catalyst loading to an impressive 
0.5% and more importantly, a -ethyl-allenamide was also tolerated and generate a 
tetrasubtituted cycloadduct (Scheme 101). 
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Scheme 101 - González Phosphite-Gold(I)-catalyzed (2+2) intermolecular cycloaddition of enol ethers with 
N-allenylsulfonamides. 
More recently, J. M. González accomplished the enantioselective version of these type 
annulations between sulfonyl allenamides and vinylarenes, providing optically active 
cyclobutanes.165 Several chiral phosphoramidite gold complexes derived from Siphos, 
Binol and Vanol gave excellent enantioselectivities. However the performance of -
substituted styrenes, enamides or enol ethers and of -substituted allenamides was not 
commented in this article. Importantly, the method also allowed the preparation of 
cyclobutanes containing challenging quaternary carbon centers (Scheme 102). 
 
Scheme 102 - Enantioselective Gold(I)-catalyzed synthesis of cyclobutane derivatives. 
Z. Chen has further explored the potential of allenamides in Au(I) catalysis and used 
them as two carbon atom component in (3+2) cycloadditions with azomethine imines or 
nitrones providing the first examples of the assembly of heterocycles using gold 
catalyzed intermolecular cycloadditions of allenes.166,167 
The intermolecular (3+2) cycloaddition of azomethine imines with allenes was already 
known by thermal or Phosphine-catalyzed proceses,168 however the regiochemistry in 
                                                     
165 Suárez-Pantiga, S.; Hernández-Díaz, C.; Rubio, E.; González, J. M. Angew. Chemie Int. Ed. 2012, 11552–11555. 
166 Zhou, W.; Li, X.-X.; Li, G.-H.; Wu, Y.; Chen, Z. Chem. Commun. 2013, 49, 3552–3554. 
167 Li, G.-H.; Zhou, W.; Li, X.-X.; Bi, Q.-W.; Wang, Z.; Zhao, Z.-G.; Hu, W.-X.; Chen, Z. Chem. Commun. 2013, 49, 4770–4772. 
168 a) Na, R.; Jing, C.; Xu, Q.; Jiang, H.; Wu, X.; Shi, J.; Zhong, J.; Wang, M.; Benitez, D.; Tkatchouk, E.; Goddard, W. A.; 
Guo, H.; Kwon, O. J. Am. Chem. Soc. 2011, 133, 13337–48. b) Jing, C.; Na, R.; Wang, B.; Liu, H.; Zhang, L.; Liu, J.; Wang, 
M.; Zhong, J.; Kwon, O.; Guo, H. Adv. Synth. Catal. 2012, 354, 1023–1034. c) Na, R.; Liu, H.; Li, Z.; Wang, B.; Liu, J.; Wang, 
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the procedure developed by Z. Chen is different. Thus the reaction of N-allenyl amides 
with azomethine imines 112 in the presence of Ph3PAuCl/AgOTf (5%), gave the 
corresponding cycloadducts 113 in moderate to good yields. C-5 substituted 
pyrazolidinone azomethine imines induce steric hindrance and the respective products 
could be obtained with dr > 10:1. However a C-4 substitution doesn’t have a similar 
effect and the corresponding product was obtained with low syn/anti selectivity 
(Scheme 103).166 
 
Scheme 103 - Gold catalyzed (3+2) cycloaddition of N-allenyl amides with azomethine imines. 
Shortly after, the same authors reported an Au(I)-catalyzed intermolecular (3+2) 
cycloaddition of allenamides, using nitrones as 1,3-dipoles.167 The work includes a 
enantioselective variant using chiral phosphoramidite gold complexes. In these cases, 
the binol-derived complexes, with aryl substituents at the 3 and 3’ positions, turned out 
to be again the optimal systems, providing the corresponding 4-alkylidenylisoxazolidine 
derivatives 114 in high yields and moderate to excellent enantioselectivities. The highest 
enantioselectivities were obtained with (R,R,R)-Au19 and (R,S,S)-Au45, which 
respectively include 9-phenantrenyl or 4-biphenyl units in these binol ortho positions 
(Scheme 104).167 
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Scheme 104 - Gold catalyzed enantioselective intermolecular (3+2) dipolar cycloaddition of N-allenyl 
amides with nitrones. 
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In conclusion, we have developed an efficient gold(I) catalyzed (2+2) cycloaddition 
methodology that provides synthetically appealing, highly substituted, cyclobutane 
derivatives in a highly or completely selective manner. The reaction works particularly 
well with styrene and enamides derivatives. 1,2-disubstituted acyclic alkenes provided 
exclusively the cyclobutanes with trans disposition of these substituents, while cyclic 
alkenes also react in a diastereoselective fashion, but to give the corresponding bi or 
tricyclic structures with cis disposition of the 1,2-subtituents. Although the simultaneous 
use of a -substituted-styrene and a -substituted allenamide was not successful, 
tetrasubstituted cyclobutanes can be made by using a -subtituted-enamide and a -
substituted allenamide. 
The methodology can be considered among the most robust, versatile and practical ways 
of assembling substituted cyclobutanes. 
 
6. Conclusion
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The high regioselectivity observed in the (2+2) annulations described in the previous 
chapter, together with the intrinsic requirement of a carbocation-stabilizing group at the 
alkene, support a a cationic stepwise mechanism, involving intermediates such as XLVI 
(Scheme 105).162 In light of this mechanism, we envisioned the possibility of intercepting 
this carbocationic intermediate by an internal nucleophile before the ring closure as a 
way of obtaining interesting bicycles through a cationic cascade. Depending on the endo 
or exo trapping of the cation XLVI, the transformation could yield either fused- or 
bridged-bicyclic skeletons of type 116 or 117.  
Particularly appealing would be the use of a carbonyl moiety as nucleophiles, since the 
reaction could produce interesting oxa-bridged carbocycles (116 , X=O, Y=C).  
 
Scheme 105 - Designed cascade cycloaddition processes. 
 
Oxygen-bridged carbocycles, particularly those containing a medium sized ring (7-9 
membered) are an important class of compounds, not only because they are widely 
present in biologically active molecules such as Englerin A,169 Mycoepoxydiene,170 
Platensimycin,171 or FR182877,172 but also because they are important intermediates for 
the preparation of other natural products, such as in the synthesis of Dactylol.173 
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Assembling these medium-sized carbocycles, which are present in a large number of 
relevant products, continues to be a major challenge in organic synthesis.174,175 Indeed, 
despite the importance of this oxa-bridged medium-sized carbocycles, practical catalytic 
access to these carbocycles are extremely scarce.176 An attractive approach for the 
preparation of these systems involves cascade processes which generate several bonds in 
a single operational step.177 
In 1987 G. A. Molander reported a versatile approach to oxabridged seven and eight 
membered rings involving the combination of dicarbonyl compounds (119) with 3-iodo-
2-[(trimethylsilyl)methyl]propene (118) as a trimethylenemethane dianion synthon.178 
The process is promoted by SnF2, which generates the allylstannane from 118 (Scheme 
106). Carbonyl allylation is then followed by hemiacetal formation and allylsilane 
cyclization, to provide the oxa-bridged carbocycles 120 in moderate to excellent yields. 
Albeit the method is interesting it needs stoichiometric reagents and is very poor from 
the atom economy point of view. 
                                                     
174 a) Illuminati, G.; Mandolini, L. Acc. Chem. Res. 1981, 14, 95–102. b) Galli, C.; Mandolini, L. Eur. J. Org. Chem. 2000, 2000, 
3117–3125. 
175 For a review on diverse methods for medium ring synthesis see: Molander, G. A. Acc. Chem. Res. 1998, 31, 603–609. 
176 a) Molander, G. A. Acc. Chem. Res. 1998, 31, 603–609. b) López, F.; Mascareñas, J. L. Chem. Eur. J. 2007, 13, 2172–2178. 
177 Nicolaou, K. C.; Edmonds, D. J.; Bulger, P. G. Angew. Chemie Int. Ed. 2006, 45, 7134–7186. 
178 a) Molander, G. A.; Shubert, D. C. J. Am. Chem. Soc. 1987, 109, 6877–6878. b) Later a related Indium-mediated annulation 
in aqueos medium was reported, see: Minehan, T.; Allatabakhsh, A.; Pham, M. Heterocycles 2007, 72, 115-122. 
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Scheme 106 – SnF2-promoted [m+n] annulations. 
As shown in the Scheme 14, page 14, interesting oxabridged cycloheptane derivatives, 
that allowed a relatively short synthesis of englerine A, 179 have been obtained by means 
of a gold-catalyzed cycloisomerization reaction of designed enynes with pendant 
carbonyl groups.30 
C. H. Oh and S.-H. Han have shown that AuCl3 or gold nanoparticles efficiently promote 
the cyclization of 1,6-allenynebenzaldehyde 121 to produce oxabridged ketone 122 as 
product.180 The first step of the proposed mechanism consists of a nucleophilic attack of 
the aldehyde oxygen onto the activated triple bond, thus giving rise to a zwitterionic 
intermediate which rearranges into a oxabridged polycyclic carbene through a (3+2) 
dipolar cycloaddition. The latter undergoes the attack of water to afford compound 122 
(Scheme 107). 
 
Scheme 107 – AuCl3 catalysed (3+2) dipolar cycloaddition of an 1,6-allenynebenzaldehyde. 
Oxabridged eight membered carbocycles were also prepared using gold catalysis. In 
2010 R.-S. Liu reported a highly stereoselective Au-catalyzed synthesis of 9-
oxabicyclo[3.3.1]nona-4,7-dienes 124 from 1-oxo-4-oxy-5-ynes 123 and a vinyl ether.181 
The proposed mechanism starts with an 6-exo-dig cyclization of the carbonyl moiety 
                                                     
179 Molawi, K.; Delpont, N.; Echavarren, A. M. Angew. Chemie Int. Ed. 2010, 49, 3517–3519. 
30 Jiménez-Núñez, E.; Claverie, C. K.; Nieto-Oberhuber, C.; Echavarren, A. M. Angew. Chemie 2006, 45, 5578–5581. 
180 Gupta, A. K.; Rhim, C. Y.; Oh, C. H.; Mane, R. S.; Han, S.-H. Green Chem. 2006, 8, 25–28. 
181 Teng, T.-M.; Das, A.; Huple, D. B.; Liu, R.-S. J. Am. Chem. Soc. 2010, 132, 12565–12567. 
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onto the alkyne affording the 1,4-dipole XLVII, which is in resonance with the gold-
carbene intermediate XLVIII. A subsequent (3+2) cycloaddition between the carbonyl 
ylide XLVIII and an external olefin, followed by a ring expansion (1,2-alkyl migration) 
that is assisted by the MOM group generates the oxonium intermediate XLIX (Scheme 
108). A final elimination process affords the oxacyclic product 124 and regenerates the 
catalyst. 
 
Scheme 108 - Synthesis of 9-oxabicyclo[3.3.1]nona-4,7-dienes from 1-oxo-4-oxy-5-ynes and a vinyl ether. 
Recently Z. Wang reported a Au-catalyzed intramolecular (4+2) cross-cycloaddition of 
alkynylcyclopropane ketones with carbonyl compounds.182 This method provides a 
stereoselective construction of oxa-bridged seven and eight membered carbocycles (126) 
fused with a furan ring from alkynylcyclopropane ketones with carbonyl compounds 
125. The authors suggests that the gold complex promote the formation of a 1,4-dipole 
equivalent, that undergo a (4+2) annulation with the aldehyde. 
 
Scheme 109 - Au-catalyzed intramolecular (4+2) cross-cycloaddition of alkynylcyclopropane ketones with 
carbonyl compounds. 
All the above mentioned methods have been developed exclusively in a racemic fashion.  
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There are some methods for the asymmetric preparation of 8-oxabicyclo[3.2.1]octanes 
based on the use of chiral-auxiliaries.183 One of the more efficient examples has been 
recently disclosed by T.-P. Loh and involves a cationic cascade cyclization reaction of 
alkenes-tethered acetals like 127 and silyl enol ethers in the presence of TiCl4.184 The 
acetal 127 derived from (2R,3R)-2,3-butanediol gave 128 with the highest 
enantioselectivity. The proposed mechanism consists of a Mukaiyama aldol reaction 
between the acetal and the silyl enol ether. Subsequently, the olefin attacks the silylated 
oxocarbenium via a transition state with the R1 and OTIPS groups adopt 
pseudoequatorial positions to yield the anti-configured product 128 (Scheme 110). 
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Scheme 110 – TiCl4 promoted cationic cascade cyclization reaction of alkenes-tethered acetals and silyl enol 
ethers. 
With regard to catalytic asymmetric processes, in 2011 E. N. Jacobsen reported an 
interesting highly enantioselective of thiourea-catalyzed intramolecular cycloaddition of 
alkenes or allenes 129 to give seven membered oxabridged carbocycles like 130 (Scheme 
111).185 A cooperative catalyst effect has been observed wherein the combination of both 
achiral (T1) and chiral (T2) thiourea catalysts lead to optimal results. The authors 
propose that the achiral thiourea T1 catalyst acts as a carboxylate-binding agent assisting 
in the benzoate abstraction. While the amine functionality of T2 binds to the substrate, 
simultaneously assisting oxidopyrylium formation and holding the substrate in the 
chiral catalyst environment. 
                                                     
183 For a review see: a) Hartung, I. V; Hoffmann, H. M. R. Angew. Chemie Int. Ed. 2004, 43, 1934–1949. For a review with 
examples based of asymmetric catalytic (4+3) cycloaddition reactions see: b) Harmata, M. Adv. Synth. Catal. 2006, 348, 
2297–2306. 
184 Li, B.; Zhao, Y.-J.; Lai, Y.-C.; Loh, T.-P. Angew. Chemie Int. Ed. 2012, 51, 8041–8045. 
185 Burns, N. Z.; Witten, M. R.; Jacobsen, E. N. J. Am. Chem. Soc. 2011, 133, 14578–14581. 
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Scheme 111 - Dual thiourea catalyst system in intramolecular oxidopyrylium (5+2) cycloadditions. 
In 2010 N. Iwasawa reported a Pt-catalyzed asymmetric synthesis of 8-
oxabicyclo[3.2.1]octane derivatives 132, based on the (3+2)-cycloaddition between 
platinum-containing carbonyl ylides generated from acyclic ,-ynones 131 and vinyl 
ethers.186 The active chiral cationic catalyst was generated in situ from the addition of 
AgSbF6 to a PtCl2-L complex (Scheme 112). 
 
Scheme 112 – Enateoselective Pt-catalyzed 8-oxabicyclo[3.2.1]octane synthesis from ,-ynones. 
Another interesting method for the enantioselective preparation of 
oxabicyclo[3.2.1]octane derivatives reported by R. P. Hsung using allenamides and 
furans was mentioned previously (Scheme 70, page 47).124 
In 2003 M. Harmata reported the first organocatalytic asymmetric (4+3) cycloaddition.187 
The reaction of pentadienal 133 with 2,5-disubstituted furans in the presence of 20 mol% 
of the chiral amine catalyst and trifluoroacetic acid afforded the cycloadducts 134 with 
good yields and up to 89% enantiomeric excess.  
                                                     
186 a) Ishida, K.; Kusama, H.; Iwasawa, N. J. Am. Chem. Soc. 2010, 132, 8842–8843. b) The racemic version of this reaction 
was previously reported, see: Kusama, H.; Ishida, K.; Funami, H.; Iwasawa, N. Angew. Chemie Int. Ed. 2008, 47, 4903–
4905. 
124 Huang, J.; Hsung, R. P. J. Am. Chem. Soc. 2005, 127, 50-51. 
187 Harmata, M.; Ghosh, S. K.; Hong, X.; Wacharasindhu, S.; Kirchhoefer, P. J. Am. Chem. Soc. 2003, 125, 2058–2059. 
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Scheme 113 - Intermolecular, organocatalytic asymmetric (4+3) cycloaddition. 
To the best of our knowledge, direct, catalytic, and enantioselective approaches to oxa-
bridged eight membered rings are unknown. However, some enantioselective 
approaches based on two-step methods have been reported. 
In 2002 C.-M. Yu reported a very efficient method to prepare oxygen-bridged medium-
sized carbocycles based on a Lewis acid catalyzed intramolecular allylsilane addition to 
a carbonium cation generated from a 1,5- or 1,6-hydroxyketone derivative 135 (Scheme 
114).188 The enantioenriched precursors 135 in the presence of of Sn(OTf)2 and Me3SiSPh 
led to the formation of the corresponding oxabridged systems 136 as sole products. 
 
Scheme 114 - Intramolecular allylic transfer reaction for the formation of 8 and 9 membered oxa-bridged 
carbocycles. 
In 2005 our group reported an asymmetric approach to the assembly of enantiopure, 
oxa-bridged, medium-sized carbocyclic systems from readily accessible 1-alkyn-3-
ketones (Scheme 115).189 The catalytic asymmetric hydrogen transfer reduction of 
ketones 137 with Noyori's ruthenium complex in iPrOH provided the desired alkynols 
138 with excellent yields and ee. Treatment of the chiral alcohols with allyl ethyl ether in 
the presence of [CpRu(MeCN)3]PF6, followed by in situ acid-catalyzed acetalization with 
MeOH gave pyrans 139. Finally, Friedel- Crafts cyclization of the acetals under SnCl4 
promotion furnished the tricycles 140. 
                                                     
188 Yu, C.-M.; Lee, J.-Y.; So, B.; Hong, J. Angew. Chemie Int. Ed. 2002, 41, 161–163. 
189 a) López, F.; Castedo, L.; Mascareñas, J. L. Org. Lett. 2005, 7, 287–290. For a related previous work see: b) López, F.; 
Castedo, L.; Mascareñas, J. L. J. Am. Chem. Soc. 2002, 124, 4218–4219. 
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Scheme 115 - Medium-sized carbocyclic systems from 1-alkyn-3-ketones. 
While catalytic asymmetric entries to oxabridged eigh membered rings are not known, 
related approaches to any type of eight-membered ring are also very scarce.190 
In 2007 S. R. Gilbertson reported a Rh-catalyzed (4+2+2) cycloadditon of dienynes and 
terminal alkynes.191 They found that the cycloaddition reaction catalyzed by 
[Rh(nbd)Cl]2 and AgSbF6 in the presence of (S,S)-Me-DuPhos at 60 ºC gave the final 
cycloadducts in good to excellent yields. However, the highest enantioselectivity was 
41% ee. 
 
Scheme 116 - Rh-catalyzed (4+2+2) cycloadditon of dienynes and terminal alkynes. 
F. D. Toste demonstrated that it is possible to assemble seven- to nine-membered 
carbocycles using gold catalyzed olefin cyclopropanations.192 High enantioselectivities 
were achieved for seven- and eight-membered ring products employing chiral gold(I) 
complexes (Scheme 117). 
                                                     
190 For a review on transition-metal-catalyzed cycloadditions for the synthesis of eight-membered carbocycles see: Yu, Z.-
X.; Wang, Y.; Wang, Y. Chem. Asian J. 2010, 5, 1072–1088. 
191 a) DeBoef, B.; Counts, W. R.; Gilbertson, S. R. J. Org. Chem. 2007, 72, 799–804. b) Gilbertson, S. R.; DeBoef, B. J. Am. Chem. 
Soc. 2002, 124, 8784–8785. 
192 Watson, I. D. G.; Ritter, S.; Toste, F. D. J. Am. Chem. Soc. 2009, 131, 2056–2057. 
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Scheme 117 - Asymmetric synthesis of medium-sized rings by intramolecular Au(I)-catalyzed 
cyclopropanation. 
In summary, despite the importance of oxabridged medium size carbocycles, catalytic 
methods for their preparation are still scarce and require relatively long synthetic 
protocols. Furthermore, catalytic enantioselective approaches are only reported for the 
preparation of seven membered rings. For the asymmetric preparation of oxacyclic eight 
membered rings only chiral-auxiliary or chiral pool approaches have been reported. 
These precedents reinforce the relevance of developing new practical, rapid, efficient, 
versatile and if possible enantioselective methodologies to construct these frameworks. 
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Gold(I)-Catalyzed Cascade Cycloadditions between Allenamides and
Carbonyl-Tethered Alkenes: An Enantioselective Approach to Oxa-
Bridged Medium-Sized Carbocycles**
Hlio Faustino, Isaac Alonso, Jos L. MascareÇas,* and Fernando Lpez*
During the last decade, research in homogeneous gold
catalysis has experienced an extraordinary growth, resulting
in the discovery of a variety of powerful transformations.[1]
Particularly relevant, in terms of versatility and synthetic
potential, are those reactions involving the cycloaddition of
two or more unsaturated components, as a variety of cyclic
and polycyclic systems can be rapidly assembled in an
efficient and usually stereoselective manner.[2] In this context,
we and others have reported several intramolecular gold-
catalyzed cycloadditions involving allenes,[3] as well as inter-
molecular cycloadditions of allenamides to dienes, (4+2), or
to alkenes, (2+2).[4,5] The high regioselectivity observed in the
(2+2) annulations,[5a] together with the intrinsic requirement
of a carbocation-stabilizing group at the alkene, suggests that
this reaction proceeds through a cationic pathway such as that
depicted in the Scheme 1 (upper).[6]
In light of this mechanism, we envisioned that intercep-
tion of the carbocationic intermediate II by an internal
nucleophile might result in the assembly of interesting
bicycles through the cationic cascade shown in the Scheme 1
(bottom).[7] Depending on the endo or exo trapping of the
cation II’, the transformation could yield either fused- or
bridged-bicyclic skeletons of type 5 or 6. Herein, we
demonstrate the viability of the endo route when a carbonyl
group (X=Y is O=CR) is used as carbocation intercepting
unit.[8] The reaction provides a straightforward, robust, and
versatile access to synthetically appealing oxa-bridged sys-
tems of type 6 (X=O, Y= carbon) containing seven-, eight-,
or even nine-membered carbocycles. Additionally, we also
disclose several examples of an enantioselective variant
promoted by chiral diphosphine/gold and/or phosphorami-
dite/gold catalysts that provides a practical asymmetric
approach to 8-oxabicyclo[3.2.1]octanes,[9] and the first direct
enantiocatalytic entry to oxygen-bridged eight-membered
carbocycles.[10]
Our study began by assessing the viability of a cascade
cycloaddition between the bisalkene 4a and 1a. We reasoned
that the different nature of the alkenes in 4a could bias the
annulation to selectively give the tricarbocycle 5aa
(Scheme 1, exo mode). However, treatment of these sub-
strates with several gold catalysts, under different reaction
conditions, failed to give 5aa, and always led to a relatively
complex mixture of products, among which we could identify
and even isolate the (2+2) adduct 3aa and the allenamide
homodimer 7a.[11] (Scheme 2).
Therefore, we explored an alternative cascade process
relying on the use of a carbonyl group as an internal
nucleophile. Interception of II’ by the carbonyl oxygen
might generate a cyclic oxocarbenium ion (III, X=O, Y=
CR; Scheme 1), susceptible of undergoing a Prins-like
terminal cyclization with the vinyl gold moiety.[12] Gratify-
ingly, slow addition over 1 hour of a solution of allenamide 1a
to a mixture of 4b and [Ph3PAuCl]/AgSbF6 (A) led to a 1.2:1
mixture of the Z- and E-configured 8-oxabicyclo[3.2.1]octane
Scheme 1. Previously reported (2+2) cycloadditions and the proposed
formal cascade cycloaddition.
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derivatives 6ab, which were isolated in 75% yield (Table 1,
entry 1).[13] Similar results, but with higher Z selectivity, were
achieved with gold catalysts B–E (Table 1, entries 3–6).
Significantly, by using the phosphite/gold complex E, the
catalyst loading could be lowered to 1 mol% (Table 1,
entry 7), and the allenamide can be added in one portion
(Table 1, entry 8), to provide (Z)-6ab in 87% yield.[14] The
robustness and practicality of the method was further
demonstrated by performing the reaction on an 8 mmol
scale (1a), with a 0.5 mol% of catalyst, which produced 2.0 g
of (Z)-6ab (84% yield) after just 5 min (entry 9).
We next evaluated the scope of the method (Table 2). Not
only was a methyl ketone competent to productively intercept
intermediate II’, but the cycloaddition also worked with
a phenyl ketone (4c), an aldehyde (4d), and a methyl ester
(4e), to give the corresponding 8-oxabicyclo[3.2.1]octane
derivatives (6ac–6ae) in good yields (Table 2, entries 1–4).
Also, substrates in which the alkene and the carbonyl moiety
(4 f and 4g) are attached by a phenyl ring, provided the
corresponding oxa-tricyclic systems, 6af and 6ag, in 41% and
65% yields, respectively (Table 2, entries 5 and 6).
This strategy also enables the synthesis of 5,7-bicarbo-
cyclic systems such as 6ah, by using cyclopentanone precur-
sors like 4h (Table 2, entry 7). This reaction was completely
diastereoselective and the relative configuration of the
product was determined by X-ray diffraction analysis.[15] The
effect of additional substituents at the styrene moiety was
investigated in the substrate 4 i (E/Z= 1.3:1: Table 2, entry 8).
In agreement with previous results for (2+2) cycloaddi-
tions,[5a] we only observed the reaction of the trans compound
((E)-4 i),[16] which efficiently afforded the oxabicylic system
6ai (77% yield; Table 2, entry 8), featuring the oxygen bridge
and the methyl group in a syn disposition (Figure 1).[17]
Importantly, the cascade cycloaddition is not restricted to
phenyl-substituted alkenes, which might be particularly
Scheme 2. Preliminary experiments with 1a and bisalkene 4a.
Table 1: Cascade cycloadditions with carbonyl-tethered alkene 4b.[a]
Entry [Au] Mol% Z/E[b] Yield of 6ab [%]
1 Ph3PAuCl/AgSbF6 (A) 5 1.2:1 75
2 Ph3PAuCl/AgSbF6 (A)
[c] 5 3.2:1 70
3 Ph3PAuNTf2 (B) 5 5.5:1 75
4 C 5 7.5:1 79
5 D 5 50:1 75
6 E 5 15:1 76
7 E 1 22:1 74
8[d] E 1 22:1 87
9[d,e] E 0.5 22:1 84
[a] 1a (1 equiv) added over one hour to a solution of 4b (1.5 equiv) and
[Au] (mol%), in CH2Cl2 at 15 8C, unless otherwise noted. Conversion
was>99%, as determined by 1H NMR spectroscopy, after 5 min. [b] Z/E
ratios determined by 1H NMR spectroscopy of the crude mixtures.
[c] Catalyst was filtered through Celite prior to its use. [d] 1a was added
in one portion. [e] Performed on an 8.0 mmol scale (1a). Tf= trifluoro-
methanesulfonyl.
Table 2: Scope of the Au-catalyzed cascade cycloaddition between allena-
mides (1) and carbonyl-tethered alkenes (4).[a]
Entry 1 Oxoalkene (4) Product 6 Yield
[%][b]
1 1a 4b, R2=Me 6ab 87
2 1a 4c, R2=Ph 6ac 86
3 1a 4d, R2=H 6ad 90
4 1a 4e, R2=OMe 6ae 75[c]
5 1a 4 f, R3=H 6af 41[d,e]
6 1a 4g, R3=Me 6ag 65[d,f ]
7 1a 4h 6ah
51
d.r.
1:0
8 1a
4 i
E/Z=1.3:1
6ai
77
d.r.
1:0
9 1a 4 j, R3=Me 6aj 63
10 1a 4k,
R3=NMeCO2Bn
6ak 65
11 1a 4 l, R3=N* 6al 75
12 1b 4b 6bb
57
d.r.
3:1
13 1c 4b 6cb 77[g]
[a] Allenamide 1 (1 equiv) was added to a mixture of oxoalkenes 4
(1.5 equiv) and catalyst E (1%) in CH2Cl2 (0.1m) at15 8C; Conversion was
>99%, as determined by 1H NMR spectroscopy, after 5–15 min. [b] Yield of
isolated 6 ; Z/E ratios, as determined by 1H NMR spectroscopy of the crude
mixtures, are >20:1, unless otherwise noted. [c] Cyclobutane 3ae was also
obtained in 14% yield. [d] The allenamide dimer 7a was also obtained in
30% yield. [e] Z/E=9:1. [f ] Z/E=10:1. [g] Z/E=3:1.
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biased to participate in the transformation owing to the
generation of benzylic carbocation intermediates (e.g. II’, R=
Ph; Scheme 1). Indeed, the presence of a methyl substituent
(4j) is enough to warrant the annulation, with the product 6aj
being isolated in a 63% yield (Table 2, entry 9).[18] Oxoena-
mides are also effective precursors, producing amino deriv-
atives, such as 6ak and 6al, in good yields (Table 2, entries 10
and 11). Substituted allenamides, such as 1b and the N-
phenyl-N-tosylallenamide (1c), also provided the corre-
sponding bicyclic products, 6bb and 6cb, in moderate to
good yields (Table 2, entries 12 and 13).
The efficiency of the above transformation suggested that
the strategy might be used to construct eight- or even nine-
membered carbocycles, simply by using oxoalkenes featuring
longer carbon tethers. Assembling these medium-sized carbo-
cycles, which are present in a large number of relevant
products, continues to be a major challenge in organic
synthesis, owing to the well-known difficulties associated
with their construction.[19,20] Gratifyingly, the gold-catalyzed
annulation of 1a with 4m–4o provided the desired 9-
oxabicyclo[3.3.1]nonanes 6am–6ao, in moderate to excellent
yields (Scheme 3). Moreover, and similarly to the cyclo-
additions leading to the seven-membered cycles, the reaction
also proceeds with more-substituted alkenes (4p, R4=Me) or
disubstituted allenamides (1b), to provide the oxa-bridged
cyclooctanes 6ap and 6bm with complete diastereoselectivity.
Unambiguous confirmation of the stereochemistry of 6bm
was obtained by X-ray diffraction analysis (Figure 1).[21] The
method also provides direct entry to 6,8-fused bicarbocycles
such as 6aq (78% yield) and, importantly, can be even be
used to make cyclononane derivatives such as 6ar (61%
yield).
Overall, these results highlight the great potential and
versatility of the method, which provides a direct and
practical access to highly valuable oxa-bridged seven-,
eight-, and even nine-membered carbocycles from readily
accessible starting materials.[22]
Owing to the recent progress in asymmetric gold catal-
ysis,[23] we were interested in exploring the viability of
achieving these annulations in an enantioselective manner.
Curiously, despite the synthetic value of oxa-bridgedmedium-
sized carbocycles, catalytic enantioselective approaches to
these systems are very scarce, and essentially limited to the
seven-membered derivatives.[9,10]
A preliminary screening of different types of chiral gold
complexes identified the dtbm-segphos complex (R)-F and
the phosphoramidite/gold complex (S,R,R)-G as suitable
catalysts to achieve the cycloaddition of 1a with several
oxoalkenes 4, in good yields and moderate-to-high levels of
enantioselectivity (Table 3).[24] In the case of the oxa-bridged
seven membered carbocycles, the best enantiomeric ratios
were obtained with (S,R,R)-G, and ranged from 82:18 to
90:10. (Table 3, entries 1–4). Interestingly, these e.r. values
could be increased up to 98:2, by performing a partial
crystallization (Table 3, entries 1 and 2). In the case of the
cyclooctanes, although the phosphoramidite gold catalyst
(S,R,R)-G provided good enantioselectivity (e.r. from 87:13 to
Figure 1. X-Ray structures of 6ai and 6bm (thermal ellipsoids are set
at 50% probability).
Scheme 3. Synthesis of 8- and 9-membered oxa-bridged carbocycles.
Reaction conditions: Allenamide 1 (1 equiv) was added to a mixture of
4 (1.5 equiv) and E (1%) in CH2Cl2 (0.1m) at 15 8C. Conversions are
>99%, as determined by 1H NMR spectroscopy, after 5–15 min.
Yields are of the isolated products. Z/E ratios, as determined by
1H NMR spectroscopy of the crude mixtures, are >20:1, unless
otherwise noted. [a] The cyclobutane derivative 3ap (12% yield) was
also obtained. [b] 3bm (12% yield) was also obtained. [c] Carried out
at 78 8C for 6 h. 3ar (26% yield), was also obtained.
Table 3: Enantioselective cycloadditions of 1a and oxoalkenes 4.
Entry[a] 4 [Au] (5 mol%) 6 Yield [%][b] e.r.[c]
1 4b (S,R,R)-G 6ab 63 83:17[d]
2 4c (S,R,R)-G 6ac 69 82:18[e]
3[f ] 4d (S,R,R)-G 6ad 83 84:16
4 4 i (S,R,R)-G 6ai 72[g] 90:10
5[h] 4m (R)-F 6am 52 95:5
6[h] 4o (R)-F 6ao 80 91:9
7[h] 4p (R)-F 6ap 45 96:4
[a] 1a (1 equiv), 4 (1.5–2 equiv) and [Au] (5 mol%) in CH2Cl2 at 78 8C,
unless otherwise noted. Conversion was >99% after 10–180 min.
[b] Yield of isolated 6 ; Z/E ratios are >20:1. [c] Determined by HPLC.
[d] e.r.=95:5 after crystallization (iPrOH/hexane). [e] e.r.=98:2 after
crystallization. [f ] At 78 to 60 8C, for 5 h. [g] d.r.=1:0. [h] At 78 to
35 8C, for 4–12 h.
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90:10),[24] the Segphos complex (R)-F provided the cyclo-
adducts 6am, 6ao, and 6ap with higher enantiomeric ratios
(between 91:9 and 96:4; Table 3, entries 5–7). Although there
is still room for improvement, these results represent the first
highly enantioselective syntheses of oxa-bridged eight-mem-
bered carbocycles and one of the very few enantiocatalytic
approaches to cyclooctanes.[10]
Finally, we also did a preliminary exploration of the
manipulability of the oxa-bridged carbocycles, and confirmed
that the presence of the exo-enamide enables a variety of
transformations (Scheme 4). Treatment of adduct 6ab with
RuO2/NaIO4 cleanly afforded the ketone 8ab (70% yield).
Alternatively, the enamide group could be hydrogenated to
give 9ab (60% yield), or reduced to the epimeric alcohols
10ab in 95% yield. Also, the presence of the methoxy group
in 6ae enabled a Lewis acid induced opening of the bridge to
yield cycloheptane 11ae.
In summary, we have discovered a simple and highly
versatile cascade cycloaddition between allenamides and
carbonyl-tethered alkenes. The reaction can be performed
at mild temperatures with just 1 mol% of the catalyst, and
provides a straightforward entry to oxa-bridged seven-, eight-,
and even nine-membered rings. Moreover, we have also
demonstrated that by using chiral gold catalysts it is possible
to obtain the products with good to high enantioselectivities.
In particular, the method provides the first enantiocatalytic
entries to eight-membered carbocycles by means of a formal
intermolecular cycloaddition reaction.
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4. Related simultaneous work by other authors 
While preparing the above manuscript, a related paper by the group of A. M. Echavarren 
appeared in the literature.193 
This article describes the intermolecular gold(I)-catalyzed reaction of terminal alkynes 
with oxoalkenes of type 115 in the presence of gold catalyst Au47, que contains a bulky 
biphenylphosphine ligand, to afford 8-oxabicyclo-[3.2.1]oct-3-enes 141. However, the 
technology is restricted to the use of arylalkynes. Methyl or phenyl groups were well 
tolerated at the -position of the alkene and in the ketone, however, aldehydes gave a 
modest 16% yield. The mechanistic proposal based on DFT calculations revealed a 
stepwise formation of the C-C and C-O bonds (Scheme 118). The nucleophilic attack of 
alkene 115 to complex L takes place with both regio- and stereoselectively and forms 
intermediate LI. Regioselective attack of the carbonyl group at the most substituted 
position then leads to oxonium cation LII, which undergoes a Prins reaction to close the 
seven-membered ring. Finally, 141 is obtained by metal elimination.  
 
 
Scheme 118 - Intermolecular gold-catalyzed cycloaddition of alkynes with oxoalkenes. 
The only reported example with substituents at the -position of the alkene led to the 8- 
cyclobutene 142 as the major product, along with 143 (Scheme 119). Oxoalkenes 
featuring longer carbon tethers that could eventually allow to prepare eight or nine-
membered carbocycles were not reported. 
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Scheme 119 - Intermolecular gold-catalyzed cycloaddition of phenylacetylene with a -subtitued alkene. 
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5.1 Objective 
The aforementioned Au-catalyzed cycloadditions between allenamides and carbonyl-
tethered alkenes suggest that this reaction proceed through a stepwise mechanism in 
which the cation in intermediate XLVI is intercepted by a carbonyl moiety (Scheme 
120).194  
 
Scheme 120 – Proposed mechanism for Au(I)-catalyzed cascade cycloadditions between allenamides and 
carbonyl-tethered alkenes. 
In light of this mechanism, we wondered whether the same reaction could be achieved 
in a fully intermolecular way, by using using external carbonyl derivatives. This strategy 
would constitute a very simple methodology for the assembly of tetrahydropyrans from 
commercial available alkenes, carbonyl derivatives and easy accessible allenamides that 
can be prepared on a multigram scale.110,111 Of course, getting all the components to react 
in a synchronized manner is not trivial.  
 
Scheme 121 - Proposed mechanism for Au-catalyzed multicomponent cycloaddition between allenamides, 
alkenes and aldehydes. 
                                                     
194 Faustino, H.; Alonso, I.; Mascareñas, J. L.; López, F. Angew. Chemie Int. Ed. 2013, 52, 6526–6530. 
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Org. Synth. 2014, 91, 12–26. 
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The requirement for a high level of synchronization becomes evident when considering 
the possible side products that could arise from these components, such as allenamide 
dimers,162-165 hydrofuncionalization products,162,128,129 or (2+2) cycloaddition between the 
allene and the alkene (Scheme 122).162-165 Other competitive processes include a (2+2) 
cycloaddition with the aldehydes to give oxetanes or a carbocationic polymerization 
process.195  
 
Scheme 122 - Possible secondary products for Au-catalyzed multicomponent cycloaddition between 
allenamides, alkenes and aldehydes. 
5.2 relevance of the pyrane skeleton 
Over the last few decades the number of biologically active natural products isolated 
which contain substituted tetratetrahydropyran units has increased dramatically. 
However, the study of their biological activity is oftentimes hampered by the lack of 
enough amounts of the natural products or their close derivatives.196 Some of these 
molecules have simple structures, such as Tubulexin A, a potential modulator of 
mitosis,197 (-)-Diospongin B with anti-osteoporotic activity,198 or (+)- and (-)-
Centrolobines, with antiflammatory and antibacterial activities.199 Others are part of 
macrocycles, such as Leucascandrolide A, an extremely potent inhibitor of tumor cell 
proliferation and a antifungal,200 Phorboxazoles, which exhibit extraordinary cytotoxic 
activity,201 or Bryostatins, with anticancer activity (Scheme 123).202 
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Scheme 123 - Biological active products containing tetrahydropyrans. 
One of the most popular methods for the preparation of tetrahypropyrans is based in the 
Prins cyclization,203,204 that normally involves a homoallylic alcohol (144), an aldehyde, 
and a Lewis acid to activate the carbonyl group (145). The Lewis acid, depending on 
experimental conditions, can also serve as a source of a nucleophilic anion. The generally 
accepted mechanism is initiated by complexation of the Lewis acid with the aldehyde, 
which activates the carbonyl carbon towards the attack by the hydroxyl group of the 
alcohol, generating the hemiacetal intermediate LIII. Loss of the Lewis acid fragment 
from the hemiacetal forms the key oxonium ion intermediate, LIV. Subsequent 6-endo 
cyclization of LIV selectively leads to secondary tetrahydropyranyl carbocation LV, 
which captures the halide or another nucleophile to afford to the tetratetrahydropyran 
product 146. 
                                                                                                                                                              
485–488. e) Evans, D. A.; Carter, P. H.; Carreira, E. M.; Charette, A. B.; Prunet, J. A.; Lautens, M. J. Am. Chem. Soc. 1999, 
121, 7540–7552. f) Kageyama, M.; Tamura, T.; Nantz, M. H.; Roberts, J. C.; Somfai, P.; Whritenour, D. C.; Masamune, S. J. 
Am. Chem. Soc. 1990, 112, 7407–7408. 
203 Review in prins cyclization: a) Crane, E. A.; Scheidt, K. A. Angew. Chemie Int. Ed. 2010, 49, 8316–8326. b) Greco, S. J.; 
Fiorot, R. G.; Valdemar Lacerda, J.; Santos, R. B. dos Aldrichimica Acta 2013, 46, 59–67. 
204 Review in tetrahydropyrans preparation: a) Clarke, P. A.; Santos, S. Eur. J. Org. Chem. 2006, 2006, 2045–2053. b) Olier, 
C.; Kaafarani, M.; Gastaldi, S.; Bertrand, M. P. Tetrahedron 2010, 66, 413–445. 
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Scheme 124 - General mechanism of the Prins cyclization. 
A number of others strategies for the construction of tetratetrahydropyrans have also 
been reported, including cyclizations involving oxocarbenium ions205 and epoxides,206 
hetero-Diels–Alder reactions,207 intramolecular nucleophilic reactions,208 Michael 
reactions,209 reductions of cyclic hemiacetals,210 cyclizations involving nonactivated 
double bonds,211 or tandem processes.212 
However the proposed cascade coupling would represent a simpler and more direct 
entry to this type of skeletons, and therefore we considered worthy to test its viability. 
 
                                                     
205 Morris, W. J.; Custar, D. W.; Scheidt, K. A. Org. Lett. 2005, 7, 1113–1116. 
206 Smith, A. B.; Dong, S.; Brenneman, J. B.; Fox, R. J. J. Am. Chem. Soc. 2009, 131, 12109–12111. 
207 Review: Jørgensen, K. A. Angew. Chem. Int. Ed. 2000, 39, 3558–3588. 
208 Hilli, F.; White, J. M.; Rizzacasa, M. A. Org. Lett. 2004, 6, 1289–92. 
209 Paterson, I.; Chen, D. Y.-K.; Coster, M. J.; Aceña, J. L.; Bach, J.; Gibson, K. R.; Keown, L. E.; Oballa, R. M.; Trieselmann, 
T.; Wallace, D. J.; Hodgson, A. P.; Norcross, R. D. Angew. Chemie Int. Ed. 2001, 40, 4055–4060. 
210 Boulard, L.; BouzBouz, S.; Cossy, J.; Franck, X.; Figadère, B. Tetrahedron Lett. 2004, 45, 6603–6605. 
211 Clarke, P. A.; Grist, M.; Ebden, M.; Wilson, C. Chem. Commun. 2003, 1560–1561. 
212 Wang, L.; Li, P.; Menche, D. Angew. Chemie Int. Ed. 2010, 49, 9270–9273. 
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5.3 Preliminary screenings 
In order to assess the viability of a multicomponent, formal (2+2+2) process, we check 
the reaction between allenamide 60b, trans-methylstyrene and benzaldehyde (Table 1). To 
minimize the formation of allenamide homodimer 151, allenamide 60b was added 
dropwise, over 2h.  
Unfortunately, in presence of catalyst Ph3PAuNTf2 we only obtained traceable amounts 
of the desired product 149baa (over 2%). A biaryl phosphine-based catalyst Au8 also 
gave only a 2% of 149baa alongside with a 4% of 150ba. The major products was the 
allene homodimer 151 (44% yield). The cationic catalyst Au48, which features a N-
heterocyclic carbene ligand provided 149baa in 15% yield, alongside with a mixture of 
other compounds. A catalyst prepared in situ from (PhO3)PAuCl (5%) and AgSbF6 (5%) 
afforded 149baa in a low 10% yield, together with 150ba (21%) and 151 (8%). The best 
result was obtained with phosphite gold(I) catalyst Au42, which afforded a 21% yield of 
the desired tetrahydropyran 149baa, alongside with 150ba (60%) and 151 (8%). 
Table 1 – Screening of catalysts 
 
Entry[a] [Au] T (ºC) Time Conv.[b] 149baa (%) 150ba (%) 151 (%) 
1 Ph3PAuNTf2 (5%) -15 24 h 60 2 0 7 
2 Au8 (5%) -15 5 h 99 2 4 44 
3[c] Au48 (2%) -15 5 min 100 15 7 22 
4 (PhO3)PAuCl (5%) /AgSbF6 (5%) 
-15 14 h 92 10 21 8 
5 Au42 (2%) -15 3 h 100 21 60 8 
[a] – 60b (1 equiv) added over two hours to a solution of 147a (2 equiv), 148a (10 equiv) and [Au] (mol%) in 
CH2Cl2 and 200 mg of 4Å molecular sieves. Yields determined by 1H-NMR analysis of the crude product 
using 1,3,5-trimethoxybenzene as internal standard. [b] – conversion of allenamide as determined by 1H-
NMR with internal standard. [c] – complex mixture of products. 
 
Although in a low yield, it is important to note that the (2+2+2) cycloaddition process 
took place with complete selectivity, since no other pyranyl regio- or stereoisomers could 
be detected by 1H-NMR analysis of the crude reaction mixtures. 
The proposed relative stereochemistry for 149baa was based on nOe experiments as 
depicted in Figure 6. 
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Figure 6 – nOe assignment for 149baa 
Considering a possible influence of the solvent and temperature in the proportion of the 
products,213 we performed a small reaction screening by varying these parametrs (Table 
2), using gold catalyst Au42. Unfortunately, the use of toluene, nitromethane or ,,-
trifluorotoluene did not improve the results obtained with CH2Cl2 at -15 ºC. However at 
-45 ºC the yield of 149baa could be improved to 33%, alongside with a 37% of 
cyclobutane 150ba. Further decreasing of the temperature did not improve the yield of 
the process. 
Table 2 – Screening of solvents and temperature 
 
Entry[a] % [Au] Solvent T (ºC) Time Conv. 149baa (%) 150ba (%) 151 (%) 
5 2% CH2Cl2 -15 3 h 100 21 60 8 
6[b] 5% MeNO2 -15 30 min 100 16 30 8 
7[b] 5% Tol -15 30 min 100 0 0 20 
8[c] 5% TFT -15 30 min 94 19 20 14 
9[d] 2% CH2Cl2 -45 1 h 100 33 37 0 
10[b] 2% CH2Cl2 -78 20 h 83 28 30 0 
[a] – 60b (1 equiv) added over two hours to a solution of 147a (2 equiv), 148a (10 equiv), Au42 (mol%) and 200 
mg of 4Å molecular sieves. Yields determined by 1H-NMR analysis of the crude product using 1,3,5-
trimethoxybenzene as internal standard. [b] – complex mixture of products. [c] – TFT - ,, -
Trifluorotoluene. [d] – isolated yields for 150ba and 149baa were 41% and 32% respectively. 
 
 
5.4 Scope of the reaction 
Even though the results with trans--methylstyrene were not excellent, they show that 
the reaction is possible, and therefore we decided to check the viability of this 
intermolecular muticomponent cycloaddition with other alkenes (Table 3). 
As shown in Table 3, allenamide 60b undergoes the (2+2+2) cycloaddition reaction with 
-methylstyrene and benzaldehyde (Table 3, entry 2), in just 30 min, to provide an 
                                                     
213 Solvents and Solvent Effects in Organic Chemistry; Reichardt, C., Ed.; 3rd ed.; Wiley-VCH Verlag GmbH & Co. KGaA: 
Weinheim, FRG, 2002. 
Screening of conditions 
145 
 
excellent 98% yield of 149bba, which was isolated as a 2:1 mixture of diastereoisomers. 
1,1-Diphenylethylene 147c afforded tetrahydropyran 149bca after only 10 min and in a 
good 85% yield (Table 3, entry 3). A small fraction of a hydrofunctionalization (5%) side 
product was also isolated. The use of 4-methyl-1,2-dihydronaphthalene 147d as alkene 
(Table 3, entry 4) led to the corresponding tricyclic product 149bda (57% yield of the 
major diastereoisomer). The crude also show some 1H-NMR characteristic signals of a 
(2+2) product and a minor diastereoisomer (dr=8.5:1), however these products could not 
be isolated and characterized. Unfortunately, alkyl substituted such as 
methylenecyclohexane 147e afford mainly hydrofunctionalization product (51%) and 
(2+2) cycloadduct (21%), alongside with a mixture of compounds that could not be 
characterized (Table 3, entry 5). 
On the contrary, 1-vinylpyrrolidin-2-one 147f participated in this reaction, affording the 
tetrahydropyran 149bfa as a single diastereoisomer, although in a modest 43% yield 
(Table 3, entry 6). Gratifyingly ethyl vinyl ether is an efficient cycloaddition partner and 
gives the corresponding tetrahydropyran 149bga in an excellent 94% yield, as a 1.5:1 
mixture of diastereoisomers (Table 3, entry 7). 
The use of 3,4-dihydro-2H-pyran 147h allowed to isolate the interesting bicycle 149bha 
as a single diastereoisomer, although in a low yield (28%), together with the (2+2) 
product (40%) (Table 3, entry 8). The crude mixture also showed a complex mixture of 
other minor compounds that could not be identified. 
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Table 3 - Scope of the alkene. 
 
Entry[a] Alkene T (ºC) Time Product(s) 149:149’ 149 [b] (%) 
1[c,d] 
 
-45 1 h 
 
1:0 32 
2[c] 
 
-15 30 min 
 
2:1 98 
4[c,e] 
 
-15 10 min - 85 
3[c,f] 
 
-45 2 h 
 
8.5:1 57 
5[c,g] 
 
-15 10 min - - - 
6[c,h] 
 
-45 - -15  6 h 
 
1:0 43 
7[g,i] 
 
-78 4 h 
 
1.5:1 94 
8[g,j] 
 
-78 1 h 
 
- 28 
[a] – 60b (1 equiv) added to a solution of 147 (2 equiv), 148 (10 equiv), Au42 (2%) (mol%) and 200 mg of 4Å 
molecular sieves. Conversion determined by 1H-NMR analysis of the crude product using 1,3,5-
trimethoxybenzene as internal standard. All reaction with 100% conversion unless otherwise noted. [b] – 
isolated yields. [c] – Allenamide added over 2 h. [d] – 41% of 150baa was also isolated [e] – 5% of a 
hydrofunctionalization product was also isolated. [f] – The yiled of 149 correspond to the major 
diastereoisomer, internal standard show a 12% of 150 and 7% of 149’ minor diastereoisomer that could  not 
be characterized. [g] – internal standard show a mixture of 21% 150 and 51% hydrofunctionalization. Other 
minor uncharacterized products were also present. 91% conversion [h] - Allenamide added directly. [i] – 2% 
more of Au42 was added at 3h to complete the reaction. [j] –A 40% yield of 150bha was isolated and a 
mixture of unidentified products was present in crude. 
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As we have seen in chapter 2, tosylallenamides also participate in (2+2) cycloadditions 
with electron-rich alkenes,163,164 and in the cascade cycloadditions between allenamides 
and carbonyl-tethered alkenes.194 Therefore they also seem to be good candidates for the 
multicomponent (2+2+2) protocol. The cycloaddition of N-phenyl-N-tosylallenamide 
with benzaldehyde and -phenylstyrene catalyzed by Au42 afforded the desired 
tetrahydropyran products, but as mixture of several isomers, probably involving Z/E 
and cis/trans isomers (Scheme 125). Unfortunately, they could not be separated by 
standard chromatography techniques.  
 
Scheme 125 – Possible products with N-phenyl-N-tosylallenamide. 
 
Curiously, when we use 2-methoxyprop-1-ene as alkene and N-phenyl-N-
tosylallenamide as allene only one diastereoisomer was obtained in a global 63% yield as 
a Z:E = 2.4:1 mixture, alongside with a 17% of the cyclobutane 150di. 
 
Scheme 126 - N-phenyl-N-tosylallenamide in the Au(I) catalyzed multicomponent cycloaddition. 
                                                     
163 Li, X.-X.; Zhu, L.-L.; Zhou, W.; Chen, Z. Org. Lett. 2012, 14, 436–439. Correction: Li, X.-X.; Zhu, L.-L.; Zhou, W.; Chen, Z. 
Org. Lett. 2012, 14, 1185–1185. 
164 Suárez-Pantiga, S.; Hernández-Díaz, C.; Piedrafita, M.; Rubio, E.; González, J. M. Adv. Synth. Catal. 2012, 354, 1651–1657. 
194 Faustino, H.; Alonso, I.; Mascareñas, J. L.; López, F. Angew. Chemie Int. Ed. 2013, 52, 6526–6530. 
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We next examined the scope of the reaction with regard to the carbonyl component 
(Table 4) using allenamide 60b and 1,1-diphenylethylene or -methylstyrene as alkene 
partners.  
Gratifyingly, the reaction is not restricted to aromatic aldehydes, and aliphatic aldehydes 
participate in the reaction with a similar efficiency (Table 4, entries 1-3). Thus 
isobutyraldehyde and -methylstyrene afford the corresponding tetrahydropyran 
149bbb in a 67% yield as a 3.4:1 mixture of diastereoisomers (Table 4, entry 1), while in 
similar conditions pentanal give the corresponding tetrahydropyran 149bbc in a 
excellent 97% yield as a 3:1 mixture of diastereoisomers (Table 4, entry 2).  
The presence of a cyclopropane at the -position of the aldehydes did not trigger 
undesired secondary reactions and together with 1,1-diphenylethylene afford the 
desired tetrahydropyran in a excellent 92% yield as a 8:1 Z:E mixture (Table 4, entry 3). 
Unfortunately the reaction of -methylstyrene with acetophenone or dimethylketone 
gave mainly the (2+2) cycloadduct and a complex mixture of other products (Table 4, 
entries 4,5). 
Table 4 – Scope of the carbonyl 
 
Entry[a] R1 148 T (ºC) Time Product(s) 149:149’ 149 (%) 
1[b] Me 
 
-45 5 min 
 
3.4:1 67 
2[b] Me 
 
-45 5 min 
 
3:1 97 
3[b,c] Ph 
 
-78 3 h 
 
- 92 
4[c,d] Me 
 
-45 1 h - - - 
5[c,d] Me 
 
-45 1 h - - - 
[a] – 60b (1 equiv) added over two hours to a solution of 147 (2 equiv), 148 (10 equiv),Au42 (2%) (mol%) and 
200 mg of 4Å molecular sieves. All reaction with 100% conversion. [b] – an 1,3-dioxetane product resulting 
from a (2+2) cycloaddition between two unities of the aldehydes was also observed, but does not influence 
the progress of the reaction. [c] – allenamide added directly. [d] – Crude inspection show mainly the (2+2) 
cycloadduct alongside with a complex mixture of other products. 
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5.5. Preliminary Screening of Chiral Gold Catalysts 
We next explored the viability of achieving these annulations in an enantioselective 
manner (Table 5) using -methylstyrene, benzaldehyde and allenamide 60b as partners, 
in CH2Cl2 at -78 ºC.  
It should be mentioned that we started the study with a protocol involving the slow 
addition of allenamide to avoid its dimerization. It was latter observed that this protocol 
is only needed with some alkenes. 
Initially we tested a gold catalyst with a triazoloisoquinolin-3-ylidene ligand Au40, that 
previously gave excellent results in the Au(I)-catalyzed (4+2) cycloaddition with 
dienes.148 Although at -78 ºC the reaction did not evolve, slowly warming up to -30 ºC for 
4 hours afforded the desired tetrahydropyran in a 79% yield, with a dr = 5:1 and a good 
78% ee for the major diastereoisomer (Table 5, entry 1). The biphosphine Segphos 
complex Au14 allowed to obtain after 2 hours the tetrahydropyran in an excellent 92% 
yield and a dr = 9:1. However the ee was 58%, considerably inferior to that obtained with 
Au40 (Table 5, entry 2). 
Next we tested several phosphoramidite gold complexes. In all cases excellent yields 
were obtained (92-98%) in very short reaction times (5 to 10 min, Table 5, entries 3-11), 
confirming once again that -acceptor ligands, such as phosphites or phosphoramidites 
are particularly adequate to perform this reaction. 
Precatalyst (R,R,R)-Au17, which bears 9-anthracenyl groups at the 3 and 3’ positions of 
the binaphthol unit, provide a moderate 40% ee for the major diastereoisomer and a dr = 
6:1 (Table 5, entry 3). Related binol based phosphoramidites, Au18 and Au44, gave 
results similar to that of Au17. Curiously the configuration of the chiral amine seems to 
have little influence on the diastereoselectivity and ee for the major diastereoisomer, thus 
for (S,R,R) Au44 a dr = 3.3:1 and a ee of 46% was obtained, while with (S,S,S) Au44 a dr 
of 3:1 and an ee of 52% was observed. In both cases the major enantiomer was the same. 
Vapol based phosphoramidite (R,R,R) Au23 afford a similar results, with a ee = 50% for 
the major diastereoisomer and a dr = 2.6:1 (Table 5, entry 7).  
A significant improvement in ee was obtained using vanol phosphoramidite (S,S,S) 
Au24, which afforded the major diastereoisomer 149bba in a 68% ee, and the minor 
149bba’ in a 54% ee, with a dr = 2.4:1. Vanol phosphoramidite (S,R,R) Au24, with a 
different configuration of the amine, afforded the tetrahydropyran in a dr = 2.2:1, with a 
slight improve in the ee of major diastereoisomer 149bba (72% ee). While the minor 
diastereoisomer 149bba’ was obtained in a good 82% ee. 
Vanol phosphoramidites (S,R,R) Au49 and (S,R,R) Au50 did not improve these results of 
(S,R,R) Au24. Carrying out the reaction with (S,R,R) Au24 in other solvents, such as 
toluene, tBuOMe, Et2O or CHCl3 did not improve the results obtained with CH2Cl2 
(S,R,R) Au24.  
                                                     
148 Francos, J.; Grande-Carmona, F.; Faustino, H.; Iglesias-Sigüenza, J.; Díez, E.; Alonso, I.; Fernández, R.; Lassaletta, J. M.; 
López, F.; Mascareñas, J. L. J. Am. Chem. Soc. 2012, 134, 14322–14325. 
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Finally we decide to check if a decreasing in the reaction temperature would permit the 
gain in enantioselectivity. Indeed, the reaction using AgNTf2 at -94 ºC afford a dr = 2:1 
and ee ‘s of 75% and 88%for 149bba and 149bba’ respectively (entry 12), while using 
AgBF4 at -94 ºC a dr of 4:1 and ee ‘s of 74% and 90%for 149bba and 149bba’ respectively 
were obtained (entry 13). 
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Table 5 – Screening of chiral catalysts 
 
Entry[a] A[b] [Au] Time 149 (%) 149: 149’ ee 149 ee 149’ 
1[c] 2 h Au40 4 h 79 5:1 +78% -19% 
2 2 h Au14 2 h 92 9:1 -58% +6% 
3 2 h (R,R,R) Au17 5 min 96 6:1 +40% -30% 
4 0 min (S,R,R) Au44 10 min 97 3.3:1 +46% -18% 
5 0 min (S,S,S) Au44 5 min 97 3:1 +52% -32 
6 0 min (R,R,R) Au18 5 min 98 6.3:1 +46% -7% 
7 0 min (R,R,R) Au23 5 min 98 2.6:1 +50% -38% 
8 0 min (S,S,S) Au24 10 min 95 2.4:1 -68% +54% 
9 2 h (S,R,R) Au24 5 min 97 2.2:1 -72% +82% 
10 0 min (S,R,R) Au49 7 min 91 1:1.1 +10% +66% 
11 0 min (S,R,R) Au50 5 min 97 2.5:1 -50% +26% 
12[d] 0 min (S,R,R) Au24 30 min 93 2:1 -75% +88% 
13[d,e] 0 min (S,R,R) Au24 30 min 91 4:1 -74% +90% 
[a] – 60b (1 equiv) to a solution of 147b (2 equiv), 148a (10 equiv) and [Au] (mol%) in CH2Cl2 and 200 mg of 
4Å molecular sieves. 100% conversion in all cases. [b] – time of addition of the allenamide. [c] - At -78 °C for 1h 
and then slowly warmed to -30 ºC for 3h more. [d] – at -94 ºC. [e] – using AgBF4 instead of AgNTf2. 
 
 
In summary, for the tested chiral gold catalysts, with chiral catalyst (S,R,R)-Au24 we can 
obtain the best commitment between of ee for both diastereoisomers and reactivity. 
While with Segphos complex Au14 good results in terms of diastereoselectivity (9:1) can 
be obtained. 
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Conclusion 
The present methodology allows the rapid construction of tetrahydropyrans derivatives 
from commercially available alkenes and aldehydes, and easy accessible allenamides. In 
addition, the atom economy and operational simplicity of the process make it a very 
good alternative to other current strategies for the synthesis tetrahydropyran. The 
method tolerates styrenes, enamides or enol ethers as alkenes and aromatic or aliphatic 
aldehydes. The proper choice of a chiral ligand at the gold catalyst allows to obtain 
moderate to good enateoselectitivies, albeit there is still room for improvement in scope, 
diestereo and enantioselectivities. 
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Overall Discussion 
The propose of this overall discussion is to provide consistency and unity to the different 
articles, according to article 41 of the regulations for the PhD studies from the University 
of Santiago de Compostela (“Reglamento de los Estudios de Doctorado de la 
Universidad de Santiago de Compostela”). 
At the outset of this thesis, a number of Au(I)-catalyzed intramolecular cycloadditions of 
allenes had been described. However reports on their intermolecular versions were 
inexistent. Previous to the work reported in this thesis, our group had reported on Au(I)-
catalyzed intramolecular (4+3) and (4+2) cycloadditions of allenedienes. Therefore we 
started our work by investigating the possibility of achieving these processes in an 
intermolecular fashion. 
As demonstrated by an initial screening of allenes and catalysts, the development of 
intermolecular variant of this type of annulations between allenes and dienes is not 
straightforward. Thus, electronically neutral allenes, such as 3-methylbuta-1,2-diene or 
electronically rich allenes such as methoxyallene failed to undergo the desired 
cycloadditions with different type of dienes in the presence of a variety of gold catalysts. 
 
Gratifyingly, treatment of isoprene with the allenamide 60b in the presence of 
PPh3AuCl/AgSbF6, at -15ºC, produced the (4+2) cyclohexene cycloadduct in 33% yield 
together with the (2+2) cycloadduct, which was isolated in 19% yield (Scheme 127). 
 
Scheme 127 – Initial result for the Au-catalyzed intermolecular cycloadditions. 
A screening of several Au and Pt catalysts revealed that neutral gold chloride is a more 
selective catalyst towards the (4+2) cycloaddition. Therefore a variety of dienes and 
allenes were proved to react efficiently in the presence of AuCl in CH2Cl2. 
In the second article included in this memory we discussed the mechanism of the 
reaction. The formation of secondary minor (2+2) cycloadducts and the nucleophilic 
trapping of intermediate LIII at its  and  positions suggest that, at least in some cases, 
the reaction might proceed through a stepwise cationic pathway such as that shown in 
Scheme 128. 
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Scheme 128 - Preliminary mechanistic proposal based on a stepwise cationic pathway. 
Further investigation has revealed that the mechanistic features are more complex. 
Although the formation of small amounts of 152 supports a stepwise pathway like that 
shown in the Scheme 128, it might be parallel alternative paths. In particular, the 
formation of the (4+2) cycloadduct could also be explained by invoking either a (4+3) 
cycloaddition of LIII and the diene, followed by a ring contraction in the resulting gold-
carbene species LIV (Scheme 129, upper), or a concerted (4+2) cycloaddition between 
LIII and the diene (Scheme 129, lower). The prevalence of one or other pathway depends 
on the charactheristics of the diene and of the gold catalyst. 
 
Scheme 129 - Alternative mechanistic pathways that could render the (4+2) adduct. 
As above mentioned, in a number of cases, in addition to the (4+2) adducts we also 
observed cyclobutane side products arising from a competitive (2+2) cycloaddition 
between the allene and one of the carbon-carbon double bonds of the diene (Scheme 
128). On these bases, and considering the relevance of the cyclobutane framework, we 
decided to specifically pursue the development of a gold-catalyzed intermolecular (2+2) 
cycloaddition. In the third article included in the memory we describe the development 
of such a process (Scheme 130). 
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Scheme 130 – Proposed mechanism for the (2+2) cycloadditions. 
The high regioselectivity observed in the (2+2) annulations, together with the intrinsic 
requirement of a carbocation-stabilizing group at the alkene, suggests that this reaction 
proceeds through a cationic pathway such as that depicted in the Scheme 130. 
In light of this mechanism, we envisioned that interception of the carbocationic 
intermediate XLVI by an internal nucleophile might allow to assemble interesting 
bicycles according to the cationic cascade shown in the Scheme 131. Therefore, the 
presence of a carbonyl group enables the endo trapping of the cation XLVI, and yield 
bridged-bicyclic skeletons of type 116. In the third chapter of the memory we 
demonstrate the viability of such a process, work that has been already published. 
 
Scheme 131 - Newly designed cascade cycloaddition processes. 
Based on the mechanism of the previous work (Scheme 131), we envisioned that 
interception of the carbocationic intermediate XLVI’ could be also performed by an 
external carbonyl group, resulting in a multicomponent assembly of tetrahydropyrans 
derivatives through the cationic cascade shown in Scheme 132. This work, yet 
unpublished, is described in an addendum to the third chapter of the memory. 
 
Scheme 132 - Proposed mechanism for Au-catalyzed multicomponent cycloaddition between allenamides, 
alkenes and aldehydes. 
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Conclusion 
In conclusion, we have disclosed the first Au(I)-catalyzed intermolecular cycloaddition 
of allenes and discovered that allenamides, in the presence of an appropriate gold 
catalyst, are excellent two carbon atom component for an array of cycloadditions. 
Thus allenamides react with acyclic conjugated dienes, in presence of catalytic amounts 
of AuCl, to provide synthetically appealing cyclohexene derivatives in a highly or 
completely selective manner. Theoretical calculations and experimental evidences 
indicate that the mechanism is rather intricate and dependent on the type of diene and 
Au-catalyst used. Furthermore, the first examples of a highly enantioselective version of 
this process have been described.  
On the other hand, styrenes or enamides participate in (2+2) cycloadditions with 
allenamides in the presence of a cationic Au(I) phosphite. This method provides 
synthetically appealing cyclobutane derivatives in a highly selective manner.  
The stepwise nature of the (2+2) cycloaddition allowed to discover an interesting cascade 
cycloaddition process. Thus using carbonyl-tethered alkenes, we developed a Au(I)-
catalyzed cascade cycloaddition with allenamides that yields oxa-bridged seven-, eight-, 
and even nine-membered rings. Moreover, we have also demonstrated that by using 
chiral gold catalysts it is possible to obtain these products with good to high 
enantioselectivities. Finally this process can also be carried out in a fully intermolecular 
way, using allenamide, alkenes and aldehydes as reaction components. The method 
provides a straigforward way of assembling a variety of tetrahydropyrans.  
It's worth mention that all these processes employ commercial available or very easy 
accessible starting materials that can be used without special purification processes. 
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Resumen 
En esta Memoria de investigación se recogen los resultados obtenidos en los estudios 
sobre cicloadiciones intermoleculares de alenos catalizadas por oro. 
Cicloadiciones (4+2) intermoleculares catalizadas por oro entre alenos y dienos  
En el primer capítulo se describen las primeras cicloadiciones intermoleculares de alenos 
catalizadas por oro. En primer lugar se descubrió que las alenamidas participan como 
componentes de dos carbonos en cicloadiciones (4+2) con 1,3-dienos acíclicos en 
presencia de distintos complejos de oro.  
Un rastreo de varios catalizadores de oro y platino nos permitió detectar que el cloruro 
de oro (AuCl) y varios catalizadores de oro catiónicos (L-Au+) eran válidos para 
catalizar este proceso, si bien, dependiendo del catalizador usado, además de los 
ciclohexenos resultantes de una cicloadición (4+2), se observaban distintas proporciones 
de un producto ciclobutánico minoritario, resultante de una cicloadición (2+2) entre la 
alenamida y el dieno. 
La reacción es muy selectiva con AuCl como catalizador (5 mol%), formándose casi 
exclusivamente el cicloaducto con el doble enlace exocíclico Z, con excelentes regio- y 
diastereo-selectividades. Además, el tipo de dienos que participan en este proceso es 
muy variado, incluyendo dienos con grupos alquílicos, arílicos o alcóxidos en distintas 
posiciones.  
El cloruro de oro no fue suficientemente activo para dienos con sustituciones alquílicas 
simultáneas en las posiciones 1 y 4. Afortunadamente en estos casos un complejo de oro 
con un ligando NHC (IPrAu+) resultó ser más eficaz. 
La utilización de una aleno-oxazolidinona quiral permitió el desarrollo de variantes 
asimétricas para estas cicloadiciones con excelentes rendimientos y 
diastereoselectividades. 
 
 
También estudiamos el desarrollo de una versión enantioselectiva de estos procesos 
(4+2), por medio de la utilización de ligandos quirales en el complejo de oro. El rastreo 
exhaustivo de varios complejos quirales de oro, con ligandos basados en fosfinas, 
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fosforamiditos o carbenos, demostró que estos complejos son activos pero dan lugar a los 
correspondientes ciclohexenos con enantioselectividades bajas o moderadas (4 – 77% ee). 
No obstante, en colaboración con el grupo de J. L. Lassaletta, se desarrolló un nuevo 
catalizador de oro con un ligando carbenico N-heterociclico con quiralidad axial que 
proporcionó excelentes enantioselectividades en estas cicloadiciones intermoleculares, 
permitiendo utilizar dienos con varios sustituyentes y generar en la cicloadición hasta 
tres nuevos estereocentros con excelente enantio, diastereo y regioselectividad. 
 
En colaboración con el grupo de A. Lledós estudiamos el mecanismo de estas 
cicloadiciones intermoleculares catalizadas por oro entre alenamidas y dienos acíclicos, 
por medio de pruebas experimentales y cálculos computacionales. La formación de los 
cicloaductos (4+2) se puede explicar mediante diferentes vías mecanísticas. Las vías 
preferidas están determinadas por la naturaleza del dieno (con sustituyentes neutros o 
electrodadores) y el tipo de catalizador de oro (AuCl vs IPrAu+). Así, en las reacciones 
catalizadas por AuCl, con dienos con sustituyentes neutros como isopreno o 2,3-dimetil-
butadieno se propone una cicloadición (4+3) concertada para dar un intermedio 
carbénico de 7 miembros (II), seguido de una de contracción del anillo. Por el contrario, 
con dienos con sustituyentes electrodadores (e.g. OMe) los datos sugieren que el 
mecanismo que opera involucra a intermedios acíclicos catiónicos como III, que 
evoluciona para dar el mismo tipo de producto de cicloadición (4+2) 
El uso de agentes oxidantes en el medio de reacción permitió atrapar tanto un 
intermedio carbénico de 7 miembros, resultante de la cicloadición (4+3) concertada, 
como el oxonio intermedio propuesto para el mecanismo catiónico por etapas. 
 Por otro lado, los datos teóricos indican que en caso de utilizarse un catalizador de oro 
catiónico, como IPrAu+, el mecanismo implicaría una cicloadición (4+2) concertada entre 
el dieno aciclico y la alenamida activada por el oro. 
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Cicloadiciones (2+2) intermoleculares catalizadas por oro entre alenos y alquenos  
La presencia de ciclobutanos resultantes de una cicloadición (2+2) como productos 
secundarios en estas cicloadiciones (4+2) nos llevó a investigar si el proceso (2+2) podría 
tener lugar selectivamente utilizado alquenos en vez de dienos. En el segundo capítulo 
se describe el desarrollo de dicho proceso. 
Un rastreo de catalizadores de oro en presencia de N-allenyl-oxazolidinona y trans--
metilestireno nos permitió identificar un complejo de oro catiónico con un ligando fosfito 
como un catalizador eficiente para este proceso. El estudió del alcance del proceso con 
respecto al alqueno demostró que los derivados de estirenos y las enamidas son 
alquenos particularmente adecuados para este tipo de cicloadición (2+2). Además, la 
reacción tolera sustituyentes en las posiciones  o  de los alquenos y el uso de alquenos 
endocíclicos permite obtener ciclobutanos fusionados con otros ciclos. 
En resumen, esta transformación representa un método práctico y sencillo para la 
obtención de ciclobutanos altamente sustituidos generalmente con completa regio- y 
estereoselectividad. 
 
La alta regioselectividad observada en las cicloadiciones (2+2) y la necesidad de grupos 
estabilizadores de carbocationes en el alqueno sugiere que la reacción ocurre a través de 
un mecanismo catiónico por etapas como el que se muestra en el siguiente esquema. 
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Cicloadiciones en cascada catalizadas por oro entre alenamidas, alquenos y carbonilos.  
Considerando un mecanismo catiónico por etapas para las cicloadiciones (2+2), 
supusimos que la intercepción del intermediario catiónico de tipo IV’ por un nucleófilo 
interno, como por ejemplo un grupo carbonilo, podría resultar en la construcción de 
sistemas oxabiciclicos muy interesantes a través de un proceso catiónico en cascada 
como el mostrado en el siguiente esquema. En el tercer capítulo se describe el desarrollo 
de dicho proceso.  
 
 
Un rastreo de alquenos con nucleofilos internos nos permitió identificar los oxoalquenos 
como componentes adecuados para las reacciones en cascada con la N-allenil-
oxazolidinona y catalizadas por complejos de oro para dar lugar a carbociclos con un 
puente de oxigeno. Una vez más un complejo de oro catiónico con un ligando fosfito 
resultó ser un catalizador eficiente para este proceso. El estudio del alcance de la 
reacción reveló que ésta funciona con una variedad de grupos carbonilo, tales como 
cetonas alquílicas, cetonas aromáticas, aldehídos o esteres. En cuanto al alcance del 
alqueno, se verificó que la reacción funcionaba con una variedad de grupos en la 
posición  del alqueno, tales como grupos aromáticos, alquílicos o amidas. La posición  
del alqueno también puede presentar sustituciones, dando lugar a la generación de tres 
nuevos centros estereogénicos de modo completamente diastereoselectivo. La elección 
del tamaño de la cadena que une el alqueno y el grupo carbonilo permite modular el 
tamaño de los oxabiciclos correspondientes, que pueden ser de siete, ocho o incluso 
nueve miembros. Además, este tipo de sistemas oxabicíclicos se pueden obtener con 
enantioselectividades buenas a altas a través del uso de complejos de oro con 
fosforamiditos o bifosfinas quirales. 
Resumen  
163 
 
 
 
La eficacia de este proceso nos llevo a plantear si el mismo se podría llevar a cabo sin 
necesidad de unir los grupos carbonilo y alqueno, de modo enteramente intermolecular, 
obteniendo de un modo sencillo tetrahidropiranos, estructuras muy importantes por ser 
parte estructural de un número muy importante de compuestos bioactivos con 
propiedades farmacológicas muy interesantes. 
 
Un rastreo de condiciones y complejos de oro en presencia de la N-allenil-oxazolidinona, 
trans--metilestireno y benzaldehído nos permitió identificar unas condiciones en las que 
se obtenía el producto deseado, aunque con bajo rendimiento. Estas consisten en el uso 
de un complejo de oro que presenta un ligando fosfito voluminoso, dos equivalentes de 
alqueno y diez de aldehído en diclorometano a bajas temperaturas (típicamente entre –
78 y -15 ºC).  
Un estudio del alcance del alqueno en estas condiciones reveló que la presencia de un 
sustituyente en la posición  del estireno permite obtener ya el producto deseado con 
rendimientos moderados a excelentes. El uso de alquenos endociclicos resulta en los 
biciclos correspondientes. Además de estirenos, las enamidas o enol éteres también son 
componentes apropiados en este proceso. Cuanto al alcance del aldehído, la reacción 
funciona igualmente bien con aldehídos aromáticos o alifáticos. 
 Un estudio de una variedad de complejos de oro quirales ha revelado que la una 
selección apropiada del catalizador, Au*1 o Au*2 puede permitir la obtención de 
hidropiranos con buena diastereo o enantioselecividad. 
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1. General experimental procedures 
 
Reactions were conducted in dry solvents under Argon atmosphere unless otherwise 
stated. Dry solvents were freshly distilled under Argon from an appropriate drying agent before 
use. Toluene was distilled from Na, THF from Na / benzophenone. CH2Cl2 was purchased from 
Aldrich. [PtCl2(C2H4)]2 and PtCl2 were purchased from Strem Chemicals. AuCl3, AuCl, 
Chloro[1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene]gold (IPrAuCl), chloro(triphenylphos 
phine)gold(I) (Ph3PAuCl), Chloro[tris(2,4-di-tert-butylphenyl)phosphite]gold (I), (Acetonitrile)[(2-
biphenyl)di-tert-butylphosphine]gold(I) hexafluoroantimonate (I), Dichloro(2-
pyridinecarboxylato)gold and AgSbF6 were purchased from Aldrich. All other chemicals were 
purchased from Aldrich and used without further purification. 
The abbreviation “rt” refers to reactions carried out at a temperature between 21-25 ºC. 
Reaction mixtures were stirred using Teflon-coated magnetic stir bars. High reaction 
temperatures were maintained using Thermowatch-controlled silicone oil baths. Thin-layer 
chromatography (TLC) was performed on silica gel plates and components were visualized by 
observation under UV light, and / or by treating the plates with p-anisaldehyde or cerium nitrate 
solutions, followed by heating. Flash chromatography was carried out on silica gel. Dryings 
were performed with anhydrous Na2SO4. Concentration refers to the removal of volatile solvents 
via distillation using a Büchi rotary evaporator followed by high vacuum. NMR spectra were 
recorded in CDCl3, at 250 MHz (Bruker), 300 MHz (Varian), 400 MHz (Varian) or 500 MHz 
(Bruker). Carbon types and structure assignments were determined from DEPT-NMR and two-
dimensional experiments (HMQC and HMBC, COSY and NOESY). NMR spectra were analyzed 
using MestReNova© NMR data processing software (www.mestrelab.com). The following 
abbreviations are used to indicate signal multiplicity: s, singlet; d, doublet; t, triplet; q, quartet; 
dd, double doublet; dt, double triplet; m, multiplet; br, broad. Mass spectra were acquired using 
chemical ionization (CI) and were recorded at the CACTUS facility of the University of Santiago 
de Compostela.  
3-(Propa-1,2-dien-1-yl)oxazolidin-2-one (1d)1, tert-butyldiphenyl(propa-1,2-dien-1-
yloxy)silane (1c),2 dimethyl 3,4-dimethylenecyclohexane-1,1-dicarboxylate 2g,3 (E)-(2-
methylbuta-1,3-dien-1-yl)benzene 2i,4 (R)-4-benzyl-3-(propa-1,2-dien-1-yl)oxazolidin-2-one 
(1g),1,5 and (4R,5S)-4-methyl-5-phenyl-3-(propa-1,2-dien-1-yl)oxazolidin-2-one (1h)6 are known 
compounds and were synthesized according to those previously reported procedures.  
 
                                                            
1 L. Wei, J. A. Mulder, C. A. Zificsak, C. J. Douglas and R. P. Hsung, Tetrahedron. 2001, 57, 459-466. 
2 I. A Stergiades and M. A. Tius, J. Org. Chem. 1999, 64, 7547-7551. 
3 B. M. Trost, L. Zhi, K. Imi, Tetrahedron Letters. 1994, 35, 1361-1364. 
4 Y. Nakao, H. Idei, K. S. Kanyiva and T. Hiyama, J. Am. Chem. Soc. 2009, 131, 5070-5071. 
5 A. W. Hill, M. R. J. Elsegood and M. C. Kimber, J. Org. Chem. 2010, 75, 5406-5409. 
6  J. E. Antoline, R. P. Hsung, J. Huang, Z. Song and G. Li, Org. Lett. 2007, 9, 1275. 
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2. Experimental data  
 
3-(Buta-1,2-dien-1-yl)oxazolidin-2-one (1f) 
Prepared according to a previously described procedure:7 Alkylation of 2-oxazolidinone 
with 1-bromobut-2-yne (1.3 equiv) affords the 3-(but-2-ynyl)oxazolidin-2-one intermediate (33% 
yield, non optimized), which provides the corresponding allenamide upon isomerization with t-
BuOK.8 
 
General procedure for the (4+2) cycloaddition of allenamides and acyclic dienes 
(Exemplified for 3da) 
 
AuCl (4.65 mg, 0.020 mmol) was added to a dried Schlenk tube containing a solution of 
isoprene (0.06 mL, 1.20 mmol) and allenamide 1d (50.1 mg, 0.4 mmol) in CH2Cl2 (4 mL), under 
Argon atmosphere. The resulting mixture was stirred at rt for 6 h (the progress of the reaction 
was easily monitored by tlc) and filtered through a short pad of florisil eluting with Et2O. The 
filtrate was concentrated affording 78.6 mg of the crude reaction mixture which was purified by 
flash chromatography (hexane/EtOAc 10-20%) to give (Z)-3-((2-methyl-2-
vinylcyclobutylidene)methyl)oxazolidin-2-one 4da ( aprox. 1.8 mg, 9.31 µmol, 2 % yield) and 3-
((4-methylcyclohex-3-en-1-ylidene)methyl)oxazolidin-2-one 3da (51 mg, 0.264 mmol, 66 % 
yield, ratio Z : E = 93 : 7). The stereochemistry of the resulting cycloadducts could be 
determined by –ray crystallographic analysis or by 2D-NMR.In case of 3da, the 2D-NMR data 
showed the Z-stereochemistry of the major adduct. 
3-((4-Methylcyclohex-3-en-1-ylidene)methyl)oxazolidin-2-one (3da) 
66 % yield, colourless oil; corresponding to a 93 : 7 mixture of Z : E 
isomers. (Z)-3da:9 1H NMR (400 MHz, CDCl3) δ 5.89 (s, 1H), 5.29 – 5.23 
(m, 1H), 4.33 (dd, J = 8.7, 7.3 Hz, 2H), 3.76 (dd, J = 8.7, 7.2 Hz, 2H), 2.77 
(tt, J = 3.9, 2.0 Hz, 2H), 2.26 (td, J = 6.4, 0.8 Hz, 2H), 2.01 (t, J = 6.4 Hz, 
                                                            
7 M. R. Tracey, T. Grebe, J. A. Mulder, R. P. Hsung, Organic Syntheses. 2005, 81, 147-151. 
8 L.  Shen, R. P. Hsung, Y. Zhang, J. E. Antoline and X. Zhang, Org. Lett. 2005, 7, 3081-3084. 
9 NMR data corresponds to the Z-isomer of 3. The minor E isomer could not be separated by standard flash 
chromatography but it can be detected in the NMR spectra of the mixture. The ratio of isomers was calculated by 
integrating the NMR signals corresponding to the C-H enamide group.  
NO
3daO
Z : E = 93 : 7
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2H), 1.65 – 1.60 (m, 3H). 13C NMR (63 MHz, CDCl3) δ 157.1 (C), 134.3 (C), 130.3 (C), 118.2 
(CH), 116.6 (CH), 62.1 (CH2), 46.3 (CH2), 31.1 (CH2), 29.7 (CH2), 27.5 (CH2), 23.3 (CH3). LRMS 
(m/z, CI): 194 [M+ +1, 100], 166 (25), 126 (49), 107 (94); 88 (93). HRMS [M+ +1], Calculated for 
C11H16NO2: 194.1181, found 194.1187. 
 
Figure S1. Key noesy signal in Z-3da 
(Z)-3-((2-Methyl-2-vinylcyclobutylidene)methyl)oxazolidin-2-one (Z-4da) 
2% yield, colourless oil. 1H NMR (400 MHz, CDCl3) δ 6.21 (t, J = 2.1 Hz, 1H), 
6.08 (dd, J = 17.4, 10.5 Hz, 1H), 5.04 (dd, J = 17.4, 1.4 Hz, 1H), 4.98 (dd, J = 
10.5, 1.4 Hz, 1H), 4.34 – 4.18 (m, 2H), 3.80 (td, J = 8.9, 6.5 Hz, 1H), 3.61 (td, 
J = 9.1, 7.5 Hz, 1H), 2.72 – 2.62 (m, 1H), 2.59-2.52 (m, 1H), 2.01 – 1.95 (m, 
1H), 1.87 – 1.78 (m, 1H), 1.40 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 156.7 (C), 
145.3 (CH), 130.1 (C), 116.7 (CH), 111.1 (CH2), 62.0 (CH2), 48.4 (C), 46.3 (CH2), 32.8 (CH2), 
24.7 (CH3), 24.6 (CH2). LRMS (m/z, CI): 194 [M+ +1, 18], 193 (28), 126 (78), 107 (100); 88 (89). 
HRMS [M+ +1], Calculated for C11H16NO2: 194.1181, found 194.1183. 
(Z)-3-((3,4-Dimethylcyclohex-3-en-1-ylidene)methyl)oxazolidin-2-one (3db) 
76% yield, corresponding to a 93 : 7 mixture of Z : E isomers, white solids, 
Mp = 77-79 ºC; (Z)-3db:10 1H NMR (500 MHz, CDCl3) δ 5.81 - 5.76 (m, 
1H), 4.33 – 4.24 (m, 2H), 3.76 – 3.69 (m, 2H), 2.64 (s, 2H), 2.20 – 2.14 (m, 
2H), 1.96 (s, 2H), 1.57 – 1.54 (m, 3H), 1.54 – 1.49 (m, 3H). 13C NMR (126 
MHz, CDCl3) δ 156.9 (C), 131.6 (C), 125.8 (C), 122.9 (C), 115.7 (CH), 62.0 (CH2), 46.3 (CH2), 
33.4 (CH2), 32.5 (CH2), 29.9 (CH2), 18.7 (CH3), 18.6 (CH3). LRMS (m/z, CI): 208 [M+ +1, 97], 
180 (22), 149 (32), 121 (100), 86 (94). HRMS [M+ +1], Calculated for C12H18NO2: 208.1388, 
found 208.1341. The structure of Z-3db was further confirmed by X-ray analysis (Figure S2). 
 
Figure S2: X-Ray structure of Z-3db (deposited at the Cambridge Crystallographic Data Centre 
with the number CCDC 804843) 
 
 
                                                            
10 A sample of isomerically pure Z-3db could be obtained after crystallization of the isolated Z : E, 93 : 7, mixture. 
Z-4da
O N
O
NO
3dbO
Z : E = 93 : 7
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3-((2-Methylcyclohex-3-en-1-ylidene)methyl)oxazolidin-2-one (3dc) 
60% yield, corresponding to a 93 : 7  mixture of Z : E isomers; colourless oils; 
(Z)-3dc:9  1H NMR (500 MHz, CDCl3) δ 5.95 (s, 1H), 5.70 – 5.59 (m, 1H), 
5.56 – 5.45 (m, 1H), 4.34 (t, J = 8.0 Hz, 2H), 3.86 (dd, J = 16.1, 8.3 Hz, 1H), 
3.78 (dd, J = 16.1, 8.6 Hz, 1H), 3.14 – 3.03 (m, 1H), 2.33 – 2.22 (m, 1H), 2.20 
– 2.10 (m, 2H), 2.10 – 1.97 (m, 1H), 1.14 (d, J = 7.0 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 
157.4 (C), 134.4 (C), 131.0 (CH), 126.1 (CH), 116.3 (CH), 62.0 (CH2), 46.4 (CH2), 31.4 (CH), 
27.3 (CH2), 26.7 (CH2), 21.5 (CH3). LRMS (m/z, CI): 194 [M+ +1, 78], 135 (23), 126 (43), 107 
(100); 88 (91). HRMS [M+ +1], Calculated for C11H16NO2: 194.1181, found 194.1178. 
(Z)-3-((2,3-Dimethylcyclohex-3-en-1-ylidene)methyl)oxazolidin-2-one (3dd) 
62% yield, corresponding to a 90 : 10 mixture of Z : E isomers; white solids, 
Mp = 98-99 ºC; (Z)-3dd:11  1H NMR (500 MHz, CDCl3) δ 5.90 (d, J = 1.8 Hz, 
1H), 5.38 (brs, 1H), 4.37 (t, J = 8.0 Hz, 2H), 3.88 (dd, J = 16.1, 8.2 Hz, 1H), 
3.77 (dt, J = 16.1, 8.1 Hz, 1H), 2.88 (q, J = 6.9 Hz, 1H), 2.34 – 2.23 (m, 1H), 
2.18 – 1.99 (m, 3H), 1.68 (s, 3H), 1.20 (d, J = 7.0 Hz, 3H). 13C NMR (126 
MHz, CDCl3) δ 157.5 (C), 136.3 (C), 136.2 (C), 121.4 (CH), 115.5 (CH), 62.0 (CH2), 46.7 (CH2), 
35.7 (CH), 27.2 (CH2), 26.2 (CH2), 21.7 (CH3), 19.9 (CH3). LRMS (m/z, CI): 208 [M+ +1, 100], 
121 (96), 100 (33), 88 (38). HRMS [M+ +1], Calculated for C12H18NO2: 208.1338, found 
208.1339. The structure of 3dd was confirmed by X-ray analysis (Figure S3). 
 
Figure S3: X-Ray structure of Z-3dd (deposited at the Cambridge Crystallographic Data Centre 
with the number CCDC 804844) 
3-((Z)-((2S*,5S*)-2,5-Dimethylcyclohex-3-en-1-ylidene)methyl)oxazolidin-2-one (3de) 
67% yield (catalyst B), white solid, Mp = 89-90 ºC; 1H NMR (400 MHz, 
CDCl3) δ 5.92 (s, 1H), 5.44 (s, 2H), 4.34 – 4.24 (m, 2H), 3.91 – 3.69 (m, 
2H), 3.09 – 2.98 (m, 1H), 2.27 – 2.16 (m, 1H), 2.13 (dd, J = 13.1, 4.3 Hz, 
1H), 1.94 – 1.79 (m, 1H), 1.13 – 1.03 (m, 3H), 0.95 (dd, J = 6.8, 3.2 Hz, 
3H). 13C NMR (101 MHz, CDCl3) δ 157.3 (C), 133.9 (C), 132.6 (CH), 130.1 (CH), 116.3 (CH), 
62.0 (CH2), 46.3 (CH2), 35.8 (CH2), 33.2 (CH), 31.1 (CH), 21.6 (CH3), 21.3 (CH3). LRMS (m/z, 
CI): 208 [M++1, 97], 192 (93), 121 (89), 105 (91), 88 (90). HRMS [M+ +1], Calculated for 
C12H18NO2: 208.1338, found 208.1337. The structure of 3de was confirmed by X-ray analysis 
(Figure S4). 
                                                            
11 A sample of isomerically pure Z-3dd could be obtained after crystallization of the isolated Z : E, 9 : 1, mixture. 
NO
3dd
Z : E = 9 :1
O
NO
O (Z)-3de
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Figure S4: X-Ray structure of Z-3de (deposited at the Cambridge Crystallographic Data Centre 
with the number CCDC 804845) 
3-((3-Methyl-2-((E)-prop-1-en-1-yl)cyclobutylidene)methyl)oxazolidin-2-one (4de) 
17% yield (with catalyst B), corresponding to a 5 : 1 mixture of Z : E isomers, 
colourless oil; Z-4de: 1H NMR (400 MHz, CDCl3) δ 6.34 (s, 1H), 5.74 – 5.67 
(m, 1H), 5.58 – 5.51 (m, 1H), 4.42 – 4.32 (m, 2H), 4.01 – 3.94 (m, 1H), 3.78 
– 3.70 (m, 1H), 3.19 – 3.11 (m, 1H), 2.98 – 2.85 (m, 1H), 2.25 – 2.15 (m, 
2H), 1.76 (d, J = 6.1 Hz, 3H), 1.23 (d, J = 6.5 Hz, 3H). 13C NMR (101 MHz, 
CDCl3) δ 156.3 (C), 133.4 (CH), 124.7 (CH), 124.0 (C), 117.3 (CH), 62.2 (CH2), 52.3 (CH), 44.9 
(CH2), 34.2 (CH), 33.6 (CH2), 20.5 (CH3), 17.8 (CH3). LRMS (m/z, CI): 208 [M++1, 4], 207 (7) 
192 (6), 121 (100), 105 (28), 88 (49). HRMS (EI) Calculated for C12H17NO2 207.1259, found 
207.1261. 
3-((Z)-((2S*,5S*)-5-(((tert-Butyldimethylsilyl)oxy)methyl)-2-methylcyclohex-3-en-1-
ylidene)methyl)oxazolidin-2-one (3df) 
52% yield (with catalyst B), white solid, Mp = 68-70 ºC; 1H NMR 
(500 MHz, CDCl3) δ 5.98 (d, J = 1.5 Hz, 1H), 5.53-5.58 (m, 2H), 
4.34 (t, J = 8.0 Hz, 2H), 3.86 (dd, J = 16.1, 8.3 Hz, 1H), 3.79 (dt, J 
= 16.0, 7.9 Hz, 1H), 3.53 – 3.41 (m, 2H), 3.14 – 3.05 (m, 1H), 2.38 
– 2.27 (m, 1H), 2.21 (dd, J = 13.0, 5.2 Hz, 1H), 2.03 – 1.94 (m, 1H), 1.13 (d, J = 7.0 Hz, 3H), 
0.86 (s, 9H), 0.01 (s, 6H). 13C NMR (126 MHz, CDCl3) δ 157.4 (C), 133.6 (C), 131.7 (CH), 127.9 
(CH), 116.6 (CH), 67.0 (CH2), 62.00 (CH2), 46.4 (CH2), 41.3 (CH), 31.7 (CH), 30.6 (CH2), 25.8 
(CH3), 21.6 (CH3), 18.2 (C), -5.5 (CH3). LRMS (m/z, CI): 338 [M++1, 65], 322 (33), 280 (37), 205 
(100). HRMS [M+ +1], Calculated for C18H32NO3Si: 338.2151, found 338.2158. The structure of 
3df was confirmed by X-ray analysis (Figure S5). 
 
Figure S5: X-Ray structure of Z-3df (deposited at the Cambridge Crystallographic Data Centre 
with the number CCDC 804846) 
4de
O N
O
NO
O OSiMe2tBuZ-3df
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(Z)-Ethyl 7-((2-oxooxazolidin-3-yl)methylene)-1,2,3,4,5,6,7,8-octahydronaphthalene-2-
carboxylate (3dg) and (Z)-ethyl 6-((2-oxooxazolidin-3-yl)methylene)-1,2,3,4,5,6,7,8-
octahydronaphthalene-2-carboxylate (3dg’).12 
80% global yield (ratio 3dg : 3dg’ = 1.8 : 1); Colourless 
oil. 1H NMR (500 MHz, CDCl3) δ 5.84 (s, 1H3dg’), 5.81 
(d, J = 1.2 Hz, 1H3dg), 4.34 - 4.27 (m, 2H3dg+ 2H3dg’), 
3.76 – 3.69 (m, 2H3dg + 2H3dg’), 3.64 (s, 6H3dg’), 3.63 (s, 
6H3dg), 2.65 (s, 2H3dg’), 2.58 (s, 2H3dg), 2.36 (s, 2H3dg + 
2H3dg’), 2.19 (q, J = 6.4 Hz, 2H3dg + 2H3dg’), 2.10 – 2.01 (m, 2H3dg + 2H3dg’), 1.94-1.96 (m, 2H3dg 
+ 2H3dg’), 1.87-1.90 (m, 2H3dg + 2H3dg’). 13C NMR (126 MHz, C6D6) δ 171.7 (C3dg), 171.6 (C3dg’), 
157.0 (C3dg’), 156.9 (C3dg), 130.5 (C3dg), 130.3 (C3dg’), 127.3 (C3dg’), 125.5 (C3dg), 124.4 (C3dg), 
122.7 (C3dg’), 116.5 (CH3dg’), 116.4 (CH3dg), 62.0 (CH2 3dg’ + 3dg), 53.3 (C3dg’ + 3dg), 52.4 (CH3 3dg’ + 
3dg), 46.3 (CH2 3dg’ + 3dg), 34.9 (CH2 3dg), 34.8 (CH2 3dg’), 31.9 (CH2 3dg’), 31.8 (CH2 3dg), 30.8 (CH2 
3dg), 30.7 (CH2 3dg’), 29.5 (CH2 3dg), 29.4 (CH2 3dg’), 27.5 (CH2 3dg’), 27.5 (CH2 3dg), 26.9 (CH2 3dg’), 
26.8 (CH2 3dg). LRMS (m/z, CI): 350 [M+ +1, 80], 318 (70), 290 (59), 263 (79), 231 (43), 203 
(71), 88 (100). HRMS [M+ +1], Calculated for C18H24NO6: 350.1604, found 350.1609. 
(Z)-3-((2-Methoxycyclohex-3-en-1-ylidene)methyl)oxazolidin-2-one (3dh) 
76% yield, colourless oil;1H NMR (500 MHz, CDCl3) δ 6.37 (d, J = 1.2 Hz, 
1H), 6.03 (dd, J = 9.2, 5.5 Hz, 1H), 5.82 – 5.76 (m, 1H), 4.48 (d, J = 4.3 Hz, 
1H), 4.36 (t, J = 8.0 Hz, 2H), 4.04 (dd, J = 16.3, 8.4 Hz, 1H), 3.89 (dd, J = 
16.6, 8.2 Hz, 1H), 3.25 (s, 3H), 2.39 – 2.31 (m, 1H), 2.26 – 2.14 (m, 2H), 2.10 
– 2.02 (m, 1H). 13C NMR (126 MHz, CDCl3) δ 157.1 (C), 133.1 (CH), 125.2 (CH), 124.0 (C), 
121.1 (CH), 68.8 (CH), 62.2 (CH2), 54.1 (CH3), 46.2 (CH2), 27.4 (CH2), 27.2 (CH2). LRMS (m/z, 
CI): 210 [M+ +1, 73], 194 (19), 192 (8), 178 (100), 176 (45), 139 (40), 130 (28), 123 (94), 121 
(32), 88 (86). HRMS [M+ +1], Calculated for C11H16NO3: 210.1130, found 210.1129. 
3-(Cyclohexa-1,3-dien-1-yl(methoxy)methyl)oxazolidin-2-one (5dh) 
13% yield, colourless oil; 1H NMR (500 MHz, CDCl3) δ 6.09 (d, J = 5.2 Hz, 
1H), 5.97 – 5.90 (m, 1H), 5.85 – 5.74 (m, 1H), 5.35 (s, 1H), 4.43 – 4.22 (m, 
2H), 3.49 (td, J = 9.2, 7.5 Hz, 1H), 3.37 (s, 3H), 3.36 – 3.32 (m, 1H), 2.25 – 
2.13 (m, 2H), 2.13 – 2.03 (m, 1H), 2.03 – 1.91 (m, 1H). 13C NMR (126 MHz, 
CDCl3) δ 158.6 (C), 132.4 (C), 126.9 (CH), 123.7 (CH), 121.5 (CH), 85.3 (CH), 62.4 (CH2), 55.9 
(CH3), 39.2 (CH2), 22.6 (CH2), 22.5 (CH2). LRMS (m/z, CI): 210 [M+ +1, 38], 194 (34), 192 (20), 
178 (78), 176 (90), 139 (40), 130 (55), 123 (87), 121 (72), 88 (100).  
 
                                                            
12 Cycloadducts 3dg and 3dg’ could not be separated under standard column chromatography. However, their 
corresponding NMR data could be easily assigned using 1D and 2D-NMR experiments (1H, 13C, dept, HMQC, HMBC, 
NOESY and COSY). 
NO
MeO
O Z-3dh
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(Z)-3-((6-Methyl-3,4-dihydro-[1,1'-biphenyl]-2(1H)-ylidene)methyl)oxazolidin-2-one (3di) 
96% yield, white solid, Mp = 106 -108 ºC; 1H NMR (500 MHz, CDCl3) δ 7.24 – 
7.18 (m, 2H), 7.16 (d, J = 7.3 Hz, 2H), 7.11 (td, J = 7.2, 1.3 Hz, 1H), 5.66 (s, 
1H), 5.62 (s, 1H), 4.27 – 4.20 (m, 1H), 4.18 – 4.13 (m, 1H), 4.10 (s, 1H), 3.67 
(dt, J = 16.7, 8.3 Hz, 1H), 3.39 – 3.34 (m, 1H), 2.27 – 2.17 (m, 2H), 2.16 – 
2.10 (m, 1H), 2.10 – 2.02 (m, 1H), 1.50 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 156.9 (C), 142.5 
(C), 138.2 (C), 133.7 (C), 128.2 (CH), 128.0 (CH), 126.3 (CH), 123.5 (CH), 116.1 (CH), 62.0 
(CH2), 46.9 (CH), 46.5 (CH2), 26.8 (CH2), 26.6 (CH2), 22.2 (CH3). LRMS (m/z, CI): 270 [M++1, 
62], 254 (1), 192 (6), 183 (100), 167 (84), 105 (20), 101 (76), 88 (77), 77 (12). HRMS [M+ +1], 
Calculated for C17H20NO2: 270.1494, found 270.1496. The structure of 3di was confirmed by X-
ray analysis (Figure S6). 
 
Figure S6: X-Ray structure of Z-3di (deposited at the Cambridge Crystallographic Data Centre 
with the number CCDC 804847) 
(Z)-3-((3,4-Dihydro-[1,1'-biphenyl]-2(1H)-ylidene)methyl)oxazolidin-2-one (3dj) 
78% yield, white solid, Mp = 92-94 ºC; 1H NMR (500 MHz, CDCl3) δ 7.27 – 
7.23 (m, 2H), 7.21 (d, J = 7.1 Hz, 2H), 7.15 (t, J = 7.0 Hz, 1H), 6.03 (s, 1H), 
5.87 – 5.81 (m, 1H), 5.77 – 5.69 (m, 1H), 4.33 (s, 1H), 4.22 – 4.09 (m, 2H), 
3.58 (dd, J = 16.3, 8.8 Hz, 1H), 3.47 (td, J = 8.9, 6.2 Hz, 1H), 2.37 – 2.26 (m, 
2H), 2.22 – 2.15 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 157.1 (C), 143.3 (C), 133.0 (C), 128.6 
(CH), 128.5 (CH), 127.5 (CH), 127.3 (CH), 126.3 (CH), 118.2 (CH), 62.1 (CH2), 46.1 (CH2), 41.8 
(CH), 28.2 (CH2), 26.8 (CH2). LRMS (m/z, CI): 256 [M++1, 39], 178 (14), 169 (100), 101 (77), 88 
(65), 77 (10). HRMS  [M+ +1], Calculated for C16H18NO2: 256.1338, found 256.1338. The 
structure of 3dj was confirmed by X-ray analysis (Figure S7). 
 
Figure S7: X-Ray structure of Z-3dj 
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(Z)-3-((4-Methyl-3,4-dihydro-[1,1'-biphenyl]-2(1H)-ylidene)methyl)oxazolidin-2-one (3dk) 
70% yield, white solid; 1H NMR (400 MHz, CDCl3) δ 7.34 – 7.25 (m, 4H), 
7.23 – 7.18 (m, 1H), 6.12 (s, 1H), 5.77 – 5.68 (m, 2H), 4.38 (s, 1H), 4.30 – 
4.19 (m, 2H), 3.69 – 3.56 (m, 2H), 2.44 – 2.30 (m, 2H), 2.01 – 1.92 (m, 1H), 
1.06 (d, J = 6.9 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ = 157.2 (C), 143.1 (C), 134.0 (CH), 
132.0 (C), 128.5 (CH), 127.5 (CH), 127.2 (CH), 126.3 (CH), 118.3 (CH), 62.1 (CH2), 46.1 (CH2), 
41.5 (CH), 37.0 (CH2), 32.8 (CH), 21.2 (CH3). LRMS (m/z, CI): 270.9 [M+ +1, 30], 269.9 (100), 
254 (46), 183 (82), 167 (39). HRMS  [M+ +1], Calculated for C17H20NO2: 270.1494, found 
270.1495. 
(Z)-1-((6-Methyl-3,4-dihydro-[1,1'-biphenyl]-2(1H)-ylidene)methyl)pyrrolidin-2-one (3ei) 
94% yield, white solid; 1H NMR (500 MHz, cdcl3) δ 7.31 – 7.25 (m, 2H), 7.23 – 
7.17 (m, 3H), 5.81 (s, 1H), 5.71 (s, 1H), 4.18 (s, 1H), 3.65 – 3.53 (m, 1H), 3.34 
– 3.24 (m, 1H), 2.45 – 2.36 (m, 2H), 2.35 – 2.28 (m, 2H), 2.27 – 2.15 (m, 2H), 
2.07 – 2.00 (m, 1H), 1.98 – 1.90 (m, 1H), 1.60 (s, 3H). 13C NMR (126 MHz, 
CDCl3) δ 174.2 (C), 142.7 (C), 137.2 (C), 134.0 (C), 128.0 (CH), 128.0 (CH), 126.1 (CH), 123.4 
(CH), 116.7 (CH), 49.2 (CH2), 47.3 (CH), 30.6 (CH2), 27.1 (CH2), 26.7 (CH2), 22.2 (CH3), 18.4 
(CH2). LRMS (m/z, CI): 268 [M++1, 41], 252 (19), 183 (88), 86 (100). HRMS [M+ +1], Calculated 
for C18H22NO 268.1701, found 268.1703. 
3-((Z)-((1R*,3S*)-((3,6-Dimethyl-3,4-dihydro-[1,1'-biphenyl]-2(1H)-ylidene)methyl)oxazoli-
din-2-one (3fi) 
79% yield, white solid, Mp = 85-87 ºC; 1H NMR (500 MHz, CDCl3) δ 7.22 – 
7.18 (m, 2H), 7.17 – 7.14 (m, 2H), 7.14 – 7.10 (m, 1H), 5.61 – 5.58 (m, 1H), 
5.57 (s, 1H), 4.34 – 4.22 (m, 2H), 4.21 (s, 1H), 3.73 (td, J = 8.9, 7.4 Hz, 1H), 
3.45 (td, J = 8.8, 6.2 Hz, 1H), 2.43 – 2.34 (m, 1H), 2.32 – 2.22 (m, 1H), 1.83 – 
1.74 (m, 1H), 1.54 (d, J = 1.5 Hz, 3H), 0.97 (d, J = 6.5 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 
157.3 (C), 143.7 (C), 142.5 (C), 133.5 (C), 128.2 (CH), 128.1 (CH), 126.3 (CH), 123.4 (CH), 
114.8 (CH), 62.0 (CH2), 47.5 (CH), 47.1 (CH2), 36.0 (CH2), 29.3 (CH), 22.1 (CH3), 17.6 (CH3). 
LRMS (m/z, CI): 284 [M++1, 66], 268 (12), 197 (100). HRMS [M+ +1], Calculated for C18H22NO2: 
284.1651, found 284.1652. The structure was confirmed by X-ray analysis (Figure S8). 
 
Figure S8: X-Ray structure of Z-3fi (deposited at the Cambridge Crystallographic Data Centre 
with the number CCDC 804848) 
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(R)-4-Benzyl-3-((Z)-((S)-6-methyl-3,4-dihydro-[1,1'-biphenyl]-2(1H)-ylidene)methyl)oxazo 
lidin-2-one (3gi). 95% yield, white solid; 1H NMR (500 MHz, CDCl3) δ 7.39 
– 7.26 (m, 8H), 7.10 – 7.06 (m, 2H), 5.82 (s, 1H), 5.65 (s, 1H), 4.28 (t, J = 
8.1 Hz, 1H), 4.26 – 4.20 (m, 1H), 4.04 (dd, J = 8.1, 5.9 Hz, 1H), 2.95 (dd, J 
= 13.7, 4.1 Hz, 1H), 2.42 – 2.20 (m, 6H), 1.69 (s, 3H). 13C NMR (126 MHz, 
CDCl3) δ 156.3 (C), 142.4 (C), 139.9 (C), 135.8 (C), 134.0 (C), 128.8 (CH), 
128.4 (CH), 128.3 (CH), 127.1 (CH), 126.5 (CH), 123.8 (CH), 114.9 (CH), 67.2 (CH2), 59.1 
(CH), 47.4 (CH), 38.5 (CH2), 27.0 (CH2), 26.9 (CH2), 22.4 (CH3). LRMS (m/z, CI): 360 [M++1, 
98], 282, (10), 268 (5), 183 (100), 178 (98). HRMS [M+ +1], Calculated for C24H26NO2 360.1964, 
found 360.1963. The structure of 3gi was confirmed by X-ray analysis (Figure S9). 
 
Figure S9: X-Ray structure of Z-3gi (deposited at the Cambridge Crystallographic Data Centre 
with the number CCDC 804849) 
(4R,5S)-4-Methyl-3-((Z)-((S)-6-methyl-3,4-dihydro-[1,1'-biphenyl]-2(1H)-ylidene)methyl)-5-
phenyloxazolidin-2-one (3hi). 99% yield, white solid; 1H NMR (400 MHz, 
CDCl3) δ 7.51 – 7.38 (m, 3H), 7.35 (m, 2H), 7.28 – 7.22 (m, 4H), 7.21 – 7.15 
(m, 1H), 5.75 (br s, 1H), 5.70 (d, J = 8.0 Hz, 1H), 5.67 (s, 1H), 4.37 (dq, J = 
13.3, 6.6 Hz, 1H), 4.27 (s, 1H), 2.37 – 2.18 (m, 3H), 2.15 – 2.08 (m, 1H), 
1.67 (d, J = 1.1 Hz, 3H), 0.72 (d, J = 6.6 Hz, 3H). 13C NMR (101 MHz, 
CDCl3) δ = 156.6 (C), 141.8 (C), 140.3 (C), 134.9 (C), 133.6 (C), 128.5 (CH), 128.2 (CH), 128.2 
(CH), 126.4 (CH), 126.0 (CH), 124.1(CH), 114.3 (CH), 78.6 (CH), 58.2 (CH), 47.3 (CH), 27.4 
(CH2), 26.1 (CH2), 22.6 (CH3), 14.7 (CH3). LRMS (m/z, CI): 360 [M++1, 76], 344 (12), 316 (68), 
282 (12), 183 (100), 178 (69), 134 (70), 118 (60); HRMS [M+ +1], Calculated for C24H26NO2: 
360.1964, found 360.1964. The structure of 3hi was confirmed by X-ray analysis (Figure S10). 
 
Figure S10: X-Ray structure of Z-3hi (deposited at the Cambridge Crystallographic Data Centre 
with the number CCDC 804850) 
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General procedure for the hydrolysis and subsequent reduction of cycloadducts 3, 
(exemplified for 3hi)  
 
A solution of (4R,5S)-4-Methyl-3-((Z)-((S)-6-methyl-3,4-dihydro-[1,1'-biphenyl]-2(1H)-
ylidene)methyl)-5-phenyloxazolidin-2-one (3hi) (50 mg, 0,14 mmol) and HCl 6 M (3 ml, 18,0 
mmol) in CHCl3 (3 ml) was stirred at 60 ºC until tlc showed complete consumption of the starting 
material. The product was extracted with Et2O, washed with saturated NaHCO3, dried with 
NaSO4, and concentrated to provide a crude oil which was used as obtained in the next step. To 
a solution of this oil in ethanol (3 ml), NaBH4 (19 mg, 0,84 mmol) was added. After stirring for 
1h, the reaction mixture was quenched by addition of acetone and water. After extraction with 
Et2O, the organic phases were dried with NaSO4 concentrated and purified by column 
chromatography (Hexane/ EtOAc, 9:1) to provide 20 mg (71% yield) of a 9:1 mixture of 
((1S,2R)-6-methyl-1,2,3,4-tetrahydro-[1,1'-biphenyl]-2-yl)methanol (6) and ((1S,2S)-6-methyl-
1,2,3,4-tetrahydro-[1,1'-biphenyl]-2-yl)methanol (6’) (colorless oil). 
((1S,2R)-6-Methyl-1,2,3,4-tetrahydro-[1,1'-biphenyl]-2-yl)methanol (6).13 1H NMR (400 MHz, 
CDCl3) δ 7.25 – 7.17 (m, 2H), 7.17 – 7.08 (m, 2H), 5.58 (d, J = 1.3 Hz, 1H), 
3.53 (dd, J = 10.6, 5.0 Hz, 1H), 3.39 (dd, J = 10.6, 6.5 Hz, 1H), 3.01 (d, J = 
6.4 Hz, 1H), 2.17 – 1.95 (m, 2H), 1.80 – 1.70 (m, 2H), 1.42 – 1.37 (m, 1H), 
1.35 (s, 3H), 1.26 (s, 1H). 13C NMR (101 MHz, CDCl3) δ 144.4 (C), 134.3 
(C), 128.6 (CH), 128.3 (CH), 126.1 (CH), 123.6 (CH), 65.6 (CH2), 48.4 (CH), 44.9 (CH), 23.8 
(CH2), 22.8 (CH2), 22.6 (CH3). LRMS (m/z, CI): 203 [M++ 1, 5], 202 (17), 185 (100), 171 (46), 
142 (31). HRMS [M+], Calculated for C14H18O: 202.1358, found 202.1353. 
The same procedure can also be applied to other cycloadducts such as 3da. 
(4-Methylcyclohex-3-en-1-yl)methanol (6da). 61% yield, colorless oil. 1H NMR (500 MHz, 
CDCl3) δ 5.48 – 5.29 (m, 1H), 3.57 – 3.48 (m, 2H), 2.16 – 1.89 (m, 3H), 
1.88 – 1.76 (m, 1H), 1.76 – 1.67 (m, 2H), 1.65 (s, 3H), 1.38 – 1.22 (m, 2H). 
13C NMR (63 MHz, CDCl3) δ 134.1 (C), 119.8 (CH), 67.8 (CH2), 36.1 (CH), 
29.4 (CH2), 28.2 (CH2), 25.6 (CH2), 23.6 (CH3). LRMS (m/z, CI): 127 [M+ 1, 
8], 126 (2), 125 (19), 109 (100). 
Reaction of 1d and 2b in the presence of MeOH (3 equiv). 
                                                            
13 The stereochemistry of the major and minor diastereoisomers 6 and 6’ could be established based on several nOe experiments, 
the values of the NMR coupling constants and the observed shielding of the CH2(OH) group by the phenyl ring (significantly 
higher in the minor 6’ isomer). 
HO
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(E)-3-(5-Methoxy-5,6-dimethylhepta-1,6-dien-1-yl)oxazolidin-2-one (7db) 
1H NMR (250 MHz, CDCl3) δ 6.65 (d, J = 14.3 Hz, 1H), 5.01 – 4.98 
(m, 1H), 4.89 (s, 1H), 4.80 (dt, J = 14.2, 7.0 Hz, 1H), 4.42 (dd, J = 9.0, 
7.2 Hz, 2H), 3.74 – 3.61 (m, 2H), 3.07 (s, 3H), 2.11 – 1.84 (m, 4H), 
1.69 (s, 3H), 1.62 (s, 3H). 13C NMR (63 MHz, CDCl3) δ 155.4 (C), 
147.0 (C), 123.8 (CH), 113.5 (CH2), 111.1 (CH), 79.2 (C), 62.1 (CH2), 49.8 (CH3), 42.6 (CH2), 
38.6 (CH2), 24.5 (CH2), 20.8 (CH3), 18.5 (CH3). LRMS (m/z, CI): 240 [M++1, 58], 208 (100), 192 
(19), 177 (11), 152 (67), 99 (76), 88 (75). HRMS [M+ +1], Calculated for C13H22NO3: 240.1600, 
found 240.1605. Together with 7db, we coud also isolate a minor amount of its isomer 8db, 
contaminated with 7db (2% yield). 
3. Preliminary results with isoprene and allenes 1c and 1d 
3.1 Table S1. Results of the reactions between allenylsilyl ether 1c and isoprene (2a) 
 
Catalyst  T (ºC) /time 3  Observations 
PtCl2 3h/ rt, 18h/ 40º C 0% Allene degradation 
[PtCl2(C2H4)]2 (2.5%) / 
P(o-tolyl)3 (5%) 
1h/ 0ºC 0% Full conversion to a complex mixture of products 
C 3h/ -15ºC 0% Full conversion to a complex mixture of products 
C 5min/ -50ºC 0% Full conversion to a complex mixture of products 
C 5min/ -75ºC 0% Full conversion to a complex mixture of products 
AuCl 5min/ 0ºC 0% Full conversion to a complex mixture of products 
AuCl 5min/ -50ºC 0% Full conversion to a complex mixture of products 
 
3.2 Reactions between 3-methylbuta-1,2-diene (1d) and dienes 2a and 2j. 
The reaction of 3-methylbuta-1,2-diene (1a) and isoprene with several Au catalysts led to 
complex mixtures of products, from which no [4+2] cycloadduct could be identified. On the other 
hand, the reaction of 1a with 2i, catalyzed by AuCl, led to the recovery of 2i after 48 hours at rt. 
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General experimental procedures 
 
Reactions were conducted in dry solvents under Argon atmosphere unless otherwise stated. CH2Cl2 
was purchased from Aldrich. AuCl, Chloro[1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene]gold 
were purchased from Strem or Aldrich. All other chemicals were purchased from Aldrich, TCI or Alfa 
Aesar and used without further purification. 
The abbreviation “rt” refers to reactions carried out at a temperature between 21-25 ºC. Reaction 
mixtures were stirred using Teflon-coated magnetic stir bars. High reaction temperatures were 
maintained using Thermowatch-controlled silicone oil baths. Thin-layer chromatography (TLC) was 
performed on silica gel plates and components were visualized by observation under UV light, and / 
or by treating the plates with p-anisaldehyde or cerium nitrate solutions, followed by heating. Flash 
chromatography was carried out on silica gel. Dryings were performed with anhydrous Na2SO4. 
Concentration refers to the removal of volatile solvents via distillation using a Büchi rotary 
evaporator followed by high vacuum. NMR spectra were recorded in CDCl3, at 250 MHz (Bruker), 
300 MHz (Varian), 400 MHz (Varian) or 500 MHz (Bruker). Carbon types and structure assignments 
were determined from DEPT-NMR and two-dimensional experiments (HMQC and HMBC, COSY 
and NOESY). NMR spectra were analyzed using MestReNova© NMR data processing software 
(www.mestrelab.com). The following abbreviations are used to indicate signal multiplicity: s, singlet; 
d, doublet; t, triplet; q, quartet; dd, double doublet; dt, double triplet; m, multiplet; br, broad. Mass 
spectra were acquired using chemical ionization (CI) or electronic impact (EI) and were recorded at 
the CACTUS facility of the University of Santiago de Compostela.  
3-(Propa-1,2-dien-1-yl)oxazolidin-2-one (1)1 is a known compounds and was synthesized according 
to the reported procedure. Products 3a, 3b, 3c, 4a and 5b are known compounds that were 
previously described.2 
                                                            
1 L. Wei, J. A. Mulder, C. A. Zificsak, C. J. Douglas, R. P. Hsung, Tetrahedron. 2001, 57, 459-466. 
2 H. Faustino, F. López, L. Castedo, J. L. Mascareñas, Chem. Sci. 2011, 2, 633-637 
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Representative procedure for the trapping experiments using Pyridine-Oxides or 
diphenylsulphoxides (exemplified for the cycloaddition with isoprene and diphenylsulfoxide, Table 
2, entry 7). 
To solution of sulfinyldibenzene (0,242 g, 1,20 mmol), 3-(propa-1,2-dienyl)oxazolidin-2-one (0,05 g, 
0,40 mmol),  and isoprene (0,24 ml, 2,40 mmol) in CH2Cl2 (4,00 ml),  in a dried Schlenk tube, AuCl 
(9,3 mg, 0,040 mmol) was added. The mixture was stirred at rt for 2 h (the progress of the reaction 
was easily monitored by tlc) and filtered through a short pad of florisil eluting with Et2O. Column 
chromatography in hexanes:Ethyl Acetate 10-100% gave: (Z)-3-((4-methylcyclohex-3-
enylidene)methyl)oxazolidin-2-one (3a, 10 mg, 0,052 mmol, 13 % yield) and 3-(4-methyl-7-
oxocyclohept-3-enyl)oxazolidin-2-one (6a, 13 mg, 0,062 mmol, 16 % yield).  
 
Representative procedure for the trapping experiments using methanol (exemplified for a 
mixture of 2,3-dimethyl-1,3-butadiene and methanol). 
To solution of 2,3-dimethyl-1,3-butadiene 98% (289 µl, 2,50 mmol), alenamide (50,1 mg, 0,4 mmol) 
and methanol (48,5 µl, 1,20 mmol) in CH2Cl2 (4 ml), in a dried Schlenk tube, AuCl (4,65 mg, 0,020 
mmol) was added. The mixture was stirred at rt for 15 min (the progress of the reaction was easily 
monitored by tlc) and filtered through a short pad of florisil eluting with Et2O. Column 
chromatography in hexanes : Ethyl Acetate 10-100% gave  (Z)-3-((3,4-dimethylcyclohex-3-
enylidene)methyl)oxazolidin-2-one  3b (40% yield), (E)-3-(5-methoxy-5,6-dimethylhepta-1,6-
dienyl)oxazolidin-2-one 5b (12% yield). 
 
(Z)-3-((2-Methyl-2-(prop-1-en-2-yl)cyclobutylidene)methyl)oxazolidin-2-one (4b) 
1H NMR (400 MHz, CDCl3) δ 6.25 (t, J = 2.1 Hz, 1H), 4.88 – 4.81 (m, 1H), 4.80 – 
4.71 (m, 1H), 4.38 – 4.17 (m, 2H), 3.80 (td, J = 8.8, 6.4 Hz, 1H), 3.63 (td, J = 9.1, 
7.8 Hz, 1H), 2.79 – 2.47 (m, 2H), 2.19 – 1.99 (m, 2H), 1.80 (s, 3H), 1.44 (s, 3H). 
13C NMR (75 MHz, CDCl3) δ 156.5 (C), 150.1 (C), 129.3 (C), 116.6 (CH), 109.3 
(CH2), 62.0 (CH2), 51.1 (C), 45.8 (CH2), 31.6 (CH2), 25.8 (CH3), 23.8 (CH2), 19.3 (CH3). LRMS (m/z, 
ESI): 208.13 (M+H)+, 164.14, 149.12, 121.10, 100.04. HRMS Calculated for C12H18NO2: 208.1332, 
found 208.1334. 
 
3-(4-Methyl-7-oxocyclohept-3-enyl)oxazolidin-2-one (6a) 
1H NMR (400 MHz, CDCl3) δ 5.56 (t, J = 5.4 Hz, 1H), 4.70 (dd, J = 8.4, 5.9 Hz, 1H), 
4.49 – 4.24 (m, 1H), 3.80 – 3.66 (m, 1H), 3.50 – 3.36 (m, 1H), 2.64 (dd, J = 6.9, 5.2 
Hz, 2H), 2.59 – 2.42 (m, 3H), 2.24 – 2.08 (m, 1H), 1.76 (s, 3H). 13C NMR (63 MHz, 
CDCl3) δ 207.4 (C), 158.5 (C), 139.0 (C), 120.1 (CH), 62.4 (CH2), 61.4 (CH), 41.9 
(CH2), 40.2 (CH2), 28.8 (CH2), 28.7 (CH2), 25.8 (CH3). LRMS (m/z, EI): 209 [M+, 65], 181 (3), 166 
4bO
NO
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(11), 122 (100), 113 (57), 94 (93). HRMS [M+], Calculated for C11H15NO3: 209.1052, found 
209.1061. 
3-(3,4-Dimethyl-7-oxocyclohept-3-en-1-yl)oxazolidin-2-one (6b) 
1H NMR (400 MHz, CDCl3) δ 4.56 (dd, J = 11.8, 3.1 Hz, 1H), 4.46 – 4.38 (m, 1H), 
4.36 – 4.28 (m, 1H), 3.80 (dt, J = 9.4, 7.5 Hz, 1H), 3.46 (td, J = 8.7, 6.7 Hz, 1H), 
2.69 – 2.56 (m, 2H), 2.50 – 2.31 (m, 2H), 2.28 – 2.17 (m, 2H), 1.79 (s, 3H), 1.76 (s, 
3H). 13C NMR (101 MHz, CDCl3) δ 207.0 (C), 158.5 (C), 131.7 (C), 126.5 (C), 62.5 
(CH2), 60.7 (CH), 41.9 (CH2), 41.6 (CH2), 36.1 (CH2), 30.2 (CH2), 21.2 (CH3), 21.1 (CH3). LRMS 
(m/z, CI): 224 [M+ +1, 79], 206 (34), 180 (21), 152 (29), 137 (91), 136 (89), 119 (76), 88 (100). 
HRMS [M+ +1], Calculated for C12H18NO3: 224.1287, found 224.1285. 
 
7-(2-Oxooxazolidin-3-yl)hepta-2,6-dienal (7c) 
1H NMR (400 MHz, CDCl3) δ 9.48 (d, J = 7.9 Hz, 1H), 6.86 – 6.75 (m, 1H), 6.68 (d, J 
= 14.3 Hz, 1H), 6.10 (dd, J = 15.6, 7.9 Hz, 1H), 4.75 (dt, J = 14.2, 7.0 Hz, 1H), 4.41 
(t, J = 8.0 Hz, 2H), 3.66 (t, J = 8.2 Hz, 2H), 2.43 (q, J = 7.1 Hz, 2H), 2.29 (q, J = 7.3 
Hz, 2H). 13C NMR (101 MHz, CDCl3) δ 193.8 (CH), 157.1 (CH), 155.3 (C), 133.4 
(CH), 125.1 (CH), 108.6 (CH), 62.1 (CH2), 42.4 (CH2), 33.0 (CH2), 28.1 (CH2). 
LRMS (m/z, EI): 195 [M+ , 5], 167 (2), 139 (1), 126 (100), 108 (3), 82 (4). HRMS [M+], Calculated for 
C10H13NO3: 195.0895, found 195.0892. 
 
3-(7-Hydroxy-7-methoxyhepta-1,5-dien-1-yl)oxazolidin-2-one (7c’) 
1H NMR (250 MHz, CDCl3) δ 6.71 – 6.58 (m, 1H), 5.90 – 5.73 (m, 1H), 5.53 – 5.39 
(m, 1H), 4.85 – 4.65 (m, 2H), 4.52 – 4.29 (m, 2H), 3.66 (dd, J = 9.0, 7.1 Hz, 2H), 
3.30 (s, 3H), 2.23 – 2.11 (m, 4H)  13C NMR (63 MHz, CDCl3) δ 155.3 (C), 134.3 
(CH), 127.2 (CH), 124.4 (CH), 110.0 (CH), 103.2 (CH), 62.1 (CH2), 52.7 (CH3), 42.5 
(CH2), 32.6 (CH2), 29.1 (CH2). LRMS (m/z, EI): 209 [M+ -18 (-H2O), 4], 195 (10), 
176 (9), 126 (100), 108 (19). HRMS [M+ -18 (-H2O)], Calculated for C11H15NO3: 209.1052, found 
209.1056. 
 
(E)-3-(3-Methoxyprop-1-en-1-yl)oxazolidin-2-one (5b’, side product of table 1 entry 16) 
1H NMR (250 MHz, CDCl3) δ 6.87 (d, J = 14.3 Hz, 1H), 4.91 (dt, J = 14.1, 7.0 
Hz, 1H), 4.52 – 4.35 (m, 2H), 3.92 (dd, J = 7.0, 1.0 Hz, 2H), 3.71 (dd, J = 9.0, 
7.2 Hz, 2H), 3.29 (s, 3H).  13C NMR (63 MHz, CDCl3) δ 155.2 (C), 127.7 (CH), 
106.3 (CH), 70.8 (CH2), 62.2 (CH2), 57.5 (CH3), 42.3 (CH2). LRMS (m/z, EI): 157 
[M+, 17], 149 (8), 142 (47), 126 (100), 113 (42). HRMS [M+], Calculated for 
C7H11NO3: 157.0739, found 157.0743. 
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1. Theoretical Calculations 
 
Calculations were carried out using the Gaussian03 program package3 at density functional theory 
(DFT) level by means of the hybrid B3LYPfunctional.4 
 
Gold metal center was described by the LANL2DZ effective core potential5 and their associated 
basis set for the outermost electrons; an extra series of f polarization functions were also added for 
this metal atom (Au: exp. = 1.050).6  
 
Single point calculations were performed in CH2Cl2 as solvent using 6-311++G(d,p) for the main 
group elements. Energy values correspond to ΔG’s (kcal·mol-1) in CH2Cl2, that were were obtained 
by adding the thermodynamic corrections from the gas phase frequency calculations, to the energy 
in solution.7  
Gsolv = Esolv + (Ggas - Egas) 
 
The structures of the reactants, intermediates, transition states, and products were fully optimized 
without any symmetry restriction. Frequency calculations were performed on all optimized structures 
to characterize the stationary points as minima (non imaginary frequencies) or transition states (one 
imaginary frequency). 
 
NBO analysis was computed with the NBO 5.0 program.8 
 
 
                                                            
3 Gaussian 03, Revision C.02, M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, J. A. 
Montgomery, Jr., T. Vreven, K. N. Kudin, J. C. Burant, J. M. Millam, S. S. Iyengar, J. Tomasi, V. Barone, B. Mennucci, M. Cossi, G. 
Scalmani, N. Rega, G. A. Petersson, H. Nakatsuji, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. 
Honda, O. Kitao, H. Nakai, M. Klene, X. Li, J. E. Knox, H. P. Hratchian, J. B. Cross, C. Adamo, J. Jaramillo, R. Gomperts, R. E. 
Stratmann, O. Yazyev, A. J. Austin, R. Cammi, C. Pomelli, J. W. Ochterski, P. Y. Ayala, K. Morokuma, G. A. Voth, P. Salvador, J. J. 
Dannenberg, V. G. Zakrzewski, S. Dapprich, A. D. Daniels, M. C. Strain, O. Farkas, D. K. Malick, A. D. Rabuck, K. Raghavachari, J. B. 
Foresman, J. V. Ortiz, Q. Cui, A. G. Baboul, S. Clifford, J. Cioslowski, B. B. Stefanov, G. Liu, A. Liashenko, P. Piskorz, I. Komaromi, R. L. 
Martin, D. J. Fox, T. Keith, M. A. Al-Laham, C. Y. Peng, A. Nanayakkara, M. Challacombe, P. M. W. Gill, B. Johnson, W. Chen, M. W. 
Wong, C. Gonzalez and J. A. Pople, Gaussian, Inc., Wallingford CT, 2004. 
4 a) C. Lee, R. G. Parr, W. Yang, Phys. Rev. 1988, 37, B785; b) A. D. Becke, J. Chem. Phys. 1993, 98, 5648. 
5 a) P. J. Hay, W. R. Wadt, J. Phys. Chem. 1985, 82, 299; b) W. R. Wadt, P. J. Hay, J. Chem. Phys. 1985, 82, 284. 
6 A. Höllwarth, M. Böhme, S. Dapprich, A.W. Ehlers, A. Gobbi, V. Jonas, K. F. Köhler, R. Stegman, A. Veldkamp, G. Frenking, Chem. 
Phys. Lett. 1993, 208, 237. 
7 A. A. C. Braga, G. Ujaque and F. Maseras, Organometallics, 2006, 25, 3647. 
8 . D. Glendening, J, K. Badenhoop, A. E. Reed, J. E. Carpenter, J. A. Bohmann, C. M. Morales, and F. Weinhold, NBO 5.0. Theoretical 
Chemistry Institute, University of Wisconsin, Madison, 2001. 
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Additional information for Figure 1 
Geometries of the species involved in the different 1,2-hydrogen migration processes that might 
occur from Int-3 are depicted in Figure S1. 
1.432
1.252
1.321 1.314
1.253
1.472
ts4a ts4b ts4c
Z-8a-(AuCl) Z-8a’-(AuCl)  
Figure S1. Geometries of the species involved in the different 1,2-hydrogen migration processes. 
 
Additional information for Reference 19 
 
1. Conversion between Int-3 and Int-3I (Figure 3, main manuscript) 
The conversion process between Int-3 and Int-3I takes place through four transition states and 
three different intermediate conformers (see Figure S2). The most stable one is intermediate Int-
3, whereas Int-3I is the most energetic. The global energy barrier of this conversion is 8.1 
kcal·mol-1 (Figure S2). 
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Figure S2. Energy profile for the conversion of Int-3 into Int-3I, and geometries of each conformer.  
 
2. Regiocomplementary approach between 2a and Int-2.  Energy profile and key stationary 
structures (Figure 4, main manuscript). 
2.144
2.842
 
Figure S3. Regiocomplementary approach. (Distances in Å) 
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3. Endo approach with (NHCAu)+ 
2.117
3.529
 
Figure S4. Endo approach with [NHCAu]+ 
Additional Information cited in Reference 20 
Besides the pathway of Figures 1 and 2, previously commented in the manuscript, four additional 
more energetic pathways were located for the AuCl-catalyzed (4 + 3) cycloaddition between 1 and 
s-cis-2a following an exo approach. These pathways correspond to (4 + 3) cycloadditions 
proceeding through transition states ts2I − ts2IV. All these new transition states are characterized by 
having different spatial arrangements of the oxazolidinone moiety in the allenamide-gold complex 
(Figure S5 and S6). Besides ts2, the one with the lowest energy barrier is ts2I and  involves a direct 
(4 + 3) cycloaddition between Int-1I and 2a, directly leading to intermediate Int-3I that displays the 
oxazolidinone group in a pseudo-axial conformation (Figure S7 and figure 3 of main manuscript).  
Compared to ts2 (Figure 2, main manuscript), ts2I is characterized by a less stable conformation of 
the oxazolidinone group in the gold-allyl cation, due to a higher 1,3-allylic strain [similar to that 
proposed for intermediate Int-2I which could not be located as a reaction intermediate (see Scheme 
4 of the main manuscript]. Indeed, the required planar conformation for the cycloaddition is just 
achieved in the transition state, rather than previously. Accordingly, the energy barrier for this 
cycloaddition is higher than that proceeding via ts2 [13.8 vs 6.6 kcal·mol-1; Δ(ΔG) = 7.2 kcal·mol-1] 
and the resulting intermediate, Int-3I, is 4.8 kcal·mol-1 less stable than Int-3, displaying the 
oxazolidinone moiety in a pseudo-axial, rather than in a pseudo-ecuatorial orientation (Figure S7 
and Figure 3 of the main manuscript). A 1,2-ring contraction in Int-3I leads to E-3a and has an 
energy barrier of 6.1 kcal·mol-1. Thus, overall this route to the isomer E-3a is feasible, but much less 
favorable than that leading to Z-3a, via Int-3, in accordance to the experimental results. Moreover, 
Int-3I can alternatively be converted into its conformer Int-3, via a global energy barrier of 3.3 
kcal·mol-1 (see Figure S6 and Figure 3 of the main manuscript).  
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ts2I ts2II ts2III ts2IV  
Figure S5. Geometries of transition states ts2I − ts2IV. 
 
Figure S6. Summary of pathways through ts2 and ts2I-IV.  
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Figure S7. Alternative exo pathway with s-cis-2a leading to E-3a (ΔG values in kcal·mol-1). 
 
Pathways proceeding through transition states ts2II, ts2III and ts2IV, have global energy barriers of 
15.3, 15.9 and 17.5 kcal·mol-1, substantially higher than that proceeding through ts2 (6.6 kcal·mol-1). 
The pathway involving ts2II leads to the Z-3a, whereas those proceeding through ts2III and ts2IV 
lead to the E-counterpart. For a summary of these pathways , see Figures  S6 and S8. 
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Figure S8. Energy profiles via ts2 (red), ts2I (pink), ts2II (yellow), ts2III (green) and ts2IV (blue). 
 
Additional Information cited in Reference 24 
From Int-5, an additional pathways for the formation of the (2 + 2) product (Z-3a) was detected(via 
ts9). However, the (4 + 2) pathway (via ts7), with an energy barrier of 9.9 kcal·mol-1 is clearly 
favored (9.9 vs 16.0 kcal·mol-1, Figure S9). 
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Figure S9. Energy profile for the two pathways found from Int-5, the more accessible 
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1. General experimental procedures 
 
Reactions were conducted in dry solvents under Argon atmosphere unless otherwise stated. Dry THF was 
obtained using Solvent Purification System (SPS). Toluene and CH2Cl2 was purchased from Aldrich. AuCl, 
Chloro[1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene]gold (Au1), Chloro[tris(2,4-di-tert-
butylphenyl)phosphite]gold (I) (Au2), Dichloro(2-pyridinecarboxylate)gold and (Au3) AgSbF6 and 2-(Di-tert-
butylphosphino)biphenyl gold(I) chloride (Au4), were purchased from Aldrich. All other chemicals were 
purchased from Aldrich, TCI or Alfa Aesar and used without further purification. 
The abbreviation “rt” refers to reactions carried out at a temperature between 21-25 ºC. Reaction mixtures 
were stirred using Teflon-coated magnetic stir bars. High reaction temperatures were maintained using 
Thermowatch-controlled silicone oil baths. Thin-layer chromatography (TLC) was performed on silica gel 
plates and components were visualized by observation under UV light, and / or by treating the plates with p-
anisaldehyde or cerium nitrate solutions, followed by heating. Flash chromatography was carried out on silica 
gel. Dryings were performed with anhydrous Na2SO4. Concentration refers to the removal of volatile solvents 
via distillation using a Büchi rotary evaporator followed by high vacuum. NMR spectra were recorded in 
CDCl3, at 250 MHz (Bruker), 300 MHz (Varian), 400 MHz (Varian) or 500 MHz (Bruker). Carbon types and 
structure assignments were determined from DEPT-NMR and two-dimensional experiments (HMQC and 
HMBC, COSY and NOESY). NMR spectra were analyzed using MestReNova© NMR data processing 
software (www.mestrelab.com). The following abbreviations are used to indicate signal multiplicity: s, singlet; 
d, doublet; t, triplet; q, quartet; dd, double doublet; dt, double triplet; m, multiplet; br, broad. Mass spectra were 
acquired using chemical ionization (CI) or electronic impact (EI) and were recorded at the CACTUS facility of 
the University of Santiago de Compostela.  
3-(Propa-1,2-dien-1-yl)oxazolidin-2-one (1)1, tert-butyl 1H-indole-1-carboxylate (5p) 2 are known compounds 
and were synthesized according to the reported procedures.  (E)-3-Propenyl-oxazolidin-2-one (5k)3, (E)-1-
Propenyl-pyrrolidin-2-one ((E)-5m) and (Z)-1-Propenyl-pyrrolidin-2-one ((Z)-5m) 4 are known compounds and 
were synthesized according to the procedure of Gilles Dujardin,5 from 1-Bromo-1-propene (mixture of cis and 
trans isomers) and the corresponding amide. (E)-3-(3-(1H-indol-3-yl)prop-1-en-1-yl)oxazolidin-2-one 8o is a 
known compound and its spectroscopical data is acording to that previously reported.6. 
                                                            
1 L. Wei, J. A. Mulder, C. A. Zificsak, C. J. Douglas, R. P. Hsung, Tetrahedron. 2001, 57, 459-466. 
2 E. Vázquez, I. W.Davies, J. F. Payack. J. Org. Chem. 2002, 67, 7551-7552. 
3 Neugnot, B.; Cintrat, J.-C.; Rousseau, B. Tetrahedron. 2004, 60, 3575-3579. 
4 B. Alcaide, P. Almendros, J. M.  Alonso, Chemistry. 2006, 12, 2874-2879. 
5 T. B. Nguyen, A. Martel, R. Dhal, G. Dujardin, J. Org. Chem. 2008, 73, 2621-2632. 
6 M. C. Kimber, Org. Lett. 2010, 12, 1128-1131. 
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Procedure for the preparation of enamides (E)-5l and (Z)-5l 
 
Prepared according to the procedure of Gilles Dujardin.5 A mixture of benzyl methylcarbamate7 (661 mg, 4.0 
mmol), 1-Bromo-1-propene (mixture of cis and trans isomers) (514 µl, 6.00 mmol), N,N'-
dimethylethylenediamine (43 µl, 0.40 mmol), K2CO3 (608 mg, 4.40 mmol), copper(I) iodide (38.1 mg, 0.20 
mmol), and toluene (1.2 ml) was placed in a tightly closed sealed tube fitted with a magnetic stirbar. The 
mixture was stirred for 16 h at reflux and then cooled to room temperature. The tube was carefully opened, 
and its content was filtered through celite, the solid residue was rinsed with CH2Cl2, and the combined filtrates 
were evaporated, filtered through florisil, and column cromatographed (hexanes / EtOAc 5-25%) to give (E)-
benzyl methyl(prop-1-enyl)carbamaten (E)-5l  (326 mg, 1.59 mmol, 40 % yield) and (Z)-benzyl methyl(prop-1-
enyl)carbamate (Z)-5l (115 mg, 0.56 mmol, 14 % yield) 
 
(E)-Benzyl methyl(prop-1-enyl)carbamate ((E)-5l) 
40% yield, yellow oil. 1H NMR (300 MHz, CDCl3) δ 7.44 – 7.26 (m, 5H), 6.98 (dd, J = 36.7, 14.4 
Hz, 1H), 5.20 (s, 2H), 4.96 – 4.76 (m, 1H), 3.06 (d, J = 8.3 Hz, 3H), 1.71 (t, J = 7.1 Hz, 3H). 13C 
NMR (75 MHz, CDCl3) δ 153.8 (C), 136.2 (C), 128.9 (CH), 128.4 (CH), 128.0 (CH), 127.9 (CH), 
104.0 (CH), 67.5 (CH2), 30.9 (CH3), 15.1 (CH3). LRMS (m/z, EI): 205 [M+, 23], 181 (8), 160 (28), 146 (10), 91 
(100). HRMS calculated for C12H15NO2: 205.1103, found 205.1107. 
(Z)-Benzyl methyl(prop-1-enyl)carbamate ((Z)-5l) 
14% yield, yellow oil. 1H NMR (300 MHz, CDCl3) δ 7.51 – 7.21 (m, 5H), 6.22 (brs, 1H), 5.17 (s, 
2H), 5.18 – 5.00 (m, 1H), 3.11 (s, 3H), 1.64 (d, J = 6.9 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 
155.3 (C), 136.4 (C), 128.9 (CH), 128.3 (CH), 127.8 (CH), 127.8 (CH), 116.8 (CH), 67.2 (CH2), 
36.0 (CH3), 12.5 (CH3). LRMS (m/z, EI): 205 [M+, 3], 161 (5), 146 (3), 114 (10), 91 (100). HRMS calculated for 
C12H15NO2: 205.1103, found 205.1106. 
 
Procedure for the preparation of enamide 5n 
 
Prepared according to the procedure of Davies and coworkers.8, p-Toluenesulfonic acid monohydrate (0.61 g, 
3.20 mmol) and phenylacetaldehyde 90% (2.0 ml, 15,4 mmol) were added sequentially to a stirred solution of 
                                                            
7 E. Artuso, I. Degani, R. Fochi, C. Magistris, Synthesis 2008, 1612-1618. 
8 C. Aciro, S. G. Davies, A. C. Garner, Y. Ishii, M.-S. Key, K. B. Ling, R. S. Prasad, P. M. Roberts, H. Rodriguez-Solla, C. O’Leary-Steele, 
Tetrahedron 2008, 64, 9320-9344. 
 
N
OBn
O
(E)-5l
N
OBn
O
(Z)-5l
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methyl propylcarbamate9 (1.5 g, 12.80 mmol) in toluene (183 ml). The reaction mixture was heated at 120 °C 
under Dean-Stark conditions for 12 h and then concentrated under vacuum. The residue was purified via flash 
column chromatography (hexanes/Et2O 15%) to give (E)-methyl propyl(styryl)carbamate (5n) in 56 % yield 
(1.57 g, 7.16 mmol). 
 
(E)-methyl propyl(styryl)carbamate 5n 
56% yield, yellow oil. 1H NMR (300 MHz, CDCl3) δ 7.99 – 7.02 (m, 6H), 5.89 (d, J = 14.9 Hz, 
1H), 3.86 (s, 3H), 3.67 (brs, 2H), 1.73 (q, J = 7.4 Hz, 2H), 1.02 (t, J = 7.4 Hz, 3H). 13C NMR 
(75 MHz, CDCl3) δ 137.4 (C), 128.9 (CH), 126.2 (CH), 125.6 (CH), 109.3 (CH), 53.5 (CH3), 
45.9 (CH2), 20.7 (CH2), 11.5 (CH3). LRMS (m/z, EI): 219 [M+, 100], 190 (31), 177 (14), 130 (34), 115 (25), 91 
(100). HRMS calculated for C13H17NO2: 219.1259, found 219.1259.  
 
Representative procedure for the (2 +2) cycloaddition of 1 with alkenes (exemplified for the cycloaddition 
with 5a). 
To a cooled solution (-15 °C) of trans--methylstyrene (5a, 162 µl, 1.25 mmol), AgSbF6 (2.86 mg, 8.31 
µmol) and Au2 (7.31 mg, 8.31 µmol) in a dried Schlenk tube, was slowly added a solution of allenamide 1 (52 
mg, 0.426 mmol) in CH2Cl2 (1 mL), over 1 hour. The mixture was additionally stirred at -15 °C for 5 min and 
filtered through a short pad of florisil®, eluting with Et2O. The solvent was evaporated and the crude mixture 
was chromatographed to give 6a (80 mg, 0.30 mmol) in 79% yield. 
 
3-((Z)-(-3-Methyl-2-phenylcyclobutylidene)methyl)oxazolidin-2-one (6a) 
79 % yield, white solid. 1H NMR (300 MHz, CDCl3) δ 7.38 – 7.17 (m, 5H), 6.40 (t, J = 2.0 
Hz, 1H), 4.17 – 4.01 (m, 1H), 3.91 (qd, J = 8.5, 0.9 Hz, 1H), 3.78 – 3.67 (m, 1H), 3.56 – 
3.38 (m, 1H), 3.15 (td, J = 9.0, 6.0 Hz, 1H), 3.05 – 2.88 (m, 1H), 2.41 – 2.24 (m, 2H), 1.26 
(d, J = 6.2 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 156.2 (C), 143.6 (C), 128.7 (CH), 126.8 
(CH), 126.5 (CH), 123.0 (C), 117.4 (CH), 62.0 (CH2), 55.0 (CH), 44.3 (CH2), 38.0 (CH), 34.0 (CH2), 20.9 
(CH3). LRMS (m/z, CI): 244 [M+ +1, 6], 195 (5), 157 (8), 135 (100), 126 (75). HRMS calculated for C15H18NO2: 
244.1338, found 244.1337. The structure of 6a was confirmed by X-ray analysis (Figure S1). 
 
Figure S1: X-Ray structure of 6a.10 
                                                            
9 M. Aresta, A. Dibenedetto, E. Quaranta, M. Boscolo, Larsson, R. Journal of Molecular Catalysis A: Chemical 2001, 174, 7-13. 
10 Deposited at the Cambridge Crystallographic Data Centre with the number CCDC 863034. 
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(Z)-3-((3-Methylene-2-(2-oxooxazolidin-3-yl)cyclobutylidene)methyl)oxazolidin-2-one (7) 
White solid. 1H NMR (250 MHz, CDCl3) δ 6.60 (q, J = 2.2 Hz, 1H), 5.61 (dt, J = 4.9, 2.4 Hz, 
1H), 5.25 – 5.05 (m, 2H), 4.44 – 4.27 (m, 4H), 3.91 – 3.66 (m, 2H), 3.62 (q, J = 8.7 Hz, 1H), 
3.48 (q, J = 8.3 Hz, 1H), 3.32 – 3.19 (m, 2H). 13C NMR (63 MHz, CDCl3) δ 157.4 (C), 156.2 
(C), 142.6 (C), 121.1 (CH), 115.4 (C), 111.0 (CH2), 62.5 (CH2), 62.3 (CH2), 58.0 (CH), 43.8 
(CH2), 40.0 (CH2), 35.3 (CH2). LRMS (m/z, CI): 251 [M+ +1, 52], 207 (9), 180 (15), 166 (31), 164 (63), 88 
(100). HRMS calculated for C12H15N2O4: 251.1032, found 251.1033. The structure of 7 was confirmed by X-
ray analysis (Figure S2). 
 
Figure S2: X-Ray structure of 7.11 
 
(Z)-3-((2-Phenylcyclobutylidene)methyl)oxazolidin-2-one (6b) 
81% yield, white solid. 1H NMR (400 MHz, CDCl3) δ 7.35 – 7.15 (m, 5H), 6.38 – 6.34 (m, 1H), 
4.34 – 4.21 (m, 1H), 4.08 (td, J = 9.0, 6.2 Hz, 1H), 3.99 – 3.87 (m, 1H), 3.55 – 3.45 (m, 1H), 
3.19 (td, J = 9.1, 6.1 Hz, 1H), 2.90 – 2.79 (m, 1H), 2.79 – 2.69 (m, 1H), 2.64 – 2.48 (m, 1H), 
1.96 – 1.83 (m, 1H). 13C NMR (101 MHz, CDCl3) δ 156.0 (C), 144.6 (C), 128.7 (CH), 126.8 
(CH), 126.5 (CH), 125.3 (C), 117.0 (CH), 62.0 (CH2), 46.7 (CH), 44.0 (CH2), 28.5 (CH2), 26.5 (CH2). LRMS 
(m/z, EI): 229 [M+, 22], 229 (22), 184 (15), 156 (25), 142 (100), 129 (29), 115 (35). HRMS calculated for 
C14H15NO2: 229.1103, found 229.1098. 
 
(Z)-3-((2-(p-Tolyl)cyclobutylidene)methyl)oxazolidin-2-one (6c) 
83% yield, white solid. 1H NMR (300 MHz, CDCl3) δ 7.25 – 7.09 (m, 4H), 6.39 (s, 1H), 4.34 – 
4.23 (m, 1H), 4.13 (td, J = 8.9, 6.2 Hz, 1H), 4.07 – 3.92 (m, 1H), 3.54 (td, J = 9.1, 7.4 Hz, 1H), 
3.25 (td, J = 9.1, 6.2 Hz, 1H), 2.96 – 2.68 (m, 2H), 2.66 – 2.46 (m, 1H), 2.34 (s, 3H), 1.99 – 
1.82 (m, 1H). 13C NMR (75 MHz, CDCl3) δ 156.0 (C), 141.7 (C), 136.0 (C), 129.4 (CH), 126.6 
(CH), 125.4 (C), 116.9 (CH), 62.0 (CH2), 46.3 (CH), 44.0 (CH2), 28.5 (CH2), 26.4 (CH2), 20.9 
(CH3). LRMS (m/z, CI): 244 [M+ +1, 39], 228 (26), 156 (40), 152 (35), 126 (100). HRMS calculated for 
C15H18NO2: 244.1338, found 244.1337. 
 
 
                                                            
11 Deposited at the Cambridge Crystallographic Data Centre with the number CCDC 863035. 
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(Z)-3-((2-(m-Tolyl)cyclobutylidene)methyl)oxazolidin-2-one (6d) 
80% yield, white solid. 1H NMR (300 MHz, CDCl3) δ 7.13 (t, J = 7.4 Hz, 1H), 7.03 – 6.90 (m, 
3H), 6.30 (q, J = 2.1 Hz, 1H), 4.25 – 4.14 (m, 1H), 4.10 – 3.98 (m, 1H), 3.96 – 3.84 (m, 1H), 
3.45 (td, J = 9.1, 7.4 Hz, 1H), 3.17 (td, J = 9.1, 6.2 Hz, 1H), 2.88 – 2.59 (m, 2H), 2.58 – 2.41 
(m, 1H), 2.26 (s, 3H), 1.91 – 1.75 (m, 1H). 13C NMR (75 MHz, CDCl3) δ 156.0 (C), 144.6 (C), 
138.3 (C), 128.6 (CH), 127.4 (CH), 127.2 (CH), 125.2 (C), 123.8 (CH), 116.9 (CH), 62.0 
(CH2), 46.7 (CH), 44.0 (CH2), 28.4 (CH2), 26.5 (CH2), 21.4 (CH3). LRMS (m/z, CI): 244 [M+ +1, 63], 243 (34), 
228 (8), 173 (18), 157 (66), 156 (70), 143 (23), 126 (100), 119 (53). HRMS calculated for C15H18NO2: 
244.1338, found 244.1338. 
 
(Z)-3-((2-(o-Tolyl)cyclobutylidene)methyl)oxazolidin-2-one (6e) 
96% yield, white solid. 1H NMR (300 MHz, CDCl3) δ 7.40 (d, J = 7.3 Hz, 1H), 7.27 – 7.11 (m, 
3H), 6.55 – 6.46 (m, 1H), 4.58 – 4.41 (m, 1H), 4.24 – 4.09 (m, 1H), 4.11 – 3.94 (m, 1H), 3.59 
(td, J = 9.1, 7.6 Hz, 1H), 3.35 (td, J = 9.0, 6.0 Hz, 1H), 2.98 – 2.82 (m, 1H), 2.82 – 2.74 (m, 
1H), 2.74 – 2.59 (m, 1H), 2.27 (s, 3H), 1.87 – 1.70 (m, 1H).  13C NMR (75 MHz, CDCl3) δ 
156.0 (C), 142.1 (C), 134.7 (C), 130.2 (CH), 126.4 (CH), 126.2 (CH), 126.0 (CH), 123.5 (C), 
117.4 (CH), 62.0 (CH2), 43.7 (CH), 43.3 (CH2), 27.0 (CH2), 25.9 (CH2), 19.1 (CH3). LRMS (m/z, CI): 244 [M+ 
+1, 52], 228 (32), 157 (44), 156 (54), 152 (98), 126 (100) 119 (55). HRMS calculated for C15H18NO2: 
244.1338, found 244.1334. 
 
(Z)-3-((2-(2-Bromophenyl)cyclobutylidene)methyl)oxazolidin-2-one (6f) 
42% yield, white solid. 1H NMR (300 MHz, CDCl3) δ 7.55 (d, J = 7.9 Hz, 1H), 7.46 (dd, J = 
7.6, 1.4 Hz, 1H), 7.32 (t, J = 7.4 Hz, 1H), 7.11 (td, J = 7.8, 1.5 Hz, 1H), 6.56 – 6.44 (m, 1H), 
4.71 – 4.58 (m, 1H), 4.20 (td, J = 9.0, 6.0 Hz, 1H), 4.05 (q, J = 8.8 Hz, 1H), 3.62 (q, J = 9.0 
Hz, 1H), 3.26 (td, J = 9.0, 6.0 Hz, 1H), 2.95 – 2.61 (m, 3H), 1.89 – 1.72 (m, 1H). 13C NMR (75 
MHz, CDCl3) δ 156.1 (C), 143.3 (C), 132.9 (CH), 128.2 (CH), 128.0 (CH), 123.2 (C), 122.4 
(C), 118.0 (CH), 62.1 (CH2), 46.3 (CH), 43.4 (CH2), 27.4 (CH2), 25.9 (CH2). LRMS (m/z, CI): 310 [M+ +1, 31], 
308 (32), 258 (7), 230 (29), 186 (37), 126 (100). HRMS calculated for C14H15NO2Br: 310.0266, found 
310.0277. 
 
(Z)-3-((6-Phenylbicyclo[4.2.0]octan-7-ylidene)methyl)oxazolidin-2-one (6g) 
74 % yield, white solid. 1H NMR (300 MHz, CDCl3) δ 7.41 (d, J = 7.4 Hz, 2H), 7.31 (t, J = 
7.6 Hz, 2H), 7.18 (t, J = 7.1 Hz, 1H), 6.27 (s, 1H), 4.03 (td, J = 8.9, 5.9 Hz, 1H), 3.77 (q, J 
= 8.7 Hz, 1H), 3.19 (q, J = 8.9 Hz, 1H), 2.82 – 2.66 (m, 2H), 2.70 – 2.49 (m, 2H), 2.43 (d, 
J = 15.0 Hz, 1H), 2.00 (td, J = 15.3, 13.9, 3.6 Hz, 1H), 1.86 – 1.73 (m, 1H), 1.69 – 1.35 
(m, 5H). 13C NMR (75 MHz, CDCl3) δ 156.4 (C), 146.7 (C), 130.1 (C), 128.4 (CH), 126.4 (CH), 126.1 (CH), 
114.5 (CH), 61.9 (CH2), 50.2 (C), 45.3 (CH2), 41.7 (CH), 32.5 (CH2), 29.0 (CH2), 24.8 (CH2), 22.5 (CH2), 20.2 
(CH2). 
N O
O
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3-(3-(2,3,4,5-Tetrahydro-[1,1'-biphenyl]-2-yl)prop-1-en-1-yl)oxazolidin-2-one (8g) 
10% yield, colourless oil. 1H NMR (300 MHz, CDCl3) δ 7.46 – 7.16 (m, 5H), 6.53 (d, J = 
14.3 Hz, 1H), 5.92 (t, J = 3.4 Hz, 1H), 4.62 (dt, J = 14.6, 7.6 Hz, 1H), 4.38 (t, J = 8.1 Hz, 
2H), 3.52 (h, J = 8.7 Hz, 2H), 2.81 – 2.70 (m, 1H), 2.23 – 2.08 (m, 3H), 2.06 – 1.91 (m, 
1H), 1.80 – 1.56 (m, 43H). 13C NMR (75 MHz, CDCl3) δ 155.3 (C), 142.9 (C), 141.3 (C), 128.2 (CH), 127.0 
(CH), 126.4 (CH), 126.3 (CH), 124.5 (CH), 109.8 (CH), 62.0 (CH2), 42.5 (CH2), 36.3 (CH), 34.0 (CH2), 26.9 
(CH2), 26.0 (CH2), 18. (CH2). 
 
(Z)-3-((2-Methyl-2-phenylcyclobutylidene)methyl)oxazolidin-2-one (6h) 
77% yield, white solid. 1H NMR (300 MHz, CDCl3) δ 7.40 (d, J = 7.5 Hz, 2H), 7.32 (t, J = 7.6 
Hz, 2H), 7.20 (t, J = 7.1 Hz, 1H), 6.33 (s, 1H), 4.08 (td, J = 8.9, 6.1 Hz, 1H), 3.90 (q, J = 8.4 
Hz, 1H), 3.31 (q, J = 9.0 Hz, 1H), 2.93 (td, J = 9.0, 6.1 Hz, 1H), 2.88 – 2.77 (m, 1H), 2.77 – 
2.63 (m, 1H), 2.25 – 2.01 (m, 2H), 1.74 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 156.4 (C), 147.5 
(C), 130.4 (C), 128.5 (CH), 126.2 (CH), 125.6 (CH), 116.1 (CH), 61.8 (CH2), 49.4 (C), 45.3 (CH2), 36.4 (CH2), 
26.3 (CH3), 24.2 (CH2). LRMS (m/z, CI): 244 [M+ +1, 18], 228 (3), 187 (3), 171 (19), 155 (26), 142 (19), 126 
(100). HRMS calculated for C15H18NO2: 244.1338, found 244.1337. 
 
(Z)-3-((7,7a-Dihydro-1H-cyclobuta[a]inden-2(2aH)-ylidene)methyl)oxazolidin-2-one (6i) 
82% yield, white solid: 1H NMR (300 MHz, CDCl3) δ 7.37 – 7.18 (m, 4H), 6.12 (s, 1H), 4.61 – 
4.40 (m, 3H), 4.20 (q, J = 8.6 Hz, 1H), 3.95 (q, J = 8.3 Hz, 1H), 3.33 – 3.07 (m, 2H), 2.96 – 
2.82 (m, 2H), 2.52 – 2.39 (m, 1H). 13C NMR (75 MHz, CDCl3) δ 155.9 (C), 143.7 (C), 142.9 
(C), 127.1 (CH), 126.7 (CH), 125.9 (CH), 125.6 (C), 124.9 (CH), 114.7 (CH), 62.1 (CH2), 
52.7 (CH), 44.6 (CH2), 38.8 (CH2), 35.0 (CH2), 34.6 (CH). LRMS (m/z, CI): 242 [M+ +1, 20], 
214 (2), 171 (5), 155 (24), 141 (6), 126 (100). HRMS calculated for C15H16NO2: 242.1181, found 242.1188. 
The structure of 6i was confirmed by X-ray analysis (Figure S3). 
 
Figure S3: X-Ray structure of 6i.12 
 
 
 
 
                                                            
12 Deposited at the Cambridge Crystallographic Data Centre with the number CCDC 863036. 
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(Z)-3-(Spiro[3.5]nonan-1-ylidenemethyl)oxazolidin-2-one (6j) and 3-(4-cyclohexylidenebut-1-en-1-
yl)oxazolidin-2-one (8j) 
78% global yield, colourless oil. 13 1H NMR (300 MHz, CDCl3) δ 6.60 (d, J = 14.3 
Hz, 0.85H), 5.91 (s, 0.15H), 5.36 (s, 0.85H), 4.77 (dt, J = 14.1, 7.0 Hz, 0.85H), 
4.44 – 4.28 (m, 2.00H), 3.76 (t, J = 8.0 Hz, 0.30H), 3.65 (t, J = 8.0 Hz, 1.70H), 
2.52 (td, J = 8.4, 2.0 Hz, 0.30H), 2.13 (q, J = 7.1 Hz, 2.00H), 2.02 – 1.82 (m, 
5.75H), 1.82 – 1.72 (m, 0.85H), 1.67 – 1.39 (m, 3.15H) 13C NMR (75 MHz, 
CDCl3) δ 156.9 (C), 155.3 (C), 138.5 (C), 136.7 (C), 123.6 (CH), 121.2 (CH), 
115.3 (CH), 111.0 (CH), 62.0 (CH2), 61.8 (CH2), 48.6 (C), 47.2 (CH2), 42.5 (CH2), 38.4 (CH2), 36.1 (CH2), 28.6 
(CH2), 28.2 (CH2), 28.0 (CH2), 25.7 (CH2), 25.1 (CH2), 23.9 (CH2), 22.8 (CH2), 22.4 (CH2), 22.2 (CH2). LRMS 
(m/z, CI): 222 [M+ +1, 99], 220 (38), 194 (10), 163 (19), 135 (94), 127 (93), 126 (98) HRMS calculated for 
C13H20NO2: 222.1494, found 222.1491. 
 
(Z)-3-((3-Methyl-2-(2-oxooxazolidin-3-yl)cyclobutylidene)methyl)oxazolidin-2-one (6k) 
76% yield, white solid. 1H NMR (300 MHz, CDCl3) δ 6.34 (q, J = 2.2 Hz, 1H), 4.66 (dt, J 
= 5.8, 2.8 Hz, 1H), 4.40 – 4.19 (m, 4H), 3.77 – 3.46 (m, 4H), 2.79 – 2.65 (m, 1H), 2.58 – 
2.40 (m, 1H), 2.05 (ddd, J = 15.5, 6.9, 2.3 Hz, 1H), 1.18 (d, J = 6.8 Hz, 3H). 13C NMR 
(75 MHz, CDCl3) δ 157.1 (C), 156.3 (C), 119.9 (CH), 119.0 (C), 62.5 (CH2), 62.0 (CH2), 
59.0 (CH), 44.2 (CH2), 41.1 (CH2), 32.0 (CH), 31.5 (CH2), 19.4 (CH3). LRMS (m/z, CI): 
253 [M+ +1, 14], 208 (7), 166 (52), 140(40), 127 (58), 88 (100). HRMS calculated for C12H17N2O4: 253.1188, 
found 253.1194. The structure of 6k was confirmed by X-ray analysis (Figure S4). 
 
Figure S4: X-Ray structure of 6k.14 
 
(Z)-Benzyl methyl(2-methyl-4-((2-oxooxazolidin-3-yl)methylene)cyclobutyl)carbamate (6l) 
91-96% yield, colourless oil: 1H NMR (500 MHz, C6D6, carried out at 50 ºC to reduce the 
presence of rotamers at rt) δ 7.19 (d, J = 7.1 Hz, 2H), 7.09 – 6.98 (m, 3H), 6.44 (d, J = 
1.0 Hz, 1H), 5.36 – 4.56 (m, 3H), 3.32 – 3.18 (m, 2H), 3.07 – 2.92 (m, 2H), 2.61 (brs, 
3H), 2.38 – 2.27 (m, 1H), 2.17 – 2.05 (m, 1H), 1.74 – 1.63 (m, 1H), 0.95 (brs, 3H). 13C 
NMR (126 MHz, C6D6 at 50 ºC) δ 155.9 (C), 155.1 (C) 137.5 (C), 128.9 (C), 128.6 (CH), 
                                                            
13 Compounds 6j and 8j could not be separated under standard chromatography techniques in silica gel. Their ratio could be easily 
determined by 1H-NMR, integrating the signals corresponding to the enamide hydrogens. 
14 Deposited at the Cambridge Crystallographic Data Centre with the number CCDC 863038. 
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128.3 (CH), 120.3 (CH), 67.1 (CH2), 62.2 (CH), 61.6 (CH2), 43.5 (CH2), 32.5 (CH3), 31.5 (CH2), 29.2 (CH), 
19.6 (CH3). LRMS (m/z, CI): 331 [M+ +1, 86], 287 (94), 239 (48),197 (100), 166 (68), 126 (49). HRMS [M++1], 
Calculated for C18H23N2O4: 331.1658, found 331.1659. 
 
(Z)-3-((3-Methyl-2-(2-oxopyrrolidin-1-yl)cyclobutylidene)methyl)oxazolidin-2-one (6m) 
71-73% yield, white solid. 1H NMR (300 MHz, CDCl3) δ 6.30 (d, J = 2.1 Hz, 1H), 4.91 (dt, 
J = 5.6, 2.7 Hz, 1H), 4.33 – 4.11 (m, 2H), 3.64 (q, J = 9.0 Hz, 1H), 3.52 (td, J = 9.1, 6.4 
Hz, 1H), 3.47 – 3.29 (m, 2H), 2.80 – 2.64 (m, 1H), 2.53 – 2.20 (m, 3H), 2.14 – 1.83 (m, 
3H), 1.13 (d, J = 6.8 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 174.1 (C), 156.3 (C), 119.5 
(C), 119.5 (CH), 62.5 (CH2), 57.1 (CH), 44.3 (CH2), 43.6 (CH2), 32.1 (CH), 31.9 (CH2), 
31.5 (CH2), 19.7 (CH3), 18.0 (CH2). LRMS (m/z, CI): 251 [M+ +1, 57], 222 (2), 194 (2), 166 (18), 138 (15), 126 
(100). HRMS [M++1], Calculated for C13H19N2O3: 251.1396, found 251.1395. 
 
(Z)-Methyl (2-((2-oxooxazolidin-3-yl)methylene)-4-phenylcyclobutyl)(propyl)carbamate (6n) 
78% yield, colourless oil: 1H NMR (500 MHz, C6D6, carried out at 50 ºC to reduce the 
presence of rotamers at rt) δ 7.18 (d, J = 7.5 Hz, 2H), 7.16 – 7.09 (m, 2H), 7.02 (t, J = 
7.2 Hz, 1H), 6.45 (q, J = 2.2 Hz, 1H), 5.41 (brs, 1H), 3.51 – 3.39 (m, 3H), 3.37 (s, 3H), 
3.22 (td, J = 8.9, 6.3 Hz, 1H), 3.16 – 3.02 (m, 2H), 3.04 – 2.95 (m, 1H), 2.69 – 2.58 (m, 
1H), 2.32 – 2.22 (m, 1H), 1.57 (brs, 1H), 1.51 – 1.39 (m, 1H), 0.71 (t, J = 7.4 Hz, 3H).  
13C NMR (126 MHz, C6D6 at 50 ºC) δ 156.3 (C), 156.0 (C), 143.0 (C), 128.9 (CH), 126.9 (CH), 126.9 (CH) 
120.0 (CH), 118.9 (C), 63.2 (CH), 61.8 (CH2), 52.4 (CH3), 46.7 (CH2), 44.2 (CH), 44.1 (CH2), 31.4 (CH2), 23.5 
(CH2), 11.6 (CH3). LRMS (m/z, CI): 345 [M+ +1, 57], 301 (81), 285 (100), 257 (60), 228 (96), 156 (62), 126 
(100). HRMS calculated for C19H25N2O4: 345.1814, found 345.1814. The structural assignment of 6n as well 
as its relative stereochemistry was established on the basis of 1D and 2D-NMR analysis (COSY, HMQC, 
HMBC and NOESY). 
 
(Z)-tert-Butyl 2-((2-oxoxazolidin-3-yl)methylene)-2,2a-dihydro-1H-cyclobuta[b]indole-3(7bH)-carbo-
xylate (6p) 
33% yield, white solid. 1H NMR (300 MHz, CDCl3) δ 7.51 (d, J = 6.7 Hz, 1H), 7.30 – 7.18 
(m, 2H), 7.07 (t, J = 7.4 Hz, 1H), 6.32 – 6.24 (m, 1H), 5.70 (d, J = 7.1 Hz, 1H), 4.36 (h, J = 
8.3 Hz, 2H), 4.25 – 4.08 (m, 1H), 4.06 – 3.86 (m, 2H), 3.17 (ddd, J = 15.1, 8.1, 2.2 Hz, 
1H), 2.61 – 2.48 (m, 1H), 1.56 (s, 9H).13C NMR (75 MHz, CDCl3) δ 156.1 (C), 153.0 (C), 
142.9 (C), 135.9 (C), 127.7 (CH), 124.9 (CH), 123.9 (CH), 122.3 (C), 120.8 (CH), 117.9 (CH), 81.8 (C), 62.4 
(CH2), 62.3 (CH), 44.1 (CH2), 39.2 (CH), 35.8 (CH2), 28.3 (CH3). LRMS (m/z, CI): 343 [M+ +1, 12], 315 (29), 
287 (67), 271 (69), 244 (95), 156 (41), 126 (98). HRMS calculated for C19H23N2O4: 343.1658, found 343.1661. 
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(E)-tert-Butyl 3-(3-(2-oxooxazolidin-3-yl)allyl)-1H-indole-1-carboxylate (8p) 
21% yield, colourless oil: 1H NMR (300 MHz, CDCl3) δ  8.12 (d, J = 7.9 Hz, 1H), 7.52 
(d, J = 7.6 Hz, 1H), 7.41 – 7.18 (m, 3H), 6.85 (d, J = 14.3 Hz, 1H), 5.00 (dt, J = 14.1, 
6.9 Hz, 1H), 4.48 – 4.38 (m, 2H), 3.75 – 3.63 (m, 2H), 3.48 (d, J = 6.9 Hz, 2H), 1.68 
(s, 9H). 13C NMR (75 MHz, CDCl3) δ 155.3 (C), 149.8 (C), 130.2 (C), 127.7 (C), 125.2 
(CH), 124.4 (CH), 122.8 (CH), 122.4 (CH), 119.4 (C), 119.0 (CH), 115.3 (CH), 108.4 (CH), 83.5 (C), 62.1 
(CH2), 42.6 (CH2), 28.2 (CH3), 25.6 (CH2). LRMS (m/z, CI): 343 [M+ +1, 58], 287 (87), 257 (69), 200 (51), 169 
(100), 154 (61). HRMS calculated for C19H23N2O4: 343.1658, found 343.1627. 
 
(Z)-tert-Butyl 8-((2-oxooxazolidin-3-yl)methylene)-2-azabicyclo[4.2.0]octane-2-carboxylate (6q) 
94% yield, white solid.1H NMR (500 MHz, C6D6, carried out at 70 ºC to reduce the 
presence of rotamers at lower temperatures) δ 6.52 (d, J = 1.8 Hz, 1H), 5.38 (ls, 1H), 
3.60 – 3.53 (m, 1H), 3.49 (q, J = 8.0 Hz, 1H), 3.40 – 3.29 (m, 2H), 2.79 (ls, 1H), 2.24 – 
2.16 (m, 1H), 2.16 – 2.06 (m, 1H), 1.70 (d, J = 14.3 Hz, 1H), 1.59 – 1.49 (m, 1H), 1.50 – 
1.37 (m, 2H), 1.35 (s, 9H), 1.24 – 1.08 (m, 2H). 13C NMR (126 MHz, C6D6, 70 ºC) 156.0 
(C), 154.8 (C), 122.4 (C), 119.5 (CH), 79.5 (C), 61.6(CH2), 52.5 (CH), 44.2 (CH2), 41.5 (CH2), 31.4 (CH), 31.0 
(CH2), 28.5 (CH3), 26.8 (CH2), 21.1 (CH2). LRMS (m/z, CI): 309 [M+ +1, 54], 281 (58), 247 (24), 235 (45), 209 
(100), 165 (50), 126 (87). HRMS calculated for C16H25N2O4: 309.1814, found 309.1818. The structure of 6q 
was confirmed by X-ray analysis (Figure S5). 
 
Figure S5: X-Ray structure of 6q.15  
 
                                                            
15 Deposited at the Cambridge Crystallographic Data Centre with the number CCDC 863037. 
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Addendum 
107b - Racemic - 3-((1R*,2S*,Z)-2,3-dimethyl-4-((2-oxooxazolidin-3-
yl)methylene)cyclobutyl)oxazolidin-2-one, dr = 2.4:1 
 1H NMR (500 MHz, CDCl3) δ 6.48 (t, J = 2.1 Hz, 0.3H), 6.38 (t, J = 2.3 Hz, 
0.7H), 4.73 (q, J = 5.2, 2.8 Hz, 0.3H), 4.67 (dd, J = 7.0, 1.7 Hz, 0.7H), 4.44 – 
4.25 (m, 4.0H), 3.80 (q, J = 8.8 Hz, 0.3H), 3.69 (t, J = 8.0 Hz, 2.0H), 3.65 – 
3.57 (m, 1.0H), 3.52 (td, J = 9.0, 6.7 Hz, 0.7H), 3.15 – 3.02 (m, 0.3H), 2.61 – 
2.48 (m, 0.3H), 2.33 – 2.24 (m, 0.7H), 2.08 – 1.91 (m, 0.7H), 1.20 (d, J = 6.8 
Hz, 2.1H), 1.16 (d, J = 6.7 Hz, 2.1H), 1.10 (d, J = 7.2 Hz, 0.9H), 1.06 (d, J = 7.2 Hz, 0.9H). 
13C NMR (75 MHz, CDCl3) δ 157.3 (C), 156.7 (C), 156.3 (C), 126.3 (C), 124.6 (C), 120.2 
(CH), 118.3 (CH), 62.6 (CH2), 62.5 (CH2), 62.1 (CH2), 62.0 (CH2), 58.2 (CH), 57.4 (CH), 44.8 
(CH2), 44.0 (CH2), 41.4 (CH2), 41.3 (CH2), 40.8 (CH), 38.6 (CH), 35.1 (CH), 34.9 (CH), 18.2 
(CH3), 17.8 (CH3), 14.6 (CH3), 13.4 (CH3). LRMS (m/z, ESI): 289.12 (M+Na)+, 267,13, 
180.10, 154.1, 140.07, 96.08. HRMS Calculated for C13H18N2NaO4: 289.1159, found 
289.1160.  
108 - Racemic - 3-((1Z)-(3-ethylidene-2-methyl-4-(2-oxooxazolidin-3-
yl)cyclobutylidene)methyl)oxazolidin-2-one, dr = 1.25:1 
 1H NMR (300 MHz, CDCl3) δ 6.64 – 6.52 (m, 1.0H), 5.75 – 5.64 (m, 
1.0H), 5.64 – 5.49 (m, 1.0H), 4.42 – 4.29 (m, 4.0H), 3.90 (q, J = 8.2 Hz, 
0.4H), 3.78 (q, J = 7.6 Hz, 1.6H), 3.60 – 3.41 (m, 2.2H), 3.34 – 3.18 (m, 
0.8H), 1.62 – 1.50 (m, 3.0H), 1.19 (dd, J = 6.9, 4.6 Hz, 3.0H). 13C NMR 
(75 MHz, CDCl3) δ 157.0 (C), 156.3 (C), 139.7 (C), 139.4 (C), 123.0 (C), 
121.8 (CH), 120.9 (CH), 120.6 (CH), 120.2 (CH), 62.5 (CH2), 62.5 (CH2), 62.2 (CH2), 55.7 
(CH), 55.6 (CH), 44.0 (CH2), 43.5 (CH2), 42.3 (CH), 40.8 (CH2), 40.5 (CH2), 40.2 (CH), 19.5 
(CH3), 18.6 (CH3), 13.5 (CH3), 13.1 (CH3). LRMS (m/z, CI): 279 [M+ +1, 45], 279 (45), 222 
(21), 192 (99), 140 (52), 116 (55), 103 (18), 88 (100). HRMS [M+ +1], Calculated for 
C14H19N2O4: 279.1345, found 279.1342.  
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General Procedures 
Dry solvents were freshly distilled under argon from an appropriate 
drying agent before use. Dry THF was obtained using Solvent Purification 
System (SPS). Toluene and CH2Cl2 was purchased from Aldrich. Gold complex 
C and E were prepared according to previously reported methods.1,2 Gold 
complexes A, B and D, AgSbF6 and 5-methylhex-5-en-2-one (4j) were 
purchased from Aldrich or Alfa Aesar. All other chemicals were purchased 
from Aldrich, TCI or Alfa Aesar and used without further purification, 
unless otherwise noted. Reactions were conducted in dry solvents under 
argon atmosphere unless otherwise stated. The abbreviation “rt” refers to 
reactions carried out approximately at 23ºC. Reaction mixtures were 
stirred using Teflon-coated magnetic stirring bars. Reaction temperatures 
were maintained using Thermowatch-controlled silicone oil baths. Thin-
layer chromatography (TLC) was performed on silica gel plates and 
components were visualized by observation under UV light, and / or by 
treating the plates with p-anisaldehyde or cerium nitrate solutions, 
followed by heating. Flash chromatography was carried out on silica gel 
unless otherwise stated. Dryings were performed with anhydrous Na2SO4 or 
MgSO4. Concentration refers to the removal of volatile solvents via 
distillation using a Büchi rotary evaporator followed by residual solvent 
removal under high vacuum. NMR spectra were recorded in CDCl3, at 250 MHz 
(Bruker), 300 MHz (Varian), 400 MHz (Varian) or 500 MHz (Varian) for 
cycloadducts. Carbon types and structure assignments were determined from 
DEPT-NMR and two-dimensional experiments (HMQC and HMBC, COSY and NOESY). 
NMR spectra were analyzed using MestreNova© NMR data processing software 
(www.mestrelab.com). The following abbreviations are used to indicate 
signal multiplicity: s, singlet; d, doublet; t, triplet; q, quartet; dd, 
double doublet; td, triple doublet; m, multiplet; br, broad. Mass spectra 
were acquired using chemical ionization (CI) electron impact (EI), or 
electrospray ionization (ESI) and were recorded at the CACTUS facility of 
the University of Santiago de Compostela. The reactions were monitored by 
TLC or GC-MS using the Agilent Technologies 6890N, Network GC System, 
equipped with the Agilent 190915-433 column and the Agilent 5973 Inert 
Mass Selective Detector in Electron Impact or Chemical Ionization Mode 
(with Methane).Melting Points was measured in a BUCHI M-560. Optical 
rotation was determined in a Jasco P-2000 Polarimeter. 
Enantioselectivities were determined in an Agilent HPLC 1100 Series with 
Chiralpak IA,IB,IA3 or IC analytical columns. X-Ray diffraction 
experiments were carried out in a Brucker SMART 1000 difractometer. 5-
                                                          
1
 Amijs, C. H. M.; López-Carrillo, V.; Raducan, M.; Pérez-Galán, P.; Ferrer, C.; Echavarren, A. M. J. 
Org. Chem. 2008, 73, 7721–7730. 
2
 de Frémont, P.; Marion, N.; Nolan, S. P. J. Organomet. Chem. 2009, 694, 551–560. 
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Phenylhex-5-en-2-one (4b)3, and 1-(2-vinylphenyl)ethanone (4f)4 are known 
compounds and were synthesized from 4-phenylpent-4-enoic acid,5 and 2-
vinylbenzoic acid6 respectively, by treatment with MeLi under previously 
reported conditions.7 5-Phenylhex-5-enal (4n)8 is a known compound and was 
prepared from 5-phenylhex-5-enoic acid9 following the same procedure as 
for 4d. 1,4-Diphenylpent-4-en-1-one (4c)10, is a known compound and was 
prepared from 4-phenylpent-4-enoic acid,5 and PhLi under previously 
reported conditions.7 3-(Propa-1,2-dien-1-yl)oxazolidin-2-one (1a),11 3-
(buta-1,2-dien-1-yl)oxazolidin-2-one (1b),12 4-methyl-N-phenyl-N-(propa-
1,2-dien-1-yl)benzenesulfonamide (1c),13 1-(2-(prop-1-en-2-
yl)phenyl)ethanone (4g),14 4-phenylpent-4-enal (4d),15  and  5-bromohex-5-
en-2-one16  are known compounds and were synthesized according to the 
reported procedures.  
Chiral gold complexes F17, G’18, H19, I20, J20, K18, and (S)-
BINAP(AuCl)221 are known compounds and were synthesized according to the 
reported procedures. Chiral gold complex G was prepared from the 
corresponding (S,R,R) phosphoramidite following the same procedure as for 
G’ (vide infra).18  
                                                          
3
 Mo, J.; Ruan, J.; Xu, L.; Hyder, Z.; Saidi, O.; Liu, S.; Pei, W.; Xiao, J. J. Mol. Cat. A: Chem. 
2007, 261, 267–275. 
4
 Hirao, A.; Kato, K.; Nakahama, S. Macromolecules 1992, 25, 535–540. 
5
 Takemiya, A.; Hartwig, J. F. J. Am. Chem. Soc. 2006, 128, 6042–6043. 
6
 Le Quement, S. T.; Nielsen, T. E.; Meldal, M. J. Comb. Chem. 2007, 9, 1060–1072. 
7
 Lee, J.; Son, H.; Park, H. Bull. Kor. Chem. Soc. 2004, 25, 1945–1947. 
8
 Bergmeier. S. C., J. Org. Chem. 2008, 73, 1462–1467. 
9 X. Jiang, C. K. Tan, L. Zhou, Y.-Y. Yeung, Angew. Chem. Int. ed. 2012, 51, 7771-7775. 
10
 Jiang, H. Chem. Eur. J., 2012, 18, 10497–10500.  
11
 L. Wei, J. A. Mulder, C. A. Zificsak, C. J. Douglas, R. P. Hsung, Tetrahedron. 2001, 57, 459-466. 
12 L. Shen, R. P. Hsung, Y. Zhang, J. E. Antoline, X. Zhang, Org. Lett. 2005, 7, 3081–3084. 
13
 A. González-Gómez, G. Domínguez, J. Pérez-Castells, Eur. J. Org. Chem. 2009, 5057-5062 
14
 Kim, J.; Li, H. B.; Rosenthal, A. S.; Sang, D.; Shapiro, T. a.; Bachi, M. D.; Posner, G. H. 
Tetrahedron 2006, 62, 4120–4127. 
15
 Prepared by reduction of 4-phenylpent-4-enoic acid and posterior oxidation, according to a 
previously reported procedure, see ref 5 and a) Baldwin, J.E., Burrell, R. C., J. Org. Chem. 2002, 
67, 3249-3256. 
16
 Bräse, S.; Wertal (nee Nüske), H.; Frank, D.; Vidović, D.; de Meijere, A. Eur. J. Org. Chem 2005, 
2005, 4167–4178. 
17
 M. J. Johansson, D. J. Gorin, S. T. Staben, F. D. Toste, J. Am. Chem. Soc. 2005, 127, 18002–18003. 
18
 A. Z. González, D. Benitez, E. Tkatchouk, W. a Goddard, F. D. Toste, J. Am. Chem. Soc. 2011, 133, 
5500–5007. 
19
 A. Z. González, F. D. Toste, Org. Lett. 2010, 12, 200–203. 
20
 I. Alonso, B. Trillo, F. López, S. Montserrat, G. Ujaque, L. Castedo, A. Lledós, J. L. Mascareñas, 
J. Am. Chem. Soc.2009, 131, 13020–13030. 
21
 V. Pawlowski, H. Kunkely, A. Vogler, Inorganica Chimica Acta 2004, 357, 1309–1312. 
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Procedures for the synthesis of the cycloaddition components of 
type 4. 
 
1-(3-Methylbut-2-enyl)-2-vinylbenzene (4a) 
 
To a suspension of magnesium turnings (0.187 g, 7.70 mmol) and I2 (one 
grain), in THF (7 ml), a half of a solution of 2-bromostyrene (0.91 ml, 
7.0 mmol), in THF (5 ml) at 0 ºC, was added. The resulting mixture was 
then heated at 40 ºC for 30 min, cooled to rt and the other half of the 
2-bromostyrene solution was then added. The resulting mixture was stirred 
for 1h at rt and heated again at 40 ºC for 1h. Then, a solution of 1-
bromo-3-methylbut-2-ene (0.92 ml, 7.0 mmol) in THF (2 ml) was added 
dropwise, and the resulting solution was stirred for 5 min. NH4Cl(aq) (50 
mL) was added and the resulting mixture was extracted with Et2O (3 x 15 
mL). The combined organic layers were successively washed with H2O (25 mL) 
and brine (25 mL), dried (MgSO4) and concentrated in vacuo. Column 
chromatography in pentane gave 0.65 g of 1-(3-methylbut-2-enyl)-2-
vinylbenzene 4a (54 % yield). Colorless oil. 1H NMR (300 MHz, CDCl3) 7.65 
– 7.56 (m, 1H), 7.36 – 7.24 (m, 3H), 7.11 (dd, J = 17.4, 11.0 Hz, 1H), 
5.75 (dd, J = 17.4, 1.5 Hz, 1H), 5.45 – 5.30 (m, 2H), 3.51 (d, J = 7.0 
Hz, 2H), 1.85 (s, 6H). 13C NMR (75 MHz, CDCl3) 139.0 (C), 136.6 (C), 134.8 
(CH), 132.1 (C), 129.1 (CH), 127.8 (CH), 126.2 (CH), 125.7 (CH), 122.9 
(CH), 115.2 (CH2), 32.0 (CH2), 25.6 (CH3), 17.8 (CH3).  
Methyl 4-phenylpent-4-enoate (4e) 
Hydrochloric acid (46.6 µl, 0.57 mmol) was added to a 
solution of 4-phenylpent-4-enoic acid5 (500 mg, 2.84 mmol) 
in methanol (12 mL), and the resulting mixture was stirred 
at 60°C overnight. The solvent was removed under reduced pressure and the 
crude was purified by flash chromatography in silica-gel (5% Et2O / 
hexanes) to afford 420 mg of methyl 4-phenylpent-4-enoate, 4e, (78 % 
yield). Colorless oil. 1H NMR (250 MHz, CDCl3) δ 7.31 - 7.06 (m, 5H), 5.17 
(s, 1H), 4.96 - 4.93 (m, 1H), 3.49 (s, 3H), 2.71 (dd, J = 9.3, 7.7 Hz, 
2H), 2.34 (dd, J = 8.9, 6.6 Hz, 2H). 13C NMR (63 MHz, CDCl3) δ 173.2 (C), 
146.7 (C), 140.3 (C), 128.2 (CH), 127.5 (CH), 125.9 (CH), 112.6 (CH2), 
51.3 (CH3), 32.9 (CH2), 30.3 (CH2). LRMS (m/z, ESI): 159.08 [M+-OMe], 
131.08 [M+-CO2Me]. 
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5-Phenylhept-5-en-2-one (E:Z = 1.3:1) .(4i)22 
Colorless oil. 1H NMR (300 MHz, CDCl3) 7.47 – 7.18 (m, 4.13H), 
7.14 (d, J = 7.2 Hz, 0.87H), 5.76 (q, J = 6.9 Hz, 0.57H), 5.58 
(q, J = 6.8 Hz, 0.43H), 2.79 (t, J = 7.8 Hz, 1.13H), 2.62 (t, 
J = 7.7 Hz, 0.87H), 2.42 (q, J = 8.1 Hz, 2H), 2.05 (s, 1.7H), 2.04 (s, 
1.3H), 1.81 (d, J = 6.9 Hz, 1.7H), 1.55 (d, J = 6.8 Hz, 1.3H). 13C NMR (75 
MHz, CDCl3) 208.0 (C), 142.2 (C), 139.9 (C), 139.9 (C), 139.1 (C), 128.3 
(CH), 128.1 (CH), 128.0 (CH), 126.5 (CH), 126.5 (CH), 126.0 (CH), 123.5 
(CH), 121.8 (CH), 42.2 (CH2), 41.9 (CH2), 33.0 (CH2), 29.7 (CH3), 29.7 
(CH3), 23.2 (CH2), 14.4 (CH3), 13.9 (CH3). LRMS (m/z, ESI): 211.11 [M+Na]+, 
171.1, 131.1, 105.1, 91.1. HRMS Calculated for C13H16NaO [M+Na]+: 211.1093, 
found 211.1091.  
Benzyl methyl(5-oxohex-1-en-2-yl)carbamate (4k)23 
Colorless oil. 1H NMR (250 MHz, CDCl3) 7.54 – 7.35 (m, 5H), 5.26 
(s, 2H), 5.03 – 5.01 (m, 2H), 3.21 (s, 3H), 2.77 – 2.58 (m, J = 
4.4 Hz, 4H), 2.19 (s, 3H). 13C NMR (63 MHz, CDCl3) 207.2 (C), 
154.6 (C), 148.3 (C), 136.2 (C), 128.2 (CH), 127.8 (CH), 127.7 (CH), 
109.3 (CH2), 67.0 (CH2), 40.9 (CH2), 36.8 (CH3), 29.5 (CH3), 28.1 (CH2). 
LRMS (m/z, ESI): 284.13 [M+Na]+, 284.13, 218.15, 192.03, 166.05, 141.00, 
91.06. HRMS Calculated for C15H19NNaO3 [M+Na]+: 284.1257, found 284.1249.  
3-(5-Oxohex-1-en-2-yl)oxazolidin-2-one (4l)24  
White solid. 1H NMR (300 MHz, CDCl3) δ 4.27 - 4.17 (m, 4H), 
3.65 (dd, J = 8.8, 7.1 Hz, 2H), 2.72 (t, J = 7.4 Hz, 2H), 
2.53 (t, J = 7.4 Hz, 2H), 2.00 (s, 3H). 13C NMR (75 MHz, 
CDCl3) δ 207.4 (C), 154.3 (C), 143.4 (C), 96.9 (CH2), 61.0 (CH2), 45.4 
(CH2), 42.3 (CH2), 29.5 (CH3), 26.6 (CH2). LRMS (m/z, ESI): 206.0 [M+Na]+, 
316.1, 268, 222, 97. HRMS (m/z, ESI) calculated for C9H13NNaO3 [M+Na]+: 
206.0788, found 206.0783. 
                                                          
22
 Prepared from 4-Phenylhex-4-enoic acid and MeLi in 38% yield (E:Z =1,1:1). See ref 7. 4-Phenylhex-
4-enoic acid (E:Z = 1.1:1) was prepared from ethyltriphenylphosphonium bromide and 4-oxo-4-
phenylbutanoic acid, in 86% yield using the procedure of reference 5. White powder. 1H NMR (300 
MHz, CDCl3) 11.4 (bs, 1H), 7.71 – 7.10 (m, 5H), 5.85 (q, J = 6.9 Hz, 0.5H), 5.67 (q, J = 6.8 Hz, 
0.5H), 2.96 – 2.88 (m, 1H), 2.73 (t, J = 7.7 Hz, 1H), 2.47 – 2.36 (m, 2H), 1.88 (d, J = 6.9 Hz, 
1.5H), 1.61 (d, J = 6.8 Hz, 1.5H). 13C NMR (75 MHz, CDCl3) 179.9 (C), 179.8 (C), 142.0 (C), 139.8 
(C), 139.5 (C), 138.6 (C), 128.5 (CH), 128.3 (CH), 128.1 (CH), 126.7 (CH), 126.7 (CH), 126.2 (CH), 
124.3 (CH), 122.4 (CH), 34.0 (CH2), 33.1 (CH2), 32.8 (CH2), 24.4 (CH2), 14.6 (CH3), 14.0 (CH3). LRMS 
(m/z, ESI): 191.11 (M+H)+, 201.05, 159.05, 131.09, 105.04. HRMS Calculated for C12H15O2: 191.1067, 
found 191.1061.  
23
 Prepared from 5-bromohex-5-en-2-one16 in 24% yield (unoptimized yield), according to a previously 
reported method: J. B. Feltenberger, R. Hayashi, Y. Tang, E. S. C. Babiash, R. P. Hsung, Org. Lett. 
2009, 11, 3666-3669. 
24
 Prepared from 5-bromohex-5-en-2-one16 in 84% yield, according to a previously reported method: J. B. 
Feltenberger, R. Hayashi, Y. Tang, E. S. C. Babiash, R. P. Hsung, Org. Lett. 2009, 11, 3666-3669. 
N
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6-Phenylhept-6-en-2-one (4m)25 
Colorless oil. 1H NMR (300 MHz, CDCl3) 7.45 – 7.20 (m, 5H), 
5.30 (s, 1H), 5.06 (s, 1H), 2.52 (t, J = 7.9 Hz, 2H), 2.44 
(t, J = 7.3 Hz, 2H), 2.10 (s, 3H), 1.74 (p, J = 7.4 Hz, 2H). 13C NMR (75 
MHz, CDCl3) 208.5 (C), 147.5 (C), 140.6 (C), 128.1 (CH), 127.2 (CH), 125.9 
(CH), 112.6 (CH2), 42.6 (CH2), 34.2 (CH2), 29.7 (CH3), 22.0 (CH2). LRMS 
(m/z, EI): 188 [M+, 98], 170 (53), 145 (73), 129 (99), 118 (80), 115 
(100), 103 (57), 91 (84), 77 (63). HRMS [M+], Calculated for C13H16O: 
188.1201, found 188.1200. 
1,5-Diphenylhex-5-en-1-one (4o)26 
Yellow solid. 1H NMR (300 MHz, CDCl3) δ 7.92 – 7.85 (m, 2H), 
7.56 – 7.36 (m, 5H), 7.35 – 7.19 (m, 3H), 5.30 (s, 1H), 5.08 
(d, J = 1.2 Hz, 1H), 2.96 (t, J = 7.3 Hz, 2H), 2.61 (t, J = 7.4 Hz, 2H), 
1.90 (p, J = 7.3 Hz, 2H).13C NMR (75 MHz, CDCl3) 200.1 (C), 147.8 (C), 
140.8 (C), 137.0 (C), 132.9 (CH), 128.5 (CH), 128.3 (CH), 128.0 (CH), 
127.4 (CH), 126.1 (CH), 112.9 (CH2), 37.7 (CH2), 34.6 (CH2), 22.7 (CH2). 
LRMS (m/z, EI): 250 [M+, 58], 250 (58), 232 (65), 206 (21), 145 (24), 130 
(82), 120 (94), 105 (100), 91 (64), 77 (98). HRMS [M+], Calculated for 
C18H18O: 250.1358, found 250.1360. MP: 64.5 ºC. 
6-Phenyloct-6-en-2-one (4p) (E:Z = 1:1)27  
 Colorless oil. 1H NMR (300 MHz, CDCl3) 7.36 – 7.26 (m, 3H), 
7.27 – 7.16 (m, 1H), 7.16 – 7.11 (m, 1H), 5.78 (q, J = 6.9 
Hz, 0.5H), 5.55 (qt, J = 6.7, 1.0 Hz, 0.5H), 2.56 – 2.47 
(m, 1H), 2.42 – 2.31 (m, 3H), 2.05 (s, 1.5H), 2.04 (s, 1.5H), 1.79 (d, J 
= 6.9 Hz, 1.5H), 1.70 – 1.50 (m, 3.5H). 13C NMR (75 MHz, CDCl3) 208.6 (C), 
208.4 (C), 142.7 (C), 140.6 (C), 140.3 (C), 139.9 (C), 128.2 (CH), 128.0 
                                                          
25
 Prepared from 5-phenylhex-5-enoic acid and MeLi in 72% yield, using the procedure in ref 7. 5-
phenylhex-5-enoic acid is a known compound and was prepared using the procedure in ref. 5. Its NMR 
data is in agreement to that previously described, see: a) Karila, D.; Leman, L.; Dodd, R. H. Org. 
Lett. 2011, 13, 5830–5833; b) X. Jiang, C. K. Tan, L. Zhou, Y.-Y. Yeung, Angew. Chem. Int. ed. 2012, 
51, 7771-7775. 
26
 Prepared from 5-phenylhex-5-enoic acid and PhLi in 33% yield, according to the procedure reported 
in ref. 7 See also ref. 25. 
27
 Prepared from 5-phenylhept-5-enoic acid and MeLi in 72% yield, according to the procedure reported 
in ref. 7 See also ref. 25. 5-Phenylhept-5-enoic acid (E:Z = 1:1) was prepared from 5-oxo-5-
phenylpentanoic acid and ethyltriphenylphosphonium bromide in 97% yield according to the procedure 
reported in ref. 5. 5-Phenylhept-5-enoic acid (E:Z = 1:1):Colorless oil. 1H NMR (300 MHz, CDCl3) 
11.67 (brs, 1.0H), 7.41 – 7.24 (m, 3.0H), 7.30 – 7.14 (m, 1.0H), 7.19 – 7.08 (m, 1.0H), 5.80 (q, J = 
6.9 Hz, 0.5H), 5.57 (q, J = 6.8 Hz, 0.5H), 2.58 (t, J = 7.4 Hz, 1.0H), 2.40 (t, J = 7.4 Hz, 1.0H), 
2.32 (td, J = 7.5, 4.3 Hz, 2.0H), 1.79 (d, J = 6.9 Hz, 1.5H), 1.75 – 1.59 (m, 2.0H), 1.57 (dt, J = 
6.9, 0.9 Hz, 1.5H). 13C NMR (75 MHz, CDCl3) 180.4 (C), 180.3 (C), 142.7 (C), 140.3 (C), 139.6 (C), 
128.4 (CH), 128.2 (CH), 128.1 (CH), 126.5 (CH), 126.5 (CH), 126.1 (CH), 123.8 (CH), 122.2 (CH), 38.2 
(CH2), 33.4 (CH2), 33.2 (CH2), 28.3 (CH2), 23.1 (CH2), 22.9 (CH2), 14.6 (CH3), 14.1 (CH3). LRMS (m/z, 
ESI): 205.12 [M+H]+, 187.11, 143.09, 117.07, 91.05. HRMS Calculated for C13H17O2: [M+H]+ 205.1223, 
found 205.1218. 
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(CH), 127.9 (CH), 126.3 (CH), 126.3 (CH), 126.0 (CH), 123.3 (CH), 121.7 
(CH), 42.6 (CH2), 38.1 (CH2), 29.6 (CH3), 28.1 (CH2), 22.2 (CH2), 22.1 
(CH2), 14.4 (CH3), 14.0 (CH3). LRMS (m/z, ESI): 225.13 (M+Na)+, 185.13, 
145.10, 117.07. HRMS Calculated for C14H18NaO: 225.1250, found 225.1248. 
1-Phenyl-2-(2-vinylphenyl)ethanone (4q)28  
 Yellow solid. 1H NMR (300 MHz, CDCl3) 8.06 (dd, J = 8.2, 1.1 
Hz, 2H), 7.66 – 7.54 (m, 2H), 7.55 – 7.43 (m, 2H), 7.38 – 
7.21 (m, 2H), 7.19 (dd, J = 7.2, 1.7 Hz, 1H), 6.89 (dd, J = 
17.3, 10.9 Hz, 1H), 5.69 (dd, J = 17.3, 1.2 Hz, 1H), 5.33 
(dd, J = 11.0, 1.3 Hz, 1H), 4.40 (s, 2H). 13C NMR (75 MHz, CDCl3) 197.1 
(C), 137.4 (C), 136.5 (C), 134.4 (CH), 133.1 (CH), 132.2 (C), 130.5 (CH), 
128.5 (CH), 128.2 (CH), 127.8 (CH), 127.3 (CH), 126.1 (CH), 116.4 (CH2), 
43.0 (CH2). LRMS (m/z, EI): 222 [M+, 20], 222 (20), 181 (9), 105 (100), 91 
(11), 77 (56). HRMS [M+], Calculated for C16H14O: 222.1045, found 222.1045. 
7-Phenyloct-7-en-2-one (4r)29 
Colorless oil. 1H NMR (300 MHz, CDCl3) 7.40 (d, J = 7.4 Hz, 
2H), 7.36 – 7.20 (m, 3H), 5.28 (s, 1H), 5.06 (s, 1H), 2.52 
(t, J = 7.4 Hz, 2H), 2.39 (t, J = 7.2 Hz, 2H), 2.08 (s, 3H), 
1.61 (p, J = 7.3 Hz, 2H), 1.46 (q, J = 7.9 Hz, 2H). 13C NMR (75 MHz, 
CDCl3) 208.6 (C), 147.9 (C), 140.9 (C), 128.1 (CH), 127.1 (CH), 125.9 
(CH), 112.2 (CH2), 43.2 (CH2), 34.9 (CH2), 29.5 (CH3), 27.4 (CH2), 23.2 
(CH2). LRMS (m/z, ESI): 225.12 [M+Na]+, 185.13, 143.09, 129.07, 105.07, 
91.05. HRMS Calculated for C14H18NaO [M+Na]+: 225.1250, found 225.1240.  
4-Methyl-N-(5-phenylpent-4-en-1-yl)-N-(prop-1-en-1-yl)benzenesulfonamide 
(4s)30  
Yellow oil. 1H NMR (300 MHz, CDCl3) δ 7.73 – 7.62 (m, 
2H), 7.42 – 7.17 (m, 7H), 6.59 – 6.41 (m, 2H), 5.66 
(dt, J = 11.6, 7.2 Hz, 1H), 4.95-4.93 (m, 1H), 3.29 
(t, J = 7.5 Hz, 2H), 2.43 (s, 3H), 2.40-2.34 (m, 2H), 1.88 – 1.72 (m, 
                                                          
28
 Prepared from 2-bromostyrene and acetophenone in 38% yield, according to a previously reported 
procedure, see: Viciu, M. S.; Germaneau, R. F.; Nolan, S. P. Org. Lett. 2002, 4, 4053–4056. 
29
 Prepared from 6-phenylhept-6-enoic acid and MeLi in 68% yield, according to the procedure of ref 7. 
6-Phenylhept-6-enoic acid was prepared from methyltriphenylphosphonium bromide and 5-
benzoylpentanoic acid according to the procedure in ref 5. The NMR spectal data of 6-phenylhept-6-
enoic acid is in agreement with that previously described, see: Karila, D.; Leman, L.; Dodd, R. H. 
Org. Lett. 2011, 13, 5830–5833. 
30
 4-Methyl-N-(5-phenylpent-4-en-1-yl)-N-(prop-1-en-1-yl)benzenesulfonamide was prepared in 98% yield 
from 1-bromo-1-propene (E : Z mixture) and 4-methyl-N-(5-phenylpent-4-enyl)benzenesulfonamide, 
according to a previously reported procedure, see: R. Hayashi, R. P. Hsung, J. B. Feltenberger, A. 
G. Lohse, Org. Lett. 2009, 11, 2125–2128. 4-Methyl-N-(5-phenylpent-4-enyl)benzenesulfonamide is a 
known compound and was synthesized according to a previously reported procedure, see: J. B. 
Feltenberger, R. Hayashi, Y. Tang, E. S. C. Babiash, R. P. Hsung, Org. Lett. 2009, 11, 3666–7. 
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2H), 1.70 (dd, J = 6.6, 1.2 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 143.3 (C), 
137.3 (C), 136.1 (C), 131.2 (CH), 129.7 (CH), 129.6 (CH), 128.6 (CH), 
128.1 (CH), 126.8 (CH), 126.6 (CH), 126.3 (CH), 107.9 (CH), 45.3 (CH2), 
27.3 (CH2), 25.7 (CH2), 21.4 (CH3), 15.3 (CH3). LRMS (m/z, ESI): 378.15 
[M+Na]+, 226.09, 201.15, 172.11, 144.09, 110.10. HRMS Calculated for 
C21H25NNaO2S [M+Na]+: 378.1498, found 378.1494. 
 
Preliminary results between 1a and bisalkenes 4a or 4s 
 
Representative procedure (exemplified for the reaction between 1a and 4a, 
Table S1, entry 1) 
To a cooled solution (-15 °C) of 4a (68.8 mg, 0.40 mmol), and 
catalyst E (0.02 mmol) in CH2Cl2 (3 mL), in dried Schlenk tube, was slowly 
added a solution of allenamide 1a (50.0 mg, 0.40 mmol) in CH2Cl2 (1 mL), 
over 1 hour. The mixture was stirred at -15 °C for 5 min and filtered 
through a short pad of florisil®, eluting with Et2O. The solvent was 
evaporated and the crude was chromatographed in hexanes/EtOAc 10-50% 
affording 7a in 38% yield 
Table S1. Preliminary results with 4a. 
 
Entry [Au] (%) T (ºC) Time of addition 3aa, yield (%) 7a, yield (%)
1 E (5%) -15 1h - 38% 
2 E (5%)  rt 2h - 42% 
3 C (5%) -15 1h 43% - 
 
(Z)-3-((2-(2-(3-Methylbut-2-en-1-yl)phenyl)cyclobutylidene)methyl) oxazo 
lidin-2-one (3aa) 
Colorless oil. 1H NMR (300 MHz, CDCl3) δ 7.41 (d, J = 6.8 
Hz, 1H), 7.30 – 7.07 (m, 3H), 6.53 – 6.42 (m, 1H), 5.16 (t, 
J = 6.9 Hz, 1H), 4.58–4.45 (m, 1H), 4.21–4.08 (m, 1H), 4.02 
(q, J = 8.6 Hz, 1H), 3.53 (q, J = 8.8 Hz, 1H), 3.35 – 3.15 
(m, 3H), 2.96–2.81 (m, 1H), 2.81–2.52 (m, 2H), 1.81 (h, J = 
5.1 Hz, 1H), 1.74 (s, 6H). 13C NMR (75 MHz, CDCl3) δ 156.1 (C), 142.1 (C), 
O N
O
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138.2 (C), 132.5 (C), 129.3 (CH), 126.6 (CH), 126.6 (CH), 126.5 (CH), 
123.6 (C), 122.7 (CH), 117.3 (CH), 62.0 (CH2), 43.5 (CH2), 43.2 (CH), 31.7 
(CH2), 27.7 (CH2), 26.1 (CH2), 25.7 (CH3), 17.8 (CH3). LRMS (m/z, ESI): 
298.18 [M+Na]+, 211.15, 155.09, 126.06, 100.04. HRMS Calculated for 
C19H24NO2 [M+Na]+: 298.1802, found 298.1801 
(Z)-3-((3-Methylene-2-(2-oxooxazolidin-3-yl)cyclobutylidene) methyl) 
oxazolidin-2-one (7a)31 
White solid. 1H NMR (250 MHz, CDCl3) δ 6.60 (q, J = 2.2 Hz, 
1H), 5.61 (dt, J = 4.9, 2.4 Hz, 1H), 5.25 – 5.05 (m, 2H), 
4.44 – 4.27 (m, 4H), 3.91 – 3.66 (m, 2H), 3.62 (q, J = 8.7 
Hz, 1H), 3.48 (q, J = 8.3 Hz, 1H), 3.32 – 3.19 (m, 2H). 13C 
NMR (63 MHz, CDCl3) δ 157.4 (C), 156.2 (C), 142.6 (C), 121.1 
(CH), 115.4 (C), 111.0 (CH2), 62.5 (CH2), 62.3 (CH2), 58.0 
(CH), 43.8 (CH2), 40.0 (CH2), 35.3 (CH2). LRMS (m/z, CI): 251 [M+ +1, 52], 
207 (9), 180 (15), 88 (100). HRMS calculated for C12H15N2O4 [M+H]+: 
251.1032, found 251.1033. MP: 129ºC. The structure of 7a was confirmed by 
X-ray analysis (Figure S1). 
 
Figure S1: X-Ray structure of 7a.32 
Table S2. Preliminary results with 4s 
 
Entry [Au](%) T (ºC) 3as, yield (%)
1 C, (5%) -15 74 
2 E, (5%) -15 67 
                                                          
31
 Previously described in: Faustino, H.; Bernal, P.; Castedo, L.; López, F.; Mascareñas, J. L. Adv. 
Synth. Cat. 2012, 354, 1658–1664. 
32
 Deposited at the Cambridge Crystallographic Data Centre with the number CCDC 863035. 
www.ccdc.cam.ac.uk/data_request/cif 
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4-Methyl-N-((Z)-2-methyl-4-((2-oxooxazolidin-3-yl)methylene)cyclobutyl)-
N-((Z)-5-phenylpent-4-en-1-yl)benzenesulfonamide (3as)  
White solid. 1H NMR (300 MHz, CDCl3) 7.67 (d, J = 8.3 
Hz, 2H), 7.40 – 7.11 (m, 7H), 6.51 – 6.36 (m, 2H), 
5.60 (dt, J = 11.6, 7.1 Hz, 1H), 4.65 (p, J = 3.0 Hz, 
1H), 4.38 – 4.19 (m, 2H), 3.81 (dd, J = 9.3, 7.8 Hz, 
1H), 3.38 – 3.22 (m, 1H), 3.16 – 2.99 (m, 1H), 2.78 – 2.59 (m, 1H), 2.41 
(s, 3H), 2.33 (qd, J = 7.2, 1.7 Hz, 2H), 2.25 – 2.03 (m, 1H), 1.98 – 1.65 
(m, 4H), 0.85 (d, J = 6.8 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 156.1 (C), 
143.5 (C), 137.6 (C), 137.3 (C), 131.1 (CH), 129.9 (CH), 129.6 (CH), 
128.7 (CH), 128.1 (CH), 127.1 (CH), 126.6 (CH), 121.1 (CH), 116.9 (C), 
63.4 (CH), 62.5 (CH2), 45.4 (CH2), 44.5 (CH2), 32.6 (CH), 32.3 (CH2), 31.0 
(CH2), 26.1 (CH2), 21.4 (CH3), 20.1 (CH3). LRMS (m/z, ESI): 503.20 [M+Na]+, 
480.08, 439.24. HRMS Calculated for C27H32N2NaO4S [M+Na]+: 503.1975, found 
503.1975. MP: 133ºC. 
 
Representative procedure for the racemic cascade cycloaddition. 
(Exemplified for the reaction between 1a and 4b, Table 1, entry 8, main 
manuscript). 
A solution of the gold complex E (19.2 mg, 0.016 mmol) in CH2Cl2 (10.0 mL) 
was placed at -15 °C in a dried Schlenk tube containing 200 mg of 4Å MS 
Then, 5-phenylhex-5-en-2-one (4b, 416 mg, 2.40 mmol) and 3-(propa-1,2-
dienyl)oxazolidin-2-one (1a, 200 mg, 1.60 mmol) were successively added. 
The mixture was stirred at -15 °C for 5 min (the progress of the reaction 
was easily monitored by tlc) and filtered through a short pad of 
florisil, eluting with Et2O, to provide a crude mixture which was purified 
on column chromatography (hexanes/EtOAc, 10-50%) to give 416 mg of (Z)-
6ab (87 % yield). 
3-((Z)-((1S*,5S*)-1-Methyl-5-phenyl-8-oxabicyclo[3.2.1]octan-2-ylidene)me 
thyl)oxazolidin-2-one ((Z)-6ab)  
White solid, 87% yield. 1H NMR (250 MHz, CDCl3) δ 7.46 – 
7.15 (m, 5H), 5.46 (d, J = 1.9 Hz, 1H), 4.54 – 4.27 (m, 
2H), 3.67 (t, J = 8.1 Hz, 2H), 2.78 – 2.55 (m, 1H), 2.44 
– 2.24 (m, 3H), 2.20 – 2.07 (m, 1H), 2.07 – 1.80 (m, 
3H), 1.72 (s, 3H). 13C NMR (63 MHz, CDCl3) δ 157.5 (C), 146.4 (C), 143.7 
(C), 128.0 (CH), 126.5 (CH), 124.2 (CH), 114.8 (CH), 83.7 (C), 82.52 (C), 
61.9 (CH2), 47.4 (CH2), 39.0 (CH2), 38.4 (CH2), 37.2 (CH2), 27.2 (CH2), 23.8 
(CH3). LRMS (m/z, CI): 300 [M+ +1, 10], 282 (91), 256 (23), 212 (42), 195 
(100), 169 (24), 88 (14). HRMS Calculated for C18H22NO3 [M+H]+: 300.1600, 
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found 300.1605. MP: 170ºC. The structure of (Z)-6ab was confirmed by X-
ray analysis (Figure S2). 
 
Figure S2. X-Ray structure of (Z)-6ab 33 
3-((Z)-((1R*,5S*)-1,5-Diphenyl-8-oxabicyclo[3.2.1]octan-2-ylidene)methyl) 
oxazolidin-2-one ((Z)-6ac) 
White solid. 86% yield. 1H NMR (300 MHz, CDCl3) δ 7.68 – 
7.55 (m, 2H), 7.50 – 7.40 (m, 2H), 7.41 – 7.26 (m, 5H), 
7.29 – 7.17 (m, 1H), 5.50 (d, J = 1.6 Hz, 1H), 3.88 – 
3.75 (m, 1H), 3.28 – 3.07 (m, 2H), 2.92 – 2.70 (m, 2H), 
2.70–2.58 (m, 1H), 2.54 – 2.41 (m, 2H), 2.36 (dd, J = 12.5, 5.0 Hz, 1H), 
2.23–1.94 (m, 3H). 13C NMR (75 MHz, CDCl3) δ 156.6 (C), 146.1 (C), 144.5 
(C), 143.9 (C), 128.0 (CH), 127.2 (CH), 126.9 (CH), 126.5 (CH), 125.9 
(CH), 124.3 (CH), 115.7 (CH), 85.1 (C), 83.9 (C), 61.8 (CH2), 46.8 (CH2), 
39.7 (CH2), 37.8 (CH2), 36.6 (CH2), 27.7 (CH2). LRMS (ESI): 362.1 [M+Na]+, 
384.1, 344.1, 179. HRMS Calculated for C23H24NO3 [M+Na]+, 362.1751, found 
362.1745. mp 153ºC. 
3-((Z)-((1S*,5S*)-5-Phenyl-8-oxabicyclo[3.2.1]octan-2-ylidene)methyl)oxa 
zolidin-2-one ((Z)-6ad) 
White solid. 90% yield. 1H NMR (300 MHz, CDCl3) δ 7.36 – 
7.19 (m, 4H), 7.22 – 7.10 (m, 1H), 5.74 (d, J = 2.2 Hz, 
1H), 5.10 (d, J = 7.1 Hz, 1H), 4.39 – 4.27 (m, 2H), 
3.90 – 3.70 (m, 2H), 2.65 – 2.48 (m, 1H), 2.38 – 2.13 
(m, 3H), 2.06 – 1.90 (m, 2H), 1.89 – 1.72 (m, 2H).13C NMR (75 MHz, CDCl3) 
δ 157.2 (C), 146.1 (C), 130.6 (C), 128.1 (CH), 126.7 (CH), 124.4 (CH), 
115.7 (CH), 83.9 (C), 74.2 (CH), 62.0 (CH2), 46.8 (CH2), 40.2 (CH2), 35.1 
(CH2), 30.4 (CH2), 25.2 (CH2). LRMS (m/z, ESI): 308.1 [M+Na]+,268.1, 181.1, 
100 . HRMS Calculated for C17H19NNaO3 [M+Na]+, 308.1257, found 308.1257. MP 
155ºC 
                                                          
33
 CCDC 917326 (6ab) contains the crystallographic data for this paper, which can be obtained from the 
CCDC via www.ccdc.cam.ac.uk/data_request/cif.  
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3-((Z)-((1S*,5S*)-1-Methoxy-5-phenyl-8-oxabicyclo[3.2.1]octan-2-ylidene) 
methyl)oxazolidin-2-one ((Z)-6ae) 
White solid. 75% yield 1H NMR (300 MHz, CDCl3) δ 7.35-
7.22 (m, 4H), 7.18 (d, J = 6.3 Hz, 1H), 6.07 (s, 1H), 
4.29 (t, J = 7.9 Hz, 2H), 4.12 (q, J = 7.7 Hz, 1H), 3.71 
(q, J = 8.5 Hz, 1H), 3.43 (s, 3H), 2.52 - 2.35 (m, 2H), 
2.23 - 1.96 (m, 4H), 1.91 - 1.79 (m, 2H).13C NMR (75 MHz, CDCl3) δ 157.9 
(C), 146.6 (C), 128.5 (C), 128.3 (CH), 126.8 (CH), 124 (CH), 117.2 (CH), 
107.2 (C), 82.5 (C), 62.7 (CH2), 51.3 (CH3), 47.2 (CH2), 38.8 (CH2), 36.2 
(CH2), 34.7 (CH2), 28.1 (CH2). LRMS (m/z, ESI): 338.1 [M+Na]+, 316.1, 
298.1, 266.1, 240.1, 211.1, 126. HRMS (m/z, ESI) calculated for C18H21NNaO4 
[M+Na]+ 338.1363, found 338.1367. MP: 62ºC. 
(Z)-Methyl 3-(2-((2-oxooxazolidin-3-yl)methylene)-1-phenylcyclobutyl)pro 
panoate ((Z)-3ae) 
Yellow oil. 14% yield. 1H NMR (300 MHz, CDCl3) δ 7.45-7.30 
(m, 4H), 7.27 - 7.20 (m, 1H), 6.46 (s, 1H), 4.17 (td, J = 
8.8, 6.4 Hz, 1H), 4.07 - 3.96 (m, 1H), 3.70 (s, 3H), 3.42 
(q, J = 8.9 Hz, 1H), 3.01 (td, J = 8.9, 6.4 Hz, 1H), 2.70-
2.62 (m, 4H), 2.49-2.37 (m, 1H),2.27-2.06 (m, 3H). 13C NMR 
(63 MHz, CDCl3) δ 174.1 (C), 156.3 (C), 147.7 (C), 128.7 (CH), 126.6 (CH), 
125.7 (C), 125.6 (CH), 118.4 (CH), 62.0 (CH2), 52.7 (C), 51.8 (CH3), 44.9 
(CH2), 33.7 (CH2), 32.5 (CH2), 30.4 (CH2), 24.6 (CH2). LRMS (m/z, ESI): 
338.1 [M+Na]+, 243.1, 197, 155, 126. HRMS (m/z, ESI) calculated for 
C18H21NNaO4 [M+Na]+ 338.1363, found 338.1365. 
3-((Z)-((5S*,9S*)-5-Methyl-5,7,8,9-tetrahydro-6H-5,9-epoxybenzo[7]annu 
len-6-ylidene)methyl)oxazolidin-2-one ((Z)-6af)34  
White solid. 41% yield, Z:E = 9:1. 1H NMR (500 MHz, CDCl3) 
δ 7.42 (d, J = 6.8 Hz, 1H), 7.30 – 7.23 (m, 2H), 7.19 (d, 
J = 6.7 Hz, 1H), 5.34 (d, J = 2.0 Hz, 1H), 5.28 (d, J = 
3.3 Hz, 1H), 4.40 (td, J = 8.5, 8.0, 4.4 Hz, 2H), 3.69 (t, 
J = 8.0 Hz, 2H), 2.22 – 2.11 (m, 1H), 2.04 (dd, J = 15.6, 
                                                          
34
 a) Purified by column chromatography on silica gel using 2% Et3N / hexanes to avoid a Z/E 
isomerization of the exo-enamide moiety. b) We could demonstrate that, for this particular case, a 
complete Z to E isomerization can be performed by treatment of a solution of (Z)-6af in Et2O/hexanes 
(1:1) with silica gel, at rt, during 2h.Therefore, the E-isomer could be fully characterized by NMR: 
(E)-6af. White solid. 1H NMR (300 MHz, CDCl3) δ 7.31 – 7.17 (m, 3H), 7.13 – 7.03 (m, 1H), 6.32 (d, J 
= 1.8 Hz, 1H), 5.27 (d, J = 3.0 Hz, 1H), 4.41 – 4.27 (m, 2H), 3.87 (td, J = 8.7, 7.1 Hz, 1H), 3.70 
(td, J = 8.7, 7.2 Hz, 1H), 2.49 – 2.36 (m, 1H), 2.25 – 2.08 (m, 1H), 1.76 (s, 3H), 1.71 – 1.58 (m, 
2H). 13C NMR (75 MHz, CDCl3) δ 157.1 (C), 145.8 (C), 142.7 (C), 129.0 (C), 127.6 (CH), 127.5 (CH), 
120.2 (CH), 119.5 (CH), 116.4 (CH), 84.2 (C), 78.4 (CH), 62.2 (CH2), 46.2 (CH2), 29.3 (CH2), 20.1 
(CH2), 20.0 (CH3). LRMS (m/z, EI): 271 [M+, 18], 229 (23), 184 (35), 145 (76), 142 (95), 141 (100), 
128 (32), 101 (63), 88 (19). HRMS [M+], Calculated for C16H17NO3: 271.1208, found 271.1205. nOe (5%) 
between the olefinic hydrogen [6.32 (d, J = 1.8 Hz, 1H)] and the methyl group at C-5 [1.76 (s, 3H)], 
indicates that the product has the E configuration (Figure S3). 
OPh OMe
N
O
O
N O
O
MeO
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6.1 Hz, 1H), 1.94 – 1.86 (m, 1H), 1.86 (s, 3H), 1.63 (dd, J = 12.8, 6.6 
Hz, 1H). 13C NMR (75 MHz, CDCl3) δ 157.5 (C), 145.3 (C), 142.2 (C), 140.8 
(C), 127.9 (CH), 127.7 (CH), 120.9 (CH), 119.9 (CH), 115.7 (CH), 84.7 
(C), 78.6 (CH), 61.9 (CH2), 47.4 (CH2), 30.0 (CH2), 25.7 (CH2), 20.9 (CH3). 
LRMS (m/z, EI): 271 [M+, 15], 243 (12), 229 (15), 184 (37), 145 (94), 142 
(97), 141 (100), 101 (65), 88 (17). HRMS Calculated for C16H17NO3 [M]+: 
271.1208, found 271.1205. The Z configuration was determined with nOe 
experiments (Figure S3) 
 
Figure S3. Significant nOe’s observed for (Z)-6af and (E)-6af.34b 
3-((Z)-((5S*,9S*)-5,9-Dimethyl-5,7,8,9-tetrahydro-6H-5,9-epoxybenzo[7] 
annulen-6-ylidene)methyl)oxazolidin-2-one ((Z)-6ag)  
White solid. 65% yield, Z:E = 10:1. 1H NMR (300 MHz, 
CDCl3) δ 7.40 (dd, J = 5.4, 3.1 Hz, 1H), 7.33 – 7.20 (m, 
2H), 7.07 (dd, J = 5.4, 3.0 Hz, 1H), 5.36 (d, J = 2.2 
Hz, 1H), 4.46 – 4.33 (m, 2H), 3.69 (t, J = 8.0 Hz, 2H), 
2.11 – 2.00 (m, 1H), 1.91 (dd, J = 11.5, 5.1 Hz, 1H), 
1.86  (s, 3H), 1.85 – 1.78 (m, 1H), 1.65 (d, J = 1.9 
Hz, 1H), 1.62 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 157.5 (C), 145.7 (C), 
144.8 (C), 140.3 (C), 127.8 (CH), 120.9 (CH), 119.2 (CH), 115.7 (CH), 
84.0 (C), 82.9 (C), 61.9 (CH2), 47.4 (CH2), 36.1 (CH2), 27.3 (CH2), 23.3 
(CH3), 21.0 (CH3). LRMS (m/z, ESI): 286.14 [M+H]+, 268.13, 181.10, 143.09. 
HRMS Calculated for C17H20NO3 [M+H]+: 286.1438, found 286.1436. MP: 148ºC. 
3-((Z)-((3aS*,7S*)-7-Phenylhexahydro-1H-3a,7-epoxyazulen-4(5H)-ylidene) 
methyl)oxazolidin-2-one ((Z)-6ah) 
White solid. 51% yield. 1H NMR (250 MHz, CDCl3) δ 7.38 - 
7.06 (m, 5H), 5.50 (d, J = 2.1 Hz, 1H), 4.40 - 4.20 (m, 
2H), 3.77 - 3.48 (m, 2H), 2.76 - 2.44 (m, 3H), 2.27 (ddd, 
J = 14.8, 6.2, 1.9 Hz, 1H), 2.14 - 1.51 (m, 8H), 1.29 
(dd, J = 11.8, 5.6 Hz, 1H).13C NMR (63 MHz, CDCl3) δ 158.2 
(C), 146 (C), 143.1 (C), 128.2 (CH), 126.8 (CH), 124.4 (CH), 114.9 (CH), 
93.1 (C), 84.9 (C), 62.3 (CH2), 48.5 (CH2), 48.4 (CH2), 48 (CH), 39.3 
(CH2), 34 (CH2), 33.9 (CH2), 28.9 (CH2), 24.9 (CH2). LRMS (m/z, ESI) 348.16 
[M+Na]+, 308.16, 221.13, 193.10, 126.06, 100.04, HRMS (m/z, ESI) 
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calculated for C
20
H
23
NNaO
3 
[M+Na]+ 348.1570, found 348.1577. MP: 127ºC. The 
structure of (Z)-6ah was confirmed by X-ray analysis (Figure S4). 
 
Figure S4. X-Ray structure of (Z)-6ah.35 
3-((Z)-((1S*,4S*,5R*)-1,4-Dimethyl-5-phenyl-8-oxabicyclo[3.2.1]octan-2-
ylidene)methyl)oxazolidin-2-one ((Z)-6ai) 
White solid. 77% yield. 1H NMR (250 MHz, CDCl3) δ  7.37 – 
7.10 (m, 5H), 5.39 (d, J = 2.2 Hz, 1H), 4.48 – 4.26 (m, 
2H), 3.75 – 3.56 (m, 2H), 2.90 (ddd, J = 15.1, 6.0, 2.3 
Hz, 1H), 2.40 (ddd, J = 12.0, 9.6, 5.3 Hz, 1H), 2.29–2.16 
(m, 1H), 2.15–1.92 (m, 3H), 1.83 (td, J = 12.3, 5.2 Hz, 1H), 1.71 (s, 
3H), 0.68 (d, J = 6.8 Hz, 3H). 13C NMR (63 MHz, CDCl3) δ 157.5 (C), 145.5 
(C), 142.2 (C), 127.9 (CH), 126.1 (CH), 124.4 (CH), 115.3 (CH), 86.0 (C), 
83.0 (C), 61.9 (CH2), 47.5 (CH2), 39.5 (CH), 39.1 (CH2), 38.0 (CH2), 34.8 
(CH2), 23.6 (CH3), 15.2 (CH3). LRMS (ESI): 336.16 [M+Na]+, 296,2, 209.1, 
181.1. HRMS Calculated for C19H23NNaO3 [M+Na]+: 336.1570, found 336.1560. 
MP: 116ºC. The structure of (Z)-6ai was confirmed by X-ray analysis 
(Figure S5). 
 
Figure S5. X-Ray structure of (Z)-6ai.36 
                                                          
35
 CCDC 930627 (6ah)contains the crystallographic data for this paper, which can be obtained from the 
CCDC via www.ccdc.cam.ac.uk/data_request/cif 
36
 CCDC 917327 (6ai) contains the crystallographic data for this paper, which can be obtained from the 
CCDC via www.ccdc.cam.ac.uk/data_request/cif 
OPh Me
N O
O
Me
S15 
 
3-((Z)-((1S*,5S*)-1,5-Dimethyl-8-oxabicyclo[3.2.1]octan-2-ylidene)methyl) 
oxazolidin-2-one ((Z)-6aj) 
Colourless oil. 63% yield. 1H NMR (300 MHz, CDCl3) δ 5.39 
(d, J = 2.1 Hz, 1H), 4.38 – 4.27 (m, 2H), 3.67 – 3.54 
(m, 2H), 2.54 – 2.40 (m, 1H), 2.26 – 2.09 (m, 2H), 1.93 
– 1.70 (m, 4H), 1.65 (dd, J = 11.7, 6.3 Hz, 1H), 1.58 
(s, 3H), 1.32 (s, 3H). 13C NMR (75 MHz, CDCl3) 157.5 (C), 144.4 (C), 114.7 
(CH), 82.4 (C), 80.5 (C), 61.9 (CH2), 47.5 (CH2), 38.8 (CH2), 38.0 (CH2), 
36.9 (CH2), 27.2 (CH2), 26.6 (CH3), 23.9 (CH3). LRMS (m/z, ESI): 260.13 
[M+Na]+, 260.13, 133.10, 105.07. HRMS Calculated for C13H19NNaO3 [M+Na]+: 
260.1257, found 260.1253. MP: 96ºC. 
Benzyl methyl((1S*,5S*,Z)-5-methyl-4-((2-oxooxazolidin-3-yl)methylene)-8-
oxabicyclo[3.2.1]octan-1-yl)carbamate ((Z)-6ak)  
White solid. 65% yield. 1H NMR (250 MHz, CDCl3) δ  
7.41 – 7.25 (m, 5H), 5.41 (d, J = 1.3 Hz, 1H), 5.10 
(s, 2H), 4.41 – 4.27 (m, 2H), 3.67 – 3.57 (m, 2H), 
2.97 (s, 3H), 2.65 – 2.39 (m, 2H), 2.35-2.25 (m, 1H), 
2.21 – 2.00 (m, 3H), 1.92 – 1.69 (m, 2H), 1.60 (s, 3H). 13C NMR (63 MHz, 
CDCl3) 157.4 (C), 155.0 (C), 143.0 (C), 136.6 (C), 128.4 (CH), 127.9 (CH), 
127.8 (CH), 115.5 (CH), 94.1 (C), 82.6 (C), 66.8 (CH2), 61.9 (CH2), 47.4 
(CH2), 37.3 (CH2), 37.2 (CH2), 33.6 (CH2), 30.0 (CH3), 27.2 (CH2), 23.7 
(CH3). LRMS (m/z, ESI): 409.17 [M+Na]+, 369.18, 325.19. HRMS Calculated 
for C21H26N2NaO5 [M+Na]+: 409.1734, found 409.1723. 
3-((1S*,5S*,Z)-5-Methyl-4-((2-oxooxazolidin-3-yl)methylene)-8-oxabicyclo 
[3.2.1]octan-1-yl)oxazolidin-2-one ((Z)-6al)  
White solid. 75% yield. 1H NMR (300 MHz, CDCl3) δ 5.43 
(d, J = 1.7 Hz, 1H), 4.49 – 4.41 (m, 1H), 4.40 – 4.23 
(m, 3H), 3.74 – 3.65 (m, 2H), 3.65 – 3.57 (m, 2H), 
2.66 – 2.50 (m, 1H), 2.42 – 2.29 (m, 3H), 2.27 – 2.12 
(m, 2H), 2.04 – 1.82 (m, 2H), 1.61 (s, 3H). 13C NMR (75 
MHz, CDCl3) δ 157.4 (C), 156.5 (C), 142.1 (C), 115.9 (CH), 92.8 (C), 82.9 
(C), 62.1 (CH2), 62.0 (CH2), 47.4 (CH2), 42.6 (CH2), 37.3 (CH2), 33.7 (CH2), 
33.2 (CH2), 26.8 (CH2), 23.5 (CH3). LRMS (m/z, ESI): 331.13 [M+Na]+, 
291.13, 222.11, 204.10, 160.11, 135,08, 105,05 . HRMS Calculated for 
C15H20N2NaO5 [M+Na]+: 331.1264, found 331.1266. 
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3-((Z)-(1S*, 3S*, 5R*)-1,3-Dimethyl-5-phenyl-8-oxabicyclo[3.2.1]octan-2-
yli dene)methyl)oxazolidin-2-one ((Z)-6bb, major isomer) 37  
White solid. 1H NMR (300 MHz, CDCl3) δ 7.40 (dd, J = 
8.4, 1.4 Hz, 2H), 7.38 – 7.27 (m, 2H), 7.28 – 7.15 (m, 
1H), 5.55 (d, J = 2.3 Hz, 1H), 4.46 – 4.35 (m, 2H), 3.72 
(q, J = 8.5 Hz, 1H), 3.68 – 3.54 (m, 1H), 2.89 – 2.61 
(m, 1H), 2.42 – 2.24 (m, 2H), 2.20 – 1.97 (m, 2H), 1.96 – 1.77 (m, 1H), 
1.68 (s, 3H), 1.65 – 1.54 (m, 1H), 1.10 (d, J = 6.6 Hz, 3H). 13C NMR (75 
MHz, CDCl3) δ 158.2 (C), 154.8 (C), 148.4 (C), 128.2 (CH), 126.3 (CH), 
123.8 (CH), 115.6 (CH), 82.4 (C), 81.4 (C), 62.1 (CH2), 48.5 (CH2), 46.9 
(CH2), 41.2 (CH2), 38.8 (CH2), 29.4 (CH3), 23.9 (CH), 17.2 (CH3). MP: 
126ºC. LRMS (m/z, ESI): 336.15 [M+Na]+, 296.16, 209.13, 157.10 HRMS 
Calculated for C19H23NNaO3 [M+Na]+: 336.1570, found 336.1566. 
 
Figure S6. Significant nOe’s of 6bb. 
3-((Z)-((1S*, 3R*, 5R*)-1,3-Dimethyl-5-phenyl-8-oxabicyclo[3.2.1]octan-2-
yli dene) methyl)oxazolidin-2-one ((Z)-6bb, minor isomer)  
White solid. 1H NMR (300 MHz, CDCl3) δ7.44 – 7.37 (m, 
2H), 7.32 (t, J = 7.6 Hz, 2H), 7.25 – 7.17 (m, 1H), 
5.45 (d, J = 2.2 Hz, 1H), 4.44 – 4.26 (m, 2H), 3.81 – 
3.57 (m, 2H), 2.84 – 2.69 (m, 1H), 2.45 – 2.20 (m, 2H), 
2.19 – 1.98 (m, 2H), 1.99 – 1.76 (m, 1H), 1.73 (s, 3H), 1.60 – 1.53 (m, 
1H), 1.16 (d, J = 6.5 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 157.5 (C), 148.2 
(C), 146.2 (C), 128.1 (CH), 126.6 (CH), 124.4 (CH), 114.8 (CH), 83.9 (C), 
82.8 (C), 61.9 (CH2), 48.5 (CH2), 47.7 (CH2), 38.7 (CH2), 37.6 (CH2), 30.4 
(CH3), 24.6 (CH), 18.8 (CH3), LRMS (m/z, ESI): 314.17 [M+H]+, 336.15, 
296.16, 209.13, 157.10, 140.07, HRMS Calculated for C19H24NO3 [M+H]+: 
314.1751, found 314.1754. 
 
                                                          
37
 a) This cycloaddition provides a 3:1 mixture of diastereoisomers at the α-enamide position (C-3) 
that could be separated by flash chromatography. b) nOe between the hydrogen at C-3 [2.89 – 2.61 (m, 
1H)] and some of the hydrogens of the phenyl group at C-5, unequivocally confirmed the proposed 
configuration for the major diastereoisomer (Figure S6). These nOes are not observed in the minor 
isomer. 
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4-Methyl-N-(((1S,5S)-1-methyl-5-phenyl-8-oxabicyclo[3.2.1]octan-2-ylide 
ne)methyl)-N-phenylbenzenesulfonamide (Z:E = 2.6:1)  
1H NMR (300 MHz, CDCl3) δ 7.42 (d, J = 8.3 Hz, 1H), 7.34 - 
6.99 (m, 13H), 6.11 (d, J = 2.4 Hz, 0.72H), 5.62 - 5.58 
(m, 0.28H), 2.68 - 2.44 (m, 1H), 2.34 (s, 3H), 2.26 - 
1.66 (m, 7H), 1.52 (s, 3H).13C NMR (75 MHz, CDCl3) δ 146.7 
(C), 146.4 (C), 146.2 (C), 143.7 (C), 141.8 (C), 141.5 (C), 141.4 (C), 
134.8 (C), 133.5 (C), 129.4 (CH), 129.2 (CH), 128.9 (CH), 128.7 (CH), 
128.0 (CH), 127.9 (CH), 127.7 (CH), 126.7 (CH), 126.7 (CH), 126.5 (CH), 
126.5 (CH), 125.4 (CH), 124.4 (CH), 124.3 (CH), 118.5 (CH), 117.1 (CH), 
84.1 (C), 83.3 (C), 82.9 (C), 81.3 (C), 39.0 (CH2), 38.7 (CH2), 38.4 
(CH2), 37.9 (CH2), 37.7 (CH2), 36.5 (CH2), 27.4 (CH2), 25.3 (CH3), 22.9 
(CH3), 21.7 (CH2), 21.5 (CH3). LRMS (m/z, ESI): 460.1 [M+Na]+, 442.18, 
287.16, 260.07, 195.11, 155.01, HRMS (m/z, ESI) calculated for C28H30NO3S 
[M+Na]+: 460.1941, found 460.1928.  MP: 64ºC. 
3-((Z)-((1S*,5R*)-1-Methyl-5-phenyl-9-oxabicyclo[3.3.1]nonan-2-ylidene) 
methyl)oxazolidin-2-one ((Z)-6am)  
White solid. 88% yield. 1H NMR (300 MHz, CDCl3) δ  7.50 
– 7.40 (m, 2H), 7.32 (t, J = 7.7 Hz, 2H), 7.20 (t, J = 
7.2 Hz, 1H), 5.66 (d, J = 2.2 Hz, 1H), 4.37 (t, J = 7.7 
Hz, 2H), 3.69 – 3.48 (m, 2H), 2.50 – 2.35 (m, 1H), 2.26 
– 2.06 (m, 2H), 2.04 – 1.88 (m, 3H), 1.87 – 1.76 (m, 1H), 1.74 – 1.63 (m, 
1H), 1.61 – 1.48 (m, 2H), 1.46 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 158.5 
(C), 151.2 (C), 151.0 (C), 128.0 (CH), 126.1 (CH), 123.6 (CH), 116.1 
(CH), 75.2 (C), 73.2 (C), 62.2 (CH2), 48.4 (CH2), 37.9 (CH2), 35.4 (CH2), 
34.6 (CH2), 27.9 (CH3), 26.6 (CH2), 17.9 (CH2). LRMS (m/z, ESI): 336.16 
[M+Na]+, 296.17, 209.14, 171.12, 105.05. HRMS Calculated for C19H23NNaO3 
[M+Na]+: 336.1570, found 336.1582. MP: 141ºC. 
3-((Z)-((1S*,5R*)-5-Phenyl-9-oxabicyclo[3.3.1]nonan-2-ylidene)methyl)oxa 
zolidin-2-one ((Z)-6an) 
White solid. 31% yield. 1H NMR (300 MHz, CDCl3) δ 7.46 – 
7.36 (m, 2H), 7.32 (t, J = 7.7 Hz, 2H), 7.21 (t, J = 
7.2 Hz, 1H), 6.00 (d, J = 1.4 Hz, 1H), 5.00 (d, J = 4.9 
Hz, 1H), 4.50 – 4.34 (m, 2H), 3.88 – 3.73 (m, 1H), 3.71 
(q, J = 8.5 Hz, 1H), 2.75 – 2.59 (m, 1H), 2.52 – 2.33 (m, 1H), 2.24 – 
1.91 (m, 5H), 1.88 – 1.65 (m, 3H). 13C NMR (75 MHz, CDCl3) 150.2 (C), 
132.3 (C), 128.1 (CH), 126.4 (CH), 123.5 (CH), 116.9 (CH), 72.3 (C), 69.3 
(CH), 62.2 (CH2), 46.2 (CH2), 37.2 (CH2), 36.2 (CH2), 28.2 (CH2), 27.5 
(CH2), 18.3 (CH2). LRMS (m/z, ESI): 300.16 [M+H]+, 282.15,195.12, 126.06. 
HRMS Calculated for C18H22NO3 [M+H]+: 300.1594, found 300.1594. MP: 139ºC. 
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3-((Z)-((1R*,5R*)-1,5-Diphenyl-9-oxabicyclo[3.3.1]nonan-2-ylidene)methyl) 
oxazolidin-2-one ((Z)-6ao)  
White solid. 96% yield. 1H NMR (250 MHz, CDCl3) δ 7.65 – 
7.48 (m, 2H), 7.47 – 7.00 (m, 8H), 5.58 (d, J = 2.1 Hz, 
1H), 4.03 (td, J = 8.8, 2.6 Hz, 1H), 3.86 (dt, J = 
10.8, 8.4 Hz, 1H), 2.86 (dt, J = 10.8, 8.8 Hz, 1H), 
2.72 – 2.55 (m, 1H), 2.50 (d, J = 11.8 Hz, 1H), 2.41 – 2.26 (m, 1H), 2.26 
– 2.02 (m, 3H), 2.01 – 1.69 (m, 4H), 1.63 – 1.46 (m, 1H). 13C NMR (63 MHz, 
CDCl3) δ 158.4 (C), 150.8 (C), 149.5 (C), 145.8 (C), 128.1 (CH), 128.0 
(CH), 127.6 (CH), 126.2 (CH), 125.9 (CH), 123.7 (CH), 117.5 (CH), 77.3 
(C), 73.9 (C), 62.5 (CH2), 46.5 (CH2), 37.9 (CH2), 34.3 (CH2), 32.2 (CH2), 
27.8 (CH2), 17.5 (CH2). LRMS (m/z, ESI): 398.17 [M+Na]+, 358.18, 271.15, 
243.12, 167.09, 126.06. HRMS Calculated for C24H25NNaO3 [M+Na]+: 398.1727, 
found 398.1742. MP: 219ºC. 
3-((Z)-((1S*,4S*,5R*)-1,4-Dimethyl-5-phenyl-9-oxabicyclo[3.3.1]nonan-2-
ylidene)methyl)oxazolidin-2-one ((Z)-6ap).38  
White solid. 57% yield, dr =1:0. 1H NMR (300MHz, CDCl3) 
7.42 (d, J = 7.4 Hz, 2H), 7.30 (t, J = 7.9 Hz, 2H), 
7.26 – 7.14 (m, 1H), 5.65 (d, J = 1.9 Hz, 1H), 4.37 (t, 
J = 7.7 Hz, 2H), 3.70 – 3.46 (m, 2H), 2.28 (td, J = 
12.7, 2.1 Hz, 1H), 2.15 – 1.87 (m, 5H), 1.80 – 1.62 (m, 2H), 1.57 – 1.47 
(m, 1H), 1.45 (s, 3H), 0.44 (d, J = 6.9 Hz, 3H). 13C NMR (75 MHz, CDCl3) 
158.4 (C), 151.3 (C), 146.2 (C), 127.5 (CH), 126.4 (CH), 125.2 (CH), 
116.0 (CH), 76.7 (C), 74.7 (C), 62.2 (CH2), 48.4 (CH2), 36.7 (CH), 36.2 
(CH2), 35.3 (CH2), 35.2 (CH2), 28.0 (CH3), 20.0 (CH3), 17.6 (CH2). LRMS 
(m/z, ESI): 328.19 [M+H]+, 223.15, 181.10, 157.10, 119.09, 100.04. HRMS 
Calculated for C20H26NO3 [M+H]+: 328.1907, found 328.1911. MP: 153ºC. 
(Z)-3-((2-(4-Hydroxypentyl)-3-methyl-2-phenylcyclobutylidene)methyl)oxazo 
lidin-2-one (3ap’). 
White solid. 12% yield. 1H NMR (300 MHz, CDCl3) 7.41 – 7.24 
(m, 4H), 7.25 – 7.12 (m, 1H), 6.49-6.47 (m, 1H), 4.17 – 4.02 
(m, 1H), 3.98 – 3.78 (m, 2H), 3.39 – 3.22 (m, 1H), 3.08 – 
2.93 (m, 1H), 2.88 – 2.70 (m, 1H), 2.51 – 2.30 (m, 2H), 2.22 
– 1.99 (m, 1H), 1.95 – 1.60 (m, 3H), 1.55 – 1.45 (m, 1H), 
1.24 (s, 1.5H), 1.21 (s, 1.5H), 1.04 (d, J = 6.8 Hz, 3H). 13C NMR (75 MHz, 
CDCl3) 156.6 (C), 147.8 (C), 128.5 (CH), 128.5 (CH), 126.2 (CH), 125.8 
(C), 125.6 (CH), 125.5 (C), 117.1 (CH), 117.1 (CH), 68.0 (CH), 67.5 (CH), 
                                                          
38
 The products 6ap and 3ap have identical Rf values.In order to separate the corresponding (2+2) 
ketone product 3ap from 6ap, the mixture of products was dissolved MeOH and NaBH4 (1 equiv) was 
added. Thus, the corresponding ketone, 3ap, was selectively reduced to the corresponding alcohol 
(3ap’, 99% yield), facilitating the isolation of pure 6ap by column chromatography. 
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62.0 (CH2), 55.8 (C), 45.1 (CH2), 42.1 (CH), 42.1 (CH), 40.1 (CH2), 39.9 
(CH2), 34.3 (CH2), 32.9 (CH2), 32.6 (CH2), 24.0 (CH3), 24.0 (CH3), 23.0 
(CH2), 22.9 (CH2), 14.2 (CH3), 14.2 (CH3). LRMS (m/z, ESI): 330.21 [M+H]+, 
312.20, 225.16, 169.10, 126.06, 105.05. HRMS Calculated for C20H28NO3 
[M+H]+: 330.2064, found 330.2070. MP: 119ºC. 
3-((Z)-((1S*,3S*,5R*)-1,3-Dimethyl-5-phenyl-9-oxabicyclo[3.3.1]nonan-2-
ylidene)methyl)oxazolidin-2-one ((Z)-6bm)39 
White solid. 53% yield, dr = 1:0. 1H NMR (300 MHz, 
CDCl3) δ  7.49 – 7.42 (m, 2H), 7.37 – 7.29 (m, 2H), 7.25 
– 7.17 (m, 1H), 5.51 (d, J = 2.2 Hz, 1H), 4.39 (t, J = 
7.6 Hz, 2H), 3.69 – 3.43 (m, 2H), 2.73 – 2.49 (m, 1H), 
2.19 (dd, J = 13.1, 5.8 Hz, 1H), 2.11 – 1.97 (m, 1H), 1.93 – 1.75 (m, 
2H), 1.74 – 1.60 (m, 3H), 1.59 – 1.47 (m, 2H), 1.46 (s, 3H), 1.08 (d, J = 
6.5 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 158.6 (C), 155.4 (C), 151.2 (C), 
128.1 (CH), 126.2 (CH), 123.7 (CH), 115.4 (CH), 75.7 (C), 73.3 (C), 62.2 
(CH2), 48.7 (CH2), 43.5 (CH2), 38.0 (CH2), 35.6 (CH2), 29.2 (CH3), 28.8 
(CH), 17.9 (CH2), 16.7 (CH3). LRMS (m/z, ESI): 328.19 [M+H]+, 241.16, 
223.15, 171.12, 131.09, 105.06. HRMS Calculated for C20H26NO3 [M+H]+: 
328.1907, found 328.1906. MP: 184ºC. The structure of (Z)-6bm was 
confirmed by X-ray analysis (Figure S7). 
 
Figure S7. X-Ray structure of (Z)-6bm.40 
(Z)-3-((2-(4-Hydroxypentyl)-4-methyl-2-phenylcyclobutylidene)methyl)oxazo 
lidin-2-one (3bm’). 
Yellow oil. 12% yield. 1H NMR (300 MHz, CDCl3) 7.36 – 7.19 
(m, 4H), 7.18 – 7.06 (m, 1H), 6.37-6.35 (m, 1H), 4.10 – 
3.94 (m, 1H), 3.94 – 3.75 (m, 2H), 3.25 – 3.08 (m, 1H), 
2.96 – 2.80 (m, 2H), 2.44 – 2.29 (m, 1H), 2.19 – 1.94 (m, 
1H), 1.87 – 1.22 (m, 7H), 1.18 (m, 3H), 1.16 (m, 3H). 13C 
                                                          
39
 The products 6bm and 3bm have identical Rf values. In order to separate the corresponding (2+2) 
ketone product 3bm from 6bm, the mixture of products was dissolved MeOH and NaBH4 (1 equiv) was 
added. Thus, the corresponding ketone, 3bm, was selectively reduced to the alcohol (3bm’, 99% 
yield) facilitating the isolation of pure 6bm by column chromatography. 
40
 CCDC 930626 (6bm) contains the crystallographic data for this paper, which can be obtained from the 
CCDC via www.ccdc.cam.ac.uk/data_request/cif 
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NMR (75 MHz, CDCl3) 156.4 (C), 156.4 (C), 148.4 (C), 148.4 (C), 133.8 (C), 
133.4 (C), 128.5 (CH), 126.2 (CH), 126.0 (CH), 116.9 (CH), 116.8 (CH), 
68.1 (CH), 67.7 (CH), 61.8 (CH2), 51.4 (C), 44.9 (CH2), 42.5 (CH2), 39.9 
(CH2), 39.8 (CH2), 38.8 (CH2), 38.5 (CH2), 32.0 (CH), 24.0 (CH3), 21.9 
(CH2), 21.7 (CH2), 19.5 (CH3). LRMS (m/z, ESI): 330.21 [M+H]+, 312.20, 
225.16, 140.07, 96.08. HRMS Calculated for C20H28NO3 [M+H]+: 330.2064, found 
330.2067.  
3-((Z)-((5S*,9R*)-9-Phenyl-6,7,9,10-tetrahydro-5,9-epoxybenzo[8]annulen-
8(5H)-ylidene)methyl)oxazolidin-2-one ((Z)-6aq) 
White solid. 78% yield. 1H NMR (250 MHz, CDCl3) 7.75 – 
7.58 (m, 2H), 7.44 – 7.27 (m, 3H), 7.32 – 7.11 (m, 3H), 
7.09 – 6.95 (m, 1H), 5.36 (s, 1H), 5.28 – 5.18 (m, 1H), 
4.02 – 3.80 (m, 2H), 3.67 (d, J = 16.6 Hz, 1H), 3.35 (q, 
J = 8.9 Hz, 1H), 3.21 – 3.02 (m, 1H), 2.55 – 2.31 (m, 2H), 2.36 – 2.21 
(m, 2H), 1.92 – 1.73 (m, 1H). 13C NMR (63 MHz, CDCl3) 156.3 (C), 145.7 
(C), 144.1 (C), 135.5 (C), 133.6 (C), 128.7 (CH), 127.6 (CH), 127.4 (CH), 
126.8 (CH), 126.4 (CH), 126.0 (CH), 124.3 (CH), 117.9 (CH), 75.8 (C), 
71.4 (CH), 61.6 (CH2), 45.7 (CH2), 36.0 (CH2), 32.4 (CH2), 26.2 (CH2). LRMS 
(m/z, ESI): 348.16 [M+H]+, 243.12, 215.09, 133.07, 88.04. HRMS Calculated 
for C22H22NO3 [M+H]+: 348.1595, found 348.1594. MP: 264ºC(degraded). 
3-((Z)-((1R*,6S*)-6-methyl-1-phenyl-10-oxabicyclo[4.3.1]decan-7-ylidene) 
methyl)oxazolidin-2-one ((Z)-6ar).  
White solid. 61% yield. 1H NMR (300 MHz, CDCl3) δ  7.51 – 
7.40 (m, 2H), 7.36 – 7.24 (m, 2H), 7.25 – 7.13 (m, 1H), 
5.57 (d, J = 2.0 Hz, 1H), 4.42 – 4.30 (m, 2H), 3.69 – 
3.57 (m, 2H), 2.39 – 2.03 (m, 6H), 1.97 (ddd, J = 11.4, 
5.4, 2.7 Hz, 1H), 1.84 – 1.46 (m, 5H), 1.57 (s, 3H). 13C 
NMR (75 MHz, CDCl3) δ 158.3 (C), 149.9 (C), 149.4 (C), 127.7 (CH), 126.1 
(CH), 125.0 (CH), 115.7 (CH), 77.5 (C), 76.7 (C), 62.2 (CH2), 48.3 (CH2), 
43.0 (CH2), 42.4 (CH2), 32.9 (CH2), 28.2 (CH3), 25.4 (CH2), 24.8 (CH2), 24.2 
(CH2). LRMS (m/z, ESI): 350.17 [M+Na]+, 310.18, 223.15, 145.10, 119.09. 
HRMS Calculated for C20H25NNaO3 [M+Na]+: 350.1727, found 350.1730. MP: 
142ºC. 
(Z)-3-((2-(5-hydroxyhexyl)-2-phenylcyclobutylidene)methyl)oxa zolidin-2-
one (3ar) 
Yellow oil. 1H NMR (300 MHz, CDCl3) δ 7.44 – 7.34 (m, 2H), 
7.37 – 7.26 (m, 2H), 7.26 – 7.14 (m, 1H), 6.44 – 6.35 (m, 
1H), 4.20 – 4.07 (m, 1H), 4.07 – 3.93 (m, 1H), 3.92 – 3.71 
(m, 1H), 3.35 – 3.25 (m, 1H), 3.13 – 2.95 (m, 1H), 2.80 – 
2.48 (m, 2H), 2.33 – 2.18 (m, 1H), 2.18 – 1.95 (m, 2H), 1.89 
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– 1.32 (m, 8H), 1.22 (s, 1.5H), 1.20 (s, 1.5H). 13C NMR (75 MHz, CDCl3) δ 
156.5 (C), 148.3 (C), 128.5 (CH), 128.2 (C), 126.2 (CH), 125.7 (CH), 
117.4 (CH), 68.0 (CH), 67.9 (CH), 61.9 (CH2), 53.5 (C), 45.1 (CH2), 39.2 
(CH2), 39.1 (CH2), 38.9 (CH2), 38.9 (CH2), 32.8 (CH2), 32.7 (CH2), 26.5 
(CH2), 26.4 (CH2), 25.4 (CH2), 25.3 (CH2), 24.7 (CH2), 23.7 (CH3).LRMS (m/z, 
ESI): 352.19 [M+Na]+, 330.21 [M+H]+, 312.20, 225.16, 155.09, HRMS 
Calculated for C20H28NO3 [M+H]+: 330.2064, found 330.2070. 
Experimental Procedures for the synthesis of 8ab-10ab and 11ae. 
 
(1S*,5R*)-1-Methyl-5-phenyl-8-oxabicyclo[3.2.1]octan-2-one (8ab)41  
To a solution of NaIO4 (74 mg, 0.35 mmol) in H20 (1.5 mL) 
was added ruthenium (IV) oxide hydrate (2.3 mg, 0.015 
mmol). The resulting green-yellow solution was stirred for 
30 min and a solution of 6ab (45 mg, 0.15 mmol) in EtOAc (0.7 mL) was 
then added in one portion. After 10 min, the color of the solution 
changed to black and a second dose of NaIO4 (74 mg, 0.35 mmol) was added. 
After 5 min, the mixture was diluted in EtOAc and filtered through a pad 
of Celite. The organic layer was washed with NaHSO3(sat) and the resulting 
precipitate was filtered off through a pad of Celite. The organic layer 
was washed with brine and dried. The solvent was removed by evaporation 
in a rotary evaporator to obtain the crude residue which was purified by 
column chromatography in hexanes/EtOAc to give 1-methyl-5-phenyl-8-
oxabicyclo[3.2.1]octan-2-one 8ab. (70% yield) White solid. 1H NMR (250 
MHz, CDCl3) δ 7.46 – 7.12 (m, 5H), 2.73 – 2.35 (m, 3H), 2.34 – 2.14 (m, 
3H), 2.13 – 1.80 (m, 2H), 1.39 (s, 3H). 13C NMR (63 MHz, CDCl3) δ 208.1 
(C), 145.2 (C), 128.3 (CH), 127.0 (CH), 124.4 (CH), 86.1 (C), 84.0 (C), 
40.2 (CH2), 36.4 (CH2), 35.8 (CH2), 33.3 (CH2), 19.2 (CH3). LRMS (m/z, 
ESI): 338.1 [M+Na]+, 289, 271, 199.1, 181.1, 155, HRMS (m/z, ESI) 
calculated for C14H16NaO2 [M+Na]+ 239.1043, found 239.1034. MP: 109ºC. 
3-(((1S*,5S*)-1-Methyl-5-phenyl-8-oxabicyclo[3.2.1]octan-2-yl)methyl)oxa 
zolidin-2-one (dr =  1.1 : 1) (9ab)  
A suspension of (Z)-3-((1-methyl-5-phenyl-8-
oxabicyclo[3.2.1]octan-2-ylidene)methyl)oxazolidin-2-one 
6ab (50 mg, 0.17 mmol) and Pd/C (10% wt, 17 mg) in EtOH 
(1.6 mL) was stirred vigorously under H2 (1 atm) at room 
temperature for 4 h. The mixture was filtered through a pad of Celite 
using EtOH as eluent and concentrated in vacuum. The product was purified 
by column chromatography in hexane/ EtOAc 20-60% to give 30 mg of 3-((1-
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 Procedure from: A. Piperno, U. Chiacchio, D. Iannazzo, S. V Giofrè, G. Romeo, R. Romeo, J. Org. 
Chem. 2007, 72, 3958–3960. 
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methyl-5-phenyl-8-oxabicyclo[3.2.1]octan-2-yl)methyl)oxazolidin-2-one 9ab 
(dr= 1.1:1, 60% yield). White solid 1H NMR (300 MHz, CDCl3) δ 7.35 - 7.11 
(m, 5H), 4.32 - 4.20 (m, 2H), 3.71 - 3.20 (m, 3H), 3.17 - 3.12 (m, 1H), 
2.22 - 1.78 (m, 5H), 1.76 - 1.44 (m, 4H), 1.34 (s, 3H). 13C NMR (75 MHz, 
CDCl3) δ 158.8 (C), 146.7 (C), 128.2 (CH), 126.6 (CH), 124.6 (CH), 124.5 
(CH), 85.2 (C), 83.9 (C), 82.5 (C), 81.5 (C), 61.7 (CH2), 46.5 (CH2), 45.6 
(CH2), 44.8 (CH2), 43.4 (CH2), 42.7 (CH3), 39.8 (CH3), 39.1 (CH2), 38.3 
(CH2), 37.1 (CH2), 36.5 (CH2), 33.7 (CH2), 32.4 (CH2), 25.1 (CH3), 24.7 
(CH3), 23.7 (CH2), 20.6 (CH2). LRMS (m/z, ESI): 302.1 [M+Na]+, 324.1, 
284.1, 197.1, 169.1, 100, HRMS (m/z, ESI) calculated for C18H24NO3 
[M+Na]+:302.1751, found 302.1755. MP: 121ºC. 
((1S*,5S*)-1-Methyl-5-phenyl-8-oxabicyclo[3.2.1]octan-2-yl)methanol (dr = 
2.6 : 1)  
To a solution of (Z)-3-((1-methyl-5-phenyl-8-
oxabicyclo[3.2.1]octan-2-ylidene)methyl)oxazolidin-2-one 
6ab (50 mg, 0.167 mmol) in CHCl3 (3.6 mL) was added HCl 
(6N) (3 ml, 18 mmol), the mixture was heated at 61 °C overnight. After 
cooling, saturated NaHCO3 was added until neutralization, the products 
were extracted with DCM, dried with NaSO4 filtered and concentrated 
providing a crude oil (1-methyl-5-phenyl-8-oxabicyclo[3.2.1]octane-2-
carbaldehyde; d.r. = 2.7:1) that was submitted to the next step without 
further purification.42 The above mention oil (1-methyl-5-phenyl-8-
oxabicyclo[3.2.1]octane-2-carbaldehyde dr = 2.7:1 ) was dissolved in MeOH 
(3 mL) and NaBH4 (9.7 mg, 0.42 mmol) was added. After stirring at rt for 5 
min, the reaction mixture was quenched with acetone. Addition of H2O, Et2O 
extraction, drying with NaSO4 and concentration by rotary evaporation 
afford the crude (dr = 2.6:1). Column chromatography in Hexanes/EtOAc 
gave 1-methyl-5-phenyl-8-oxabicyclo[3.2.1]octan-2-yl)methanol (37 mg, 
0.159 mmol) as a mixture of diatereoisomers (dr = 2.6:1) 10ab (major) and 
10ab’ (minor) in 95% yield.43 White solid. 1H NMR (250 MHz, CDCl3) δ 7.39 – 
7.27 (m, 2.00H), 7.31 – 7.17 (m, 2.00H), 7.21 – 7.06 (m, 1.00H), 4.10 – 
3.93 (m, 0.28H), 3.74 (dd, J = 10.9, 3.3 Hz, 0.28H), 3.63 (dd, J = 10.8, 
5.0 Hz, 0.72H), 3.31 (dd, J = 10.8, 7.2 Hz, 0.72H), 2.24 – 1.43 (m, 
9.00H), 1.41 (s, 0.84H), 1.34 (s, 2.16H). 13C NMR (63 MHz, CDCl3) δ 146.8 
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 This intermediate aldehyde could also be chromatographed, isolated in 85% yield, and characterized. 
Colorless oil. (1-Methyl-5-phenyl-8-oxabicyclo[3.2.1]octane-2-carbaldehyde 1H NMR (300 MHz, CDCl3) 
δ 10.15 (d, J = 3.3 Hz, 0.26 H), 9.80 (d, J = 2.2 Hz, 0.74 H), 7.47 – 7.37 (m, 2H), 7.41 – 7.29 (m, 
2H), 7.32 – 7.20 (m, 1.00 H), 2.78 – 2.64 (m, 0.74 H), 2.38 – 2.19 (m, 1.26 H), 2.20 – 1.63 (m, 
7H), 1.58 (s, 2.22 H), 1.56 (s, 0.78 H). 13C NMR (75 MHz, cdcl3) δ 205.6 (C), 203.2 (C), 146.3 (C), 
146.2 (C), 128.1 (CH), 126.7 (CH), 124.4 (CH), 124.4 (CH), 85.2 (C), 84.1 (C), 81.0 (C), 57.5 (CH), 
54.0 (CH), 38.2 (CH2), 36.9 (CH2), 36.8 (CH2), 36.2 (CH2), 35.2 (CH2), 33.7 (CH2), 25.5 (CH3), 25.0 
(CH3), 20.7 (CH2), 19.4 (CH2). LRMS (m/z, ESI): 253.12 [M+Na]+, 213.13. 195.12, 155.09, 129.07, 
91.05. HRMS Calculated for C15H18NaO2 [M+Na]+: 253.1199, found 253.1192. 
43
 Both diastereoisomers(10ab and 10ab‘) can be easily separated by column chromatography. 
S23 
 
(C, 10ab), 146.6 (C, 10ab’), 128.1 (CH, 10ab’), 128.0 (CH, 10ab), 126.6 
(CH, 10ab’), 126.4 (CH, 10ab), 124.4 (CH, 10ab), 124.4 (CH, 10ab’), 85.1 
(C, 10ab’), 83.7 (C, 10ab), 83.0 (C, 10ab’), 82.6 (C, 10ab), 64.8 (CH2, 
10ab’), 64.5 (CH2, 10ab), 47.0 (CH, 10ab), 42.2 (CH, 10ab’), 38.5 (CH2, 
10ab’), 38.1 (CH2, 10ab), 37.2 (CH2, 10ab), 36.4 (CH2, 10ab’), 35.6 (CH2, 
10ab’), 33.0 (CH2, 10ab), 25.4 (CH3, 10ab), 24.6 (CH3, 10ab’), 22.8 (CH2, 
10ab), 22.7 (CH2, 10ab’). LRMS (m/z, ESI): 255.1[M+Na]+, 215.1, 197, 155. 
HRMS (m/z,ESI) calculated for C
15
H
20
NaO
2 
[M+Na]+ 255.1356, found 255.1363. 
(E)-3-((4-Hydroxy-4-phenylcycloheptylidene)methyl)oxazolidin-2-one 
(11ae)44  
TiCl4 (0.48 mL, 0,48 mmol, 1M in CH2Cl2) was slowly added 
to a stirred solution of (Z)-3-((1-methoxy-5-phenyl-8-
oxabicyclo[3.2.1]octan-2-ylidene)methyl)oxazolidin-2-one 
6ae (50 mg, 0.16 mmol) and Et3SiH (0.20 mL, 1.27 mmol) 
in CH2Cl2 (1.6 mL) at -70 °C, under an argon atmosphere. The reaction 
mixture was stirred at -70ºC for 2 h and then NaHCO3(sat)(1.5 mL) and Et2O 
(3 mL) were added at this temperature and the resulting mixture was 
stirred overnight at rt. The organic phases were separated and the 
aqueous phases were extracted with Et2O (3 x 3 mL). The combined organic 
phases were washed with brine (5 mL), dried over Na2SO4 and concentrated 
under reduced pressure. The residue was purified by column chromatography 
on silica gel (hexanes/EtOAc 10-90%) to give (E)-3-((4-hydroxy-4-
phenylcycloheptylidene)methyl)oxazolidin-2-one 11ae (29 mg, 0.10 mmol) in 
64 % yield. White solid. 1H NMR (250 MHz, CDCl3) δ 7.41 (d, J = 7.7 Hz, 
2H), 7.26 (t, J = 7.4 Hz, 2H), 7.20 - 7.15 (m, 1H), 5.83 (s, 1H), 4.30 
(t, J = 8.0 Hz, 2H), 3.75 – 3.60 (m, 2H), 2.63 - 2.15 (m, 5H), 2.14 - 
2.03 (m, 1H), 1.95 - 1.60 (m, 5H). 13C NMR (63 MHz, CDCl3) δ 157.5 (C), 
150.4 (C), 137.6 (C), 128.3 (CH), 126.7 (CH), 124.3 (CH), 118.6 (CH), 
75.7 (C), 62.3 (CH2), 46.6 (CH2), 42.6 (CH2), 39.9 (CH2), 34.4 (CH2), 24 
(CH2), 22.6 (CH2). LRMS (m/z, ESI): 310.1 [M+Na]+, 270.1, 183.1, 155, HRMS 
(m/z, ESI) calculated for C17H21NNaO3 [M+Na]+ 310.1414, found 310.1408. 
 
Enantioselective Cascade Cycloadditions 
Chiral gold complex (S,R,R)-G  
Chiral gold complex G was prepared from the corresponding (S,R,R) 
phosphoramidite following a standard procedure.18 
                                                          
44
 Procedure from: S. Xing, Y. Li, Z. Li, C. Liu, J. Ren, Z. Wang, Angew. Chem. Int. Ed.  2011, 50, 
12605–12609. 
HO
Ph
N
O
O
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Light yellow solid. 1H NMR (500 MHz, CDCl3) δ 8.48 (d, J = 
8.3 Hz, 1H), 7.87 (d, J = 8.1 Hz, 1H), 7.81 (dd, J = 
16.1, 8.0 Hz, 2H), 7.73 (t, J = 7.5 Hz, 1H), 7.65 (t, J = 
7.4 Hz, 1H), 7.58 – 7.46 (m, 4H), 7.35 – 7.25 (m, 6H), 
7.19 (d, J = 3.3 Hz, 4H), 7.13 (t, J = 7.4 Hz, 1H), 7.09 
(t, J = 7.4 Hz, 1H), 6.99 (t, J = 7.7 Hz, 2H), 6.91 (t, J 
= 7.6 Hz, 2H), 6.59 (d, J = 7.5 Hz, 2H), 6.37 (d, J = 7.2 Hz, 2H), 4.82 – 
4.61 (m, 2H), 1.67 (brs, 6H). 13C NMR (63 MHz, CDCl3) δ 146.7, 146.5, 
144.7, 144.6, 141.1, 140.6, 140.0, 139.6, 134.4, 134.1, 129.0, 128.9, 
128.7, 128.0, 127.8, 127.6, 127.4, 126.8, 126.5, 126.2, 125.8, 125.7, 
125.4, 123.6, 123.6, 122.6, 122.1, 122.0, 121.8, 54.3 (CH), 21.0 (CH3). 
31P NMR (202 MHz, CDCl3) δ 127.9.  
Table S1. Preliminary optimization of the asymmetric cycloaddition 
between 1a and 4b, using several types of chiral gold complexes.[a] 
 
 
[a]
 Allenamide 1a was added over 1 h unless otherwise noted. Reactions were 
carried out at -15ºC unless otherwise noted. Er’s determined by chiral HPLC [b] 
Determined by 1H-NMR of crude reaction mixtures. [c] Allenamide 1a was added at 
once. [d] 2.5 mol% of [Au] was used. [e] Reaction carried out at -78ºC. [f] AgNTf2 
was
 
used instead of AgSbF6.
 [g] 
reaction was carried out at -78ºC. 
Entry [Au] t (min) Z : E[b] 6ab, yield (%) er 
1 (R)-H 5 34 : 1 60 55:45 
2 (S,S,S)-I 5 19 : 1 75 54:46 
3[c]  (S,R,R)-I’ 10 11 : 1 82 50:50 
4[c] (R,R,R)-J (1%) 5 27 : 1 84 64:36 
5  (R,R)-K 5 27 : 1 82 58:42 
6[c] (R,R,R)-L 5 48 : 1 (Conv> 99%) 66:34 
7[c,d] (S)-BINAP(AuCl)2 5 25 : 1 57 55:45 
8 (R)-F 5 35 : 1 77 77:23 
9[c] (S,R,R)-G 10 46 : 1 54 74:26 
10[c,e] (S,R,R)-G 60 1 : 0 63 82:18 
11[c,e-f] (S,R,R)-G 10 1 : 0 63 83:17 
12[c] (S,S,S)-G’ 10 51 : 1 (Conv> 99%) 69:31 
13[g] (R)-N 5 32 : 1 71 50:50 
14[g] (S)-M 30 112 : 1 60 57:43 
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Table S2. Optimization of the cycloaddition between 1a and 4m with 
(S,R,R)-G and (R)-F[a] 
 
Entry [Au] [Ag] T (ºC)/ t (min) 6am, yield (%) er 
1 (S)-O AgSbF6 -30ºC / 120 min 74 54:48 
2 (S)-M AgSbF6 -78ºC / 150 min 32 59:40 
3 (R)-N AgSbF6 -78ºC / 390 min 84 92:7 
4 (R)-N AgNTf2 -78ºC-rt / 
overnight 
23 74:26 
5 (S,R,R)-G  AgNTf2 -78ºC / 30min 80 88:12 
6 (R)-F  AgSbF6 -30ºC / 90min 76 90:10 
7 (R)-F  AgNTf2 -30ºC / 60min 96 92:8 
8 (R)-F  AgNTf2 -78ºC-35ºC/ 12h 52 95:5 
[a]
 Allenamide 1a was added at once. 
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Table S3. Expanded table 4 of the main manuscript 
Entry[a] 4 [Au] (mol%) 6, (%)[b] er [c] 
1[d] 4b (R)-F
 
(5) 6ab, 77 77 : 23  
2 4c (R)-F
 
(5) 6ac, 85 87 : 13 
3 4d (R)-F
 
(5) 6ad, 90 80 : 20 
4 4b (S,R,R)-G (5) 6ab, 63 83 : 17[e] 
5 4c (S,R,R)-G (5) 6ac, 69 82 : 18[f] 
6[g] 4d (S,R,R)-G (5) 6ad, 83 84 : 16 
7 4i (S,R,R)-G (5) 6ai, 72[h] 90 : 10 
8 4m (S,R,R)-G (5)  6am, 80 88 : 12 
9 4o (S,R,R)-G (5) 6ao, 97 87 : 13 
10 4p (S,R,R)-G (5) 6ap, 80[i] 90 : 10 
11[j] 4m (R)-F
 
(5)  6am, 52 95 : 5 
12[j] 4o (R)-F (5) 6ao, 80 91 : 9 
13[j] 4p (R)-F (5) 6ap, 51 96 : 4 
[a]: 1a (1 equiv), 4 (1.5 - 2 equiv) and [Au] (5 mol%) in 
CH2Cl2 at -78 ºC, unless otherwise noted. Conversions > 99% 
after 10-180 min. [b] Isolated yields of 6. Z : E ratios are > 
20 :1. [c] Determined by HPLC. [d] Carried out at -15ºC.[e] er 
= 95:5 after crystallization. [f] er = 98:2 after 
crystallization. [g] Carried out from -78 to -60ºC, for 5h. 
[h] dr = 1:0. [i] Consisting of a 2:1 mixture of 6ap and 3ap. 
[j] Carried out from -78 to -35ºC, for 4h. 
 
 
Representative procedure for the enantioselective cascade cycloaddition. 
(Exemplified for the reaction between 1a and 4b with (S,R,R)-G, table 4 
main manuscript, entry 1) 
In a dried Schlenk tube containing 200 mg of 4Å MS, a solution of 
(S,R,R)-G (7.4 mg, 8.0 µmol), AgSbF6 (3.1 mg, 8.0 µmol) and 5-phenylhex-5-
en-2-one (41.9 mg, 0.240 mmol), in CH2Cl2 (1.6 ml) at -78 °C, was added. 
Then 3-(propa-1,2-dienyl)oxazolidin-2-one (1a, 20 mg, 0.160 mmol) was 
added at once. The mixture was stirred at -78 °C for 10 min (the progress 
of the reaction was easily monitored by tlc) and filtered through a short 
pad of florisil eluting with Et2O. After rotary evaporation, the crude 
mixture (E:Z = 1:0) was purified by column chromatography (Hexanes/EtOAc 
10-50%) to give 30.0 mg of (Z)-3-((1-methyl-5-phenyl-8-
oxabicyclo[3.2.1]octan-2-ylidene)methyl)oxazolidin-2-one 6ab (63 % 
yield). Enantioselectivity was determined by chiral HPLC analysis on 
Chiralpak IB at rt, (Hexane - iPrOH = 95:5, 0.5 ml/min).  
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Racemic sample(Z)-6ab, , Chiralpak IB 
 
Table 4 main manuscript, entry 1, er = 83:17  
 
This product [(Z)-6ab (63% yield, er= 83:17) [α]D23 = -30 (c = 0.7, CHCl3)] 
could be further enantioenriched by dissolving it in iPrOH under heating. 
The solution was allowed to reach rt, hexane was added until the solution 
becomes cloudy, and the mixture was allowed to stand overnight at rt. The 
solution was decanted and filtered through a HPLC filter. Evaporation of 
the solvent gave a fraction of (Z)-6ab with er= 95:5 (38% yield).  
 
 
(Z)-3-((1,5-diphenyl-8-oxabicyclo[3.2.1]octan-2-ylidene)methyl)oxazoli 
din-2-one (Z)-6ac  
Enantioselectivity was determined by chiral HPLC analysis on Chiralpak 
IA3 at rt, (Hexane - iPrOH = 90:10, 0.5 ml/min).  
Racemic sample(Z)-6ac, , Chiralpak IA3 
 
Table 4 main manuscript, entry 2, er = 82:18 
  
This product [(Z)-6ac (69% yield, er = 82:18)] could be further 
enantioenriched by redissolving it in iPrOH under heating. The solution 
was allowed to reach rt, hexane was added until the solution became 
cloudy, and the mixture was allowed to stand overnight at rt The solution 
was decanted and filtered through a HPLC filter. The precipitate and 
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crystals were dried under vacuum to gave (Z)-6ac with er= 98:2. [α]D23 = 
23 (c = 0.5, CHCl3). 
 
 
3-((Z)-((1S,5S)-5-Phenyl-8-oxabicyclo[3.2.1]octan-2-ylidene)methyl)oxazo 
lidin-2-one (Z)-6ad  
Enantioselectivity was determined by chiral HPLC analysis on Chiralpak IA 
at rt, (Hexane - iPrOH = 90:10, 0.5 ml/min).  
Racemic sample(Z)-6ad, , Chiralpak IA 
 
Table 4 main manuscript, entry 3, er = 84:16. [α]D23 = -31(c = 0.84, 
CHCl3). 
 
 
(Z)-3-((1,4-Dimethyl-5-phenyl-8-oxabicyclo[3.2.1]octan-2-ylidene)methyl) 
oxazolidin-2-one (Z)-6ai  
Enantioselectivity was determined by chiral HPLC analysis on Chiralpak IB 
at rt, (Hexane - iPrOH = 90:10, 0.5 ml/min).  
Racemic sample(Z)-6ai, , Chiralpak IB 
 
Table 4 main manuscript, entry 4, dr = 1:0, er = 90:10. [α]D23 = -34(c = 
0.7, CHCl3). 
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(Z)-3-((1-Methyl-5-phenyl-9-oxabicyclo[3.3.1]nonan-2-ylidene)methyl)oxazo 
lidin-2-one (Z)-6am  
Enantioselectivity was determined by chiral HPLC analysis on Chiralpak IB 
at rt, (Hexane - iPrOH = 95:5, 0.5 ml/min,  
Racemic sample(Z)-6am, , Chiralpak IB 
 
Table 4 main manuscript, entry 5, er = 95:5. [α]D23 = 66.4(c = 1, CHCl3). 
 
 
(Z)-3-((1,5-diphenyl-9-oxabicyclo[3.3.1]nonan-2-ylidene)methyl)oxazo 
lidin-2-one (Z)-6ao  
Enantioselectivity was determined by chiral HPLC analysis on Chiralpak IA 
at rt, (Hexane - iPrOH = 90:10, 0.5 ml/min).  
Racemic sample(Z)- 6ao, Chiralpak IA 
 
Table 4 main manuscript, entry 6, er = 91:9. [α]D23 = 87.3(c = 1, CHCl3). 
  
 
3-(Z)-1,4-Dimethyl-5-phenyl-9-oxabicyclo[3.3.1]nonan-2-ylidene)methyl)oxa 
zolidin-2-one (Z)- 6ap Enantioselectivity was determined by chiral HPLC 
analysis on Chiralpak IA3 at rt, (Hexane - iPrOH = 95:5, 0.5 ml/min).  
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Racemic sample(Z)-6ap, , Chiralpak IA3 
 
Table 4 main manuscript, entry 7, er = 96:4. [α]D23 = +52.2(c = 0.5, 
CHCl3). 
  

  
 
 
Addendum: Gold(I)-catalyzed multicomponent cascade cycloaddition between 
allenamides, alkenes and aldehydes. 
 
Supporting material for chapter 3, Addendum 

Supporting material for chapter 3, Addendum 
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The general procedures are those indicated in the Supporting material for chapter 3, 
article 4. In addition it should be mention the following: 
All the alkenes and aldehydes used were bought from Aldrich, Alfa Aesar, TCI or Acros 
and used without further purification, except 4-methyl-1,2-dihydronaphthalene, 
synthesized according to the reported procedure,214 in a 5 gram scale with 97% yield 
from Methylmagnesium bromide 3.0 M and 1-Tetralone. 
Representative procedure for the racemic multicomponent cycloaddition. (Exemplified 
for the reaction between 60b and trans--methylstyrene and benzaldehyde, Table 3, page 
146, entry 1). 
To solution of trans--Methylstyrene (42 µl, 0,320 mmol), benzaldehyde (162 µl, 1,60 
mmol)  and Au42 (3,89 mg, 3,20 µmol) in CH2Cl2 (1 mL), at -45 °C in a dried Schlenk tube 
with 200 mg of powder MS, a solution of 3-(propa-1,2-dienyl)oxazolidin-2-one (20.0 mg, 
0,160 mmol) in CH2Cl2 (0.5 mL) was slowly added over 2 hours. 
The mixture was stirred at -45 °C for 2 hours (the progress of the reaction was easily 
monitored by tlc) and filtered through a short pad of florisil eluting with EtOAc. The 
solvent was removed and the crude dissolved in 0.6 mL of a 1,3,5-trimethoxybenzene 
0.266 M solution in CDCl3 for 1H-NMR analysis. The crude mixture was then purified on 
column chromatography (hexanes/EtOAc, 10-50%) to give 3-((Z)-(-3-methyl-2-
phenylcyclobutylidene)methyl)oxazolidin-2-one (150ba) (16 mg, 0,066 mmol, 41 % yield) 
and 3-((Z)-(-5-methyl-2,6-diphenyl-2H-pyran-3(4H,5H,6H)-ylidene)methyl)oxazolidin-2-
one (149baa) (18 mg, 0,052 mmol, 32 % yield). 
 
Representative procedure for the enantioselective multicomponent cycloaddition. 
(Exemplified for the reaction between 60b and -methylstyrene and benzaldehyde with 
(S,R,R)-Au24, Table 5, entry 13) 
 To solution of -methylstyrene (42 µl, 0.32 mmol) and AgBF4 (1.6 mg, 8.0 µmol), (S,R,R)-
Au24 (7.4 mg, 8.0 µmol) in CH2Cl2 (1.5 mL), at -94 °C (Hexane/N2 bath) in a dried 
Schlenk tube with 200 mg of powder MS, solid 60b (20 mg, 0.16 mmol) was added. The 
mixture was stirred at -94 °C for 30 min (the progress of the reaction was easily 
monitored by tlc) and filtered through a short pad of florisil eluting with EtOAc to 
provide a crude mixture which was purified on column chromatography 
(hexanes/EtOAc, 10-50%) to give (Z)-3-((6-methyl-2,6-diphenyl-2H-pyran-3(4H,5H,6H)-
ylidene)methyl)oxazolidin-2-one 149bba (dr = 4:1) (51 mg, 0.15 mmol, 91 % yield). 
Enantioselectivity was determined by chiral HPLC analysis on Chiralpak IA3 at rt, 
(Hexane - iPrOH = 9:1, 0.5 ml/min).  
Racemic sample 149bba, 149bba:149bba’ = 1:1.2, Chiralpak IA3: 
 
 
                                                     
214 Silva, L. F.; Siqueira, F. A.; Pedrozo, E. C.; Vieira, F. Y. M.; Doriguetto, A. C. Org. Lett. 2007, 9, 1433–1436. 
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Racemic sample 149bba, 149bba:149bba’ = 13.7:1, Chiralpak IA3: 
 
 
Table 5, page 151, entry 13, ee 149bba = 74%, ee 149bba’ = 90%: 
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149baa - Racemic - 3-((Z)-((2R*,5S*,6R*)-5-methyl-2,6-diphenyldihydro-2H-pyran-3(4H)-
ylidene)methyl)oxazolidin-2-one 
 1H NMR (500 MHz, CDCl3) δ 7.54 – 7.45 (m, 2H), 7.38 – 7.27 (m, 
3H), 7.30 – 7.21 (m, 4H), 7.22 – 7.14 (m, 1H), 5.87 (d, J = 1.3 Hz, 1H), 
5.41 (s, 1H), 4.87 (d, J = 3.7 Hz, 1H), 3.96 – 3.87 (m, 1H), 3.58 (q, J = 
8.3 Hz, 1H), 3.37 – 3.30 (m, 1H), 3.07 (td, J = 8.8, 5.2 Hz, 1H), 2.79 
(ddd, J = 14.1, 6.0, 1.4 Hz, 1H), 2.33 (dd, J = 14.1, 5.0 Hz, 1H), 2.30 – 2.19 (m, 1H), 0.71 (d, J 
= 6.8 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 156.3 (C), 140.9 (C), 140.6 (C), 133.3 (C), 128.0 
(CH), 127.9 (CH), 127.9 (CH), 127.4 (CH), 126.6 (CH), 125.6 (CH), 119.0 (CH), 79.5 (CH), 
61.8 (CH2), 45.8 (CH2), 37.9 (CH2), 34.9 (CH), 14.0 (CH3). LRMS (m/z, ESI): 372.16 
(M+Na)+, 332.16, 282.28, 263.14, 245.13, 117.07, 91.06. HRMS Calculated for 
C22H23NNaO3: 372.1570, found 372.1564. 
COSY between 4.87 (d, J = 3.7 Hz, 1H) and 2.30 – 2.19 (m, 1H). 
Irradiating 4.87 (d, J = 3.7 Hz, 1H) nOe with: 3.9% 2.30 – 2.19 (m, 1H); 6.2% 5.41 (s, 1H); 
1.9% 2.79 (ddd, J = 14.1, 6.0, 1.4 Hz, 1H). 
Irradiating 5.41 (s, 1H) nOe with: 5.5% 4.87 (d, J = 3.7 Hz, 1H); 3.9% 7.54 – 7.45 (m, 2H); 
1.1% 3.37 – 3.30 (m, 1H); 1.0% 3.07 (td, J = 8.8, 5.2 Hz, 1H); 1% 2.79 (ddd, J = 14.1, 6.0, 1.4 
Hz, 1H). 
Irradiating 5.87 (d, J = 1.3 Hz, 1H) nOe with:1% 3.37 – 3.30 (m, 1H); 2% 2.79 (ddd, J = 
14.1, 6.0, 1.4 Hz, 1H); 3% 2.33 (dd, J = 14.1, 5.0 Hz, 1H).  
 
Significant nOe’s observed. 
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149bba - Racemic - 3-((Z)-((2S*,6S*)-6-methyl-2,6-diphenyldihydro-2H-pyran-3(4H)-
ylidene)methyl)oxazolidin-2-one 
 1H NMR (500 MHz, CDCl3) δ 7.51 – 7.46 (m, 4H), 7.37 – 7.32 (m, 3H), 
7.31 – 7.27 (m, 2H), 7.19 (t, J = 7.7 Hz, 1H), 5.78 – 5.75 (m, 1H), 5.60 (s, 
1H), 3.96 (td, J = 8.8, 5.3 Hz, 1H), 3.59 (q, J = 8.7 Hz, 1H), 3.31 (q, J = 
8.6 Hz, 1H), 2.78 (td, J = 8.8, 5.3 Hz, 1H), 2.58 – 2.49 (m, 1H), 2.38 (dt, J 
= 14.3, 4.7 Hz, 1H), 2.25 (dt, J = 13.3, 5.0 Hz, 1H), 2.05 (ddd, J = 13.3, 11.5, 4.1 Hz, 1H), 
1.67 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 155.7 (C), 148.7 (C), 141.2 (C), 139.0 (C), 128.2 
(CH), 128.0 (CH), 127.9 (CH), 126.3 (CH), 124.7 (CH), 116.7 (CH), 75.7 (C), 73.0 (CH), 61.7 
(CH2), 45.3 (CH2), 45.3 (CH2), 37.1 (CH2), 27.1 (CH3), 25.9 (CH2). Analysis on a 
235bba:235bba’ 1:1 sample: LRMS (m/z, ESI): 372.16 (M+Na)+, 332.16, 263.14, 245.13, 
143.11, 117.11. HRMS Calculated for C22H23NNaO3: 372.1570, found 372.1560.  
Irradiating 5.78 – 5.75 (m, 1H) nOe with: 1% 3.31 (q, J = 8.6 Hz, 1H); 1% 2.58 – 2.49 (m, 
1H); 4% 2.38 (dt, J = 14.3, 4.7 Hz, 1H). 
Irradiating 5.60 (s, 1H) nOe with: 4% 1.67 (s, 3H), 1% 3.31 (q, J = 8.6 Hz, 1H), 1% 2.78 (td, 
J = 8.8, 5.3 Hz, 1H). 
Irradiating 1.67 (s, 3H) nOe with: 5% 5.60 (s, 1H) 
 
Significant nOe’s observed. 
 
149bba’ - Racemic (Minor diastereoisomer, by exclusion of the 149bba spectra (in which 
149bba was almost pure)- 3-((Z)-((2S*,6R*)-6-methyl-2,6-diphenyldihydro-2H-pyran-
3(4H)-ylidene)methyl)oxazolidin-2-one 
 1H NMR (300 MHz, CDCl3) δ 7.52 – 7.40 (m, 4H), 7.38 – 7.27 (m, 5H), 
7.22 – 7.15 (m, 1H), 5.81 (q, J = 1.8 Hz, 1H), 5.15 (t, J = 1.6 Hz, 1H), 
3.79 (ddd, J = 9.2, 8.4, 5.9 Hz, 1H), 3.55 – 3.46 (m, 1H), 3.20 (ddd, J = 
9.2, 8.3, 7.6 Hz, 1H), 2.86 – 2.72 (m, 1H), 2.72 – 2.60 (m, 1H), 2.47 – 
2.41 (m, 1H), 2.31 – 2.27 (m, 2H), 1.43 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 155.8 (C), 
146.7 (C), 140.7 (C), 137.0 (C), 128.4 (CH), 128.3 (CH), 128.0 (CH), 127.9 (CH), 126.7 (CH), 
125.3 (CH), 116.9 (CH), 76.7 (C), 73.9 (CH), 61.7 (CH2), 45.3 (CH2), 34.6 (CH2), 32.7 (CH3), 
26.3 (CH2). LRMS (m/z, ESI): 372.16 (M+Na)+, 332.16, 263.14, 245.13, 143.11, 117.11. 
HRMS Calculated for C22H23NNaO3: 372.1570, found 372.1560.  
Irradiating 5.81 (q, J = 1.8 Hz, 1H) nOe with: 3% 2.47 – 2.41 (m, 1H); 1% 2.72 – 2.60 (m, 
1H). 
Irradiating 5.15 (t, J = 1.6 Hz, 1H) nOe with: 1.4% 3.20 (ddd, J = 9.2, 8.3, 7.6 Hz, 1H); 1% 
2.72 – 2.60 (m, 1H) 
Irradiating 1.43 (s, 3H) nOe with: 2% with 2.47 – 2.41 (m, 1H) 
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Significant nOe’s observed. 
 
149bca - (Z)-3-((2,6,6-triphenyldihydro-2H-pyran-3(4H)-ylidene)methyl)oxazolidin-2-one 
 1H NMR (300 MHz, CDCl3) δ 7.61 – 7.45 (m, 4H), 7.47 – 7.29 (m, 
7H), 7.33 – 7.16 (m, 3H), 7.20 – 7.07 (m, 1H), 5.78 (d, J = 1.5 Hz, 1H), 
5.24 (s, 1H), 3.88 – 3.69 (m, 1H), 3.48 (q, J = 8.2 Hz, 1H), 3.19 (q, J = 
8.0 Hz, 1H), 2.88 – 2.65 (m, 2H), 2.69 – 2.42 (m, 3H). 13C NMR (75 
MHz, CDCl3) δ 156.0 (C), 148.1 (C), 144.1 (C), 140.6 (C), 136.9 (C), 
128.4 (CH), 128.1 (CH), 127.9 (CH), 127.8 (CH), 127.8 (CH), 127.1 (CH), 127.0 (CH), 126.3 
(CH), 125.2 (CH), 117.2 (CH), 80.0 (C), 73.8 (CH), 61.7 (CH2), 45.4 (CH2), 35.5 (CH2), 26.5 
(CH2). LRMS (m/z, ESI): 434.17 (M+Na)+, 394.18, 325.26, 241.09, 193.10, 145.07, 117.07. 
HRMS Calculated for C27H25NNaO3: 434.1727, found 434.1721. 
 
(E)-3-(5,5-diphenylpenta-1,4-dien-1-yl)oxazolidin-2-one 
 1H NMR (300 MHz, CDCl3) δ 7.45 – 7.17 (m, 10H), 6.70 (dt, J = 14.3, 
1.5 Hz, 1H), 6.08 (t, J = 7.6 Hz, 1H), 4.85 (dt, J = 14.3, 6.7 Hz, 1H), 
4.46 – 4.37 (m, 2H), 3.72 – 3.65 (m, 2H), 2.94 – 2.86 (m, 2H). 13C 
NMR (75 MHz, CDCl3) δ 155.27 (C), 142.56 (C), 142.20 (C), 139.53 
(C), 129.62 (CH), 128.16 (CH), 128.02 (CH), 127.18 (CH), 127.08 
(CH), 127.02 (CH), 126.64 (CH), 124.42 (CH), 109.20 (CH), 62.04 (CH2), 42.48 (CH2), 30.10 
(CH2). LRMS (m/z, CI): 306 [M+ +1, 64], 235 (42), 209 (72), 183 (78), 128 (72), 116 (100), 88 
(96). HRMS [M+ +1], Calculated for C20H20NO2: 306.1494, found 306.1482. 
 
149bda - Racemic - 3-((Z)-((2S*,4aR*,10bS*)-10b-methyl-2-phenyl-4,4a,5,6-tetrahydro-2H-
benzo[h]chromen-3(10bH)-ylidene)methyl)oxazolidin-2-one 
 1H NMR (500 MHz, CDCl3) δ 7.55 (d, J = 7.4 Hz, 1H), 7.40 (d, J = 7.4 
Hz, 2H), 7.34 – 7.24 (m, 3H), 7.17 – 7.07 (m, 2H), 7.04 (d, J = 7.1 Hz, 
1H), 6.03 (s, 1H), 5.73 (s, 1H), 4.05 (q, J = 8.2, 7.8 Hz, 1H), 3.86 (q, J = 
8.4 Hz, 1H), 3.38 (q, J = 8.5 Hz, 1H), 3.07 – 2.98 (m, 1H), 2.82 – 2.71 
(m, 1H), 2.65 – 2.55 (m, 1H), 2.50 (t, J = 12.4 Hz, 1H), 2.42 (dd, J = 
13.3, 4.9 Hz, 1H), 2.18 – 2.08 (m, 1H), 2.08 – 1.94 (m, 1H), 1.63 (s, 3H), 1.56 (dtd, J = 13.4, 
9.4, 4.1 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ 156.1 (C), 141.9 (C), 140.8 (C), 136.2 (C), 
135.3 (C), 128.3 (CH), 127.9 (CH), 127.8 (CH), 127.6 (CH), 126.4 (CH), 126.3 (CH), 116.7 
(CH), 74.6 (C), 72.9 (CH), 61.9 (CH2), 45.3 (CH2), 42.6 (CH), 33.9 (CH2), 30.3 (CH3), 28.3 
(CH2), 27.8 (CH2). LRMS (m/z, ESI): 328.17 (M+Na)+, 358.18, 289.16, 214.09, 117.07. 
HRMS Calculated for C24H25NNaO3: 398.1727, found 398.1719. 
Irradiation at 6.03 (s, 1H) nOe with: 1% 3.38 (q, J = 8.5 Hz, 1H); 5% 2.42 (dd, J = 13.3, 4.9 
Hz, 1H). 
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Irradiation at 5.73 (s, 1H) nOe with: 2% 3.38 (q, J = 8.5 Hz, 1H); 2% 3.07 – 2.98 (m, 1H) 
(these indicate Z geometry at the enamide); 1% 2.18 – 2.08 (m, 1H); 5% 1.63 (s, 3H). 
Irradiation at 1.63 (s, 3H) nOe with: 9% 5.73 (s, 1H); 8% 2.18 – 2.08 (m, 1H). 
 
Significant nOe’s observed. 
 
149bfa - 3-((Z)-((2S*,6S*)-6-(2-oxopyrrolidin-1-yl)-2-phenyldihydro-2H-pyran-3(4H)-
ylidene)methyl)oxazolidin-2-one 
 1H NMR (500 MHz, CDCl3) δ 7.42 – 7.37 (m, 2H), 7.36 – 7.26 (m, 
3H), 6.07 (s, 1H), 5.57 (dd, J = 9.4, 4.8 Hz, 1H), 5.50 (s, 1H), 3.95 – 
3.86 (m, 1H), 3.78 (q, J = 8.5 Hz, 1H), 3.47 (q, J = 8.1 Hz, 1H), 3.40 (q, 
J = 7.8 Hz, 1H), 3.32 (q, J = 8.2 Hz, 1H), 3.26 – 3.13 (m, 1H), 2.68 – 
2.57 (m, 1H), 2.53 – 2.44 (m, 1H), 2.42 – 2.32 (m, 2H), 2.05 – 1.92 (m, 
3H), 1.92 – 1.83 (m, 1H). 13C NMR (75 MHz, CDCl3) δ 175.3 (C), 156.2 (C), 139.7 (C), 129.7 
(C), 128.3 (CH), 128.2 (CH), 127.5 (CH), 119.1 (CH), 77.7 (CH), 77.2 (CH), 61.9 (CH2), 45.4 
(CH2), 42.3 (CH2), 31.4 (CH2), 28.1 (CH2), 27.8 (CH2), 17.9 (CH2). LRMS (m/z, ESI): 365.15 
(M+Na)+, 256.13, 238.12, 171.08, 117.07, 98.06. HRMS Calculated for C19H22N2NaO4: 
365.1472, found 365.1474. 
Irradiating 5.50 (s, 1H) nOe with: 5% 5.57 (dd, J = 9.4, 4.8 Hz, 1H); 2% 3.32 (q, J = 8.2 Hz, 
1H); 2% 3.26 – 3.13 (m, 1H), 
Irradiating 5.57 (dd, J = 9.4, 4.8 Hz, 1H) nOe with: 5% 5.50 (s, 1H). 
 
Significant nOe’s observed. 
 
149bga + 149bga’ - (Z)-3-((6-ethoxy-2-phenyldihydro-2H-pyran-3(4H)-
ylidene)methyl)oxazolidin-2-one 
 1H NMR (500 MHz, CDCl3) δ 7.47 – 7.26 (m, 5.0H), 
6.32 (s, 0.4H), 6.30 (s, 0.6H), 5.80 (s, 0.4H), 5.60 (s, 
0.6H), 4.83 (t, J = 4.0 Hz, 0.6H), 4.70 (dd, J = 8.0, 3.8 
Hz, 0.4H), 4.17 – 4.01 (m, 2.0H), 3.95 (dq, J = 9.5, 7.0 
Hz, 0.4H), 3.59 – 3.45 (m, 1.2H), 3.45 – 3.41 (m, 
0.6H), 3.41 – 3.34 (m, 1.2H), 3.29 (dq, J = 9.3, 7.0 Hz, 
0.6H), 2.84 – 2.75 (m, 0.6H), 2.41 (dd, J = 6.3, 4.1 Hz, 0.8H), 2.33 (dt, J = 14.1, 4.9 Hz, 0.6H), 
2.04 – 1.92 (m, 1.0H), 1.92 – 1.82 (m, 0.6H), 1.77 – 1.65 (m, 0.4H), 1.24 (t, J = 7.1 Hz, 1.20H), 
0.75 (t, J = 7.1 Hz, 1.80H). 13C NMR (75 MHz, CDCl3) δ 156.76 (C), 156.58 (C), 141.26 (C), 
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139.03 (C), 128.60 (CH), 128.07 (CH), 127.88 (CH), 127.52 (CH), 127.37 (CH), 127.16 (CH), 
126.32 (C), 126.03 (C), 119.45 (CH), 119.39 (CH), 97.91 (CH), 96.49 (CH), 73.11 (CH), 72.27 
(CH), 63.71 (CH2), 63.23 (CH2), 62.03 (CH2), 61.94 (CH2), 45.72 (CH2), 45.40 (CH2), 31.79 
(CH2), 31.14 (CH2), 26.91 (CH2), 24.76 (CH2), 15.16 (CH3), 14.36 (CH3).  
 Irradiation at 5.60 (s, 0.6H), major diastereoisomer, noe with: 4% 7.47 – 7.26 (m, 5.0H); 
2% 4.83 (t, J = 4.0 Hz, 0.6H); 6% 3.41 – 3.34 (m, 1.2H). 
Irradiation at 4.83 (t, J = 4.0 Hz, 0.6H), major diastereoisomer, noe with: 2% 5.60 (s, 
0.6H); 3.45 – 3.41 (m, 0.6H); 4% 2.33 (dt, J = 14.1, 4.9 Hz, 0.6H). 3% 2.04 – 1.92 (m, 1.0H), 
2% 1.92 – 1.82 (m, 0.6H). 
Irradiation at 5.80 (s, 0.4H), minor diastereoisomer, noe with: 4% 7.47 – 7.26 (m, 5.0H); 
6% 3.59 – 3.45 (m, 1.2H) 
1H NMR (500 MHz, C6D6) δ 7.44 – 7.38 (m, 2.0H), 7.22 (t, J = 7.6 Hz, 0.8H), 7.19 – 7.10 (m, 
1.6H), 7.07 (t, J = 7.3 Hz, 0.60H), 6.41 (s, 1.0H), 5.76 (s, 0.4H), 5.58 (s, 0.6H), 4.77 (t, J = 3.5 
Hz, 0.6H), 4.52 (dd, J = 8.3, 3.6 Hz, 0.4H), 4.06 – 3.96 (m, 0.4H), 3.49 – 3.38 (m, 0.6H), 3.41 
– 3.29 (m, 0.4H), 3.18 – 3.08 (m, 0.6H), 3.08 – 2.96 (m, 1.4H), 2.95 – 2.86 (m, 0.6H), 2.76 – 
2.66 (m, 0.6H), 2.54 – 2.42 (m, 1.4H), 2.45 – 2.37 (m, 0.6H), 2.14 – 2.03 (m, 0.4H), 1.98 – 1.88 
(m, 1.0H), 1.82 – 1.71 (m, 1.6H), 1.74 – 1.64 (m, 0.4H), 1.17 (t, J = 7.0 Hz, 1.2H), 0.66 (t, J = 
7.0 Hz, 1.8H). 
Irradiation at 5.76 (s, 0.4H), minor diastereoisomers show noe with: 3% 7.44 – 7.38 (m, 
2.0H); 7% 2.54 – 2.42 (m, 1.4H). This confirms the Z geometry at the enamide. In benzene 
the signals from the enamide do not overlap with those from the ethoxy group. (See 
HSQC) 
LRMS (m/z, ESI): 326.14 (M+Na)+, 258.11, 214.08, 171.08, 129.07, 88.04. HRMS Calculated 
for C17H21NNaO4: 326.1363, found 326.1370.  
 
Significant nOe’s observed. 
 
149bha - 3-((Z)-((2S*,4aR*,8aS*)-2-phenyltetrahydro-2H,5H-pyrano[2,3-b]pyran-3(4H)-
ylidene)methyl)oxazolidin-2-one 
 1H NMR (500 MHz, CDCl3) δ 7.49 – 7.43 (m, 2H), 7.37 – 7.27 (m, 
3H), 6.01 (q, J = 1.4 Hz, 1H), 5.48 (s, 1H), 5.02 (d, J = 2.8 Hz, 1H), 
3.97 (td, J = 8.8, 5.6 Hz, 1H), 3.88 – 3.79 (m, 1H), 3.79 – 3.70 (m, 
1H), 3.58 – 3.50 (m, 1H), 3.40 – 3.31 (m, 1H), 3.24 (td, J = 8.7, 5.6 
Hz, 1H), 2.51 – 2.40 (m, 2H), 2.07 – 1.97 (m, 1H), 1.84 – 1.73 (m, 
1H), 1.71 – 1.62 (m, 1H), 1.62 – 1.47 (m, 2H). 13C NMR (75 MHz, CDCl3) δ 156.48 (C), 
140.43 (C), 129.15 (C), 127.95 (CH), 127.67 (CH), 127.20 (CH), 119.53 (CH), 97.27 (CH), 
75.87 (CH), 63.18 (CH2), 61.90 (CH2), 45.79 (CH2), 35.36 (CH), 33.31 (CH2), 25.38 (CH2), 
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23.11 (CH2). LRMS (m/z, ESI): 338.14 (M+Na)+, 298.14, 229,12, 214.09, 183.12, 129.07. 
HRMS Calculated for C18H21NNaO4: 338.1363, found 338.1356. 
Irradiation at 5.48 (s, 1H) (alpha to oxigen and phenyl) noe with: 4% 7.49 – 7.43 (m, 2H); 
3.5% 5.02 (d, J = 2.8 Hz, 1H); 1.4% 3.40 – 3.31 (m, 1H), 2.0% 3.24 (td, J = 8.7, 5.6 Hz, 1H). 
Irradiation at 5.02 (d, J = 2.8 Hz, 1H) (alpha to two oxigens) noe with: 3.6% 5.48 (s, 1H); 
2% 3.58 – 3.50 (m, 1H); 1% 2.51 – 2.40 (m, 2H); 3.8% 2.07 – 1.97 (m, 1H). 
 
Significant nOe’s observed. 
 
150bh - 3-((Z)-((1R*,6R*)-2-oxabicyclo[4.2.0]octan-8-ylidene)methyl)oxazolidin-2-one 
 1H NMR (500 MHz, CDCl3) δ 6.47 – 6.42 (m, 1H), 4.73 (dt, J = 7.0, 2.3 
Hz, 1H), 4.36 (t, J = 8.1 Hz, 2H), 4.23 – 4.14 (m, 1H), 3.75 (q, J = 9.0 
Hz, 1H), 3.72 – 3.63 (m, 1H), 3.60 – 3.52 (m, 1H), 2.51 – 2.42 (m, 1H), 
2.46 – 2.37 (m, 1H), 2.29 – 2.22 (m, 1H), 2.03 – 1.92 (m, 1H), 1.66 – 1.57 
(m, 1H), 1.59 – 1.43 (m, 2H). 13C NMR (75 MHz CDCl3) δ 156.15 (C), 
121.52 (C), 118.53 (CH), 72.49 (CH), 63.24 (CH2), 62.34 (CH2), 44.30 (CH2), 30.45 (CH), 
30.32 (CH2), 25.25 (CH2), 22.05 (CH2). LRMS (m/z, ESI): 232.09 (M+Na)+, 210.11, 173.10, 
105.07HRMS Calculated for C11H15NNaO3: 232.0944, found 232.0937.  
Irradiation at 4.73 (dt, J = 7.0, 2.3 Hz, 1H), NOE with: 0.8% 4.23 – 4.14 (m, 1H); 1.5% 3.75 
(q, J = 9.0 Hz, 1H); 2.7% 2.46 – 2.37 (m, 1H) 
 
Significant nOe’s observed. 
 
E-149dia - Racemic - N-((E)-((2S*,6R*)-6-methoxy-6-methyl-2-phenyldihydro-2H-pyran-
3(4H)-ylidene)methyl)-4-methyl-N-phenylbenzenesulfonamide (contaminated with the 
(2+2) cycloaduct) 
 1H NMR (500 MHz, CDCl3) δ 7.45 (d, J = 8.1 Hz, 1H), 7.38 (q, J = 7.0, 6.6 
Hz, 4H), 7.28 – 7.18 (m, 3H), 7.17 (d, J = 8.1 Hz, 2H), 7.09 (d, J = 8.0 Hz, 
2H), 6.96 (dd, J = 7.7, 1.8 Hz, 2H), 5.31 (t, J = 1.8 Hz, 1H), 5.11 (s, 1H), 3.22 
(s, 3H), 2.52 (dt, J = 14.3, 4.2 Hz, 1H), 2.37 (s, 3H), 2.36 – 2.11 (m, 2H), 1.79 – 
1.72 (m, 1H), 1.56 (td, J = 13.0, 5.0 Hz, 1H), 1.31 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 
143.5 (C), 141.4 (C), 138.9 (C), 138.7 (C), 134.0 (C), 129.2 (CH), 128.8 (CH), 128.2 (CH), 
128.1 (CH), 127.7 (CH), 126.8 (CH), 124.2 (CH), 98.7 (C), 73.9 (CH), 48.2 (CH3), 35.4 (CH2), 
23.2 (CH3), 22.0 (CH2), 21.5 (CH3). LRMS (m/z, ESI): 486.17 (M+Na)+, 432.16, 380.13 
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(probably from the (2+2) product, (M+Na)+), 326.12, 276.14, 218.10, 185.10, 119.06. HRMS 
Calculated for C27H29NNaO4S: 486.1710, found 486.1706. 
Irradiation at 5.31 (t, J = 1.8 Hz, 1H) nOe at: 10% 7.17 (d, J = 8.1 Hz, 2H); 1% 5.11 (s, 1H);. 
this nOe seems to indicate that we have the E isomer, however it is not a clear evidence. 
Irradiation at 5.11 (s, 1H) nOe at: 6% 7.38 (q, J = 7.0, 6.6 Hz, 4H); 1% 5.31 (t, J = 1.8 Hz, 
1H); 4% 3.22 (s, 3H); 3% 2.36 – 2.11 (m, 2H). 
Irradiation at 3.22 (s, 3H) nOe at: 2% 5.11 (s, 1H); 2% 1.31 (s, 3H). 
Irradiation at 1.31 (s, 3H). nOe at: 3% 3.22 (s, 3H); 1% 1.79 – 1.72 (m, 1H), 2% 1.56 (td, J = 
13.0, 5.0 Hz, 1H) 
 
Significant nOe’s observed. These nOes seems to indicate that we have the E isomer, 
however it is not a clear evidence. 
 
Z-149dia - Racemic - N-((Z)-((2S*,6R*)-6-methoxy-6-methyl-2-phenyldihydro-2H-pyran-
3(4H)-ylidene)methyl)-4-methyl-N-phenylbenzenesulfonamide 
 1H NMR (500 MHz, CDCl3) δ 8.13 (d, J = 7.7 Hz, 2H), 7.63 (q, J = 7.8, 7.4 
Hz, 1H), 7.49 (t, J = 7.7 Hz, 2H), 7.36 (d, J = 8.0 Hz, 2H), 7.25 – 7.03 (m, 
5H), 6.69 (d, J = 7.3 Hz, 2H), 6.17 (s, 1H), 4.96 (s, 1H), 2.98 (s, 3H), 2.49 – 
2.41 (m, 1H), 2.40 (s, 3H), 2.29 (dt, J = 13.7, 4.8 Hz, 1H), 2.05 (td, J = 10.6, 9.5, 4.0 Hz, 1H), 
1.70 (td, J = 12.6, 5.7 Hz, 1H), 1.30 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 143.6 (C), 139.9 
(C), 139.4 (C), 138.3 (C), 134.4 (C), 133.7 (CH), 130.2 (CH), 129.3 (CH), 128.5 (CH), 128.4 
(CH), 128.3 (CH), 128.1 (CH), 127.8 (CH), 127.2 (CH), 127.2 (CH), 126.8 (CH), 120.5 (CH), 
99.1 (C), 71.8 (CH), 48.5 (CH3), 36.4 (CH2), 25.8 (CH2), 23.8 (CH3), 21.5 (CH3). LRMS (m/z, 
ESI): 486.17 (M+Na)+, 472.15, 381.30, 353.27, 185.10. HRMS Calculated for 
C27H29NNaO4S, 486.1710 found 486.1706.  
Irradiation at 6.17 (s, 1H) nOe at: 3% 7.36 (d, J = 8.0 Hz, 2H); 4% 6.69 (d, J = 7.3 Hz, 2H); 
5% 2.29 (dt, J = 13.7, 4.8 Hz, 1H). 
Irradiation at 4.96 (s, 1H) nOe at: 5% 7.25 – 7.03 (m, 5H); 2% 6.69 (d, J = 7.3 Hz, 2H); 3% 
2.98 (s, 3H). 
Irradiation at 2.98 (s, 3H) nOe at: 1% 4.96 (s, 1H); 2% 1.30 (s, 3H). 
Irradiation at 1.30 (s, 3H).nOe at: 3% 2.98 (s, 3H); 2% 2.05 (td, J = 10.6, 9.5, 4.0 Hz, 1H).  
 
Significant nOe’s observed. 
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149bbb - Racemic - 3-((Z)-((2S*,6S*)-2-isopropyl-6-methyl-6-phenyldihydro-2H-pyran-
3(4H)-ylidene)methyl)oxazolidin-2-one 
 1H NMR (300 MHz, CDCl3) δ 7.57 – 7.39 (m, 2H), 7.43 – 7.16 (m, 3H), 
6.09 (t, J = 1.7 Hz, 1H), 4.59 – 4.51 (m, 1H), 4.41 (t, J = 8.0 Hz, 2H), 3.92 
(q, J = 8.1 Hz, 1H), 3.65 (q, J = 8.5 Hz, 1H), 2.49 – 2.21 (m, 2H), 2.16 – 
1.71 (m, 3H), 1.54 (s, 3H), 1.06 (dd, J = 6.8, 2.6 Hz, 6H). 13C NMR (75 
MHz, CDCl3) δ 156.7 (C), 150.5 (C), 133.6 (C), 127.9 (CH), 126.2 (CH), 124.5 (CH), 116.3 
(CH), 74.0 (C), 74.0 (CH), 62.1 (CH2), 45.6 (CH2), 39.1 (CH2), 32.3 (CH), 29.1 (CH3), 27.1 
(CH2), 19.9 (CH3), 16.7 (CH3). LRMS (m/z, ESI): 338.17 (M+Na)+, 298.05, 229.16, 211.15, 
155.09, 107.09. HRMS Calculated for C19H25NNaO3: 338.1727, found 338.1733.  
Irradiating 6.09 (t, J = 1.7 Hz, 1H) nOe with: 1% 3.92 (q, J = 8.1 Hz, 1H); 6% 2.16 – 1.71 
(m, 3H). 
Irradiating 4.59 – 4.51 (m, 1H) nOe with: 6% 3.92 (q, J = 8.1 Hz, 1H); 2% 3.65 (q, J = 8.5 
Hz, 1H); 3% 2.16 – 1.71 (m, 3H); 4% 1.54 (s, 3H); 3% 1.06 (dd, J = 6.8, 2.6 Hz, 6H). No nOe 
with the aromatic region. 
Irradiating 1.54 (s, 3H) nOe with: 4% 4.59 – 4.51 (m, 1H), 3% 2.16 – 1.71 (m, 3H). 
 
Significant nOe observed. 
 
149bbb’ - Racemic - 3-((Z)-((2R*,6S*)-2-isopropyl-6-methyl-6-phenyldihydro-2H-pyran-
3(4H)-ylidene)methyl)oxazolidin-2-one 
 1H NMR (500 MHz, CDCl3) δ 7.40 – 7.33 (m, 2H), 7.34 – 7.27 (m, 2H), 
7.20 (ddt, J = 7.9, 6.7, 1.3 Hz, 1H), 6.03 (t, J = 1.8 Hz, 1H), 4.27 – 4.15 
(m, 2H), 4.04 (dt, J = 4.5, 1.7 Hz, 1H), 3.56 – 3.47 (m, 1H), 2.92 – 2.83 
(m, 1H), 2.49 (dddt, J = 12.7, 10.5, 6.8, 1.7 Hz, 1H), 2.30 – 2.19 (m, 2H), 
2.19 – 2.11 (m, 1H), 1.98 – 1.87 (m, 1H), 1.41 (s, 3H), 1.02 (dd, J = 12.4, 6.8 Hz, 6H) 13C 
NMR (75 MHz, CDCl3) δ 157.2 (C), 147.4 (C), 131.5 (C), 128.1 (CH), 126.4 (CH), 125.7 
(CH), 117.0 (CH), 75.0 (C), 74.7 (CH), 62.1 (CH2), 44.8 (CH2), 35.4 (CH2), 34.0 (CH3), 32.2 
(CH), 26.4 (CH2), 19.6 (CH3), 16.5 (CH3). LRMS (m/z, ESI): 338.17 (M+Na)+, 298.05, 229.16, 
155.09, 105.07. HRMS Calculated for C19H25NNaO3: 338.1727, found 338.1731.  
Irradiation at 6.03 (t, J = 1.8 Hz, 1H), nOe with: 5% 2.19 – 2.11 (m, 1H). 
Irradiation at 4.04 (dt, J = 4.5, 1.7 Hz, 1H) nOe with: 3% 7.40 – 7.33 (m, 2H), 6% 3.56 – 
3.47 (m, 1H),; 2% 2.92 – 2.83 (m, 1H); 3% 1.98 – 1.87 (m, 1H); 3% 1.02 (dd, J = 12.4, 6.8 Hz, 
6H). 
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Significant nOe’s observed. 
 
149bbc - Racemic - 3-((Z)-((2S*,6S*)-2-butyl-6-methyl-6-phenyldihydro-2H-pyran-3(4H)-
ylidene)methyl)oxazolidin-2-one 
 1H NMR (500 MHz, CDCl3) δ 7.48 (d, J = 7.7 Hz, 2H), 7.32 (t, J = 7.7 Hz, 
2H), 7.21 (t, J = 7.3 Hz, 1H), 6.01 (s, 1H), 4.72 (d, J = 7.6 Hz, 1H), 4.39 (t, J 
= 8.0 Hz, 2H), 3.87 (q, J = 8.2 Hz, 1H), 3.70 (q, J = 8.3 Hz, 1H), 2.47 (td, J 
= 12.7, 5.9 Hz, 1H), 2.40 – 2.32 (m, 1H), 2.14 (dt, J = 13.4, 4.3 Hz, 1H), 
1.90 (td, J = 12.5, 5.4 Hz, 1H), 1.70 – 1.58 (m, 1H), 1.52 (s, 3H), 1.57 – 1.46 (m, 2H), 1.47 – 
1.36 (m, 1H), 1.38 – 1.18 (m, 2H), 0.88 (t, J = 7.3 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 
156.8 (C), 149.6 (C), 133.7 (C), 128.0 (CH), 126.3 (CH), 124.7 (CH), 115.8 (CH), 74.3 (C), 
70.7 (CH), 62.1 (CH2), 45.9 (CH2), 37.9 (CH2), 34.3 (CH2), 30.2 (CH3), 28.0 (CH2), 25.9 
(CH2), 22.6 (CH2), 14.0 (CH3). LRMS (m/z, ESI): 352.19 (M+Na)+, 312.20, 243.17, 225.16, 
194.11, 169.10, 155.09, 123.12. HRMS Calculated for C20H27NNaO3: 352.1883, found 
352.1891.  
Irradiation at 6.01 (s, 1H) nOe with: 5% 2.14 (dt, J = 13.4, 4.3 Hz, 1H). 
Irradiation at 4.72 (d, J = 7.6 Hz, 1H), nOe with: 5% 3.87 (q, J = 8.2 Hz, 1H); 2% 3.70 (q, J 
= 8.3 Hz, 1H); 5% 1.52 (s, 3H). 
 
Significant nOe’s observed. 
 
149bbc’ - Racemic - 3-((Z)-((2R*,6S*)-2-butyl-6-methyl-6-phenyldihydro-2H-pyran-3(4H)-
ylidene)methyl)oxazolidin-2-one 
 1H NMR (500 MHz, CDCl3) δ 7.39 – 7.35 (m, 2H), 7.33 – 7.29 (m, 2H), 
7.23 – 7.18 (m, 1H), 5.89 (t, J = 1.7 Hz, 1H), 4.26 – 4.17 (m, 3H), 3.50 – 3.41 
(m, 1H), 3.05 – 2.96 (m, 1H), 2.59 – 2.48 (m, 1H), 2.28 – 2.21 (m, 2H), 2.19 
– 2.11 (m, 1H), 1.75 – 1.66 (m, 1H), 1.67 – 1.51 (m, 2H), 1.43 (s, 3H), 1.44 – 
1.22 (m, 3H), 0.93 (t, J = 7.2 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 157.1 (C), 147.1 (C), 
133.6 (C), 128.1 (CH), 126.5 (CH), 125.7 (CH), 116.3 (CH), 75.4 (C), 70.8 (CH), 62.1 (CH2), 
45.3 (CH2), 35.1 (CH2), 34.0 (CH2), 33.8 (CH3), 27.6 (CH2), 25.6 (CH2), 22.8 (CH2), 14.1 
(CH3). LRMS (m/z, ESI): 352.19 (M+Na)+, 298.05, 243.17, 225.16, 155.09, 123.12. HRMS 
Calculated for C20H27NNaO3: 352.1883, found 352.1892. 
Irradiation all aromatic region nOe with: 3% 4.26 – 4.17 (m, 3H); 6% 2.28 – 2.21 (m, 2H); 
3% 1.43 (s, 3H). 
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Irradiation at 5.89 (t, J = 1.7 Hz, 1H) nOe with: 4% 2.19 – 2.11 (m, 1H). 
Irradiation at 1.43 (s, 3H), nOe with: 2% 7.39 – 7.35 (m, 2H); 3% 2.28 – 2.21 (m, 2H). 
The proton in alpha to the oxo is under one CH2 of the oxazolidinone, making impossible 
to get a nOe and confirm the Z geometry at the enamide. The nOe between the Aromatic 
region and 4.26 – 4.17 (m, 3H) in alpha to the oxo confirm that we have trans 
configuration. Once these protons cannot be from the oxazolidinone because they are too 
far. 
 
Significant nOe’s observed. 
 
E-149bcd - (E)-3-((2-cyclopropyl-6,6-diphenyldihydro-2H-pyran-3(4H)-
ylidene)methyl)oxazolidin-2-one 
 1H NMR (500 MHz, CDCl3) δ 7.51 (dd, J = 8.4, 1.3 Hz, 2H), 7.43 – 
7.38 (m, 2H), 7.32 – 7.20 (m, 5H), 7.18 – 7.14 (m, 1H), 5.77 (s, 1H), 
4.67 (d, J = 9.6 Hz, 1H), 4.46 (td, J = 8.9, 4.4 Hz, 1H), 4.41 – 4.32 (m, 
1H), 3.96 (q, J = 9.2 Hz, 1H), 3.67 (td, J = 8.8, 4.4 Hz, 1H), 2.82 (dt, J = 
14.9, 4.2 Hz, 1H), 2.76 (dt, J = 13.9, 4.1 Hz, 1H), 2.46 – 2.37 (m, 1H), 
2.10 (ddd, J = 13.8, 12.8, 4.2 Hz, 1H), 1.52 – 1.40 (m, 1H), 0.81 – 0.67 
(m, 2H), 0.38 – 0.24 (m, 2H). 13C NMR (75 MHz, CDCl3) δ 158.47 (C), 147.77 (C), 141.49 
(C), 128.97 (C), 128.87 (CH), 128.46 (CH), 128.01 (CH), 127.42 (CH), 127.12 (CH), 126.66 
(CH), 80.85 (C), 79.08 (CH), 62.64 (CH2), 40.22 (CH2), 35.02 (CH2), 23.03 (CH2), 9.29 (CH), 
7.13 (CH2), 6.82 (CH2).  
Irradiating 5.77 (s, 1H) (alpha to oxo), noe with: 3% 7.51 (dd, J = 8.4, 1.3 Hz, 2H); 1% 4.67 
(d, J = 9.6 Hz, 1H); 1% 2.46 – 2.37 (m, 1H). 
Irradiating 4.67 (d, J = 9.6 Hz, 1H) (enamide proton), noe with: 1% 5.77 (s, 1H); 3% 3.67 
(td, J = 8.8, 4.4 Hz, 1H); 1% 1.52 – 1.40 (m, 1H); 3% 0.38 – 0.24 (m, 2H).  
 
Significant nOe’s observed. 
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Z-149bcd - (Z)-3-((2-cyclopropyl-6,6-diphenyldihydro-2H-pyran-3(4H)-
ylidene)methyl)oxazolidin-2-one 
 1H NMR (500 MHz, CDCl3) δ δ 7.39 – 7.33 (m, 4H), 7.29 – 7.21 (m, 
4H), 7.20 – 7.11 (m, 2H), 5.87 (s, 1H), 4.30 – 4.14 (m, 2H), 3.99 (d, J 
= 6.7 Hz, 1H), 3.46 (td, J = 8.7, 6.5 Hz, 1H), 3.09 (td, J = 8.8, 7.7 Hz, 
1H), 2.71 – 2.58 (m, 2H), 2.46 – 2.37 (m, 1H), 2.38 – 2.28 (m, 1H), 
1.13 – 0.99 (m, 1H), 0.61 – 0.52 (m, 1H), 0.52 – 0.41 (m, 2H), 0.44 – 0.34 (m, 1H). 13C NMR 
(75 MHz, CDCl3) δ 157.25 (C), 148.43 (C), 145.08 (C), 133.28 (C), 128.02 (CH), 127.84 (CH), 
127.13 (CH), 126.71 (CH), 126.31 (CH), 125.47 (CH), 116.93 (CH), 78.82 (C), 73.62 (CH), 
62.06 (CH2), 45.75 (CH2), 35.66 (CH2), 26.26 (CH2), 15.03 (CH), 2.90 (CH2), 2.75 (CH2). 
LRMS (m/z, ESI): 398.17 (M+Na)+, 358.18, 289.16, 193.10, 167.09, 117.07, 91.05. HRMS 
Calculated for C24H25NNaO3: 398.1727, found 398.1731.  
Irradiation at 5.87 (s, 1H) noe with: 1% 3.46 (td, J = 8.7, 6.5 Hz, 1H); 1% 3.09 (td, J = 8.8, 
7.7 Hz, 1H); 2% 2.71 – 2.58 (m, 2H); 4% 2.38 – 2.28 (m, 1H). 
Irradiation at 3.99 (d, J = 6.7 Hz, 1H) noe with: 3% aromatic region; 4% 3.46 (td, J = 8.7, 
6.5 Hz, 1H); 2% 3.09 (td, J = 8.8, 7.7 Hz, 1H); 2% 1.13 – 0.99 (m, 1H); 2% 0.61 – 0.52 (m, 
1H); 3% 0.44 – 0.34 (m, 1H). 
Irradiation at 3.46 (td, J = 8.7, 6.5 Hz, 1H) noe with: 1% 5.87 (s, 1H); 5% 4.30 – 4.14 (m, 
2H); 5% 3.99 (d, J = 6.7 Hz, 1H); 15% 3.09 (td, J = 8.8, 7.7 Hz, 1H). 
Irradiation at 3.09 (td, J = 8.8, 7.7 Hz, 1H) noe with: 1% 5.87 (s, 1H); 5% 4.30 – 4.14 (m, 
2H); 2% 3.99 (d, J = 6.7 Hz, 1H); 15% 3.46 (td, J = 8.7, 6.5 Hz, 1H) 
 
Significant nOe’s observed. 
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Article 4 - Gold(I)-catalyzed cascade cycloadditions 
between allenamides and carbonyl-tethered alkenes: an 
enantioselective approach to oxa-bridged medium-sized 
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Faustino, H.; Alonso, I.; Mascareñas, J. L.; López, F. Angew. Chemie Int. Ed. 2013, 52, 6526–
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***
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